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Abstract 
Background 
Perioperative hypothermia is a significant problem for all surgical patients. All 
modes of anaesthesia (general, regional or neuraxial) adversely affect 
thermoregulation resulting in a subsequent temperature decline and resultant 
inadvertent hypothermia. Other surgical and environmental factors such as cool 
ambient operating theatre temperature and body exposure also contribute to heat loss.    
In addition to causing discomfort to surgical patients, particularly awake patients, 
perioperative hypothermia is associated with other, more serious, side effects 
including increased infection rates, increased blood loss, delayed wound healing and 
increased hospital stay.    
Caesarean section is a common but major surgical procedure that is most often 
performed under neuraxial anaesthesia. In obstetric patients, perioperative 
hypothermia also has the potential to disrupt skin-to-skin contact and breastfeeding 
in the immediate postoperative phase. It is therefore imperative that measures are 
undertaken to reduce the occurrence of perioperative hypothermia as it is not only the 
mother, but also the newborn, that are adversely affected by the occurrence of this 
preventable condition. Current evidence-based guidelines for the prevention of 
perioperative hypothermia specifically exclude obstetric patients. This has left health 
care practitioners without clear evidence-based recommendations on which to base 
thermal care for this vulnerable population.    
There are some special considerations that may partially explain the reluctance to 
include obstetric patients in these guidelines. These include the altered physiology 
that occurs with pregnancy, but also practical issues with methods of warming 
currently used in the general adult population. A further complication seen in this 
population is the influence of intrathecal (spinal) morphine, which is commonly 
administered for a greater duration of postoperative analgesia, but which intensifies 
temperature decline.  
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Aims 
The overall aim of this research program was to establish effective treatment and 
management strategies for perioperative hypothermia for the obstetric population, to 
contribute to the knowledge base for future guideline, policy and care planning.    
 
Methods 
This research program was conducted in three phases: 
1. A systematic review of the effectiveness of current evidence to prevent and treat 
perioperative hypothermia specifically for caesarean section patients. This was based 
upon a published protocol. Search strategies aimed to identify both published and 
unpublished literature in all languages, and searches were complete to May 2012. 
Two independent reviewers (with a third where consensus was needed) utilised 
Joanna Briggs Institute MASTARI critical appraisal methods, narrative analysis and 
meta-analysis using Rev-Man software. Recommendations for both practice and 
further research were generated, based upon the review results, and attributed a JBI 
Level of Evidence. 
2. A retrospective, case-control study was conducted from May 2013-May 2014 to 
further examine temperature decline between both women receiving intrathecal 
morphine, and not receiving intrathecal morphine, for emergency or elective 
caesarean section. Two researchers collected data from 358 charts. Data analysis 
included logistic regression to predict the outcome of hypothermia across the 
population.  Inter-rater reliability was determined using the kappa statistic.          
3. A pragmatic, single-blinded, randomised controlled trial of the effectiveness of a 
preoperative warming regime for women receiving intrathecal morphine for elective 
caesarean section was conducted from February 2015- February 2016, in 50 healthy 
women. Computer-generated randomisation was used to allocate participants to 
either the usual care group, or the intervention group who received 20 minutes of 
preoperative forced air warming. The primary outcome of maternal temperature 
change was assessed via aural canal and bladder temperature measurements at 
regular intervals.  Secondary outcomes included maternal thermal comfort, shivering, 
mean arterial pressure, agreement between aural and bladder temperature, and 
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neonatal outcomes (axillary temperature at birth, Apgar scores, breastfeeding and 
skin-to-skin contact).  Data was analysed using SPSS™ 22 and MedCalc™ software.  
 
Results 
The first phase of the research program (the systematic review) found that 
intravenous fluid warming is effective at maintaining maternal temperature, and 
reducing shivering, however does not improve maternal thermal comfort or neonatal 
temperature. Warming devices, comprising of either under body or over body upper 
body forced air warming, were effective at preventing hypothermia and this 
effectiveness increased if forced air warming was applied preoperatively.    
Preoperative active warming also decreased shivering and improved neonatal 
temperature, however did not improve Apgar scores. Leg wrapping was not effective 
at maintaining maternal temperature. The review also identified that warming was 
less effective in the studies where intrathecal morphine was administered.  
The second phase of the research program (the retrospective, case-control study) 
found that there was statistically significant temperature decline across the whole 
population of women receiving spinal anaesthesia for caesarean section, whether or 
not they received intrathecal morphine (0.62°C, 95% CI 0.54-0.69) p<0.001, t (291) 
= 16.7). The subset of women that experienced the phenomenon of profound and 
prolonged intrathecal morphine related hypothermia could not be explored further 
due to a low identification of this condition (2% of the study population), however 
results indicated that temperature decline with either fentanyl or morphine was not 
dose-related. In addition, level of block did not influence hypothermia, but 
emergency surgery, pregnancy-induced hypotension and increased Body Mass Index 
were found to be protective factors regarding the risk of developing perioperative 
hypothermia.  
The third phase of the research program revealed no significant difference in aural 
temperature change from baseline to the end of the procedure between groups when 
examined using a general linear model with the Intention to Treat principle, and with 
adjustment for baseline temperature and surgery duration:  F (1, 47) = 1.2, p =0.28, 
partial eta squared = 0.03. An exploratory analysis of secondary outcomes indicated 
that there were no statistically significant differences between groups in any of the 
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secondary outcomes, except in post-spinal mean arterial pressure (Md=89, n =25 in 
the control group versus Md=85, n=25 in the intervention group, U = 248.5, z =2.36, 
p=0.03) although this difference had limited clinical significance.  
 
Conclusion  
Maintaining temperature and reducing temperature decline in the population of 
women undergoing caesarean section, particularly those receiving intrathecal 
morphine, is challenging. Based upon this research, some recommendations that 
currently apply to the general adult population can be extended to the obstetric 
population, however it appears that single interventions alone may be insufficient to 
reduce perioperative hypothermia in women receiving neuraxial anaesthesia. Women 
who receive intrathecal morphine may experience less benefit seen from 
conventional warming methods, in comparison to other populations. Warming 
appears to be well tolerated by obstetric patients. Evidence from this research 
program can be used by health care organisations to develop evidence-based 
guidelines for the surgical thermal care of obstetric patients. This will help to 
establish standards of care, assisting in the ultimate goal of reducing perioperative 
hypothermia for women undergoing caesarean section.  
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Chapter 1: Introduction 
1.1 INTRODUCTION 
Temperature decline and subsequent heat loss during surgery is associated with 
numerous undesirable side effects with potentially serious complications for the 
surgical patient (NCCNSC 2008). Obstetric patients undergoing caesarean section 
are particularly vulnerable to heat loss and unintentional perioperative hypothermia 
related to the length of surgery, the amount of body surface exposure, and the 
predominant use of neuraxial anaesthesia.  Inadvertent perioperative hypothermia is 
largely preventable with adequate care planning in reference to published guidelines 
(NCCNSC 2008); however, current evidence-based guidelines for the prevention of 
perioperative hypothermia specifically exclude obstetric patients. This leaves health 
care practitioners without clear evidence-based recommendations on which to base 
thermal care for this vulnerable population. This chapter will provide context for the 
thesis by presenting a brief background on the key concepts related to the problem of 
perioperative hypothermia in obstetric patients. This will be followed by an outline 
of the aims of the research program as well as the scope and significance of the 
program. The chapter will conclude with an outline of the thesis. 
1.2 PERIOPERATIVE HYPOTHERMIA 
Inadvertent perioperative hypothermia, generally defined as the unintentional cooling 
of the body’s core temperature below 36°C (NCCNSC 2008) related to undergoing a 
surgical procedure, is associated with numerous side effects that are undesirable and 
best avoided in the postoperative patient. As well as causing general discomfort for 
patients, other complications include (but are not limited to) increased blood loss 
(Rajagopalan, Mascha, Na, & Sessler, 2008), higher wound infection rates (Kurz, 
Sessler, & Lenhardt, 1996), suppressed immune function (Beilin et al., 1998), 
increased hospital stay (Kurz, et al., 1996) and greater hospital costs (Mahoney & 
Odom, 1999). Both general and neuraxial anaesthesia, as well as external, 
environmental and surgical factors, contribute to the heat loss that patients can 
experience when they undergo most surgical procedures. Rates of inadvertent 
perioperative hypothermia remain high, at between 50-54% for general adult surgical 
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populations (Hooven, 2011; Munday, Hines, & Chang, 2013), but as high as 80% in 
caesarean section patients receiving spinal anaesthesia (Chakladar & Harper, 2010). 
These rates are unacceptably high and perioperative hypothermia is largely 
avoidable.     
The recognition that impaired thermoregulation results from anaesthesia and surgery, 
and the direct adverse impact that impaired thermoregulation has upon a host of 
patient outcomes, has steadily increased over the last 25 years. Much of the early 
knowledge around this topic can be attributed to Daniel Sessler and his colleagues 
(Sessler, 1993). All modes of anaesthesia (general, regional or neuraxial) influence 
the thermoregulatory system. Environmental and surgical factors also contribute to 
heat loss. The cool ambient temperature of operating theatres, body exposure, fluid 
and blood loss, as well as preoperative fasting requirements are all contributory 
factors to perioperative heat loss (NCCNSC 2008).  
Prevention of perioperative hypothermia is multi-faceted and requires consistent 
vigilance on the part of health care providers. Risk factor tools and evidence-based 
guidelines are available for health care providers to, firstly, assist in the prevention of 
perioperative hypothermia, but also secondly, to assist in the management of the 
condition once it occurs (Association of Operating Room Nurses ARP Committee, 
2007; Hooper et al., 2010; NCCNSC 2008). The most comprehensive, and widely 
cited, guideline available to date was developed by the National Collaborating Centre 
for Nursing and Supportive Care (NCCNSC) for the National Institute for Health and 
Care Excellence in 2008 (NCCNSC 2008).  Obstetric patients were notably excluded 
from these internationally recognised guidelines at their initial development. 
Subsequent reviews of the guidelines have again failed to integrate recommendations 
for obstetric patients (National Institute for Health and Care Excellence 2015).  There 
has also been a lack of synthesized evidence for perioperative hypothermia 
prevention for obstetric patients, leaving health care providers without clear 
evidence-based guidance on the appropriate methods of preventing this adverse and 
uncomfortable condition.  
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1.3 CAESAREAN SECTION 
Caesarean section refers to the operative delivery of the baby via a surgical incision 
in the mother’s abdomen.  It is undertaken for many varying reasons such as where 
vaginal delivery may be complicated, inadvisable or in emergency circumstances, for 
both the health of the mother and/or baby. In Australia, caesarean section delivery 
occurs in approximately 1 in 3 births, with 95894 caesarean section deliveries 
occurring in Australia in 2011, accounting for 32% of births (Australian Institute of 
Health and Welfare 2014, 2014).   
Caesarean section is, in most cases, performed under neuraxial (epidural or spinal) 
anaesthesia, which provides women with the opportunity to be awake for the delivery 
of the baby.  Neuraxial anaesthesia also reduces the risks from general anaesthesia, 
which is generally only performed when there is deemed to be clinical need related 
to co-existing morbidity (Hughes, Levinson, Rosen, & Shnider, 2002), or maternal 
preference. Common side effects from neuraxial anaesthesia include hypotension and 
itching. Furthermore, neuraxial anaesthesia impairs thermoregulation resulting in 
heat loss (Sessler, 2008).  In addition, heat loss in caesarean section patients is also 
influenced by pregnancy-associated vasodilation (Dunn, York, Cheek, & Yeboah, 
1993), relatively large amounts of blood and fluid loss, and a high degree of body 
exposure needed to access the surgical site. These factors, alongside impaired 
thermoregulation from neuraxial anaesthesia, increase the vulnerability of women 
undergoing caesarean section to develop perioperative hypothermia.  Spinal opioids 
are commonly given to enhance analgesia during surgery, and to prolong 
postoperative pain relief (Hess, Snowman, & Wang, 2005; Hughes, et al., 2002). 
However, some women that receive intrathecal morphine develop particularly 
prolonged hypothermia with paradoxical symptoms of diaphoresis and feeling hot 
(Hess, et al., 2005; Ryan, Price, Warriner, & Choi, 2012).  For these women, 
conventional warming methods are not as effective or appropriate as when used to 
treat the more common perioperative hypothermia usually experienced. Furthermore, 
intrathecal morphine use is a key differential between studies that have found 
varying levels of effectiveness of warming for women undergoing caesarean section 
(Halloran, 2009).  
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1.4 PERIOPERATIVE HYPOTHERMIA PREVENTION FOR OBSTETRIC 
PATIENTS 
Methods of warming recommended for general surgical populations include both 
passive and active strategies.  Active warming, which includes forced air warming, 
intravenous fluid warming and heated mattresses, has shown more effectiveness at 
reducing temperature decline than passive warming, which revolves around the use 
of warmed cotton blankets or reflective coverings (Moola & Lockwood, 2011; 
NCCNSC 2008).  
The use of active warming interventions for caesarean section has been reported to 
be as low as 16% (Woolnough, Hemingway, Allam, Cox, & Yentis, 2009) and 18% 
(Aluri & Wrench, 2014) in the UK, however its use in Australia for obstetric patients 
has not yet been quantified.  Primary research of the use of warming strategies to 
prevent perioperative hypothermia in the caesarean section population varies in 
relation to results, quality and usefulness.  The effectiveness of forced air warming, 
which is recommended by NICE for general adult populations (NCCNSC 2008) has 
varied between studies (Fallis, Hamelin, Symonds, & Wang, 2006; Horn et al., 
2002).   Furthermore, questions have been raised about the practicality of over body 
forced air warming strategies, and the tolerability of warming, for obstetric patients 
(Chakladar & Harper, 2010; Petsas, Vollmer, & Barnes, 2009).  In addition, warming 
strategies have been less effective in studies where intrathecal morphine has been 
administered (Halloran, 2009). Nevertheless, due to the adverse side effects, 
discomfort and disruption for women undergoing caesarean section caused by 
perioperative hypothermia, it is imperative that effective methods of preventing this 
condition are identified.  
 
1.5 RESEARCH AIMS 
The starting point for this research program was to address the deficit of evidence 
based recommendations for maternal thermal care by undertaking a systematic 
review of the current evidence of effectiveness of interventions to prevent or manage 
hypothermia experienced by women undergoing caesarean section.  From this work, 
a gap in the evidence surrounding temperature decline, and the effectiveness of 
warming interventions, in the specific group of women receiving intrathecal 
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morphine for caesarean section was identified. This provided the impetus for the 
subsequent two phases of the research program; an observational study, and a 
pragmatic, randomised controlled trial.  Therefore, the aims of this research program 
were as follows: 
1. To review existing evidence regarding the effectiveness of 
interventions to prevent or manage hypothermia experienced by women undergoing 
caesarean section (by systematic review) 
2. To investigate temperature decline and hypothermia related to 
intrathecal morphine, and identify the subset of women experiencing profound and 
problematic hypothermia related to intrathecal morphine (via retrospective case-
control study) 
3. To test a preoperative warming regime to reduce temperature decline 
in women receiving intrathecal morphine for caesarean section (via randomised 
controlled trial). 
 
1.6 SIGNIFICANCE AND SCOPE OF THE RESEARCH PROBLEM 
The lack of evidence-based recommendations to encompass or specifically address 
obstetric patients means that there has been no clear directives for health care 
providers to follow, a lack of clarity surrounding which methods of prevention are 
both effective or appropriate, and therefore a danger that this patient group will be 
neglected, resulting in high rates of unintended perioperative hypothermia. The 
systematic review of the experimental evidence on the prevention and management 
of perioperative hypothermia synthesised the available evidence, and generated 
evidence-based recommendations that could be applied specifically to this 
population. This systematic review also highlighted gaps in the evidence, and raised 
the question as to whether warming interventions are as effective, and whether 
hypothermia is exacerbated, in patients that receive intrathecal morphine during 
spinal anaesthesia (which in many institutions is standard care) (Cobb, Cho, Hilton, 
Ting, & Carvalho, 2016 ) for caesarean section.      
To partially address this question, a retrospective case control study aimed to 
compare heat loss and hypothermia between women undergoing caesarean section 
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both with and without intrathecal morphine. After establishing that there was 
significant temperature decline experienced across the population of women 
undergoing caesarean section, whether or not they received intrathecal morphine, and 
identifying that there was a gap in the science regarding whether preoperative 
warming is effective for women who receive intrathecal morphine for caesarean 
section, a pragmatic randomised controlled study was conducted to test this 
intervention. Preoperative warming has been shown to have benefit at reducing 
temperature decline in many populations (Andrzejowksi, Hoyle, Eapen, & Turnbull, 
2008) and is recommended by NICE for general adult surgical patients (NCCNSC 
2008), however in the obstetric population had only been tested where women had 
not received intrathecal morphine, which provides effective postoperative analgesia, 
but which is associated with a number of side effects such as pruritus, nausea and 
vomiting, respiratory depression and impaired thermoregulation. Therefore, the 
randomised controlled study aimed to test a feasible period of active preoperative 
warming in this population. In this research program, inadvertent perioperative 
hypothermia is categorised as a temperature <36.0°C, based upon the common cut-
off cited in the most up-to-date literature (NCCNSC 2008).  
   
1.7 OUTLINE OF THESIS 
 This thesis presents the three phases of the research program as a series of 
published, accepted and submitted publications, each contributing to new knowledge 
for the prevention of perioperative hypothermia for women undergoing caesarean 
section.    
Chapter 2 reviews the literature to establish the basis for this research program, 
including the existing literature surrounding perioperative hypothermia, and 
specifically the relevance and treatment of the condition for caesarean section 
patients.   This chapter informs the work in the subsequent chapter and, in particular, 
the development of the systematic review in the following chapter.  
Chapter 3 presents phase one of the research program: a systematic review of the 
evidence of effectiveness of interventions to assist perioperative temperature 
management for women undergoing caesarean section. The shortened version of this 
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systematic review, published in Worldviews on Evidence Based Nursing, which 
focuses on the primary outcome of maternal temperature, is included in this chapter.  
Chapter 4 includes the secondary outcomes from the full systematic review, 
published in the JBI Database of Systematic Reviews and Implementation Reports, 
namely shivering, maternal thermal comfort, length of Post Anaesthetic Care Unit 
(PACU) stay, neonatal temperature at birth, Apgar scores and umbilical pH.  The full 
review is included in Appendix A.   
Chapter 5 includes phase two of the research program, an observational study of 
hypothermia and temperature decline in women receiving intrathecal morphine for 
caesarean section, and presented as the paper accepted for publication in the Journal 
of PeriAnesthesia Nursing.   
Chapter 6 reports phase three of the research program, a randomised controlled trial 
of the effectiveness of a prewarming regime to prevent maternal temperature decline 
in women receiving intrathecal morphine for caesarean section, as the paper 
submitted for publication. 
Chapter 7 is the discussion of the overall findings of the research program in the 
context of current evidence, the significance of the findings and recommendations 
for practice.  
Finally, Chapter 8 presents the conclusions of the research program and presents 
areas for further research.     
Additional information related to the three phases of the research program, including 
but not limited to, data collection forms and ethics approvals as well as the full JBI 
version of the systematic review, are included as appendices.  
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Chapter 2: Background and Literature 
Review 
2.1 INTRODUCTION 
Inadvertent perioperative hypothermia is generally defined as the unintentional 
cooling of the body’s core temperature below 36°C (NCCNSC 2008) related to 
undergoing a surgical procedure. The association of inadvertent perioperative 
hypothermia with numerous adverse effects for surgical patients (NCCNSC 2008) is 
well documented (as reported in Chapter 1). Inadvertent perioperative hypothermia is 
a common problem for patients undergoing caesarean section (Chakladar & Harper, 
2010). The rate of hypothermia, if not managed, for women undergoing caesarean 
section under spinal anaesthesia has been estimated as being as high as between 32% 
(Hess, et al., 2005) and 80% (Chakladar, Dixon, & Harper, 2011). Similarly, the rate 
of hypothermia in general surgical adult populations has also been found to be high, 
at around 50-54% (Hooven, 2011; Munday, Hines, & Chang, 2013). 
Caesarean section is a major surgical procedure and can involve relatively large 
amounts of blood and fluid loss, which increases the vulnerability of women 
undergoing caesarean section to developing hypothermia. A high degree of body 
exposure is required during caesarean section in order to access the surgical site and 
heat loss results from the exposed skin and body cavities (Dunn, et al., 1993).  In 
many cases, women await surgery in cool waiting areas wearing thin surgical gowns. 
The patient’s preoperative thermal status also influences heat loss and their 
progression to hypothermia.  In addition, pregnancy associated vasodilation (Dunn, 
et al., 1993) also contributes to core heat loss, promoting the loss of heat from the 
body’s core compartment to the peripheries. This effect is also heightened by 
vasodilation related to anaesthesia. Regional anaesthesia is, in most cases, the 
anaesthetic mode of choice for caesarean section surgery (Fallis, et al., 2006) but 
may also be an aggravating factor for the development of hypothermia (Frank, El-
Rahmany, Cattaneo, & Barnes, 2000) by inhibiting normal thermoregulation, 
particularly when opioids are used (Hess, et al., 2005).  Effective prevention or 
treatment for inadvertent perioperative hypothermia in this group of patients has not 
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yet been definitively established, which has provided the impetus for this research 
program. 
2.2 THERMOREGULATION 
Core temperature, in all humans, is maintained only within very narrow limits 
(Sessler, 2000) via a system of afferent and efferent signals and the hypothalamus. 
Normally core temperature is maintained between 36.5-37.5°C. The body depends 
upon this narrow range for normal functioning to occur (Insler & Sessler, 2006). 
Core temperature, as differentiated from peripheral temperature (which varies more 
widely), refers to the temperature of the body’s core compartment.  This is comprised 
of tissues that are well-perfused and of higher uniform temperature than the 
remainder of the body (Insler & Sessler, 2006). Although these temperatures do 
fluctuate according to circadian rhythm and, in females, according to the menstrual 
cycle (Bicalho, Viana Castro, Cunha Cruvinel, & Bessa  Jr, 2006) (Kurz, 2008), core 
body temperature has been described as ‘one of the most tightly regulated parameters 
of human physiology’ (Kurz, 2008)p627 and also as the ‘best single indicator of 
thermal status in humans’ (Sessler, 2008)p318. 
A three stage system of thermoregulation has been acknowledged (Bicalho, et al., 
2006).  Afferent signals are sent from the skin, deep tissues and spinal cord to the 
central nervous system (stage one), the hypothalamus centrally processes these 
signals (stage two) and then sends efferent signals to adjust temperature (by either an 
increase or decrease) (stage three). Simply described, if the hypothalamus detects a 
deviation in temperature level then it sends an appropriate response to either increase 
heat loss (for example, sweating) or decrease heat loss (for example, vasoconstriction 
and shivering), thus returning thermal balance. The space or range between the ‘too 
hot’ and ‘too cold’ response (called the inter-threshold range) is generally just 0.4°C 
(Buggy & Crossley, 2000). Thus, temperature control is a very fine balance.  
Generally, the body also generates heat by various methods: basal metabolic rate 
(generated by the body’s maintenance of normal functions), thermogenesis 
(generated from food digestion), physical activity (absent during anaesthesia) and 
hormonal influences (Insler & Sessler, 2006). At any time, the human body can lose 
or gain heat via four mechanisms; radiation (for example, when heat is lost between 
the body and the cooler ambient environment of the operating theatre), conduction 
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(for example when heat is lost between skin and cooler linen), convection (such as 
heat loss between exposed skin and the cooler ambient environment) and evaporation 
(such as heat loss from exposed body cavities) (Buggy & Crossley, 2000; Dunn, et 
al., 1993; Sarti, Recanati, & Furlan, 2005).   
Thermoregulatory shivering as a response to cold, characterised by involuntary 
activities or tremor of muscles, increases metabolic heat production (Insler & Sessler, 
2006) but can also be an unpleasant and uncomfortable experience for patients.  The 
core thermoregulatory threshold for shivering is normally 35.5°C (Insler & Sessler, 
2006; Kurz, 2008) and its presence may, therefore, be an indication of a ‘too cold’ 
thermal response; however shivering, in some instances, is thought to be non-
thermoregulatory. Efferent responses to cold include vasoconstriction and, as 
described above, shivering.  Vasoconstriction occurs more widely and regularly than 
shivering and works to reduce heat lost through the mechanisms of radiation and 
convection (Kurz, 2008), by reducing blood flow particularly to the extremities.   
Both warm and cold receptors are situated all over the body (Kurz, 2008), however 
humans have many more cold receptors than warm receptors (Buggy & Crossley, 
2000; Insler & Sessler, 2006) and thus, peripheral thermoregulatory responses are 
geared towards detecting cold rather than warmth (Insler & Sessler, 2006). 
Behavioural influences on thermoregulation (such as the ability to add or remove 
extra clothing, or take other cooling or warming measures as necessary) have been 
described as ‘quantitatively more important’ (Buggy & Crossley, 2000)p615 than 
autonomic responses in terms of temperature regulation. In unanaesthetised patients, 
impulses sent by the hypothalamus to the cerebral cortex, cause behavioural 
responses (such as adding clothing as described above) (Buggy & Crossley, 2000), 
but in anaesthetised patients the ability to use behavioural means of temperature 
control are impaired, if not altogether absent.  
 
2.3 THERMOREGULATION AND ANAESTHESIA 
General, regional and neuraxial anaesthetics all have an influence on the 
thermoregulatory system, albeit in slightly varying ways. Regional or neuraxial 
anaesthetics (either epidural or spinal or combined spinal-epidural) are the common 
modes of anaesthesia for women undergoing CS, as compared to general anaesthesia.  
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These modes of anaesthesia are beneficial in terms of both maternal and anaesthetic 
preferences. From a maternal perspective, neuraxial anaesthesia provides the 
opportunity to stay awake during surgical delivery (Hughes, et al., 2002). From an 
anaesthetic perspective, avoiding general anaesthesia minimises the risk of airway 
management issues and of drug depression for the newborn baby (Hughes, et al., 
2002). The choice of anaesthetic depends on the urgency of the surgery (not only 
emergency versus elective, but also the degree of emergency), preferences of both 
the mother and anaesthetist, and anaesthetic judgement (based on safety and comfort 
for the mother, as well as providing the best working conditions for the surgeon) 
(Hughes, et al., 2002). 
In all surgical procedures, external and surgical factors combine with anaesthetic 
related autonomic temperature control impairment to influence the degree of heat 
loss experienced. External factors such as the requirement for patients to wear thin 
surgical gowns, remain nil by mouth and often experience prolonged preoperative 
waiting periods are also of relevance to obstetric surgical patients, and can impair 
thermal status (NCCNSC 2008). During anaesthesia, the inter-threshold range is 
thought to increase, whilst responses to maintain heat are decreased.  During regional 
anaesthesia, there is as much as a three-fold increase from the normal inter-threshold 
range (or thermoneutral zone), which is therefore widened (Kurz, 2008). Skin 
temperatures in blocked areas may be misinterpreted as elevated by the central 
thermoregulatory system (Kurz, Sessler, Narzt, Lenhardt, & Lackner, 1995). The 
shivering threshold is reduced (Kurz, 2008) and the reduced gain of shivering above 
the level of the block (Buggy & Crossley, 2000) does not compensate for the lack of 
shivering below the level of the block.  
During neuraxial anaesthesia, central thermoregulation and peripheral 
thermoregulation are both adversely effected (Kurz, 2008). A three stage process of 
heat loss (or redistribution of heat) is described during neuraxial anaesthesia (Sessler, 
2000): firstly heat redistributes from the core to the peripheries (similar as occurs 
during general anaesthesia,) caused by vasodilation of the anaesthetised section of 
the body. This 1-2°C loss typically occurs during the first hour. Secondly, 
vasoconstriction loss in the anaesthetised sections of the body decreases the 
efficiency of heat maintenance. Thirdly, there is a decrease in the vasoconstriction 
and shivering thresholds even in non-anaesthetised areas (Bicalho, et al., 2006; 
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Sessler, 2000). Interestingly, patients may experience a sense of thermal comfort or 
warmth after initiation of regional anaesthetic blocks, possibly due to the lack of skin 
temperature detection below the level of the block being misinterpreted as warmth 
(Kurz, 2008). 
2.4 DETECTION OF HYPOTHERMIA 
The early detection or identification of hypothermia and decreased thermal status can 
facilitate action to prevent further deterioration. Preoperative thermal status 
influences the degree to which core-periphery heat redistribution will occur (Arkilic, 
Akca, Taguchi, Sessler, & Kurz, 2000). Preoperative fasting, the requirement to wear 
thin hospital gowns during the preoperative wait, and the administration of 
preoperative medications notably sedation, contribute to reduced temperatures in 
patients when they arrive in the perioperative suite.  Knowledge of the patient’s 
preoperative thermal status is vital when planning perioperative care and this 
expectation has been reflected in guidelines relating to perioperative management of 
hypothermia for all surgical (non-obstetric) patients (Hooper, et al., 2010; NCCNSC 
2008). Risk factor tools are available to assist in the identification of patients at high 
risk of developing hypothermia (Hooper, et al., 2010; NCCNSC 2008) so that 
measures to safeguard normothermia in the operating suite can be put into place. 
These risk factor tools are however generalised to adult patient groups only and have 
not been promoted for use in obstetric surgical patients.  In fact, the evidence-based 
guidelines, The Management and Prevention of Inadvertent Perioperative 
Hypothermia, developed by the National Institute for Clinical Health and Excellence 
(NICE) in the UK actually exclude pregnant patients from the guideline (NCCNSC 
2008). Experts argue that these could be potentially transferable to obstetric patients 
as guidelines are needed for this group of patients (Chakladar & Harper, 2010). A 
number of systematic reviews (Galvao, Liang, & Clark, 2010; Moola & Lockwood, 
2011) have scrutinised the management of perioperative hypothermia using various 
interventions but these have largely overlooked obstetric patients as a distinct and 
particularly vulnerable group.  
Hypothermia during neuraxial anaesthesia is often not detected until patients reach 
the Post Anaesthetic Care Unit (PACU).  A study of temperature monitoring and 
management found that there is a lack of temperature monitoring during neuraxial 
anaesthesia (Arkilic, et al., 2000) as it is often not considered a necessity by 
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anaesthetists (Arkilic, et al., 2000). Others have confirmed that temperature 
monitoring is indeed often overlooked, perhaps due to the lack of an optimum 
monitoring site or because malignant hyperthermia, a separate serious perioperative 
complication, is not a risk factor with neuraxial anaesthesia (Frank, et al., 2000) (and 
therefore the perceived importance of temperature monitoring is decreased).  In 
reality temperature should be monitored routinely (Arkilic, et al., 2000), in order to 
detect temperature variations as they occur. Expert opinion suggests that core 
temperature should indeed be measured in patients undergoing neuraxial anaesthesia, 
particularly those undergoing major surgery (Lenhardt, 2003) or surgery involving 
the body cavities (Sessler, 2008) which would therefore include caesarean section.  
In addition, patient detection of heat loss is also impaired during anaesthesia so they 
may not initially perceive the heat loss due to impaired thermoregulation and 
detection of lower temperatures (Insler & Sessler, 2006). The apparent lack of 
monitoring temperature intraoperatively means that hypothermia becomes more a 
problem to treat rather than prevent, in many cases, resulting in a reactive rather than 
proactive approach. In this respect, it becomes the responsibility of nurses caring for 
these patients postoperatively to resolve the hypothermia. Prevention of perioperative 
hypothermia was rated as one of the top ten priorities (eighth out of 10 priority 
issues) by a recent survey of perioperative nurses regarding patient safety issues, 
however only 31% (966) of 3137 respondents rated it as a high priority (Steelman & 
Graling, 2013) and it was suggested that nurses at the front line of direct patient care 
were more likely to recognise the need for a focus on this aspect of care.    
Temperature monitoring can occur at many different sites: whilst a handful of these 
sites are considered to be indicative of true core temperature, a number of other sites 
offer a ‘near-core’ reading.  These ‘near-core’ sites are generally easier from which 
to obtain readings.  The gold standard of core temperature measurement is the use of 
the pulmonary artery, however other core sites include the tympanic membrane, 
distal oesophagus and nasopharynx (Sessler, 2008). Near-core sites, such as the oral 
cavity, axilla, bladder, rectum and skin-surface, can be used to given an indication of 
core temperature however there are also limitations associated with these methods, 
often related to accuracy.  In such a tightly regulated parameter as human thermal 
status, the influence of inaccurate measurement can be magnified.   A suggested rule 
of thumb for the combined inaccuracy of a temperature measurement site or device, 
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is that this should not exceed 0.5°C (Sessler, 2008). Both in clinical practice and 
clinical research, it is therefore imperative that careful consideration is given to the 
mode of temperature measurement used.   
During neuraxial anaesthesia for caesarean section surgery, more invasive methods 
of temperature measurement (such as pulmonary artery or oesophageal) are 
extremely unlikely to be utilised, however bladder measurements is possibly a more 
feasible and less disruptive option (as bladder catheterisation is necessitated during 
caesarean section surgery). As discussed earlier, it also appears to be common 
practice for temperature measurement during neuraxial anaesthesia to be neglected 
completely.  A balance between patient comfort and an acceptable level of device 
accuracy seems desirable.    
 
2.5 ADVERSE OUTCOMES RELATED TO PERIOPERATIVE 
HYPOTHERMIA 
Whilst all patients are at risk of perioperative hypothermia and the associated side 
effects, these effects of hypothermia can be especially serious for women undergoing 
caesarean section and their newborns, notwithstanding the discomfort and 
inconvenience resulting from hypothermia that requires treatment.    
Postpartum haemorrhage is a serious postpartum concern for caesarean section 
patients and therefore, the avoidance of risk factors that can increase blood loss, such 
as hypothermia, should be undertaken. A meta-analysis of fourteen published 
randomised controlled trials relating to blood loss and ten published randomised 
controlled trials relating to transfusion requirements, has revealed that even mild 
hypothermia increases blood loss and transfusion requirements (Rajagopalan, et al., 
2008). Although there was a limited search strategy (searching for published studies 
only) and a limited quality appraisal system used for this meta-analysis, the results 
remain of interest. Normothermia was found to be associated with lower blood loss 
than hypothermia. Blood loss is estimated to increase by around 16% with mild 
hypothermia and the relative risk of blood transfusion is increased by around 22% 
with mild hypothermia (Rajagopalan, et al., 2008). 
The detrimental effects of hypothermia also extend to wound healing.  Hypothermia 
has been linked with delayed wound healing and increased wound infection rates in 
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some surgical patient groups, such as colo-rectal surgery (Kurz, et al., 1996). Indeed, 
it has been indicated that perioperative hypothermia can suppress immune function 
(Beilin, et al., 1998). Although, conversely, two retrospective case-control studies 
(Edwards, Madani, & Duff, 2003; Munn, Rouse, & Owen, 1998) failed to find an 
association between perioperative hypothermia and wound infection, these studies 
both have limitations, not least in the use of postoperative temperature readings as an 
indicator of intraoperative hypothermia (rather than the use of intraoperative 
readings) (Munn, et al., 1998). A systematic review of 26 intraoperative warming 
randomised controlled trials to prevent postoperative complications (Scott & 
Buckland, 2006) favoured the use of warming to reduce wound infections, but the 
search strategy utilised during this review was limited in its breadth and 
completeness of searches. No unpublished literature was sought, thus increasing the 
risk of publication bias. In addition, although a description of quality indicators used 
to select studies is provided, it is unclear if a validated tool was utilised for critical 
appraisal.  Of the 26 included studies, 17 did not have a clear randomisation process 
described: therefore, there is some question of the quality of the studies included in 
this review, and therefore the validity of the results.     
Greater morbidity, whether directly or indirectly associated with inadvertent 
perioperative hypothermia, would be expected to lengthen hospital stay.   Indeed, the 
occurrence of inadvertent perioperative hypothermia has been linked with increased 
duration of hospital stay, in a randomised controlled trial of 200 patients undergoing 
colorectal surgery which investigated the effects of normothermia versus 
hypothermia in relation to surgical wound infection and duration of hospitalization 
(Kurz, et al., 1996). In addition to the possible benefits that normothermia affords 
patients in relation to lower incidence of post-surgical wound infections, patients 
remaining normothermic had shorter hospital stays (Kurz, et al., 1996) even amongst 
those who had no infection.  However, temperatures of the hypothermic group in this 
study were kept at 34.5°C, which may be considered more extreme than the milder 
hypothermia experienced by most patients experiencing inadvertent perioperative 
hypothermia. In addition, it appears that postoperative temperature was not 
monitored or controlled for, therefore introducing the potential for confounding the 
study results.  
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Inadvertent perioperative hypothermia may also result in increased Post Anaesthetic 
Care Unit stay (PACU) (Lenhardt et al., 1997). A prospective randomised controlled 
trial found that hypothermic patients reached fitness to discharge from PACU 
approximately 40 minutes later than normothermic patients undergoing major 
abdominal surgery (Lenhardt, et al., 1997), even if core temperature was not included 
as part of a discharge criteria.  This suggests that, aside from the time, resources and 
cost factors associated with rewarming hypothermic patients to meet temperature 
related discharge criteria, hypothermia can also affect the overall recovery of patients 
in other aspects. Inadvertent perioperative hypothermia has also been shown to 
increase duration of effect of certain medications, such as muscle relaxants (Heier & 
Caldwell, 2006; Leslie, Sessler, Bjorksten, & Moayeri, 1995), with the duration of 
neuromuscular blockade doubling with a 2°C drop in temperature (Heier & Caldwell, 
2006), which can also impact on duration of time spent in the perioperative suite.  
Taking the above factors into consideration, it is not surprising that inadvertent 
perioperative hypothermia has been linked with increased costs by a meta-analysis 
examining the costs of maintaining normothermia (Mahoney & Odom, 1999) 
balanced with outcomes across varying patient groups. The authors found that an 
average temperature drop of 1.5°C resulted in hospital costs between US$2500-7000 
resulting from adverse outcomes. However, this meta-analysis, apparently conducted 
without a rigorous critical appraisal to determine the quality of included studies, has 
not been updated since first publication in 1999. With the volume of literature and 
new knowledge acquired since this date, updated analysis would be worthwhile.  As 
health care providers seek to improve efficiency and meet the increasing demands for 
services, it becomes even more vital that the reduction of preventable adverse patient 
outcomes is prioritised. At the very least, awareness of perioperative normothermia 
should be promoted to identify and alleviate hypothermia related patient discomfort 
for all patients.  
As well as the discomfort from perceived cold, shivering, accompanying decreased 
thermal status, has been reported to be a source of distress to women undergoing 
caesarean section (Liu & Luxton, 1991; Roy, Girard, & Drolet, 2004), in a 
randomised double-blind study of the effect of prophylactic epidural fentanyl 
administration upon shivering (Liu & Luxton, 1991), and a prospective double-
blinded randomised controlled trial of intrathecal meperidine to reduce shivering   
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(Roy, et al., 2004). The latter study found that intrathecal meperidine reduced the 
incidence and intensity of shivering, but the optimal dose was not established.  It also 
appears that intraoperative shivering only was investigated; therefore questions 
remain as to the incidence of postoperative shivering. Liu and Luxton’s study of 
epidural fentanyl administration found that shivering was reduced in the intervention 
group (Liu & Luxton, 1991), however fentanyl non-shiverers also experienced the 
largest decrease in mean axillary temperature.    
Shivering may also interfere with patient monitoring (Liu & Luxton, 1991), 
impairing the ability of devices to obtain readings due to patient movement. It is 
especially important that pre-emptive measures are taken to reduce shivering, 
associated with perioperative hypothermia, during caesarean section as it may impair 
the mother’s ability to hold her newborn (Leslie & Sessler, 2003) (both immediately 
post-delivery and in the recovery room) and also postoperatively (Butwick, Lipman, 
& Carvalho, 2007) when it can interfere with bonding and the instigation of 
breastfeeding. These factors can adversely affect maternal experience and 
satisfaction with care. In addition, particularly disruptive shivering may be sufficient 
to disrupt the surgical procedure (Leslie & Sessler, 2003).  
The adverse effects of inadvertent perioperative hypothermia are not limited to the 
mother alone. Fetal temperature is related to, and usually slightly higher than, 
maternal temperature (Butwick, et al., 2007) and thus, the baby’s temperature also 
alters, as the mother’s temperature decreases (or increases). Discrepancies between 
what is considered normal newborn temperature exist due to disagreements in 
literature and textbooks with inadequate referencing to support provided figures 
(Takayama, Wang, Uyemoto, Newman, & Pantell, 2000) but a recent study of full 
term infant’s medical records found that mean axillary temperature was 36.5°C 
(Takayama, et al., 2000), whereas 36.5°C has been previously cited as a lower limit 
of newborn temperature (Takayama, et al., 2000). The authors argue that normal 
newborn temperature needs to be redefined, citing their results to support the 
assertion that normal newborn temperature may be lower than previously thought. 
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2.6 TREATMENT AND PREVENTION FOR INADVERTENT 
PERIOPERATIVE HYPOTHERMIA FOR CAESAREAN SECTION 
PATIENTS 
Women undergoing caesarean section have been neglected in evidence-based 
recommendations and guidelines developed to enhance perioperative care and reduce 
hypothermia for surgical patients. This is evident in the explicit exclusion of 
pregnant patients from the widely recognised NICE guidelines on inadvertent 
perioperative hypothermia (NCCNSC 2008). The lack of guidance has potentially 
left this patient group at risk of being overlooked in regard to implementing regimes 
designed to protect perioperative patients against inadvertent perioperative 
hypothermia in practice. This is unfortunate, not least because the thermal status of 
the mother is also linked to the thermal status of the newborn baby; thus, it is not 
only the mother in isolation that may suffer from the occurrence and adverse effects 
of inadvertent perioperative hypothermia. As Baker and Lawson emphasise in a 
retrospective chart review of maternal and newborn outcomes related to 
perioperative hypothermia in elective low-risk caesarean section births, ‘every effort 
should be made to prevent hypothermia in both mother and newborn’ (Baker & 
Lawson, 2012) despite this study failing to find a statistically significant relationship 
between the odds of a newborn being hypothermic if the mother was hypothermic.    
As the authors also discuss, any episode of hypothermia, for mother or infant, is 
clinically significant (Baker & Lawson, 2012) p77. 
It is reported that despite the side effects of hypothermia being clinically significant 
for both mother and newborn, and the high rates of hypothermia reported, that the 
use of warming interventions during caesarean section is low. The use of warming 
interventions in the United States (Carpenter & Baysinger, 2012) and Australia has 
not been quantified, but a telephone survey of maternity departments in the UK 
reported its usage to be as low as 16%, (Woolnough, Hemingway, et al., 2009) 
despite warming interventions being readily available within the institutions 
included.  
Warming interventions can be broadly categorised as either passive or active. 
Warming can be applied preoperatively, intraoperatively and postoperatively. 
Multiple studies in different patient populations (including caesarean section 
patients) suggest that preoperative warming strategies are effective at reducing 
incidence of inadvertent perioperative hypothermia, (Andrzejowksi, et al., 2008; 
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Bock, Muller, Bohrer, Martin, & Motsch, 1998; Chung et al., 2012; Just, Trevlen, 
Delva, & Lienhart, 1993; Munday, Hines, & Chang, 2013) by increasing peripheral 
heat content and therefore reducing the intraoperative core-periphery heat gradient 
through which heat loss occurs.  Passive warming strategies usually refer to the use 
of warmed cotton blankets or other covering such as reflective (often called ‘space’) 
blankets and these have the benefit of tending to be cheaper per unit, however less 
effective than other modes of warming. Active warming interventions may include 
the use of forced-air warming devices, circulating-water garments, intravenous fluid 
warming and heated mattresses: some of these interventions have been tested for the 
caesarean section population (Butwick, et al., 2007; Chakladar, et al., 2011; Fallis, et 
al., 2006; Horn, et al., 2002; Woolnough, Allam, Hemingway, Cox, & Yentis, 2009; 
Yokoyama et al., 2009).  
Primary research investigating IPH prevention and treatment for caesarean section 
patients has been undertaken and this varies in terms of quality and usefulness. 
Despite the use of forced air warming being well supported by systematic reviews 
(Galvao, et al., 2010; Moola & Lockwood, 2011) and by evidence-based guidelines 
(Hooper, et al., 2010; NCCNSC 2008) for other patient groups (excluding pregnant 
patients), the use of this intervention for caesarean section patients has been 
investigated with differing results (Butwick, et al., 2007; Fallis, et al., 2006; Horn, et 
al., 2002). Two studies investigating forced air warming (one upper body warming 
and warmed fluids, one lower body warming) found it to have no effectiveness for 
CS patients (Butwick, et al., 2007; Fallis, et al., 2006), whilst another study utilising 
upper body warming found that hypothermia and shivering were reduced by use of 
the intervention (Horn, et al., 2002). Results from Butwick et al.’s study of lower 
body warming need to be considered with caution, due to confounding introduced by 
ten out of 15 of the control group also receiving warming (Butwick, et al., 2007).  
Blinding is not clear, or not addressed in these forced air warming studies (Chung, et 
al., 2012; Fallis, et al., 2006; Horn, et al., 2002), however the difficulties associated 
with blinding both participants and outcome assessors to an intervention that is often 
noisy and not easily disguised, are apparent. Objective measurements, such as 
temperature, may be at less risk of bias from the lack of blinding, however studies of 
warming often assess subjective data, such as thermal comfort, therefore the risk of 
bias from inadequate blinding is of greater concern in these instances.   
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Intravenous fluid warming has also been used for IPH prevention in this population 
but with conflicting results (Fallis, et al., 2006) utilising both fluid and forced air 
warming, found no beneficial effect on perioperative hypothermia, but another study 
found mothers in the intervention group to have higher core temperatures from 
delivery to the end of surgery (Yokoyama, et al., 2009), although blinding and 
allocation concealment were not clear in this study.  The usefulness of fluid warming 
may depend on key factors such as the rate, volume and actual infusion temperature 
achieved and, as such, fluid warming studies present variations in study design 
related to these factors.  
A key differential between the studies described may be the use of intrathecal 
morphine (Halloran, 2009), which is thought to play a role in the development or 
prolonging of inadvertent perioperative hypothermia in some patients.  In those 
studies in which patients received intrathecal morphine (Butwick, et al., 2007; Fallis, 
et al., 2006), warming interventions were not found to be effective (Halloran, 2009) 
although there may be other methodological and intervention factors which influence 
these findings, such as operating temperatures of the devices and the ambient 
temperature of the environment. The use of intrathecal morphine does have side 
effects, and one such side effect is the development of profound intrathecal morphine 
related hypothermia.   
 
2.7 PROFOUND INTRATHECAL MORPHINE RELATED 
HYPOTHERMIA 
The use of intrathecal morphine during obstetric neuraxial anaesthesia is 
commonplace. Local anaesthetics such as bupivacaine are injected into the 
subarachnoid space to achieve spinal anaesthesia and opioids, such as fentanyl or 
morphine, are added to enhance analgesia during surgery and prolong postoperative 
pain relief (Hess, et al., 2005; Hughes, et al., 2002; Ryan, et al., 2012). Common side 
effects of morphine experienced by patients include pruritus (itching), nausea and 
vomiting, while respiratory depression is also a risk. Whilst there are high rates of 
hypothermia during and after spinal anaesthesia amongst women undergoing 
caesarean section, some women who receive intrathecal morphine develop 
particularly problematic and prolonged hypothermia (Hess, et al., 2005; Hui et al., 
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2006; Kavee, Ramanathan, Bernstein, Zakowski, & 1991; Sayyid, Jabbour, & 
Baraka, 2003; Wishaw, 1997). 
An early report of problematic or prolonged hypothermia, with paradoxical 
symptoms, associated with intrathecal morphine was published in the form of a case 
report in 1992 (Kosai, et al., 1992). Since this time, further recognition of the 
problem has occurred (Bicalho, et al., 2006; Hess, et al., 2005; Hui, et al., 2006; 
Ryan, et al., 2012; Sayyid, et al., 2003; Wishaw, 1997). Profound intrathecal 
morphine-related hypothermia is characterised by a prolonged episode of profound 
temperature drop, which is, in most cases, accompanied by diaphoresis and 
sometimes nausea, thus causing extreme discomfort for patients in the postoperative 
phase. Profound hypothermia has been reported at temperatures as low as 33.1°C 
(Kosai, et al., 1992) and the time taken for the hypothermia to resolve has been 
reported at between 2hrs (Hess, et al., 2005) to 19hrs (Kosai, et al., 1992). 
For caesarean section patients, this can interfere with recovery in the immediate 
postoperative period (Butwick, et al., 2007; Halloran, 2009), (an important phase 
during which bonding and breastfeeding are initiated), while resolution of the 
hypothermia and associated symptoms are sought. It is difficult to treat. Some studies 
have found conventional warming methods, both passive and active, to have little 
benefit during prolonged intrathecal morphine related hypothermia (Hess, et al., 
2005; Kosai, et al., 1992; Ryan, et al., 2012; Sayyid, et al., 2003) and these may not 
be tolerable for a patient who feels hot and sweaty, despite their hypothermic 
temperature.   
Our knowledge regarding profound hypothermia and intrathecal morphine tends to 
be from case reports and anecdotal sources, mainly consisting of published 
correspondence. There is however one observational study that has reported on the 
incidence of intrathecal morphine related hypothermia after caesarean section (Hess, 
et al., 2005), and one controlled trial published in 1991 that found that women 
undergoing spinal anaesthesia with intrathecal morphine for caesarean section had 
significantly lower temperatures for up to 24 hours, as compared to those who 
received epidural morphine (Kavee, et al., 1991).  
 The exact mechanism by which intrathecal morphine contributes to hypothermia is 
not yet known (Butwick, et al., 2007). It is thought that cephalic spread of the 
morphine contributes to hypothermia in patients given intrathecal morphine (Hess, et 
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al., 2005) who develop prolonged hypothermia.  It has been suggested that morphine 
spreads in the cerebrospinal fluid (CSF) to the hypothalamus and thus acts on the 
temperature set point (Hess, et al., 2005). The possibility of morphine dosage 
amounts being related to the likelihood of profound hypothermia developing has 
been considered however, even relatively small doses of morphine (150mcg) have 
been shown to promote a hypothermic effect (Hui, et al., 2006). A recent randomised 
study compared the hypothermic and pain-relieving effect of a very small dose 
(50mcg) and a dose of 100mcg of intrathecal morphine (Ischak et al., 2013). This 
study found no statistically significant difference in body temperature or 
postoperative pain, or time to nadir temperature between groups. However, the 
lowest temperature recorded in this study was 34.9°C, and it is not reported in which 
group of participants this was recorded (Ischak, et al., 2013), thereby limiting the 
usefulness of the results.   
In other populations, the height of spinal blockade and increasing age have been 
identified as predictors of hypothermia after spinal anaesthesia without intrathecal 
morphine (Frank, et al., 2000). Central regulatory control under spinal block was also 
studied in men undergoing urology surgery. More extensive spinal blocks (higher 
blockades) resulted in greater thermoregulatory impairment than less extensive 
blocks (lower blockades) in this population (Frank, et al., 2000). The height of spinal 
blockade may be a factor worth exploration in the investigation of the mechanism by 
which intrathecal morphine causes prolonged hypothermia in some women.  
Studies with small sample sizes have investigated effective warming methods for 
women undergoing caesarean section, both under spinal anaesthesia with/without 
intrathecal morphine and epidural anaesthesia.  Preoperative (Horn, et al., 2002) and 
intraoperative warming has been shown to improve outcomes for newborns as well 
as mothers, but in studies where mothers have received intrathecal morphine, 
intraoperative warming has had less effect (Butwick, et al., 2007; Fallis, et al.; Hess, 
et al., 2005). No prior studies have been conducted, however, utilising preoperative 
warming strategies in the population of women receiving intrathecal morphine for 
caesarean section. In addition, active warming methods may not be tolerable for 
these patients, due to the symptoms of sweating and discomfort described.   
There is some evidence that pharmacological treatments can be helpful in the 
treatment of profound and problematic intrathecal morphine related hypothermia in 
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the face of more widely used warming techniques failing to be effective or tolerable.  
Case reports only describe the effectiveness of Lorazepam (a benzodiazepine) in 
resolving intrathecal morphine induced profound hypothermia (Hess, et al., 2005; 
Ryan, et al., 2012). Additionally, the use of Naloxone has been described, via case 
reports only, for the same purpose (Bicalho, et al., 2006; Sayyid, et al., 2003; 
Wishaw, 1997). Opioids have been given to decrease muscle shivering as they are 
known to modify the shivering threshold but in the case reports described (Sayyid, et 
al., 2003) excessive sweating alongside shivering instead is noted (Bicalho, et al., 
2006), with shivering and sensation of cold returning after the administration of 
drugs such as Lorazepam.  
 
2.8 RESEARCH PROBLEM 
Identification of optimum warming methods for women undergoing caesarean 
section is required to enable the implementation of best practice in relation to 
reducing perioperative hypothermia for this group of patients, for whom guidance is 
currently lacking. Established warming techniques and regimes in other patient 
populations may have decreased effectiveness or appropriateness for women 
undergoing caesarean section. For example, the effectiveness of forced air warming 
systems may depend on the portion or extent to which the body is covered. It may be 
that during caesarean section sufficient body coverage required to fully benefit from 
forced air warming is impossible.   
 In addition, for the subset of women who develop prolonged hypothermia after 
receiving intrathecal morphine alternative and specific strategies may be required.  
To formulate these strategies, an in depth understanding of the incidence, mechanism 
and factors contribute to prolonged hypothermia following intrathecal morphine 
administration would be beneficial, as would an exploration of the effectiveness of 
strategies that are currently used to manage this problem. Determining relevant 
factors that result in morphine related hypothermia in some patients but not others 
may assist to develop the best methods of treatment as well as prevention of the 
problem (which is always preferable). The factors which make some patients 
receiving intrathecal morphine more susceptible than others to develop profound 
morphine related hypothermia, are not well understood.  It is also not known whether 
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methods of administration or spinal technique related factors affect the likelihood of 
the condition developing. Treatment regimes, both from a medical or nursing 
standpoint, would be useful in the management and prevention of both profound 
intrathecal morphine related hypothermia and the more commonplace inadvertent 
perioperative hypothermia that occurs after caesarean section surgery.  It is not yet 
known whether preoperative warming would benefit the population of women 
receiving intrathecal morphine for caesarean section.  
 
2.9 SUMMARY 
Inadvertent perioperative hypothermia in women undergoing neuraxial anaesthesia 
for caesarean section is a significant clinical issue and there is a lack of guidance to 
assist health care practitioners to prevent or treat this condition. Practical 
considerations specific to the obstetric population may limit the usefulness of 
warming interventions currently used for the general surgical population.  In 
addition, a subset of women may develop profound and prolonged hypothermia after 
neuraxial anaesthesia for caesarean section: this is thought to be related to the use of 
intrathecal morphine for prolonged analgesia. Limited research has been conducted 
on this topic and the existing evidence mainly comprises of case reports.  Even for 
those women not experiencing profound and prolonged hypothermia, intraoperative 
warming appears to have been less effective in the population of women receiving 
intrathecal morphine, however the use of preoperative warming, particularly in 
relation to timing and duration, has not yet been tested. Thus, effective treatment and 
prevention regimes for this population are yet to be confirmed.  
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Chapter 3: Effectiveness of Warming 
Interventions on Maternal Core 
Temperature for Women 
Undergoing Caesarean Section. 
3.1 INTRODUCTION 
Given that systematic reviews form the highest level of evidence ((NHMRC 1999) 
providing a basis for evidence-based health care recommendations (Merlin, Weston, 
& Tooher, 2009) and that a lack of synthesised evidence was found regarding the 
management of perioperative hypothermia amongst women undergoing caesarean 
section, a systematic review was developed to address this deficit.  This systematic 
review was based upon a published protocol (Munday, Hines, & Wallace, 2012), 
developed by the author, following the methodology of the Joanna Briggs Institute 
(JBI) for the systematic review of quantitative evidence. The review included 12 
studies deemed to be of sufficient quality for inclusion in the review, utilising both 
meta-analysis and narrative analysis to form recommendations for practice and 
further research. The full version of the review was published in the JBI Database of 
Systematic Reviews and Implementations Reports (Munday et al., 2013) and is 
included in Appendix A. Several publications arose from the full systematic review 
including a shortened version of the review (Munday et al., 2014), the full published 
JBI review (Munday et al., 2013), and a JBI Best Practice Information Sheet (Giles et 
al., 2013). The following publication will be presented in this chapter: Munday J, 
Hines S, Wallace K, Chang AM, Gibbons K, Yates P. A systematic review of the 
effectiveness of warming interventions for women undergoing caesarean section. 
Worldviews on Evidence-Based Nursing. 2014. 11(6): 383-393. (Munday, et al., 
2014) 
The JBI MAStARI Appraisal Tool for Randomised Controlled Trials, utilised in the 
review, is included in Appendix B. Also included as appendices are the search 
strategy (Appendix C), search results (Appendix D), verification of study eligibility 
form (Appendix E), customised data extraction instrument (Appendix F), included 
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studies (Appendix G), excluded studies (Appendix H) and the JBI Levels of 
Evidence (Appendix I).  
In addition to the primary outcome of maternal core temperature, the full review 
(Munday et al., 2013) included the secondary outcomes of maternal shivering, 
maternal thermal comfort, length of stay in PACU (Post Anaesthetic Care Unit), 
newborn temperature measured at birth, Apgar scores at 1, 5 and 10 minutes, and 
newborn umbilical pH. The results for these secondary outcomes will be presented in 
the following Chapter 4.   
 
3.1.1 Contribution of Authors 
The concept for the systematic review was based upon the deficit of synthesised 
evidence for the prevention of perioperative hypothermia (as established in Chapter 
1), and also arose from my previous evidence-based practice project in the area of 
perioperative hypothermia for the general adult population, as well as my area of 
practice in the obstetric PACU caring for many women experiencing perioperative 
hypothermia. 
The author team for the systematic review was J Munday, S Hines, K Wallace, K 
Gibbons and P Yates. I am identified as the principal and corresponding author, 
based on the criteria specified by the International Committee of Medical Journal 
Editors (ICMJE 2016), and the primary reviewer for this review (see Appendix J, 
Statement of Contributions). 
 
3.2 PUBLISHED SYSTEMATIC REVIEW (WORLDVIEWS ON 
EVIDENCE-BASED NURSING) 
Abstract 
Background: Women undergoing caesarean section are vulnerable to adverse effects 
associated with inadvertent perioperative hypothermia, but there has been a lack of 
synthesized evidence for temperature management in this population. This 
systematic review aimed to synthesize the best available evidence in relation to 
preventing hypothermia in mothers undergoing caesarean section surgery.  
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Methods:  Randomised controlled trials meeting the inclusion criteria (adult patients 
of any ethnic background, with or without co-morbidities, undergoing any mode of 
anaesthesia for any type of caesarean section) were eligible for consideration.  Active 
or passive warming interventions versus usual care or placebo, aiming to limit or 
manage core heat loss in women undergoing caesarean section were considered. The 
primary outcome was maternal core temperature. A comprehensive search, with no 
language restrictions, was undertaken of multiple databases from their inception until 
May 2012. Two independent reviewers using the standardized critical appraisal 
instrument for randomised controlled trials from the Joanna Briggs Institute Meta-
Analysis of Statistics Assessment and Review Instruments (JBI-MASTARI) assessed 
retrieved papers for methodological quality and conducted data collection. Where 
possible, results were combined in a fixed effects meta-analysis using the Cochrane 
Collaboration Review Manager software. Due to heterogeneity for one outcome, 
random effects meta-analysis was also used. 
 
Results: A combined total of 719 participants from 12 studies were included. 
Intravenous fluid warming was found to be effective at maintaining maternal 
temperature and preventing shivering. Warming devices, including forced air 
warming and under-body carbon polymer mattresses, were effective at preventing 
hypothermia. However, effectiveness increased if applied preoperatively. 
Preoperative warming devices reduced shivering and improved neonatal 
temperatures at birth. Intravenous fluid warming did not improve neonatal 
temperature and the effectiveness of warming interventions on umbilical pH remains 
unclear.   
 
Linking Evidence to Action: Intravenous fluid warming by any method improves 
maternal temperature and reduces shivering during and after caesarean section, as 
does preoperative body warming. Preoperative warming strategies should be utilized 
where possible. Preoperative and/or intraoperative warmed IV fluids should be 
standard practice. Warming strategies are less effective when intrathecal opioids are 
administered.  Further research is needed to investigate interventions in emergency 
caesarean section surgery. Larger scale studies using standardized, clinically 
meaningful temperature measurement time points are required.  
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Introduction  
Women undergoing caesarean section are vulnerable to perioperative core 
temperature decline in part due to vasodilation and neuraxial anaesthesia (Dunn, 
York, Cheek, & Yeboah, 1993). Inadvertent perioperative hypothermia (IPH), 
defined as a core temperature below 36°C related to undergoing surgery (NCCNSC, 
2008) is a common, but detrimental, condition with serious adverse effects, affecting 
both mothers and neonates. Babies born to hypothermic mothers may be at risk of 
lower temperatures, umbilical pH and Apgar scores at birth (Petsas, Vollmer, & 
Barnes, 2009, Horn et al., 2002). In addition, IPH has potential to adversely affect 
maternal experiences due to discomfort and disruption from shivering, which can 
impair the mother’s ability to initiate breastfeeding. 
Earlier systematic reviews (Galvao, Liang, & Clark, 2010; Moola & Lockwood, 
2011) and guidelines for IPH management (AORN, 2007; ASPAN, 2001; Hooper et 
al., 2010; NCCNSC, 2008) focus on adults or all age populations, and have excluded 
pregnant or caesarean section patients.  Evidence-based IPH guidelines are required 
for this population as not all established recommendations targeting the general 
population are transferable to caesarean section patients (Chakladar & Harper, 2010). 
Practical problems may exist with forced air warming (recommended by NICE 
(NCCNSC 2008)) for obstetric patients (Chakladar, Dixon, & Harper, 2011; 
Chakladar & Harper, 2010; Petsas et al., 2009). Any risks associated with warming 
may be magnified for pregnant patients as maternal overheating or high maternal 
body temperature may also adversely affect fetal wellbeing (Lieberman et al., 2000).   
In addition, thermoregulatory responses of pregnant women may influence the 
effectiveness and appropriateness of warming; for example, vasodilation is 
exacerbated by neuraxial anaesthesia and oxytocics, thus heat loss is increased (Liu 
& Luxton, 1991). If not managed, the rate of hypothermia in patients undergoing 
spinal anaesthesia for caesarean section could be as high as 80% (Harper & 
Alexander, 2006). However, hypothermia is usually initially undetected during 
neuraxial anaesthesia due to a lack of temperature monitoring (Arkiliç, Akça, 
Taguchi, Sessler, & Kurz, 2000; Sessler, 1997) and behavioural thermoregulation 
impairment (Arkiliç et al., 2000). Even in small amounts, intrathecal morphine is 
known to be associated with hypothermia (Hui et al., 2006). Cephalic spread of 
intrathecal morphine is proposed to decrease the thermoregulatory set point (Hess, 
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Snowman, & Wang, 2005) which may explain the paradoxical symptoms sometimes 
found with intrathecal morphine- associated hypothermia, whereby diaphoresis 
alongside hypothermia has been observed (Hess et al., 2005). As active warming 
may not be tolerable for these patients, thermal maintenance in patients given 
intrathecal morphine presents a greater challenge.  
This review seeks to synthesize the best available evidence, and to address the lack 
of existing guidance, for the outcome of hypothermia prevention in mothers 
undergoing caesarean section by providing recommendations specifically for this 
population. Differences in effectiveness for warming interventions between different 
modes of anaesthesia for caesarean section are also examined.  This article is derived 
from a published systematic review (Munday, et al. 2013) which also included 
further outcomes relating to maternal shivering, thermal comfort, neonatal 
temperature at birth, Apgar scores and umbilical pH, which was developed from a 
published systematic review protocol (Munday, Hines, & Wallace, 2012). 
Objectives The main objective of this review was to synthesize the best available 
evidence on the effectiveness to prevent hypothermia in women undergoing 
caesarean section.  The review also asked whether there were any differences in 
effectiveness between patients undergoing different modes of anaesthesia for 
caesarean section.  
 
 
Methods 
Inclusion criteria 
Participants The review included adults over the age of 18 years, of any ethnic 
background, with any co-morbidities, undergoing either elective or emergency 
caesarean section under any mode of anaesthesia (spinal, epidural, combined spinal-
epidural or general anaesthesia), receiving interventions to prevent or treat heat loss.  
Interventions This review included active or passive warming interventions versus 
usual care or placebo applied to women undergoing caesarean section surgery, 
applied either preoperatively or intraoperatively. Active warming interventions 
include forced air warming devices, warmed intravenous fluids, warmed mattresses 
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and warmed coverings.  Passive warming interventions include unheated coverings, 
such as leg wrapping.  
 
Outcomes 
Primary outcome. Maternal core temperature, measured during the preoperative, 
intraoperative and postoperative phases. 
Secondary outcomes.  Maternal shivering, maternal thermal comfort, length of stay 
in PACU (Post Anaesthetic Care Unit), newborn temperature measured at birth, 
Apgar scores at 1, 5 and 10 minutes, and newborn umbilical pH (results for 
secondary outcomes available in the full published version of this review; Munday et 
al. 2013). 
Study Design Any randomised controlled study that met the inclusion criteria with 
reduction of perioperative hypothermia as a primary or secondary outcome was 
considered.  
Search Strategy The electronic search sought published, unpublished and grey 
literature, in any language in CINAHL, Embase, ProQuest, Web of Science, Scopus, 
Current Contents, CENTRAL, Dissertation and Theses PQDT (via ProQuest), 
Mednar, Open Grey and Clinical Trials, from the inception of the databases until 
May 2012.  The full search strategy is available within the full published systematic 
review (Munday, et al. 2013). Initial keywords included: perioperative or 
preoperative or intraoperative, surgical, temperature or core temperature, 
thermoregulation, hypothermia, shivering, Caesarean section, Caesarean delivery, 
parturient, maternal, warming, active warming, passive warming.  
 
Review methods.  The full article was retrieved for all those search results that 
appeared to meet the inclusion criteria, and were assessed for relevance to the review 
using a form developed by the reviewers and based on the recommendations of the 
Cochrane Collaboration (Higgins & Deeks, 2011). Two independent reviewers 
assessed methodological quality of papers using the standardized critical appraisal 
instrument for RCTs from JBI-MASTARI (see Appendix I and II). Disagreements 
regarding three papers were adjudicated by consultation with the third reviewer.  
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Two independent reviewers extracted data using the previously piloted data 
extraction tool, based on the JBI data extraction tool for quantitative studies.  
Additional information was requested from authors of five included studies 
(Chakladar, Dixon, & Harper, 2012; Chung et al., 2012; Fallis, Hamelin, Symonds, 
& Wang, 2006; Reidy, Preston, Douglas, Sherlock, & Tyler, 2008; Woolnough, 
Allam, Hemingway, Cox, & Yentis, 2008), three of whom provided additional 
information (Chakladar et al., 2012; Fallis et al., 2006; Reidy et al., 2008).  
Where meta-analysis was possible, results were combined in a fixed effects meta-
analysis using the Cochrane Collaboration Review Manager software (RevMan 5.2; 
The Nordic Cochrane Centre, Copenhagen, Denmark). Due to heterogeneity for one 
comparison and outcome, random effects meta-analysis was also used. Results of the 
meta-analysis are presented using odds ratio (OR; for categorical data) and weighted 
mean difference (for continuous data), along with their 95% confidence intervals 
(CI).  Heterogeneity was assessed using the standard Chi-square test and I2.  
Standard deviation (SD) was calculated from the standard error of the mean (SEM; 
Rosner, 2011; The Joanna Briggs Institute, 2008) reported for one study (Smith et al., 
2000). Variations between studies, particularly the time points of temperature 
measurements, meant that only limited meta-analyses were possible.  The remaining 
data were synthesized into a narrative summary.   
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Results  
A combined total of 719 participants from 12 randomised controlled trials (RCTs) 
were included (Figure 1). Mode of anaesthesia was spinal or epidural anaesthesia in 
the majority of studies.  Maternal core temperature measurement method varied 
widely but although there are reliability issues between sites the choice of site was 
not used as a basis for exclusion.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Flowchart of study retrieval and selection 
 
Total number of papers 
identified from database 
searches: n=2467 
Total papers after removal of 
duplicates, title/abstract 
checking: n= 86 
Studies for critical appraisal: 
n= 26 
Studies for inclusion in the 
review: n= 12 
 
Papers excluded after removal 
of duplicates, title/abstract 
checking: n= 2381 
Papers excluded after 
verification of relevance to 
study criteria: n=62   
 
 
 
Papers excluded after critical 
appraisal: n= 14 
Addition of papers identified 
from reference lists: n= 2  
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Warmed versus unwarmed IV fluids 
Seven studies (Chan, Morley-Forster, & Vosu, 1989; Chung et al., 2012; Goyal  
Kundra, S., Grewal, A., Kaul, T.K., Singh, M.R., 2011; Oshvandi et al., 2011; Smith  
et al 2000; Woolnough et al., 2008; Yokoyama et al., 2009) compared intravenous 
fluid (IV) warming with other interventions, with most using room temperature 
fluids as a comparator (Chan et al., 1989; Goyal  et al., 2011; Oshvandi et al., 2011; 
Smith  et al., 2000; Yokoyama et al., 2009). Wide variation exists in methods of both 
fluid warming and administration temperatures. Warming cupboards were used in 
four studies, (Chan et al., 1989; Chung et al., 2012; Woolnough et al., 2008; 
Yokoyama et al., 2009) with temperature settings ranging between 38-45°C. Two 
studies (Chung et al., 2012; Woolnough et al., 2008) measured the administration 
temperature of the fluids at the distal end, and found this to be 37-38°C.  The fluid 
warmers used in three studies were Hotline™ (Smith et al., 2000; Woolnough et al., 
2008) and Astotherm™ (Goyal et al.,   2011). Fluids in these studies were warmed to 
42°C (Smith et al., 2000; Woolnough et al., 2008) and 39°C (Goyal   et al., 2011).   
Water baths were also utilized in two studies (Oshvandi et al., 2011; Yokoyama et 
al., 2009) as a secondary method of warming the IV tubing to maintain the 
temperature of the fluids already warmed in a warming cupboard (Yokoyama et al., 
2009). The commonly used comparator was ‘room temperature’ fluids which 
typically ranged from 20-25°C (Chan et al., 1989; Goyal et al., 2011; Oshvandi et al., 
2011; Smith et al., 2000; Yokoyama et al., 2009).  
Two studies of IV fluid warming were combined using meta-analysis for mean 
maternal temperature on arrival to PACU (Figure 2) (Goyal et al., 2011; Smith et al., 
2000). The two combined studies compared the temperature on arrival to PACU for 
women receiving intravenous fluids at room temperature (22°C and 20-22°C) (Goyal  
et al., 2011:Smith  et al., 2000) versus women receiving intravenous fluids warmed 
via a fluid warmer to either 39°C (Goyal  et al., 2011) or via Hotline™ to 42°C 
(Smith  et al., 2000). The administration of warmed IV fluids compared to room 
temperature fluids at 20-22°C resulted in a significantly higher mean temperature on 
arrival to PACU (mean difference 0.30, 95% CI 0.11-0.49).  
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Figure 2: Intravenous fluid warming versus room temperature fluids and mean 
maternal temperature on arrival to PACU  
 
IV fluid warming was also effective for the outcome of mean maternal temperature 
after 30 minutes in PACU (Figure 3), showing the higher mean temperature persisted 
into the recovery phase (mean difference 0.51, 95% CI 0.35-0.68) (Goyal et al., 
2011; Smith et al., 2000). 
 
Figure 3: Intravenous fluid warming versus room temperature fluids and mean 
maternal temperature at 30 minutes in PACU  
 
Smith et al. (2000) also demonstrated a significantly higher maternal temperature at 
discharge from recovery in the warmed IV fluid group (36.5°C, SD: +/- 0.6°C versus 
36.1°C, SD: +/- 0.6°C, p <0.05), but the lack of discharge temperature time points in 
other fluid warming studies limits comparability.   
Warmed IV fluids and reflective blanket resulted in higher tympanic maternal 
temperature (via thermocouple) at the time of delivery (36.7°C, SD: +/- 0.3°C) 
versus unwarmed IV fluids and reflective blanket (36.2°C, SD +/- 0.3°C), p <0.05 
and repeated measures analysis of variance indicated this higher temperature 
remained at 15 minutes, 30 minutes and 45 minutes after delivery (36.4° C, SD +/- 
0.2°C) versus (35.5°C, SD +/- 0.3°C, p<0.05) (Yokoyama et al., 2009). Another 
study (Oshvandi et al., 2011) found the average core temperature at the end of 
anaesthesia was also higher in patients administered pre-surgery warmed IV fluids 
versus room temperature fluids  (36°C, SD: +/- 0.5°C versus 35.34°C, SD: +/- 
0.06°C, p<0.05).  
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A comparison of warmed IV fluids via Hotline™ versus room temperature fluids at 
multiple temperature measurement time points found a significantly greater number 
of hypothermic (<36°C) patients at the end of surgery for the unwarmed group 
(24/32 patients or 75%) versus 16/32 patients (46%) in the warmed group, p <0.05 
(Smith et al., 2000). In addition, a significantly lower core final temperature for the 
unwarmed (control) group (35.6 °C, SD: +/- 0.7°C versus 36.1°C, SD: +/- 0.6°C in 
the warmed group, p <0.05) was also found.    
Patients receiving warmed IV fluids plus warmed skin preparation fluids and extra 
clothing versus those receiving room temperature fluids had significantly higher 
mean aural and bladder temperatures between baseline to PACU arrival (p<0.05; 
Chan et al., 1989). There was a 1.0°C (SD: +/- 0.02°C) drop in mean bladder 
temperature between baseline and arrival in PACU for the control group versus a 
drop of 0.6°C in the intervention group (SD +/- 0.01°C) (p<0.05).  Aural temperature 
decline from baseline to PACU arrival was 0.9°C (SD +/- 0.06°C) in the control 
group versus 0.5°C (SD +/- 0.04°C) in the intervention group (p<0.05).  
Aural temperature was significantly higher at 60 minutes after induction of 
anaesthesia or in the recovery phase in three studies (Chung et al., 2012; Oshvandi et 
al., 2011; Woolnough et al., 2009) for those who received warmed fluid preload 
versus room temperature fluids. Although a statistically significantly higher mean 
aural temperature was found in women receiving warmed intravenous fluid preload 
(35.9°C SD +/- 0.5°C) compared to those receiving room temperature fluid preload 
(35.4°C SD +/- 0.6°C, p=0.001) in one study, both results are below the cut-off for 
hypothermia thereby reducing clinical significance (Oshvandi et al., 2011).  
Similarly, another study of warmed fluid preload versus room temperature preload 
versus forced air warming (Chung et al., 2012) found that the greatest temperature 
decrease during the 60 minutes after CSE insertion was by the room temperature 
group (0.4°C difference, 95% CI 0.2-0.6°C, p=0.015). 
Finally, a three group study comparing warmed IV fluids via Hotline™ versus 
cabinet warmed IV fluids versus room temperature fluids found a significantly 
greater mean infrared aural temperature decrease in the room temperature group 
during the first 60 minutes following CSE, although the authors only report results 
for the decrease in room temperature fluids (0.4°C (95% CI 0.2-0.6°C, p=0.015) 
(Woolnough et al., 2008). Warmed IV fluids administered both pre surgery and 
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during surgery appear to have benefits for increasing maternal temperature, as 
measured in the latter intraoperative phase and into the recovery phase until 
discharge.  
 
Warming Devices 
Five studies of warming devices were included (Table 1).  Data are largely presented 
by narrative analysis due to clinical heterogeneity (see Table 1). Three forced air 
warming studies used a 43°C setting for participants (Chung et al., 2012; Fallis et al., 
2006; Horn et al., 2002) however in one of these studies (Fallis et al., 2006) heat 
settings were changed for some participants (one participant commenced on the 
lower setting of 38°C before progressing to the high setting, while 14 of 32 
participants commenced on the higher setting before subsequently adjusting to a 
lower setting). 
Table 1 Forced air warming studies: intervention and comparison groups 
Study  Intervention/s Control  Control 2  
Forced air 
warming 
Warmed 
IV fluids 
Covering / 
blanket 
Warmed 
IV fluids 
Covering / 
blanket 
Warmed 
IV fluids 
Fallis et al., 
2006 
Upper body 
forced air 
warming 
Yes Warmed 
cotton 
blanket 
Yes n/a n/a 
Horn et al., 
2002 
Upper body 
forced air 
warming 
Yes Single 
cotton 
blanket 
Yes n/a n/a 
Chung et al., 
2012 
Upper body 
forced air 
warming 
No Forced air 
warming 
blanket 
switched 
OFF 
Yes Forced air 
warming 
blanket 
switched 
OFF 
No 
Chakladar et 
al., 2011 
Under body 
carbon 
polymer 
warming 
switched 
ON 
Yes Carbon 
polymer 
warming 
blanket 
switched 
OFF 
Yes n/a n/a 
Reidy et al., 
2008 
Under body 
forced air 
warming 
Yes ‘standard 
care’ 
warmed 
cotton 
blankets  
Yes n/a n/a 
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Chakladar et al.’s unpublished study (Chakladar et al., 2012) of a carbon polymer 
mattress turned on to 40°C versus a carbon polymer warming mattress turned off 
(and warmed IV fluids to 41°C in both groups) found a significantly lower incidence 
of IPH, both statistically and clinically, in the intervention group (3/58 participants) 
versus the control group (11/58 participants, p = 0.043), but the statistical test was 
not specified. 
Reidy et al.’s (2008) unpublished study of a forced air warming mattress versus 
‘standard care’ found a significant difference between groups in mean maternal 
temperature on entering PACU: 36.1°C (SD +/- 0.4°C) in the intervention group 
versus 35.7°C (SD +/- 0.5°C) in the control group (p=0.01).  The mean difference for 
the two studies, when combined using random effects meta-analysis, favours under 
body warming in comparison to warmed cotton blankets or warmed IV fluids alone, 
for initial admission temperature to PACU (0.29, 95%CI 0.09 to 0.48; see Figure 4). 
Moderate heterogeneity (Deeks, Higgins, Altman, 2011) as indicated by the I2 value 
(Figure 4) is noted and there are some differences in the interventions.  Both studies 
utilized under-body warming. However, a carbon polymer mattress at 40°C was used 
by Chakladar and colleagues (2012), whereas a forced air mattress at 38°C was used 
by Reidy et al (2008). Control participants in one study received the under-body 
mattress turned off and warmed IV fluids (Chakladar et al., 2012), whereas the 
control group in the other study received two warmed cotton blankets plus warmed 
IV fluids (Reidy et al. 2008). Chakladar et al. (2012) used temporal artery 
measurements to assess maternal temperature, whereas Reidy et al. (2008) used oral 
thermometers. 
 
 
Figure 4 Under body warming mattress versus control and temperature (°C) on 
PACU arrival. 
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Chung et al. (2012) reported statistically significant differences (p=0.004) between 
‘core’ temperature decreases (as measured by aural infrared thermometry) at 45 
minutes, reporting less temperature decrease in patients in the warmed IV fluid (-
0.5°C SD: +/- 0.3°C) and forced air prewarming groups (-0.6°C SD: +/- 0.4°C) than 
in the control group: (–0.9°C SD: +/- 0.4°C), although the statistical test is not 
specified. 
Table 2 Upper body forced air warming, final maternal OT temperature and 
variations between studies. 
  
Study Ambient  
OT temp* (°C) 
Anaesthet
ic Mode 
Opioid Warming 
(timing) 
Final maternal temperature 
in OT * (°C) 
Interventi-
on  
Control Interve-
ntion 
Control P 
value 
Fallis 
et al., 
2006  
Entrance: 
21.6 ± 1.2. 
Exit: 23 ± 
1.2. 
Entrance: 
21.6 ± 0.9 
Exit: 22.2 
±0.6 
Spinal Intrathecal 
morphine  
Fentanyl 
citrate  
Intraopera
-tive 
36.1°C± 
0.4°C 
35.9°C ±  
0.4°C 
NS (via 
independe
nt t test)  
Horn 
et al., 
2002 
23.9± 0.5 24.1 ± 0.3 Epidural  Nil  Preoperati
-ve and 
intraopera
-tive 
37.1°C 
± SD 
0.4°C 
36.0°C ± 
0.5°C 
<0.05 
(via 
Student’s t 
test) 
* mean and SD 
 
Fallis et al.’s (2006) study of intraoperative upper body forced air warming also 
reported mean oral temperature decrease during the procedure up to 60 minutes 
(thereafter data was omitted due to decreased sample size). Mean temperature 
decrease was not statistically or clinically significant: -0.8°C SD: +/- 0.5°C (control 
group) versus -0.7°C SD: +/-0.4°C (intervention group) via repeated measures 
ANOVA (p=0.508). Differences in the mean final temperature on exit from the 
operating theatre were also not statistically significant (35.9°C SD: +/- 0.4°C in the 
control group versus 36.1°C SD: +/- 0.4°C in the intervention group, p=. 189). 
In contrast to Fallis et al.’s (2006) study, significantly (p<0.001) higher operating 
room final temperatures were found in patients in Horn et al.’s (2002) prewarming 
study for the forced air warming group where participants received 15 minutes of 
forced air prewarming plus intraoperative warming (37.1°C SD: +/- 0.4°C) versus 
(36.1°C SD +/- 0.5°C) in the control group.   
These results suggest that forced air preoperative warming plus intraoperative 
warming is more effective at maintaining maternal intraoperative temperature than 
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intraoperative forced air warming alone.  The strongest results for forced air warming 
for maternal temperature maintenance during caesarean section thus far have been 
achieved from preoperative application.  Although under body warming mattresses 
achieved higher maternal core temperatures in comparison with warmed cotton 
blankets, there were few studies examining this intervention.  
One study (Sun et al., 2004) compared tight versus loose elastic bandage leg 
wrapping in women undergoing elective caesarean section under epidural 
anaesthesia, where reduction of hypothermia was a secondary outcome. Maternal 
sublingual temperature was recorded every three minutes35 at five ‘observation 
times’, however only baseline and delivery results were reported, with no significant 
differences and no p values reported (tightly wrapped group 36.5°C, SD: +/- 0.4°C at 
delivery versus the loosely wrapped group 36.4°C, SD: +/- 0.3°C), with the average 
reduction from baseline to delivery also given: tightly wrapped group (0.4°C, SD: 
0.2°C) versus loosely wrapped group (0.5°C, SD: 0.3°C). From this single study, leg 
wrapping presented no benefits for maintaining maternal temperature, however, these 
observations should be considered with caution as they are only derived from a 
single study.  
 
Conclusions 
This review includes 12 RCTs in three broad categories of interventions within the 
specific population of women undergoing caesarean section.  Methodological issues, 
variations in outcome measurement methods, insufficient homogeneity of control 
groups between the studies and in some cases limited extractable data reduced 
synthesis by meta-analysis and thus the strength of recommendations made by this 
review. Wide but subtle variations in treatments also impacted on homogeneity. 
Although there are questions about the reliability and accuracy of the wide range of 
temperature measurement devices and routes used across all included studies, this 
was beyond the scope of this review. Consistency of the core temperature 
measurement route within studies was considered as vital, and an indicator of the 
quality of outcome measurements. 
Variations in hypothermia definition were evident despite increasing guidance that 
core temperatures below 36°C should be considered as hypothermic in perioperative 
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patients (ASPAN, 2001; Hooper et al., 2010; NCCNSC, 2008). In this review, these 
variations did not cause difficulties as studies tended to report temperature decline. 
As the <36°C indicator for hypothermia becomes more widely accepted and 
incorporated into practice guidelines, its usefulness in clinical studies will increase.  
As there were too few included studies that utilized different modes of anaesthesia, 
no assessment of effectiveness of interventions in relation to anaesthesia mode was 
possible.  However, forced air warming was less effective where participants 
received intrathecal morphine (Fallis et al., 2006; see Table 2). Addition of 
intrathecal opioids, in particular morphine, may have influenced the degree and 
incidence of hypothermia and therefore the effectiveness of interventions included in 
this review. The use of opioids is not clear in all studies, therefore limiting the 
analysis of this issue.   
Findings that warmed IV fluids are effective in maintaining normothermia are 
consistent with an earlier systematic review of a broad population (Moola & 
Lockwood, 2011), and support NICE guidance (NCCNSC, 2008) that has so far 
applied to only non-pregnant patients. NICE guidelines support the warming of 
fluids to 37°C for volumes of 500mls and above (NCCNSC, 2008). All but one 
(Chan et al., 1989) of the included fluid warming studies in this review warmed 
fluids to 37°C or above. When fluids were warmed to a lower temperature of 36.5°C 
(Chan et al., 1989) a reduction in heat loss in the warmed group was still found. This 
review does not make a recommendation of one method of warming fluids over 
another. Warmed IV fluids should be standard practice for maintaining 
normothermia for patients undergoing caesarean section, as they are easy to 
administer and do not appear to cause practical concerns for patients and caregivers.  
The effectiveness of preoperative warming strategies in this population is confirmed 
by this review. Again, this recommendation had previously been provided for either 
general population groups (Moola & Lockwood, 2011) or non-pregnant patients 
(NCCNSC, 2008). Preoperative warming provides clinical value in reducing 
intraoperative heat loss even if used for relatively short periods and may be cost-
effective, especially if utilizing existing resources. Horn et al (Horn et al., 2002) 
emphasize that warming prior to epidural insertion precedes the vasodilation that 
contributes to hypothermia. The overall effectiveness of intraoperative, as opposed to 
preoperative, upper body forced air warming is less clear. Horn et al. (2002) found a 
 Chapter 3: Effectiveness of Warming Interventions on Maternal Core Temperature for Women Undergoing 
Caesarean Section. 43 
combination of both preoperative and intraoperative warming to be effective, 
however Fallis et al. (2006) found that intraoperative warming alone did not maintain 
normothermia, although the potential influence of intrathecal opioids administered in 
this study should be considered. Table 2 also details differences in mode of 
anaesthesia and ambient temperature between studies.  
Concerns regarding practicality and tolerability in pregnant patients were not 
widespread within these studies. The inability to tolerate active warming were found 
by participants in one upper-body warming study, (Fallis et al., 2006) during which 
some participants adjusted to a lower setting (and one participant commenced on a 
low setting before increasing). Forced air warmers are generally designed to progress 
to a lower setting automatically after a certain period if the highest setting is chosen. 
Therefore, the reduction in the temperature setting in Fallis et al.’s (2006) study does 
not appear to be extraordinary.  Fallis et al. (2006) also found that thermal comfort 
was enhanced by active warming. This suggests the request to reduce the device 
temperature setting by some participants does not signify widespread warming 
related thermal discomfort.  
Clinician concerns that upper body warming blankets present practical difficulties - 
especially after delivery - were not an issue in the forced air warming studies in this 
review (Chakladar et al., 2011; Petsas et al., 2009). Practical difficulties regarding 
intraoperative upper-body forced air warming may be addressed by preoperative 
application. In addition, active under-body or lower-body warming may assist with 
these concerns. Unfortunately no lower body warming studies were of sufficient 
quality for inclusion. Tolerability of under-body warming in terms of discontinuation 
of warming via carbon polymer mattress was required for one participant out of 58 
who found the intervention too hot (Chakladar et al., 2012). Further study of the 
effectiveness of carbon polymer mattresses would be beneficial, particularly in 
comparison to forced air warming mattresses, and also in emergency caesarean 
section situations where it is suggested that they may make clinical differences, 
reducing preparation time (Chakladar et al., 2012).  
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Limitations 
Limitations of this review include a predominance of studies of elective patients, 
therefore limiting applicability to the emergency caesarean section population, which 
may have resulted in introducing a risk of bias into the review. Also studies were 
mainly small scale. Meta-analysis was limited due to the clinical heterogeneity of the 
included studies. Analysis of intraoperative temperature was reduced due to the 
many variations in temperature reporting points and temperature measurement 
methods.  
Industry sponsorship in the form of equipment donations for 3 of the 12 included 
studies (Fallis et al., 2006, Horn et al. 2002, Woolnough et al., 2009) could be seen 
as a limitation to the overall results of this review, however none of these studies 
contributed to meta-analyses for the outcome of maternal warming.  
 
Linking Evidence to Action 
• Preoperative warming interventions lead to improved maternal 
thermoregulation in caesarean section surgery and should be used whenever possible. 
• Intravenous fluid warming increased intraoperative and postoperative 
temperatures, whether given as a preload or intraoperatively. 
• Upper-body forced air warming applied preoperatively achieved better 
temperature maintenance than if only applied intraoperatively. 
• Warming appears to have less effect when intrathecal opioids are 
administered, however, further investigation into this factor is required.  
• Findings from this review, in relation to IV fluid warming and 
preoperative forced air warming, confirm that recommendations made for general 
adult groups may be applied to the population of women undergoing caesarean 
section surgery under neuraxial anaesthesia.  
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Implications for research 
 
Future studies should be directed to use standardized and clinically meaningful 
temperature measurement time points including primary endpoints, thus facilitating 
analysis and comparisons of effectiveness of these interventions. Research is needed 
to investigate the effectiveness of interventions in emergency caesarean section 
surgery, as well as studies of the efficacy of lower-body in comparison to upper-body 
warming, and the use of under-body warming mattresses.  
  
 Chapter 3: Effectiveness of Warming Interventions on Maternal Core Temperature for Women Undergoing 
Caesarean Section. 46 
References  
Arkiliç, C.F., Akça, O., Taguchi, A., Sessler, D.I., Kurz, A. (2000). Temperature 
monitoring and management during neuraxial anesthesia: an observational study. 
Anesthesia & Analgesia, 91(3), 662-666. 
 
American Society of PeriAnesthesia Nurses. (2001). Clinical guidelines for the 
prevention of unplanned perioperative hypothermia. Journal of PeriAnesthesia 
Nursing, 16(5), 305-314. 
 
Association of Operating Room Nurses ARP Committee. (2007). Recommended 
Practices for the prevention of unplanned perioperative hypothermia. AORN Journal, 
85(5), 972-4, 976-84, 986-8. 
 
Chakladar, A., Dixon, M.J., & Harper, C.M., (2011) Warming mattress to prevent 
inadvertent perioperative hypothermia and shivering during elective Caesarean 
Section. British Journal of Anaesthesia. 107(2), 290P-291P.  
 
Chakladar, A., Dixon, M.J., & Harper, C.M., (2012) Actively warming patients with 
a mattress during Caesarean section reduces the incidence of hypothermia and 
attenuates fall in haemoglobin (abstract). Brighton and Sussex University Hospitals 
NHS Trust. 
 
Chakladar, A., Harper, C.M. (2010). Peri-operative warming in caesarean sections: 
guidance would be NICE. Anaesthesia, 65(2), 212-213. 
 
Chan, V.W., Morley-Forster, P.K., & Vosu, H.A. (1989) Temperature changes and 
shivering after epidural anesthesia for cesarean section. Regional Anesthesia, 14(1), 
48-52. 
 
 Chapter 3: Effectiveness of Warming Interventions on Maternal Core Temperature for Women Undergoing 
Caesarean Section. 47 
Chung, H.S., Lee, B-S., Yang, H.J., Kweon, K.S., Kim, H-H., Song, J., & Shin, D.W. 
(2012). Effect of preoperative warming during cesarean section under spinal 
anaesthesia.  Korean Journal of Anesthesiology, 62(5), 454-460. 
 
Deeks, J.J., Higgins, J.P.T., & Altman, D.G. (2011).  Chapter 9: Analysing data and 
undertaking meta-analyses, in J.P.T Higgins, S.Green, & The Cochrane 
Collaboration (Eds.), Cochrane Handbook for Systematic Reviews of Interventions 
(version 5.1.0). Chichester, England: Wiley-Blackwell. Available at: 
http://handbook.cochrane.org/ 
 
Dunn, P, A., York, Y., Cheek, T.G., & Yeboah, K. (1993). Maternal Hypothermia: 
Implications for Obstetric Nurses. Journal of Obstetric, Gynecologic, & Neonatal 
Nursing, 23(3), 238-242. 
 
Fallis, W.M., Hamelin, K., Symonds, J., & Wang, X. (2006). Maternal and newborn 
outcomes related to maternal warming during cesarean delivery. Journal of Obstetric, 
Gynecologic, & Neonatal Nursing, 35(3), 324-31. 
 
Galvao, C., Liang, Y., Clark, A. (2010) Effectiveness of cutaneous warming systems 
on temperature control: meta-analysis. Journal of Advanced Nursing, 66(6), 1196-
1206 
 
Goyal, P., Kundra, S., Grewal, A., Kaul, T.K., & Singh, M.R.  (2011). Efficacy of 
intravenous fluid warming for maintenance of core temperature during lower 
segment cesarean section under spinal anesthesia. Journal of Obstetric Anaesthesia 
and Critical Care, 1(2), 73-77. 
 
Harper, C.M., & Alexander, R. (2006). Hypothermia and Spinal Anesthesia. 
Anaesthesia, 61(6), 612. 
 
 Chapter 3: Effectiveness of Warming Interventions on Maternal Core Temperature for Women Undergoing 
Caesarean Section. 48 
Hess, P.E., Snowman, C.E., & Wang, J. (2005) Hypothermia after cesarean delivery 
and its reversal with lorazepam. International Journal of Obstetric Anesthesia, 14(4), 
279-83. 
 
Hooper, V.D., Chard, R., Clifford, T., Fetzer, S., Fossum, S., Godden, B.,…Wilson, 
L. (2009). ASPAN's Evidence-Based Clinical Practice Guideline for the Promotion 
of Perioperative Normothermia. Journal of PeriAnesthesia Nursing, 24(5), 271-287. 
 
Horn, E-P., Schroeder. F., Gottschalk. A., Sessler, D.I., Hiltmeyer, N., Standl, T., & 
Schulte am Esch, J. (2002). Active warming during cesarean delivery. Anesthesia & 
Analgesia, 94, 409-414. 
 
Hui, C-K., Huang, C-H., Lin, C-J., Lau, H-P., Chan, W-H., & Yeh, H-M. (2006). A 
randomised double blind controlled study evaluating the hypothermic effect of 150 g 
morphine during spinal anaesthesia for Caesarean section. Anaesthesia, 61(1), 29-31. 
 
Lieberman, E., Lang, J., Richardson, D.K., Frigoletto, F.D., Heffner, L.J., & Cohen, 
A. (2000). Intrapartum Maternal Fever and Neonatal Outcome. Pediatrics, 105(1), 8-
13. 
 
Liu, W., & Luxton, M.  (1991) The effect of prophylactic fentanyl on shivering in 
elective caesarean section under epidural analgesia. Anaesthesia, 46(5), 344-348. 
 
Moola, S., & Lockwood, C. (2010). The effectiveness of strategies for the 
management and /or prevention of hypothermia within the adult perioperative 
environment: systematic review. JBI Library of Systematic Reviews, 8(19), 752-792. 
 
Munday, J., Hines, S., & Wallace, K.  (2012) The clinical effectiveness of 
interventions to assist perioperative temperature management for women undergoing 
 Chapter 3: Effectiveness of Warming Interventions on Maternal Core Temperature for Women Undergoing 
Caesarean Section. 49 
Caesarean Section: A systematic review (Protocol) JBI Library of Systematic 
Reviews, 10(14, Suppl), S138 - S152  
 
Munday, J., Hines, S., Wallace, K., Chang, A.M., Gibbons, K., & Yates, P. (2013). 
The clinical effectiveness of interventions to assist perioperative temperature 
management for women undergoing Cesarean Section: a systematic review. JBI 
Database of Systematic Reviews and Implementation Reports, 11(6), 45-111 
 
National Collaborating Centre for Nursing and Supportive Care.  (2008). Clinical 
Practice Guideline. The management of inadvertent perioperative hypothermia in 
adults. National Institute for Clinical Health and Excellence. 
 
Oshvandi, K., Shiri, F.H., Safari, M., Fazel, M.R., Salavati, M., & Tehrani, T.H. 
(2011). Effect of pre-warmed intravenous fluid therapy on prevention of 
postoperative shivering after caesarean section. HAYAT: Journal of Faculty of 
Nursing and Midwifery, 17(4), 5-15. 
 
Petsas, A., Vollmer, H., & Barnes, R. (2009). Peri-operative warming in Caesarean 
Sections. Anaesthesia, 64(8), 921-922. 
 
Reidy, J., Preston, R., Douglas, J., Sherlock, R., Tyler, J. (2008) The effect of 
maternal warming during cesarean delivery on neonatal temperature.  Unpublished 
manuscript.   
 
Rosner, B. (2011).  Fundamentals of biostatistics (7th ed). Boston, MA: Brooks/Cole. 
 
Sessler, D.I. (1997). Mild perioperative hypothermia. New England Journal of 
Medicine, 336, 1730-1737 
 
 Chapter 3: Effectiveness of Warming Interventions on Maternal Core Temperature for Women Undergoing 
Caesarean Section. 50 
Smith, C.E., Fisgus, J.R., Kan, M., Lengen, S.K., Myles, C., Jacobs, D., …Hagen, 
J.F. (2000). Efficacy of IV Fluid Warming in Patients Undergoing Cesarean Section 
with Regional Anesthesia. American Journal of Anesthesiology, 27 (part 2), 84-88. 
 
Sun, H.L., Ling, Q.D., Sun, W.Z., Wu, R.S-C., Wu, T.J., Wang, S.C., & Chien, C.C. 
(2004). Lower limb wrapping prevents hypotension, but not hypothermia or 
shivering, after the introduction of epidural anesthesia for cesarean delivery. 
Anesthesia & Analgesia, 99, 241-4. 
 
The Joanna Briggs Institute. (2008). The Joanna Briggs Institute Reviewer's Manual. 
Adelaide, Australia: The Joanna Briggs Institute. 
 
Woolnough, M.J., Hemingway, C., Allam, J., Cox, M., & Yentis, S.M. (2009). Intra-
operative fluid warming in elective caesarean section: a blinded randomised 
controlled trial. International Journal of Obstetric Anesthesia, 18, 346-51. 
 
Yokoyama, K., Shimada, Y., Matsushima, T., Bito, H., & Sakamoto, A. (2009). 
Effect of administration of pre-warmed intravenous fluids on the frequency of 
hypothermia following spinal anesthesia for Cesarean delivery. Journal of Clinical 
Anesthesia, 21, 242-8 
  
 Chapter 3: Effectiveness of Warming Interventions on Maternal Core Temperature for Women Undergoing 
Caesarean Section. 51 
3.3 CHAPTER SUMMARY 
This systematic review was undertaken to synthesise the evidence to examine the 
effectiveness of warming interventions for preventing and managing inadvertent 
perioperative hypothermia for women undergoing caesarean section, in the absence 
of evidence-based recommendations specifically for this population.  The shortened 
systematic review was published in Worldviews on Evidence-Based Nursing and this 
version of the review, (including the objectives, search strategy, findings, results and 
conclusions related to the primary outcome of maternal temperature), is presented in 
this chapter (Munday, et al., 2014).  The next chapter will present the results and 
interpretation of the secondary outcomes of the systematic review, which were 
published in the full version (Munday, Hines, Wallace, et al., 2013). This version of 
the review was also used as the basis for a JBI Best Practice Implementation Sheet. 
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Chapter 4: Effectiveness of Warming 
Interventions on Secondary 
Maternal and Neonatal 
Outcomes 
4.1 INTRODUCTION 
While preventing maternal heat loss is the primary intention of warming regimes, 
and is the central focus of this research program, there are a number of secondary 
outcomes of interest that are linked to maternal heat loss, either directly or indirectly.   
These secondary outcomes can directly impact upon overall maternal postoperative 
recovery and experience of caesarean section delivery, and potentially the health 
status of the newborn after delivery. Therefore, a number of relevant secondary 
outcomes were considered in the systematic review detailed in Chapter 3. These 
secondary outcomes were as follows: maternal shivering; newborn core temperature 
at birth obtained immediately after birth; umbilical pH; Apgar scores; length of 
PACU and maternal thermal comfort (Munday, Hines, Wallace, et al., 2013). The 
review methods are detailed in Chapter 3 (and in the full JBI version included in 
Appendix A).  In this chapter, I will present the results and discussion pertaining to 
these secondary outcomes as an excerpt from the full review:  
Munday J, Hines S, Wallace K, Chang AM, Gibbons K, Yates P. 2013.  The clinical 
effectiveness of interventions to assist perioperative temperature management for 
women undergoing caesarean section: a systematic review.  JBI Database of 
Systematic Reviews and Implementation Reports. 11(6), 45-111 
 
4.2 RESULTS 
The findings of the full review are presented according to the included interventions, 
with sub-headings for each outcome (as per the published version). 
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4.2.1 Intravenous Fluid Warming 
Intravenous fluid warming and prevention of shivering 
Six of the seven fluid warming studies (Chan, Morley-Forster, & Vosu, 1989; 
Chung, et al., 2012; Goyal et al., 2011; Oshvandi et al., 2011; Smith et al., 2000; 
Woolnough, Allam, et al., 2009) also measured participant shivering. In two studies 
dichotomous data are presented from the assessment of the presence or absence of 
shivering (Goyal, et al., 2011; Smith, et al., 2000) before and after caesarean section 
(Goyal, et al., 2011) or in PACU (Smith, et al., 2000). In addition, details of 
interventions to treat shivering once it occurred were recorded (number and type) 
(Goyal, et al., 2011; Smith, et al., 2000). Similar four-point scales recording the 
degree of shivering intensity were used by two studies (Woolnough, Allam, et al., 
2009) (Chan, et al., 1989), while a five point scale was used by Oshvandi (Oshvandi, 
et al., 2011) attributed to Crossley and Mahajan (Crossley & Mahajan, 1994) and a 
four point scale was used by Chung et al. (Chung, et al., 2012) attributed to Wrench 
(Wrench, Cavill, Ward, & Crossley, 1997). Three studies using shivering scales also 
reported on presence and absence of shivering (Chung, et al., 2012; Oshvandi, et al., 
2011; Woolnough, Allam, et al., 2009). 
The single study that compared an intervention of warmed fluids, warmed skin 
preparation and additional clothing with another intervention of room temperature 
fluids, room temperature skin preparation and single hospital gown (Chan, et al., 
1989) could not be included in the meta-analysis (because of the extra interventions) 
and did not find a significant difference in incidence of shivering between groups (11 
of 21 patients reported shivering in the intervention group versus 13/19 in control 
group, no p value reported). Five studies (Chung, et al., 2012; Goyal, et al., 2011; 
Oshvandi, et al., 2011; Smith, et al., 2000; Woolnough, Allam, et al., 2009) 
comparing IV fluid warming with room temperature fluids were combined in a meta-
analysis of effectiveness warmed IV fluids on the incidence of shivering (Figure 4). 
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Figure 4: Intravenous fluid warming versus room temperature fluids and the 
incidence of shivering  
Two of the three groups in Oshvandi et al.’s study (Oshvandi, et al., 2011), the 
warmed IV fluid and room temperature groups, were included in this meta-analysis, 
as per advice for managing multiple-group studies in the Cochrane Handbook for 
Systematic Reviews of Interventions (Deeks, Higgins, & Altman, 2011).  In addition, 
for Woolnough et al.’s three group study (Woolnough, Allam, et al., 2009) the two 
warmed fluid groups were combined together, as the interventions were sufficiently 
similar, and compared to the room temperature group. The combined result 
significantly favours intravenous fluid warming (OR 0.54, 95% CI 0.33-0.89) for 
reducing shivering in this population. 
 
Intravenous fluid warming and maternal thermal comfort 
Maternal thermal comfort was assessed by both of the three group studies (Chung, et 
al., 2012; Woolnough, Allam, et al., 2009). Woolnough et al.’s study of Hotline™ 
warmed fluids versus warming cabinet fluids versus room temperature fluids used a 
0-10 numerical rating scale with 0 indicating ‘worst imaginable cold’, 5 as ‘thermally 
neutral/comfortable’ and 10 indicating ‘insufferably hot ’(Woolnough, Allam, et al., 
2009). The authors considered a score of less than 4 to correspond to feeling cold, 
whilst a score of more than 6 corresponded to feeling hot. Similarly, Chung et al.’s 
three group study of warmed IV preload versus unwarmed IV preload (and versus 
upper body forced air prewarming) which used a 100mm Visual Analogue Scale 
(VAS) with 0mm indicating ‘insufferably hot’, 50mm ‘thermally neutral’ and 
100mm as ‘worst imaginable cold’, reported on thermal discomfort (reporting on 
data for cold VAS scores between 50mm-100mm) (Chung, et al., 2012). 
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There was a statistically significant difference in the number of patients reporting 
thermal discomfort (a thermal comfort score of <4) between the three groups in 
Woolnough et al.’s three group study (p=0.32) although the statistical test is not 
specified (Woolnough, Allam, et al., 2009). In the room temperature fluids group: 
8/25 (32%) scored <4, whereas 3/25 (12%) scored <4 in the warming cabinet group 
and only 1/25 (4%) scored <4 in the Hotline group (Woolnough, Allam, et al., 2009). 
This also appears to be clinically significant: in this study patients demonstrate 
greater thermal comfort if receiving warmed intravenous fluids. No statistically 
significant difference or clinically significant (p= 0.093) difference in maternal 
thermal comfort was found between preload of warmed IV fluid, upper body forced 
air warming with room temperature preload and room temperature preload (no 
warming) in Chung et al.’s study with cold VAS data reported (59.3mm, SD: 
13.2mm versus 59.0mm, SD: 12.1mm versus 69.0mm, SD: 15.9mm respectively) 
(Chung, et al., 2012). There were differences between these studies in relation to the 
temperature settings of fluid warming devices: fluids in Chung’s study were warmed 
to 40°C via a warming cabinet (Chung, et al., 2012), whereas in Woolnough et al.’s 
study which found a significant difference in thermal comfort from warmed fluids, 
warming cabinet fluids were stored at 45°C and Hotline™ fluids were set to 42°C 
(Woolnough, Allam, et al., 2009). Greater volumes of fluid were infused in 
Woolnough et al.’s study (2.0 litres, SD: 0.4 litres in the room temperature group, 2.1 
litres, SD: 0.4 litres in the warming cabinet group and 2.4 litres, SD: 1.4 litres in the 
Hotline group) (Woolnough, Allam, et al., 2009) as opposed to Chung et al.’s study 
(1.1 litres, SD: 0.1litres in the room temperature group, 1.2 litres, SD: 0.2 litres in the 
warmed fluid preload group and 1.2litres, SD: 0.1 litres in the forced air warming 
group) (Chung, et al., 2012). 
These differing results could also be examined in the context of what ‘room 
temperature’ refers to in each study. Chung et al.’s study did not report data on 
ambient temperature (Chung, et al., 2012), whereas Woolnough et al. report that 
ambient temperature was 24.2°C (SD: +/- 0.9°C) in the room temperature group, 
23.9°C (SD: +/-1.4°C) in the warming cabinet group and 24.2 °C (SD: +/-0.8°C) in 
the Hotline group (Woolnough, Allam, et al., 2009).  Woolnough et al. did not 
examine the differences in ambient temperature between groups in this study 
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(Woolnough, Allam, et al., 2009). Thus it remains unclear whether differences in 
ambient temperature explain the conflicting results between these studies.  
 
Intravenous fluid warming and time to discharge from PACU 
Time to discharge from PACU was assessed only in two IV fluid warming studies 
(Goyal, et al., 2011; Smith, et al., 2000) but for one it remains unclear whether time 
to discharge as reported actually refers to time to fitness for discharge, or actual time 
to discharge (which may be dependent on many external factors, such as availability 
of ward staff) (Smith, et al., 2000). 
Goyal et al.’s study of warmed IV fluids versus room temperature IV fluids found no 
statistically significant difference in PACU discharge times in minutes (min) 
between groups: 105.5min (SD: +/- 9.5min) in the room temperature group versus 
107.3min (SD: +/- 9.2min) in the intervention group (Goyal, et al., 2011). Similarly, 
Smith et al.’s study of warmed IV fluids versus room temperature IV fluids found no 
significant difference in time to PACU discharge in minutes between groups: 109min 
(SD: 6min) in the intervention group versus 103min (SD: +/- 7min) in the control 
group (no p value was reported) (Smith, et al., 2000). The administration of 
intraoperative warmed IV fluids does not appear to shorten PACU stays for patients.  
 
Intravenous fluid warming and Apgar scores 
Apgar scores were evaluated by a paediatrician at one minute after delivery in two 
IV warming studies, both also using reflective blankets (Chung, et al., 2012; 
Yokoyama, et al., 2009), but these two studies could not be combined in meta-
analysis due to clinical heterogeneity. While study groups were similar in both 
studies, there were differences between studies in the temperature of warmed fluids, 
methods of administering warmed fluids and methods of temperature measurement. 
The Apgar score was significantly higher for the warmed IV fluids group in 
Yokoyama et al.’s study in comparison to the room temperature fluids group 
((Yokoyama, et al., 2009). In Chung et al.’s three group study the Apgar score was 
lower, but not significantly, for the warmed IV fluid preload compared to the room 
temperature fluid preload and the upper body forced air warming groups (Chung, et 
al., 2012) (see Table 1).  
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Table 1: Apgar scores at one minute – IV fluid warming  
Study Apgar score at one minute  
Warmed IV 
fluid* 
Room 
temperature 
fluids* 
Upper body 
forced air 
warming 
p value 
Yokoyama et al 
(2009)  
9 (8-9) 8 (8-9) n/a 0.029 
(Mann-
Whitney U-
test) 
Chung et al (2012) # 
*preload  
8.07 ± 1.10 8.20 ± 0.86 8.13 ± 0.86 0.927* 
(statistical test 
not specified) 
^ median (range), # mean (SD) * across three groups 
 
No significant difference in Apgar score between groups at five minutes after 
delivery (p= 0.18) was found by Yokoyama et al (Table 2), in contrast to the 
statistically significant result for Apgar scores at one minute (Yokoyama, et al., 
2009). 
Table 2: Apgar scores at five minutes – IV fluid warming versus room temperature 
fluids (Yokoyama et al, 2009)  
Study - Yokoyama et al 
(2009)  
Apgar Score at five minutes (number/total number)  
Apgar score Warmed IV 
fluids 
Room temperature 
fluids 
p value 
Mann-
Whitney U-
test 
8 1/15 0/15 0.18 
9 12/15 15/15 
10 2/15 0/15 
 
Intravenous fluid warming and umbilical pH 
While umbilical pH was also evaluated in the same two IV fluid warming studies 
that compared Apgar scores, these studies could not be combined due to clinical 
heterogeneity because of the source of blood for pH measurement. Chung et al. 
measured umbilical vein pH immediately after birth (Chung, et al., 2012), whilst 
Yokoyama et al. measured umbilical artery pH (Yokoyama, et al., 2009). Yokoyama 
et al. reported a statistically significantly higher pH for the warmed IV fluid group in 
comparison to the room temperature fluid group but the clinical significance of these 
results is limited (Yokoyama, et al., 2009), while Chung et al.’s study found no 
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statistically or clinically significant difference between the three groups receiving 
warming (Chung, et al., 2012) (Table 3). Yokoyama et al. also reported that 
umbilical pH data were averaged according to the number of patients receiving 
ephedrine (five participants in both groups) (Yokoyama, et al., 2009). 
Table 3: Umbilical pH – IV fluid warming versus room temperature fluids 
Study  Umbilical pH: artery (Yokoyama et al 2009)/ vein (Chung 
et al 2012) 
p value 
Warmed IV 
fluids*^ 
Room temperature 
fluids*^ 
Upper body 
forced air 
warming^ 
 
Yokoyama 
et al (2009)  
7.33 ± 0.045 7.29 ± 0.034 n/a 0.023 (via 
analysis of 
covariance) 
Chung et al 
(2012) *preload  
7.33 ± 0.06 7.35 ± 0.04 7.32 ± 0.04 0.349 
(statistical test 
not specified) 
^ mean ± SD 
 
Intravenous fluid warming and neonatal temperature 
Of the fluid warming studies, the only study that measured newborn temperature via 
the rectal route at five minutes after delivery (and after newborn head wrapping and 
placement under radiant heater) found no statistically or clinically significant 
difference (p=0.16 Student’s t test) between groups (37.2°C, SD: +/- 0.3°C in the 
warmed fluid group versus 37.0°C, SD: +/- 0.4°C in the unwarmed fluid group) 
(Yokoyama, et al., 2009). Again, neonatal temperature data in Yokoyama et al.’s 
study was averaged according to the number of patients receiving ephedrine 
(Yokoyama, et al., 2009). 
 
Intravenous fluid warming: summary 
Warmed IV fluids are effective at improving maternal temperature whether 
administered pre or intraoperatively, and are also effective at reducing shivering. It 
remains unclear whether warmed IV fluids have a positive effect on maternal thermal 
comfort, umbilical pH or Apgar scores. This intervention was also not found to 
improve newborn temperature at birth or reduce time to discharge from PACU.  
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4.2.2 Warming devices: covers and mattresses 
Warming devices and prevention of shivering 
Three of the five forced air warming studies (see Table 1, Chapter 3) included 
shivering as a secondary outcome (Chung, et al., 2012; Fallis, et al., 2006; Horn, et 
al., 2002). Dichotomous data are presented in terms of presence or absence of 
shivering, but two studies (Fallis, et al., 2006; Horn, et al., 2002) also present ordinal 
data in relation to intensity of shivering (slight, moderate/intensive shivering). These 
two studies (Fallis, et al., 2006; Horn, et al., 2002) use the same four-point shivering 
scale (0=no shivering, 1=mild shivering, 2=moderate shivering, 3=severe shivering) 
as used by Chan et al.’s study (Chan, et al., 1989) of warmed IV fluids effect on 
temperature and shivering in women undergoing CS. Details of these two studies are 
presented in Table 2, Chapter 3. Chung et al.’s three-group study (Chung, et al., 
2012) uses an alternative four-point scale with different descriptors (referenced to 
Wrench 1997) (Wrench, et al., 1997) and was not entered into the table due to its 
three-group design and the different scale used for assessing shivering. Again, 
clinical heterogeneity prevented meta-analysis of these studies in relation to 
shivering.  
Possible bias resulting from unblinded investigators assessing shivering in two of the 
studies (Fallis, et al., 2006; Horn, et al., 2002) should be highlighted. Blinding of 
investigators is unclear in the remaining study (Chung, et al., 2012). Shivering 
assessment took place both during and after surgery (Chung, et al., 2012) and after 
every 15-minute temperature measurement (Fallis, et al., 2006; Horn, et al., 2002). 
Fallis et al. (Fallis, et al., 2006) and Horn et al. (Horn, et al., 2002) again present 
differing results in relation to the effectiveness of upper body forced air warming but 
this time related to the presence of shivering: Fallis et al. report that there was no 
statistically significant difference between groups (Fallis, et al., 2006), whereas Horn 
et al found that there was a significantly lower level of shivering presence in the 
preoperative forced air warming group (Horn, et al., 2002) (Table 4).  These results 
can also be considered in light of the other characteristics of these studies presented 
in Table 2, Chapter 3 and discussed above.  
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Table 4: Presence of shivering in preoperative upper body forced air warming 
studies  
Study Presence of shivering p value 
Upper body forced 
air warming 
Control 
Fallis et al (2006) 10/32 10/30 p=0.861(Mantel-
Haenszel test) 
Horn et al (2002)  2/15 9/15 p<0.05(Fisher’s 
exact test) 
 
Results from Chung et al.’s three group study also support the effectiveness of 
preoperative forced air warming in reducing shivering to 20% (3/15) but not to the 
extent of warmed IV fluids in which 13% (2/15) experienced shivering versus 53.3% 
(8/15) in the room temperature fluid group (p=0.035) (Chung, et al., 2012). 
Results from these studies (Chung, et al., 2012; Fallis, et al., 2006; Horn, et al., 2002) 
suggest that forced air warming applied in the preoperative phase of care reduces 
shivering, but forced air warming applied intraoperatively may have less effect on 
reducing shivering.   
 
Warming devices and thermal comfort 
Maternal thermal comfort was measured by the four forced air warming studies 
(Chung, et al., 2012; Fallis, et al., 2006; Horn, et al., 2002; Reidy, Preston, Douglas, 
Sherlock, & Tyler, 2008), with continuous data gained from the use of self-reported 
thermal comfort scales. Descriptors of thermal comfort status were common between 
three studies (Chung, et al., 2012; Fallis, et al., 2006; Horn, et al., 2002): ‘worst 
imaginable cold’, ‘thermally neutral’ and ‘insufferably hot’; but again narrative 
summary only is possible due to clinical heterogeneity in relation to slight variations 
in intervention and control groups between the studies. 
Chung et al. (Chung, et al., 2012) and Horn et al. (Horn, et al., 2002) both used a 
100mm Visual Analogue Scale (VAS) but with hot/cold scores reversed between the 
studies (for example, 0 = cold on Horn’s scale, (Horn, et al., 2002) but 0 = hot on 
Chung’s scale) (Chung, et al., 2012). Fallis et al. used a 0-10 scale with the above 
descriptors, with 0 referring to cold and 10 referring to hot (Fallis, et al., 2006). 
Thermal comfort scores were assessed at 15-minute intervals throughout surgery in 
both Horn (Horn, et al., 2002) and Fallis et al.’s (Fallis, et al., 2006) studies but time 
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points of thermal comfort assessment remain unclear in the remaining two studies 
(Chung, et al., 2012; Reidy, et al., 2008). Additional information was obtained from 
Fallis et al. in relation to their thermal comfort data, as no data could be extracted 
from the figures presented in the original published article (Fallis, et al., 2006).  
Reidy et al.’s study of an under-body forced air warming mattress versus ‘standard 
care’ used a three point Likert scale (with responses of ‘too cold’, ‘comfortable’, ‘too 
hot’) and reports that maternal thermal comfort did not increase, although no data is 
provided for this outcome (Reidy, et al., 2008). Again, the risk of bias arising from 
the lack of blinding of investigators assessing thermal comfort needs to be 
recognized, but with consideration of the practical difficulties of blinding both 
patients and investigators to forced air warming. The other under-body warming 
mattress study in this review (Chakladar, et al., 2011) did not measure thermal 
comfort but it is interesting to note that further data obtained from the authors 
confirm that the intervention was discontinued for one patient in the warming group 
due to the patient feeling hot.  
VAS scores were not statistically or clinically significantly different between groups 
in Chung et al.’s three group study comparing preoperative upper body forced air 
warming, warmed IV fluid preload and room temperature fluids: 59.0mm (SD: 
12.1mm) in the forced air warming group versus 59.3mm (SD 13.2mm) in the 
warmed IV fluid preload versus 69.0mm (SD: 15.9mm) in the room temperature 
fluid group (p=0.927, but statistical test not specified), although the latter group’s 
thermal comfort appeared to be warmer (Chung, et al., 2012).  
Horn et al. reports data for thermal comfort after 15 minutes of treatment: 52mm 
(SD: 9mm) in the control group versus 63mm (SD: 11mm) but reports that there 
were no statistically significant differences in thermal comfort between the groups at 
other time points (Horn, et al., 2002).     
In contrast, Fallis et al.’s study of intraoperative forced air warming found 
statistically and clinically significant differences in thermal comfort between the 
study groups in favour of intraoperative warming at 30, 45, 60 and 75 minutes 
(although at the 75 minute time interval, subject numbers were greatly reduced in 
both groups) (Fallis, et al., 2006). No data are provided for the 15 minute interval 
which would facilitate comparison with Horn’s study and vice versa no data for 
further time intervals were provided by Horn et al. (Horn, et al., 2002). Thermal 
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comfort scores were consistently lower in the control group in Fallis et al.’s study 
(Fallis, et al., 2006) (Table 5). 
Table 5: Thermal comfort scores: Intraoperative upper body forced air warming 
(Fallis et al 2006)  
Time 
(mins) 
Sample 
size 
Thermal comfort scores  (0=cold   to 10 =hot ) P value 
(repeated 
measures 
ANOVA) 
Intervention: upper body 
forced air warming 
Control: warmed 
cotton blanket 
Mean ± SD Mean ± SD 
30  62 5.7 ± 0.3 4.8 ± 0.3 0.016 
45  52 6.3 ± 0.3 4.84 ± 0.3 <0.001 
60 37 5.8± 0.4 4.6 ± 0.3 0.014 
75 17 5.5 ± 0.3 4.5 ± 0.3  0.045 
 
The characteristics of both Horn et al (Horn, et al., 2002) and Fallis et al.’s studies 
(Fallis, et al., 2006) (Table 4) are interesting in the context of these varying results, 
especially in relation to ambient temperature. Ambient temperature on entrance to 
the operating theatre was lower in Fallis et al.’s study (Fallis, et al., 2006) – a cooler 
environment may mean that greater thermal comfort could be gained from the 
application of a warming device. It is also worth noting that 14 women in Fallis et 
al.’s study requested that the warming device be lowered to a reduced temperature 
setting during surgery (Fallis, et al., 2006) suggesting that thermal comfort, in terms 
of feeling too hot, was not optimal for these women throughout surgery.  
Results on the effectiveness of forced air warming on maternal comfort are, 
therefore, inconclusive with varying results between studies. The relationship 
between ambient temperature and the possibly linked receptiveness of patients to 
forced air warming should be considered, as should the possibility of high forced air 
warming settings being intolerable for some patients.  
 
Warming devices and time to discharge from PACU 
Time to discharge from PACU was not an outcome of interest in the included 
warming mattress and coverings studies. 
Warming devices and Apgar scores 
Apgar scores measured at one minute were an outcome of interest in four studies 
(Chung, et al., 2012; Fallis, et al., 2006; Horn, et al., 2002; Reidy, et al., 2008). Two 
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studies measured Apgar scores at five minutes (Chung, et al., 2012; Horn, et al., 
2002) and one continued to report at ten minutes (Horn, et al., 2002). A paediatrician 
determined Apgar scores in both Chung et al.’ s (Chung, et al., 2012) and Horn et 
al.’s (Horn, et al., 2002) studies but it is unclear which healthcare professional 
measured Apgar scores in the remaining two studies (Fallis, et al., 2006; Reidy, et 
al., 2008). No significant difference in Apgar scores between groups in any of the 
above studies was found.  
Reidy et al.’s study of maternal under-body forced air warming mattress found no 
statistically significant effect on Apgar scores at one or five minutes: the median 
Apgar score at one minute was 9 (range 6-10) in the intervention group versus 9 
(range 4-10) for the control group (p=0.12, the statistical test was not specified), and 
median Apgar score at five minutes was 9 (range 8-10) in the intervention group, and 
9 (range 9-10) in the control group (p=0.12, the statistical test was not specified) 
(Reidy, et al., 2008). 
Upper body forced air prewarming versus warmed IV fluid preload versus room 
temperature preload and no forced air warming, also found no statistical or clinically 
significant difference in mean Apgar scores at one minute between groups (8.1, SD: 
+/- 0.8 in the upper body warming group versus 8.1, SD: +/-1.1 in the warmed IV 
fluid group versus 8.2, SD: +/-0.9 in the room temperature group, p=0.927 via 
analysis of variance) (Chung, et al., 2012). Intraoperative forced air warming also 
demonstrated no statistically or clinically significant difference in Apgar scores at 
one and five minutes: median 8 (range 5-9) for the intervention group, median 8.5 
(range 3-9) for the control group at one minute and median 9 (range 8-9) for the 
intervention group, 9 (8-9) for the control group at five minutes (although no p value 
is provided and it is not clear what statistical test was used) (Fallis, et al., 2006).  
Again, results were similar between groups, and no statistically or clinically 
significant difference was found in the upper body forced air prewarming study that 
measured Apgar at one, five and ten minutes: at one minute, 9/15 patients obtained 
an Apgar of 9 in the warmed group, and 9/15 obtained an Apgar of 9 in the control 
group (no p values reported) (Horn, et al., 2002).  It therefore appears that forced air 
warming does not appear to either increase or decrease Apgar scores at one or five 
minutes. 
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Warming devices and umbilical pH 
Umbilical pH was also assessed by the four studies above (in which Apgar score was 
also assessed).  Both Chung et al. (Chung, et al., 2012) and Horn et al. (Horn, et al., 
2002) measured umbilical vein pH directly after birth. Fallis et al. (Fallis, et al., 
2006) and Reidy et al. (Reidy, et al., 2008) also measured umbilical vein pH but the 
time at which this occurred was not reported.  These studies could not be combined 
for meta-analysis due to key differences in interventions and controls, thus a 
narrative analysis is presented. Chung’s three group study (with a sample size of 15 
participants in each of the three groups) found no significant difference in umbilical 
vein pH measured directly after birth between the three groups (7.3, SD: +/- 0.04 in 
the forced air warming group versus 7.3, SD: +/- 0.06 in the warmed IV fluid group 
versus 7.4, SD: +/-0.04 in the room temperature fluid group, p= 0.35 via analysis of 
variance) (Chung, et al., 2012).  
The remaining three studies are presented in Table 8. As with Chung’s study (Chung, 
et al., 2012), both studies by Fallis (Fallis, et al., 2006) and Reidy (Reidy, et al., 
2008) found no benefit from maternal forced air warming in regards to umbilical pH. 
Horn et al.’s study of upper body prewarming presents contrasting results and found 
that umbilical vein pH was significantly improved in babies born to mothers in the 
warmed group (Horn, et al., 2002) (see Table 6), with babies in the control groups 
having a mean umbilical vein pH of 7.24 (SD ± 0.07) versus a mean umbilical vein 
pH of 7.32 (SD ±0.07) in the intervention group. Information regarding gestation in 
weeks is not provided by Horn et al. but participants were ‘healthy’ and booked for 
elective surgery (Horn, et al., 2002), suggesting that gestation or maternal medical 
history may not be relevant in the respect of differences in neonatal outcomes in this 
study. Both Horn et al. (Horn, et al., 2002) and Chung et al. (Chung, et al., 2012) 
utilized preoperative warming but with differing results. It remains unclear whether 
forced air warming, in particular when applied during the preoperative phase of care, 
improves umbilical pH.  
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Table 6: Umbilical vein pH and forced air warming 
Study  Umbilical vein pH # P value 
Upper body forced 
air warming* 
Under-body forced 
air warming mattress 
Control 
Mean ± SD Mean ± SD Mean ± 
SD 
Fallis et al 
(2006)  
7.30 ± 0.0^ 
(n= 31) 
n/a 7.30 ± 
0.0^ 
(n= 28) 
Not 
provided 
Horn et al 
(2002)*  
7.32 ± 0.07 
(n=15) 
n/a 7.24  ± 
0.07 
(n=15) 
<0.05 
(one-way 
analysis of 
variance) 
Reidy et al 
(2008)  
n/a 7.30 ± 0.1 
(n=36) 
7.30 ± 
0.04 
(n=32) 
0.09 
(statistical 
test not 
specified) 
  # Mean ± SD; ^ SD 0.0 taken directly from article; *applied preoperatively  
 
Warming devices and neonatal temperature 
Three of the forced air warming studies also measured neonatal temperature, either 
as rectal temperature at delivery (Fallis, et al., 2006; Horn, et al., 2002) or axillary 
temperature one minute after delivery (Reidy, et al., 2008). In Reidy et al.’s study of 
the use of forced air warming mattress, neonatal temperature was a primary outcome 
but the study found no statistically or clinically significant difference in neonatal 
temperature between the warmed and control groups (Reidy, et al., 2008). Mean 
neonatal axillary temperature at one minute was 36.8°C (SD: +/- 0.3°C) in the 
warmed group versus 36.9 °C (SD: +/- 0.3°C) in the control group (p= 0.40). The 
authors report that temperature was also checked at five and ten minutes after 
delivery but no data was available for inclusion in this review.     
Mean newborn rectal temperature was found to be 37.7°C (SD: +/- 0.4°C) in the 
warmed group (of 32 participants) in Fallis et al.’s study of upper body forced air 
warming and 37.5°C (SD: 0.4°C) in the control group (of 29 participants), which was 
stated to be a non-significant statistical difference although no p-value was reported 
(Fallis, et al., 2006). Horn’s study of upper body forced air prewarming, in contrast, 
did find a statistically and clinically significant higher newborn rectal temperature for 
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the warmed air group (37.1°C, SD: +/-0.5°C) versus 36.2°C, SD: +/-0.6°C for the 
control group, p<0.001) (Horn, et al., 2002).  
Forced air intraoperative warming (upper body or under-body) did not therefore 
significantly improve newborn temperature at birth, but upper body forced air 
prewarming was found to have a positive effect.  
 
Summary 
Forced air warming is effective at improving maternal temperatures, particularly if 
applied preoperatively. Similarly, preoperative warming was found to have an 
increase in almost 1°C (0.9°C) in mean neonatal rectal temperature at birth whereas 
intraoperative warming did not. Under-body warming appears to have a positive 
effect on maternal temperature. Preoperative forced air warming was also found to 
reduce shivering. Results were inconclusive on the effects of forced air and under 
body warming on maternal thermal comfort, Apgar scores and umbilical pH. 
 
4.2.3 Leg Wrapping 
One study compared leg wrapping with tight elastic bandages with leg wrapping with 
loose elastic bandages in women undergoing elective caesarean section surgery 
under epidural anaesthesia, with 30 participants in each group (Sun et al., 2004). The 
primary outcome was the effect of the intervention on hypotension (a common 
occurrence during epidural anaesthesia) but reduction of hypothermia and shivering 
were secondary outcomes.   
Leg wrapping is reported as being applied before administration of the epidural but 
after the attachment of monitoring, preload of unwarmed fluids and the elevation of 
the patient’s legs to 45° (which seems unlikely given the practicalities of 
administering the epidural).  
 
Leg wrapping and prevention of shivering 
Shivering was measured by an observer, blinded to group assignment, and simply 
assessed as being either present or absent. There was no difference in the presence of 
shivering between the groups (21/30 participants shivered in both the tight leg 
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wrapping and also the loose leg wrapping group, p= 0.61) (Sun, et al., 2004). Data 
for this outcome, as with hypothermia, was only collected until immediately 
following delivery. As with maternal temperature, leg wrapping is therefore not 
effective at preventing shivering in this population, based on evidence from this 
single study. 
 
Leg wrapping and other outcomes 
Thermal comfort, time to discharge from PACU, Apgar score, umbilical pH and 
neonatal temperature were not included as outcomes of interest in this leg wrapping 
study (Sun, et al., 2004). 
 
Leg wrapping: summary 
Leg wrapping was therefore not effective at improving maternal temperature or 
shivering; however, these observations are derived from a single study and therefore 
should be considered with caution. 
 
4.3 DISCUSSION 
Shivering is commonly experienced during caesarean section surgery performed 
under neuraxial anaesthesia. Findings from this review indicate that intravenous fluid 
warming and preoperative forced air warming have a role to play in shivering 
prevention. Pharmacological therapies, which may be used for shivering, were 
beyond the scope of this review. Shivering is a complex multifactorial phenomenon 
(Chan, et al., 1989) and not purely thermoregulatory in all instances. Possible 
explanations for shivering have been described: thermoregulatory shivering triggered 
by core hypothermia (Sessler, 2008), shivering as a response to fever development 
(Sessler, 2008), shivering due to local anaesthetic injection stimulation of cold 
receptors (Chan, et al., 1989; Sessler, 2008) and finally, shivering due to tremulous 
muscular activity that is in fact non-thermoregulatory. Intrathecal drugs may also 
contribute to the development of shivering (Woolnough, Allam, et al., 2009). 
Thermal comfort should also be considered in the context of ambient temperature. 
Operating theatres are generally cool environments, in accordance with clinical 
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guidelines to this effect – for example, in Australia, Australian College of Operating 
Room Nurses (ACORN) standards guide operating room temperatures to be between 
20-22°C, although provision is made that in certain circumstances, such as for 
obstetric patients, variations in ambient temperature may be necessary. (Australian 
College of Operating Room Nurses 2012. ) The American Society of PeriAnesthesia 
Nurses (ASPAN) clinical practice guidelines for the promotion of normothermia 
state that ambient operating room temperatures should be between 20-25°C (Hooper, 
et al., 2010) while NICE guidelines state that ambient temperatures should be over 
21°C while patients are exposed, and can be reduced once the active warming 
commences (NCCNSC 2008). Ambient temperature was generally above 22°C for 
the majority of studies included in this review. The degree of comfort derived from 
an active warming intervention may be greater if the commencing ambient 
temperature is lower, as may be evident in the contrasting results seen between Fallis 
et al. (Fallis, et al., 2006) and Horn et al.’s studies (Horn, et al., 2002). Participants in 
Fallis et al.’s study were subject to an initially cooler ambient temperature (Fallis, et 
al., 2006) in contrast to those in Horn et al.’s study, where the ambient temperature 
was higher (Horn, et al., 2002). Those in the cooler initial environment had a 
significant increase in thermal comfort scores (Fallis, et al., 2006) whereas those in 
the warmer environment did not significantly increase thermal comfort (Horn, et al., 
2002). Ambient operating room temperature also increased in the forced air warming 
group in Fallis et al.’s study, and the authors highlight this as a possible contributing 
factor to higher thermal comfort scores in this group (Fallis, et al., 2006). 
Ambient temperature was insufficiently reported in some studies even though it is 
also particularly relevant to the administration of room temperature fluids. 
Unfortunately, one study that used room temperature fluids neglected to provide 
details of ambient temperature for any of the study groups (Chung, et al., 2012), 
therefore omitting any indication of the administration temperature of the room 
temperature fluids. Details of oxytocin administration would also be useful when 
assessing thermal comfort score results, as Woolnough et al. discuss (Woolnough, 
Allam, et al., 2009), this drug may alter perceptions of warmth due to its tendency to 
cause facial flushing.  
Visual analogue scales (VAS or numerical rating scales were used to measure 
thermal comfort but there was a variety of shivering scales used, albeit similar in 
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nature of descriptors. The assessment of shivering relied largely on the subjective 
assessment of the (often un-blinded) observers. The reliability of the scales used was 
not addressed and no scale used appears to have been cross-validated.   
Although it is known that the temperature status of both mother and newborn are 
related, the clinical benefit of warming mothers in relation to newborn outcomes is 
not clear. Populations studied were similar in terms of gestation, age and excluded 
conditions. Horn et al.’s study of pre- and intraoperative warming versus unwarmed 
cotton blankets resulted in the most positive neonatal outcomes in regards to 
umbilical pH and rectal temperature (Horn, et al., 2002), although reasons for this are 
unclear. Chung et al. suggest that the short prewarming period of 15 minutes in their 
study was insufficient to affect neonatal outcomes (Chung, et al., 2012). Some 
conflicting results were found in relation to neonatal outcomes from IV fluid 
warming: while one study found IV fluid warming increased both Apgar at one 
minute and umbilical pH (Yokoyama, et al., 2009) another study did not (Chung, et 
al., 2012). Only one IV fluid warming study measured rectal temperature at birth, 
and this study measured temperature after five minutes, during which time the 
newborn had been placed under a warmer (Yokoyama, et al., 2009). While the 
disparity in neonatal outcomes between existing studies can be considered in relation 
to study variations, further studies of key neonatal outcomes and maternal warming 
are required to make more substantive conclusions about clinical benefits to 
neonates.  
 
4.4 SUMMARY 
While the primary outcomes of maternal perioperative hypothermia and heat loss 
from a systematic review on warming regimes were presented in Chapter 3, this 
chapter provided evidence on the effect of maternal warming upon other maternal 
and neonatal outcomes. Shivering, commonly experienced by women during and 
after caesarean section, is reduced where IV fluids were warmed and where 
preoperative forced air warming had been utilised. However, shivering is 
multifactorial and not only related to thermoregulation (Chan, et al., 1989), but  can 
occur with normothermia and in some instances is thought to be related to decreased 
sympathetic nervous system activity or anaesthetic drugs, amongst other possible 
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causes (Horn et al., 1998). The influence of warming interventions upon maternal 
comfort is unclear, however the ambient temperature of the operating theatre appears 
to be important in this context, partly due to the variations in ambient temperature 
seen in studies reporting varying effectiveness of warming upon thermal comfort. 
Further investigation into maternal warming and the impact upon neonatal outcomes, 
is required as benefits for neonates remain unclear from the synthesis of studies 
included in this systematic review (Munday, Hines, Wallace, et al., 2013).  
Therefore, neonatal outcomes, as well as maternal outcomes of shivering and thermal 
comfort, should be included as outcomes in future studies evaluating the 
effectiveness of maternal warming interventions.  
Based upon the primary outcome of maternal temperature, and the reported 
decreased effectiveness of warming seen where women have received intrathecal 
opioids, notably morphine, (as addressed in Chapter 3), an observational study 
utilising a retrospective case-control design was conducted.   The primary aim of this 
study was to investigate and establish whether there were differences in maternal 
temperature decline between women that receive, and those who do not receive, 
intrathecal morphine.    
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Chapter 5: Perioperative Hypothermia and 
Intrathecal Morphine  
5.1 INTRODUCTION 
The concept for this observational study arose from the literature (discussed in 
Chapter 2) which explored the phenomenon of hypothermia apparently associated 
with the administration of intrathecal morphine, the findings from the systematic 
review (Chapter 3) that intraoperative warming appeared to be less effective where 
intrathecal opioids were administered (Munday, Hines, Wallace, et al., 2013), and 
from my observations in the clinical area whereby there are cases of women 
receiving intrathecal morphine noted to experience a high degree of prolonged heat 
loss, together with symptoms of diaphoresis.    
The study sought to compare temperature decline and hypothermia between women 
receiving intrathecal morphine (which can be considered standard care) and those 
who did not receive intrathecal morphine (commonly for reasons of allergy, patient 
preference due to unwanted side effects of morphine, or to avoid reactivation of the 
herpes simplex virus in known carriers). The study also sought to identify how many 
women, within the study population, experienced profound and prolonged 
hypothermia, with paradoxical symptoms (as described in Chapter 2). A further 
secondary aim was to consider any identifiable clinical factors associated with 
hypothermia in women undergoing caesarean section. Ethical approval for this study  
(as appropriate for a study deemed low-risk due to the data collection methods 
consisting of chart reviews) was obtained from the Mater Human Research Ethics 
Committee in May 2013 (see Appendix K), along with Research Governance 
approval (Appendix K). Following this, administrative ethical approval was obtained 
from Queensland University of Technology’s Human Research Ethics Committee 
(see Appendix K).    
Two methods of identifying eligible women were utilized.  The register maintained 
by the Acute Pain Service (APS) was initially accessed to aid identification of 
women who had received spinal anaesthesia for caesarean section, with and without 
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intrathecal morphine. However, this register was found to be incomplete.  Therefore, 
this necessitated the hand searching of the charts of all eligible women, identified as 
undergoing caesarean section under neuraxial anaesthesia via records maintained by 
the Health Records department.  The necessity to review an extremely large number 
of charts to identify eligible participants resulted in data collection taking place over 
an extended period of time (12 months) from start to finish.  Data collection was 
completed in May 2014.  
MS Access ™ was used to develop a database, following the format of a hard copy 
data collection form (see Appendix L), in which to input data directly from patient 
charts. Data were collected by two researchers (myself, and a research assistant) and, 
after training, a sample of duplicate charts was reviewed to enable inter-rater 
reliability to be established (see accepted paper).  A guide for data collection, for 
reference, for the use of the research assistant, was also produced (see Appendix M).  
The study, as reproduced here, is the final version accepted by publication by the 
Journal of PeriAnesthesia Nursing, with some minor rewording for clarity.  
 
5.1.1 Contribution of Authors 
The author team for the manuscript presented here included J Munday, S Osborne 
and P Yates (see Statement of Contributions, Appendix N).  I am identified as the 
principal and corresponding author, based on the criteria by the International 
Committee of Medical Editors (ICMJE 2016). 
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5.2 INTRATHECAL MORPHINE RELATED PERIOPERATIVE 
HYPOTHERMIA IN WOMEN UNDERGOING CAESAREAN 
SECTION: A RETROSPECTIVE, CASE-CONTROL STUDY 
 
Abstract 
Purpose 
Rates of inadvertent perioperative hypothermia amongst women undergoing spinal 
anaesthesia for caesarean section are reported to be high.  Intrathecal morphine has 
been noted to have a potentially potent effect upon thermoregulation. This 
retrospective case-control study sought to investigate the incidence of perioperative 
hypothermia in women undergoing caesarean section with and without intrathecal 
morphine and to describe any clinical factors associated with the condition, the 
identification of which would provide direction for nursing priorities in the care of 
the condition.  
 
Methods 
The charts of 358 women who had undergone emergency or elective caesarean 
section under spinal anaesthesia were reviewed: 179 having received intrathecal 
morphine and 179 having received spinal anaesthesia without intrathecal morphine 
(control group). SPSS version 22 was used for data analysis, including logistic 
regression to predict the outcome of hypothermia across the study population.  
 
Findings 
There was no significant difference (p = 0.62, 95%CI -0.09 – 0.15) in mean 
postoperative temperature for the morphine group (mean PACU arrival temperature 
35.91°C, SD 0.59) and the no morphine group (mean PACU arrival temperature 
35.88°C, SD 0.52).  However, within groups, the temperature decline preoperatively 
to postoperatively was statistically (and clinically) significant. 
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Conclusion  
The results refute the suggestion that intrathecal morphine contributes to greater core 
temperature decline in this population, however it does confirm that perioperative 
hypothermia is a prevalent concern for women undergoing caesarean section, and 
that pre-emptive measures should be routinely considered by healthcare providers.   
 
Keywords: caesarean section, intrathecal morphine, observational, opioids, 
perioperative hypothermia. 
 
Purpose 
Perioperative hypothermia, in all surgical populations, is physiologically detrimental 
provoking a range of adverse side effects (Kurz, Sessler & Lenhardt., 1996; Beilin, et 
al., 1998; Scott & Buckland, 2006; Leslie, et al., 1995; NCCNSC, 2008; Reynolds, & 
Beckmann., 2008). Whilst there are reported high rates of hypothermia (defined as a 
core temperature < 36°C related to undergoing surgery under anaesthesia) 
(NCCNSC., 2008; Reynolds, et al., 2008) during and after spinal anaesthesia 
amongst women undergoing caesarean section, (Hess, Snowman & Wang., 2005) it 
is noted that intrathecal morphine may have a potentially potent effect upon 
thermoregulation, and that a small subset of women who receive intrathecal 
morphine develop particularly prolonged hypothermia. (Hess, et al., 2005; Wishaw, 
1997; Hui, et al., 2006; Sayyid, Jabbour, & Baraka., 2003; Kavee., et al, 1991). This 
presents a challenge for healthcare providers caring for these women postoperatively.  
Profound hypothermia after intrathecal morphine administration has been reported at 
temperatures as low as 33.1°C (Kosai, et al., 1992), however other reports have 
described a nadir of 33.2-34.9°C (Hess, et al., 2005; Ryan, et al., 2012; Bicalho, et 
al., 2006; Sayyid, et al., 2003; Kanawaza, & Okutani., 2015; Giladi, & Ioscovich., 
2015). As opposed to the commonly experienced perioperative hypothermia, a 
prolonged episode of profound temperature drop is experienced (reportedly ranging 
from 2hrs (Hess, et al., 2005) to 19hrs (Kosai, et al, 1992) to return to 
normothermia). In these cases, diaphoresis (sweating) and a sensation of feeling hot 
is commonly described, and this is sometimes accompanied by nausea and itching, 
causing extreme discomfort. For women undergoing caesarean section, any 
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experience of perioperative hypothermia (whether this is prolonged and symptomatic 
as described above, or the commonly seen perioperative heat loss) can interfere with 
immediate postoperative recovery (Butwick, Lipman, & Carvalho, 2007).   
The exact mechanism by which intrathecal morphine contributes to hypothermia is 
not definitively known (Butwick, et al., 2007). Core temperature, in all humans, is 
maintained within very narrow limits (Horn, et al., 2002) by the hypothalamus.  The 
thermoneutral zone (also referred to as the inter-threshold range) (Buggy, & 
Crossley., 2000) – that is, the temperature range between which temperature 
receptors do not provoke the hypothalamus to initiate a ‘too hot’ or ‘too cold’ 
response - is tightly controlled within generally just a 0.4°C range (Buggy, & 
Crossley., 2000). Outside of this range both behavioural and autonomic responses are 
initiated to alter temperature. It is thought that cephalic (head wards) spread of the 
morphine contributes to prolonged hypothermia by (Hess, et al., 2005), altering the 
temperature set point, (Hess, et al., 2005; Kanazawa & Okutani, 2015) whereby the 
new upper temperature set-point (or threshold) triggering sweating (a ‘too hot’ 
response) is below the normal inter-threshold range (Bicalho, et al., 2006). Therefore 
sweating is seen at a hypothermic temperature. 
The reduced benefit of active warming when spinal opioids have been administered 
has been suggested by a systematic review of warming interventions in this 
population (Munday., et al 2014) and other literature (Butwick, et al., 2006; Fallis, et 
al., 2006; Halloran, 2009). Evidence suggests that preoperative (Horn, et al., 2002) 
and intraoperative active warming, shown to improve maternal and neonatal 
outcomes, has been less effective where women have received intrathecal morphine 
(Hess et al., 2005; Butwick et al., 2007; Fallis, et al., 2006). In addition, conventional 
active warming strategies may have little benefit in profound and prolonged 
hypothermia, (Hess, et al., 2005; Ryan, et al., 2012; Sayyid, et al., 2003; Kosai, et al., 
1992; Halloran, 2009) due to patients feeling hot and sweaty, despite being 
hypothermic, not tolerating warming. Case reports suggest pharmacological 
interventions utilizing benzodiazepines such as Lorazepam (Hess, et al., 2005; Ryan, 
et al., 2012) or opioid antagonists such as Naloxone (Wishaw, 1997; Sayyid, et al., 
2003; Bicalho, et al., 2006; Kanazawaa & Okutani, 2015) can be helpful in the 
treatment of prolonged intrathecal morphine related hypothermia.   Shivering and the 
return of cold sensation after the administration of Lorazepam has been described 
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(Hess, et al., 2005). The return of the perception of cold enables warming to be 
applied. 
A small observational study of 100 patients reported incidence of hypothermia 
amongst women receiving intrathecal morphine for caesarean section was 32% and, 
within this figure, a subgroup was identified with an incidence of prolonged 
hypothermia (with a mean temperature of 34.9°C) of 6% and 7% (Hess, et al., 2005) 
Patients with prolonged hypothermia were symptomatic for between 120-360 
minutes, however patients who were ‘asymptomatic’ but hypothermic returned to 
normothermia within 30 minutes postoperatively. A controlled trial also found that 
women receiving intrathecal morphine for caesarean section had significantly lower 
temperatures for up to 24 hours, as compared to those who received epidural 
morphine (Kavee, et al., 1991). 
Prolonged hypothermia following intrathecal morphine administration for caesarean 
section has been observed anecdotally in the study hospital setting and is known to 
be uncomfortable for women and problematic for recovery room nurses and 
midwives to treat, however no figures exist to quantify this in the study hospital. This 
study aimed to, firstly, establish the incidence of perioperative hypothermia 
experienced by caesarean section patients receiving spinal anaesthesia with and 
without morphine to compare hypothermia incidence between these groups, and 
secondly, to examine the prevalence of prolonged, profound hypothermia.  The study 
also intended to identify any surgical or intraoperative factors influencing 
hypothermia within this population. 
 
Methods 
A retrospective case-control design reviewed inpatient charts of eligible participants 
admitted between 2007 and 2014.  Administration of intrathecal morphine (combined 
with intrathecal fentanyl and hyperbaric bupivacaine) is standard care in our 
institution; therefore the ‘no morphine group’ were selected first by identifying 
patients who, due to clinical reasons such as allergy, did not receive intrathecal 
morphine.  This group was then matched with patients who did receive intrathecal 
morphine. Each element of the data collection tool was linked to relevant factors 
identified in the literature, such as age, body mass index (BMI), preoperative 
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temperature and surgery duration, as well as intraoperative interventions, and 
anaesthetic variables such as spinal block.   An operational definition of profound 
hypothermia was established, also based on the literature (Hess, et al., 2005; Ryan, et 
al., 2012; Sayyid, et al., 2003; Kosai, et al., 1992; Halloran, 2009). Based on this 
operational definition, data were collected on shivering, nausea, vomiting, 
hypotension and sweating. The admission temperature on arrival to the Post 
Anaesthetic Care Unit (PACU) via aural canal Genius First TempTM thermometers 
(with an accuracy of +/- 0.2°C between 36°C to 39°C and of +/-0.3 °C below 36°C) 
(Covidien, 2011) obtained by the registered nurses working in PACU, was 
considered to indicate perioperative thermal status and used to generate a categorical 
variable for perioperative hypothermia. 
Women undergoing elective or emergency caesarean section under spinal anaesthesia 
(in a public tertiary hospital in South-East Queensland, Australia) were eligible for 
inclusion.  Assuming a prevalence of hypothermia in both groups could be as high as 
35%, based on earlier published rates of hypothermia receiving spinal anaesthesia for 
caesarean section (Hess, et al., 2005) and previous audits of hypothermia within adult 
(non-obstetric) patients at the study hospital, the required sample size to report a 95% 
confidence interval of 28-42% was 179 patients per group, allowing for ten cases of 
hypothermia per independent variable to enable the use of logistic regression. 
(Peduzzi, et al., 2006). 
After training, inter-rater reliability was established between the two researchers 
using the kappa statistic to test agreement on key categorical variables (surgery 
status, intrathecal morphine status, intraoperative fluid warming, hypotension), and 
the intraclass correlation coefficient for continuous variables (age, PACU arrival 
temperature, PACU discharge temperature, parity), using SPSS™ (V15). Results 
were used to indicate if further training was required. Confidentiality was 
maintained: no identifiable patient data were retained. Ethical approval was obtained 
from the hospital and university human research ethics committees. 
Descriptive statistics (using SPSS™ V15) assessed sample characteristics and 
summarised hypothermia incidence. Variables with a high amount of missing data 
were not considered further, however no cases were dropped completely due to 
missing data. Mean and standard deviations are reported for normally distributed 
continuous data, median and range for non-normally distributed continuous data, and 
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frequencies and percentages for categorical variables. The independent samples t-test 
was used to examine differences in means for normally distributed dependent 
variables. The paired samples t-test was used to evaluate postoperative temperature 
in relation to preoperative temperature. The Chi-squared test of independence (using 
Yates’ Continuity Correction) was used to compare groups.  One-way ANOVA was 
used to explore differences between groups in relation to independent variables with 
multiple categories. One-way analysis of covariance (ANCOVA) was used to 
examine mean PACU arrival temperature for both groups, with preoperative 
temperature as a covariate. A statistical significance level of p = < 0.05 was used. 
Correlation between continuous variables using Pearson product-moment correlation 
coefficient was checked prior to logistic regression, for which SPSS™ (V22) was 
utilised to investigate potential factors influencing the development of hypothermia. 
 
Findings 
A total of 358 charts of women undergoing spinal anaesthesia for elective or 
emergency caesarean section were included. Both groups were similar in relation to 
demographic and surgical variables (see Tables 1-3), apart from median surgical 
duration (in minutes) which was significantly longer in the no morphine group (p = 
0.04) and intrathecal fentanyl dose (mcg), which was also significantly greater in the 
no morphine group (p = 0.02). Although statistically significant, it is unlikely that the 
small difference of only three minutes in median surgical duration between the 
groups has any clinical significance. 
Table 1: Demographic variables  
  Variable Morphine (n=179):  
Mean (SD) / number (%) 
No Morphine (n=179): 
Mean (SD) / number (%) 
Age (yrs) 30.6 (SD 5.6) (n=178) 30.5 (SD 6.2) (n-178) 
Pre-pregnancy BMI  25.4 (SD 6.13) (n =174)  25.7 (SD 5.3) (n=168) 
Pre-pregnancy weight 
(kg) 
68.7 (SD 17.8) (n=145) 68.6 (SD 15.5) (n=144) 
Height (cm) 162 (SD 7.2) (n=140)  163.3 (SD 7.3) (n=141)  
Gestation (days)  264.1 (SD 20.1) (n=177)  265.1 (SD 17.7) (n=179)  
Gravidity  
 
3 (range 1-11) (n = 178)  3 (1-10) (n = 179)  
Parity  
 
2 (range: 1-8) (n = 177)  2 (1-8) (n = 178)  
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See Tables 2 & 3 (Supplementary Data – Appendix O) 
Mean temperature and hypothermia incidence. 
The small difference in mean postoperative (PACU arrival) temperature between 
groups (0.03°C) was not statistically significant (p = 0.62, 95%CI -0.09 – 0.15) with 
mean temperatures in both groups below the 36°C threshold (35.91°C SD 0.60 in the 
morphine group, versus 35.88°C SD 0.55 in the no morphine group). No significant 
association was found between morphine or no morphine and hypothermia status. 
(x2 (1, n= 358) = 0.18, p = 0.67, phi = -.028) Based on the odds ratio, the odds of 
women experiencing hypothermia in the morphine group was 0.90 times less than if 
they had not received intrathecal morphine, using the cut-off temperature of <36°C 
to indicate hypothermia. After adjusting for preoperative temperature, there was still 
no significant difference in mean PACU arrival temperature between groups: F (44, 
247) = 0.005, p = 0.941, partial eta squared 0.00). 
Table 4: Temperature: preoperative, PACU arrival and PACU discharge (°C) 
Temperature (°C) Intrathecal morphine 
(mean, SD)  
No intrathecal 
morphine (mean, 
SD)  
Preoperative  36.6 (SD 0.48) n = 155 36.5 (SD 0.43) n=137 
PACU arrival  35.9 (SD 0.60)  35.9 (SD 0.55)  
Ready to 
discharge from 
PACU  
36.3 (SD 0.50) n=169 36.2 (SD 0.48) n=162 
Temperature 
decline  
0.65 (SD 0.65) 0.57 (SD 0.60) 
 
Temperature decline. 
Both groups displayed a statistically and clinically significant temperature decline 
between preoperative measurement to PACU arrival time (in the morphine group: t 
(154) = 12.4, p <0.001 two-tailed, and, for the no morphine group: t (136) = 11.2, p < 
0.001 two-tailed), before an increase at ‘ready to discharge’ from PACU (see Table 
4).   The main effect comparing the two groups was not significant: F (1, 270) = 0.43, 
p = 0.52, partial eta squared = 0.002.  
Overall, the entire study population (both groups together) experienced a statistically 
significant decrease in mean temperature (°C) (0.62°C, 95% CI 0.54-0.69). p<0.001, 
t (291) = 16.7) from the preoperative to postoperative phase (mean preoperative 
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temperature 36.5°C, SD 0.46, arrival to PACU 35.9°C, SD 0.58). However, the 
number of patients documented on the anaesthetic chart as having received any form 
of intraoperative warming was low (19%, n = 68), although, due to poor 
documentation, warming is likely to be under-reported. Active intraoperative 
warming could not be considered further due to the large amount of missing data (> 
20%).   
   
Prolonged intrathecal morphine related hypothermia  
Only 8 patients experienced immediate postoperative hypothermia accompanied by 
sweating, nausea or vomiting, however two of these patients had received no 
intrathecal morphine. This small group represents 2% of the overall study population 
and therefore, little further investigation of this condition was conducted.  
 
Anaesthetic and surgical factors associated with hypothermia. 
Within the morphine group, differing morphine dosage of either 0-100mcg (n = 98, 
mean 36.0°C, SD 0.6), or 101-200mcg (n = 80, mean 35.9°C, SD 0.6) did not result 
in a significant difference in PACU arrival temperature (t (1.16, p = 0.25, two tailed). 
When categorised into dosage groups, fentanyl dosage did initially result in a 
statistically significant difference in mean PACU arrival temperature (see Table 5), 
with   post-hoc comparisons (using the Tukey HSD test) indicating the mean 
temperature for 10mcg was significantly different than the other groups.   However, 
the 10mcg group size was small (n = 15) and included one extremely low value 
(33.6°C). Although mean temperature for this group remains lower, when the 
analysis was re-run without this value, there was no significant difference between 
the groups: F (3, 341) = 1.5, p = 0.22, eta squared 0.01.  
Table 5: Mean postoperative temperature and fentanyl dose 
Fentanyl dose  Mean postoperative temperature 
(°C) 
10mcg * 35.6 (SD 0.7)  
15mcg 35.9 (SD 0.6)  
20mcg 35.9 (SD 0.6)  
25mcg  35.9 (SD 0.5)  
*with outlier of 33.6°C removed 
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There was no significant association between the level of spinal anaesthetic insertion 
and postoperative hypothermia (x2 (2, n = 266) = 3.4, p = 0.18, phi = 0.11) or 
between the position of spinal anaesthetic administration (sitting or lateral) and 
postoperative hypothermia: x2 (5, n = 232) = 0.19, p = 0.67, phi = 0.53). Based on 
the odds ratio, the odds of developing hypothermia if receiving spinal anaesthesia in 
the sitting position was 1.29 times greater than if placed in the lateral position. 
Patients with pregnancy-induced hypertension (PIH) experienced higher mean 
PACU arrival temperatures with a mean temperature decline of 0.5°C, with a 
statistically significant higher mean preoperative temperature than those without the 
condition (see Table 6).   
Table 6: Pregnancy Induced Hypertension and mean temperature 
Variable   Mean postoperative (PACU 
arrival) temperature °C  (mean, 
SD)  
Mean preoperative 
temperature °C (mean, SD) 
PIH  36.3 (SD 0.6)  36.8 (SD 0.4)  
No PIH  35.9 (SD 0.5)  36.5 (SD 0.5)  
P value <0.001 0.005 
 
Both groups had similar numbers of both emergency and elective patients (see Table 
2).  Differences in incidence of hypothermia between emergency and elective 
patients were investigated; a significant association was found between category of 
surgery and hypothermia status (Χ2 (1, n=356) = 87 p = 0.03, phi = 0.16).  Based on 
the odds ratio, the odds of women developing hypothermia was 0.52 times less likely 
if having an emergency rather than an elective caesarean section.  Elective patients 
experience statistically significant greater temperature decline than emergency 
patients (see Table 7). Mean PACU arrival temperature differed significantly 
between elective and emergency patients, despite no significant difference in 
preoperative temperature between these groups. The magnitude of the difference in 
the means (0.21, 95% CI 0.09 to 0.32) was small (eta squared = 0.03). The 
statistically significant higher number of patients with PIH, (shown to have higher 
mean preoperative and postoperative temperatures) in the emergency population may 
contribute to the higher overall mean temperatures experienced by this group (see 
Table 7). 
  Table 7: Temperature outcomes: emergency and elective patients  
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Temperature 
outcome 
Category  Mean 
difference 
[95% CI] 
Sig 
Emergency  Elective  
Mean preoperative 
temperature (°C) 
36.4 (SD 0.5)  36.5 (0.5)  0.04 [-0.06, 
0.15] 
0.4 
Mean PACU arrival 
temperature (°C)  
36.0 (SD 0.6)  35.8 (SD 
0.5)  
0.21 [0.09, 
0.32] 
0.001** 
Postoperative 
hypothermia  
80 (48%)  121 (64%)  n/a 0.03* 
Temperature decline: 
preoperative 
temperature to 
PACU arrival (°C) 
-0.53 (SD 0.6) -0.69 (SD 
0.6)  
0.16 [0.01, 
0.30] 
0.03* 
Pregnancy-induced 
hypertension (PIH) 
26 (15.6%)  6 (3.2%)  n/a 0.001** 
 significance  < 0.05; ** significance < 0.01  
 
Binary logistic regression indicates that BMI, category of surgery, PIH and 
preoperative temperature were significant predictors of postoperative hypothermia 
status.  
Table 8:  Predictors of postoperative hypothermia status 
Variable  OR  95% CI  Significance 
(p value)  
BMI 0.54 0.32- 0.91 0.02 
PIH 0.2 0.06-0.6 0.004 
Preoperative 
temperature  
0.36 0.20-0.70 0.001 
 
 
Discussion 
A high incidence of postoperative hypothermia was found both in women who 
received intrathecal morphine, and those who did not, during spinal anaesthesia for 
caesarean section, with no significant difference in temperature decline or 
hypothermia incidence between groups. Within the group of patients who 
experienced hypothermia, this study suggests an incidence of prolonged hypothermia 
with paradoxical symptoms far less than Hess’ work (Hess, et al., 2005), however 
this low incidence should be approached with caution (see Limitations). The 
observation of this clinically important phenomenon in practice suggests that it is 
more prevalent than the data indicates and that it may be better explored via a case 
series of already identified cases in this population and setting.   
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Although these results do not suggest a significant association between intrathecal 
morphine and maternal postoperative temperature, nor that opioid dosage amounts or 
spinal insertion level or position appear to influence postoperative temperature, they 
do establish a statistically and clinically significant temperature decline across the 
whole study population of women receiving spinal anaesthesia for caesarean section. 
While the 0.6°C temperature decline may appear small, it is clinically significant 
because it is sufficient to drop mean temperature from what is defined as a 
normothermic temperature to mild hypothermia (below 36°C) (NCCNSC, 2008; 
Reynolds, et al., 2008).  
Results of this study, and other work (Bamgbade, 2012), suggests that preoperative 
temperature measurement is poorly implemented in many settings including obstetric 
theatres.  This is despite its importance in identifying thermal status, which enables 
perioperative staff to implement pre-emptive action, as appropriate, to prevent 
further temperature decline (or, indeed, increase), with the aim of maintaining 
temperature within normal ranges. This reflects the position of the widely cited 
National Institute for Health and Care Excellence (NICE) guidelines for inadvertent 
perioperative hypothermia which recommend preoperative thermal status monitoring 
prior to patient transfer to the operating suite, but stops short of making any 
recommendations for obstetric patients (NCCNSC, 2008). The ASPAN Evidence-
Based Clinical Practice Guideline for the Promotion of Perioperative Hypothermia 
also emphasise the importance of measuring patient temperature on admission and 
assessing the patient’s thermal comfort level (Hooper, et al., 2010). Given the high 
rates of perioperative hypothermia reported in this population, it appears reasonable 
that this recommendation be extended to the obstetric population undergoing 
caesarean section.  
Similarly, intraoperative temperature monitoring for obstetric patients is not routine 
in our institution, despite patients routinely receiving intravenous fluid warming.   
This echoes findings from a European survey of intraoperative temperature 
monitoring and management, which indicated that in many instances active warming 
was instigated without temperature monitoring (Torossian, 2008). Again, the 
requirement for intraoperative temperature monitoring, as recommended by NICE, 
for all patients with an anaesthesia time exceeding 30 minutes, seems reasonable to 
apply to the population of women undergoing caesarean section (NCCNSC, 2008).  
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The extent of temperature decline experienced by elective patients also suggests that 
focus needs to be directed towards planning effective thermal care for this group. 
While the urgency often associated with emergency caesarean section can impede 
preoperative thermal care planning, processes should be established for routine 
elective surgery that do facilitate thermal care planning. Other work has suggested 
that active warming for this population is under-utilised (Woolnough, et al., 2009; 
Sultan, et al., 2015), despite recommendations to the contrary (Sultan, et al., 2015; 
Munday, et al., 2014). Although incomplete documentation impedes the investigation 
of the proportion of patients that did receive intraoperative warming in this study, the 
temperature decline evident in both groups suggests that more can be done to 
improve perioperative heat loss.  Perioperative nurses and the entire perioperative 
team have a part to play in this process.    
 
Limitations 
Although this study design, by its nature, lacks control of potentially confounding 
factors not documented in patient charts (for example ambient temperature), data 
included a wide range of demographic and intraoperative variables. Although 
intraoperative temperature data would be valuable, PACU arrival temperature, which 
appears to be measured consistently on arrival to PACU, was considered an indicator 
of immediate postoperative temperature, to identify hypothermia and intraoperative 
temperature decline. Measurement time points for preoperative temperatures also 
varied. In order to reduce bias during data collection, inter-rater reliability was 
established between the two researchers responsible for data collection. This type of 
study cannot account for some contributing external and environmental factors, such 
as a cool ambient operating theatre temperature (21.3°C +/- 0.3°C), which has been 
identified as a significant predictor of inadvertent hypothermia, as opposed to 
warmer ambient temperatures (Frank, et al., 1992). Ambient temperature should 
certainly be an independent variable in controlled study designs considering body 
temperature.  
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Conclusions 
The evidence appears to refute the suggestion that intrathecal morphine contributes 
to greater core temperature decline in this population, and confirms that perioperative 
hypothermia is a prevalent concern for women undergoing caesarean section.  It also 
reiterates the importance of nurses caring for perioperative patients taking pre-
emptive measures including the routine measurement of preoperative temperature 
and appropriate resultant action. Further work is needed to explore the phenomenon 
of prolonged intrathecal morphine related hypothermia with paradoxical symptoms, 
in relation to identifying associated factors that may contribute to this condition and 
therefore aid in perioperative care planning.   
 
Funding: no external funding 
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5.3 CHAPTER SUMMARY 
The evidence from this study suggests that the incidence of perioperative 
hypothermia is of equal concern for women undergoing spinal anaesthesia for 
caesarean section, irrespective of whether they receive intrathecal morphine. Both 
groups experienced a statistically significant temperature decline of 0.62°C. While 
this difference is less than a degree, it is also clinically significant, and in many 
patients this will result in the change in status from being normothermic to 
hypothermic.  In patients who are already hypothermic when surgery commences, 
this temperature decline is even more significant.  
While the systematic review results indicated that intraoperative warming was less 
effective in the studies where intrathecal opioids had been administered (Munday, 
Hines, Wallace, et al., 2013), no studies were identified that tested preoperative 
warming where participants had received intrathecal opioids (in particular, 
morphine), although preoperative warming had been found to be of benefit to those 
populations tested, who did not receive intrathecal opioids (Munday, et al., 2014).    
Despite the findings from the systematic review suggesting that preoperative 
warming is of benefit, and the findings from this observational study indicating that 
perioperative hypothermia is a problem in the majority of women undergoing 
caesarean section, there remains a gap in the science regarding the duration and 
timing of active warming strategies for optimal thermal care of women undergoing 
caesarean section, particularly those receiving intrathecal morphine.  In Chapter 6, I 
will present the methods and findings from a randomised controlled trial, which 
tested a preoperative warming regime, in the population of women receiving 
intrathecal morphine for caesarean section, for the primary outcome of maternal 
temperature decline. 
 Chapter 6: Preoperative Warming for Maintenance of Normothermia in Women Receiving Intrathecal Morphine 
for Caesarean Section. 95 
 
Chapter 6: Preoperative Warming for 
Maintenance of Normothermia 
in Women Receiving Intrathecal 
Morphine for Caesarean 
Section.  
6.1 INTRODUCTION 
Results from the systematic review and the observational study presented in the 
earlier chapters informed the development of a randomised controlled trial, which 
tested the effect of preoperative warming upon maternal temperature in women 
receiving intrathecal morphine for caesarean section. The impetus for this study 
arose from the following observations:  firstly, the systematic review suggested that 
warming may be less effective where intrathecal opioids, specifically morphine, had 
been administered, however these results pertained to intraoperative warming only.   
Preoperative warming in the context of intrathecal opioids for caesarean section had 
not been tested, although preoperative warming appeared to be effective at reducing 
maternal temperature decline where opioids had not been given. Secondly, results 
from the observational study suggested that there was significant temperature decline 
in women whether they received intrathecal morphine or not, indicating that effective 
interventions to reduce this decline are needed. Thirdly, this randomised controlled 
trial aimed to establish both the effectiveness of a period of preoperative warming 
that was feasible and practical for integration into the perioperative pathway. The 
duration and timing of preoperative warming was based upon relevant literature. The 
approach took into consideration the demands of perioperative routines as anecdotal 
evidence from the practice area suggested that longer durations of preoperative 
warming would be hard to achieve in the current perioperative system of care. 
Guidance for general adult preoperative warming suggests that an hour of 
preoperative warming be applied (NCCNSC 2008), however recent studies of 
preoperative warming, in other populations have found shorter periods to be effective 
(Horn et al., 2012).  Intrathecal morphine administration is part of standard care for 
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women undergoing caesarean section, not only in the institution where the study was 
conducted but also in many healthcare facilities due to the benefits gained from 
prolonged postoperative analgesia. Therefore adequate methods of protecting 
normothermia for these women are required.    
The paper presented here is a version accepted for publication. Also included 
Appendix P are the Mater Human Research Ethics Approval, Mater research 
governance approval, Queensland University of Technology administrative ethics 
approval.  Also included as appendices are the participant information and consent 
form (Appendix Q), the anaesthetic protocol (Appendix R) and data collection forms 
(Appendix S). As well as the intention-to-treat analysis reported in the paper for 
publication, per protocol analysis was also undertaken. This is reported in Appendix 
T.  
 
 
6.1.1 Contribution of Authors 
I was the primary investigator, responsible for designing the research protocol, data 
collection, data analysis and writing up the final manuscript. Dr Sonya Osborne was 
involved in reviewing the research protocol, review and discussion of data analysis 
procedures and reviewing the final manuscript. Professor Patsy Yates also reviewed 
the research protocol and the final manuscript (see Statement of Contributions, 
Appendix U).  To reduce variability in practice, and therefore potential confounding, 
a protocol of the anaesthetic and perioperative management of patients enrolled in 
the study was deemed necessary. This was developed in consultation with 
anaesthetic medical staff, namely Dr David Sturgess, but also with the support of the 
Deputy Director of Anaesthesia, Dr Simon Maffey, and widespread consent from 
other anaesthetic medical staff. Support from the study was also obtained other 
relevant nursing, midwifery, theatre and medical staff. Education sessions were 
conducted for ward and theatre staff, prior to the commencement of the study, and 
resource folders were made available for reference.  Statistical advice was obtained 
from Lee Jones and Edward Gosden (Research Methods Group, Queensland 
University of Technology).  
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6.2 SUBMITTED PAPER: PREOPERATIVE WARMING VERSUS NO 
PREOPERATIVE WARMING FOR MAINTENANCE OF 
NORMOTHERMIA IN WOMEN RECEIVING INTRATHECAL 
MORPHINE FOR CAESAREAN DELIVERY: A SINGLE BLINDED, 
RANDOMISED CONTROLLED TRIAL 
 
Abstract 
Introduction  
Rates of hypothermia for women undergoing spinal anaesthesia for caesarean 
delivery are high and prevention is desirable. This trial compared the effectiveness of 
pre-operative warming versus usual care amongst women receiving intrathecal 
morphine, which is thought to exacerbate perioperative heat loss.  
 
Methods 
A prospective, single-blinded, randomised controlled trial compared 20 minutes of 
forced air warming (plus intravenous fluid warming) versus no active preoperative 
warming (plus intravenous fluid warming) in 50 healthy American Society of 
Anesthesiologists  (ASA) graded II women receiving intrathecal morphine for 
elective caesarean delivery.  The primary outcome of maternal temperature change 
was assessed via aural canal and bladder temperature measurements at regular 
intervals.  Secondary outcomes included maternal thermal comfort, shivering, mean 
arterial pressure, agreement between aural temperature, and neonatal outcomes 
(axillary temperature at birth, Apgar scores, breastfeeding and skin-to-skin contact). 
The intention-to-treat population was analysed with descriptive statistics, general 
linear model analysis, linear mixed model analysis, Chi-square test of independence, 
Mann-Whitney, and Bland Altman analysis. Full ethical approval was obtained, and 
the study was registered on the Australia and New Zealand Clinical Trials Registry 
(Trial No: 367160, registered at     http://www.ANZCTR.org.au/). 
Results 
Intention-to-treat analysis (n=50) revealed no significant difference in aural 
temperature change from baseline to the end of the procedure between groups: F (1, 
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47) = 1.2, p =0.28. There were no other statistically significant differences between 
groups in any of the secondary outcomes. 
 
Conclusions 
A short period of pre-operative warming is not effective in preventing intraoperative 
temperature decline for women receiving intrathecal morphine. A combination of 
preoperative and intraoperative warming modalities may be required for this 
population. 
 
Introduction 
Women undergoing caesarean section are a vulnerable but often overlooked 
population in guidelines for perioperative temperature management. Inadvertent 
perioperative hypothermia, defined as the unintentional cooling of core temperature 
to below 36ºC during surgery (NCCNSC 2008) has detrimental physiological effects 
which have been well-studied in the non-pregnant population. These include 
increased blood loss (Rajagopalan, et al., 2008), higher wound infection rates (Kurz, 
et al., 1996), immune function suppression (Beilin, et al., 1998), prolonged drug 
action (Heier & Caldwell, 2006; Leslie, et al., 1995), increased duration of recovery 
stays (Lenhardt, et al., 1997) and increased hospital stay (Kurz, et al., 1996), 
increased costs (Mahoney & Odom, 1999),  shivering (Liu & Luxton, 1991; Roy, et 
al., 2004) and, importantly, discomfort. Impacts upon neonatal outcomes, such as 
temperature at birth (Horn, et al., 2002), umbilical vein (Horn, et al., 2002), and 
arterial pH and Apgar scores (Yokoyama, et al., 2009) have been demonstrated in 
some studies as well a relationship between neonatal hypothermia and 
hypoglycaemia (Baker & Lawson, 2012). Hypothermia is often undetected until the 
postoperative phase, causing significant disruption to postoperative care, as well as 
maternal-newborn bonding and feeding, whilst rewarming is applied.  
Rates of perioperative hypothermia amongst women undergoing caesarean under 
spinal anaesthesia have been estimated as being as high as between 32% (Hess, et al., 
2005) to 80% (Chakladar, et al., 2011). In addition, perioperative hypothermia 
appears to be intensified by intrathecal morphine (Cobb, et al., 2016 ; Halloran, 
2009; Hess, et al., 2005; Hui, et al., 2006). Since, in clinical practice, spinal 
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anaesthesia, commonly utilising intrathecal morphine, often comprises standard care 
for this population, it is important that health care providers establish pre-emptive 
measures to reduce the occurrence of hypothermia, shifting the emphasis from 
treatment to prevention for all women undergoing caesarean delivery. 
Guidelines for the general adult population advise 30 minutes of preoperative 
warming (NCCNSC 2008). A shorter period may be more clinically acceptable and 
practical, while still reducing intraoperative core temperature decline. Horn et al. 
tested passive warming versus 10, 20 or 30 minutes of preoperative forced air 
warming, in a randomised controlled trial of 200 patients undergoing laparoscopic 
surgery under general anaesthesia, finding that 10 minutes of preoperative warming 
resulted in significantly improved core temperature (Horn, et al., 2012). An optimum 
warming period of 20 minutes was recommended where clinically possible (Horn, et 
al., 2012). Fifteen minutes of preoperative warming before induction of epidural 
anaesthesia, plus continuation of forced air warming during surgery, has also shown 
efficacy at reducing hypothermia in a population of women receiving epidural 
anaesthesia but who did not receive opioids (Horn, et al., 2002). 
This single blinded, randomised controlled trial compared the effect of a period of 20 
minutes of preoperative forced air warming alongside intraoperative intravenous (IV) 
fluid warming with usual clinical care (IV fluid warming and no preoperative forced 
air warming) in a population of women receiving intrathecal morphine during 
elective caesarean delivery on the primary outcome of maternal temperature change 
from baseline to the end of the procedure.  Secondary outcomes – for exploratory 
analysis only - included temperature decline assessed over time, hypothermia, 
maternal thermal comfort, mean arterial pressure (MAP), shivering, agreement with 
aural canal and bladder temperature measurements, neonatal axillary temperature at 
birth, Apgar scores at 1 and 5 minutes, skin-to-skin contact at birth, breastfeeding at 
birth and upon discharge from hospital and incidence of wound complications.  
 
Methods 
Study Design 
Women with singleton pregnancies booked for elective caesarean delivery at term 
under spinal anaesthesia with intrathecal morphine were enrolled in this pragmatic, 
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single-blinded randomised controlled study, following hospital and university ethics 
approval, and informed consent. Exclusion criteria included known allergy to 
morphine, known impaired thermoregulation or thyroid disorders, vascular disease or 
poor cutaneous perfusion, ASA score >II, history of preeclampsia or eclampsia, 
planned Intensive Care Unit (ICU) admission, tympanic membrane/aural canal that 
was not visible on otoscopy and baseline temperature >37°C. The study was 
registered on the Australia and New Zealand Clinical Trials Registry (Trial No: 
367160, registered at http://www.ANZCTR.org.au/ on 10th October 2014 by the 
principal investigator Judy Munday). 
 
Study Protocol 
After informed consent, and otoscopy, participants were randomly assigned to either 
the control or the intervention group. The randomisation schedule was computer–
generated, utilising fixed-size blocks (at www.randomisation.com) of five per block 
and placed within sequentially numbered opaque envelopes. An independent 
coordinator generated the allocation sequence, and allocation to groups was 
concealed from the blinded outcome assessor.  
Participants in the control group received usual care consisting of no active warming 
during the admission and preoperative period. Participants in the intervention group 
received 20 minutes of full body preoperative warming in which perioperative 
midwives independent of the study applied a forced-air warming device (Cocoon™) 
set to 43°C in the preoperative waiting area, prior to entering the operating room for 
induction of spinal anaesthesia.  The investigator remained in the operating theatre 
and did not access the preoperative waiting area to ensure blinding. A delay of more 
than 20 minutes between the end of the preoperative warming and transfer to theatre 
was considered a protocol deviation. Patients were monitored during the intervention 
to assess for adverse side effects related to warming, such as diaphoresis or nausea 
and vomiting.  
All women received intravenous fluid warming (compound sodium lactate) warmed 
to 38.5°C (via Biegler™ fluid warmer), were covered with a warmed cotton blanket 
and surgical drapes, and received standardized intraoperative anaesthetic medication 
and intravenous fluids. After induction of spinal anaesthesia, a temperature sensing 
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indwelling urinary catheter (Mon-a-Therm™) was inserted. All patients received 
spinal anaesthesia (or combined spinal-epidural anaesthesia with no opioids via the 
epidural catheter) in the sitting position at the L3-4 interspace, with 2.2 to 2.4mls 
hyperbaric 0.5% bupivacaine, intrathecal morphine 100mcg, and intrathecal fentanyl 
15 to 20mcg. Block height was tested using ice, and the procedure commenced once 
a sensory block above T4 was achieved. Intravenous carbetocin 100mcg was 
administered at delivery. Rectal paracetamol 1g and diclofenac 100mg were 
administered at the end of the procedure. Variations to the protocol were documented 
and recorded. Ambient preoperative holding bay and operating room temperature 
was recorded via thermostat. At the end of the procedure, all patients were covered 
with a warmed cotton blanket and a reflective foil blanket, prior to transfer to PACU. 
If temperature decline, or temperature < 35.5° C (as per institutional guidelines), 
shivering or cold discomfort was experienced in PACU, further warmed blankets 
were offered and/or forced air warming commenced as per routine care.  
Maternal temperature was measured using both a calibrated Genius™ aural canal 
thermometer (cited as reading a mean of -0.4° C less than pulmonary artery 
measurement) (Robinson, Charlton, Seal, Spady, & Joffres, 1998) and Mon-a-
Therm™ indwelling urinary catheterization (cited as providing accuracy to within 
0.1° C of pulmonary artery measurement) (Russell & Freeman, 1996) at the 
following time points: baseline, pre-spinal, post-spinal, every 15 minutes and at the 
end of the procedure, on arrival to PACU, then every 15 minutes until ready for 
discharge from PACU. Maternal thermal comfort was measured using a 100mm 
Visual Analogue Scale (VAS), used in a number of studies measuring patient thermal 
comfort (Buggy & Crossley, 2000; Fallis, et al., 2006; Fossum, Hays, & Henson, 
2001; Sessler & Ponte, 1990; Wilson & Kolcaba, 2004). Shivering was assessed via 
a three-point scale used in previous studies in this population (Saito, Sessler, Fujita, 
Ooi, & Jeffrey, 1998; Woolnough, Allam, et al., 2009) in the absence of a validated 
shivering scale. Mean arterial pressure (MAP) was measured at baseline, pre-spinal, 
post-spinal and at the end of the procedure, however only baseline, pre-spinal and 
post-spinal measurements were analysed due to the individual difference in the use 
of vasopressors in response to clinical need; which was not specified in the 
anaesthetic protocol. An independent midwife assessed neonatal axillary 
temperature, and Apgar scores, at 1 and 5 minutes after birth. Duration of skin-to-
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skin at birth, feeding intention, breastfeeding and timing of feed at birth were 
recorded, as well as breastfeeding at 10 days post-natally which was determined 
retrospectively from the Universal Postnatal Contact Survey. Wound infection and 
dehiscence upon hospital discharge, and patient concerns with the post-natal wound 
(at 10 days) were also determined via chart review. Demographic data collection 
included maternal age, parity and gravidity. Surgical variables such as intraoperative 
blood loss, volume of intravenous fluid infusion, anaesthetic medication (including 
any which deviate from the agreed protocol) duration of procedure, preoperative and 
operating room (OR) ambient temperature were also recorded. This manuscript 
adheres to the CONSORT criteria for the reporting of RCTs (Ioannidis et al., 2004). 
 
Statistical Analysis  
Descriptive statistics were generated to summarize sample characteristics, and 
hypothermia prevalence. Data are expressed as means and standard deviations, 
median and range or as frequencies and percentages as indicated. A general linear 
model was used to assess the primary outcome of aural temperature change between 
groups, with adjustment for baseline temperature and surgery duration.  
An exploratory analysis of secondary outcomes was undertaken, using linear mixed 
model analysis (to allow for fixed effects of baseline temperature, time and group, 
and a random intercept for repeated measures) for aural temperature decline from 
immediately after spinal insertion until the end of the procedure. Linear mixed model 
analysis was also used to assess thermal comfort between groups at repeated time 
points.  Pearson Chi-Square test of independence with Continuity Correction was 
used to analyse hypothermia incidence, shivering and neonatal outcomes, with the 
Mann-Whitney U Test used for non-parametric mean arterial pressure data. Bland-
Altman analysis (using MedCalc™) examined agreement31 between aural canal and 
bladder temperature, and to provide a means to establish the accuracy of the aural 
canal measurements used for the primary analysis.   SPSS™ software (version 22) 
was utilised for all other data analysis:  p <0.05 was considered statistically 
significant for the primary outcome, and p <0.01 for the secondary outcomes.    
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All analyses were performed on the Intention-to-Treat (ITT) population, which 
included all participants in the groups to which they were assigned, irrespective of 
protocol deviations.  
A required sample size of 15 participants in each group was calculated, based on a 
repeated measures design with the initial temperatures being the same and the 
temperature decline being 0.4°C greater in the unwarmed group than the warmed 
group 45 minutes after commencement of surgery. A standard deviation of 0.4°C 
was used in the calculation, based on the data reported by Chung et al. (Chung, et al., 
2012). A type I error rate of 0.05 and a power of 90% were specified. The sample 
size was inflated from a total of 30 to a total of 50 to allow for attrition.  
 
Results  
Patients were enrolled in the study between February 2015 and February 2016. All 
50 patients completed the study (Figure 1), however there were 13 protocol 
deviations: seven in the preoperative warming group and six in the control group.  
Three patients in the pre-operative warming group had suspected bladder injury and 
received methylene blue dye; from the point of this occurrence bladder temperature 
for these patients was disregarded.   
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Assessed for eligibility (n = 132) 
Excluded (n= 82) 
 Declined to participate 
(n=40)  
 Pyrexial on admission (n= 9) 
 Emergency surgery prior to 
booked procedure (n=15) 
 Other reasons (n = 18)  
Randomised (n = 50) 
Allocation to prewarming (n= 25)  
 Received allocated intervention 
(n= 18) 
 Did not receive allocated 
intervention (n= 7) 
Allocated to control (n = 25)  
 Received allocated intervention 
(n= 19) 
 Did not receive allocated 
intervention (n = 6)  
Lost to follow up/withdrawn (n=0) 
Intention to treat (primary) analysis 
(n=25) 
Enrolment 
Allocation  
Follow up   
Analysis    
Intention to treat (primary) analysis 
(n=25) 
 
Lost to follow up /withdrawn (n=0) 
Figure 1: Study Flow-chart 
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Maternal baseline characteristics, as well as surgical and anaesthetic variables, were 
similar across treatment groups apart from baseline temperature (Table 1). In the 
warming group, four patients experienced sweating. Due to this, one patient ceased 
the warming period two minutes early by request. Nil other adverse events related to 
the warming intervention were reported.  
Table 1: Maternal baseline, surgical and anaesthetic data  
Variable  Pre-operative 
warming: 
median, (range) 
(n=25)  
Control: mean, 
SD/median, range 
(n=25)  
Age (yrs)  31 (23-41) 36 (19-40)  
BMI 22.9 (16.2-38.2) 23.8 (17.6-40.3) 
Gravidity  2 (1-7) 2 (1-6)  
Parity  2 (1-5) 2 (1-5)  
ASA I 
ASA II 
21 
4 
19 
6 
Estimated blood loss (mls) 400 (200-700) 400 (200-600) 
Surgical duration (mins)  46 (31-76) 46 (27-72) 
Intraoperative Intravenous 
Fluid (mls)  
1500 (800-2100) 1500 (800-2050)  
Baseline temperature (°C) 36.6 (35.7-36.9) 36.8 (35.9-36.9) 
Mean arterial pressure (MAP)  86 (69-100) 85 (71-96) 
Spinal Time (mins)  12 (6-31)  14 (8-22)  
Clean up time (mins)  9 (4-15)  10 (5-14)  
Preoperative ambient 
temperature (°C) 
23 (22-25)  24 (23-26)  
OT Ambient Temperature 
(°C) 
21.4 (20.2-23) 21.5 (20.6-22.6) 
BMI: Body Mass Index; ASA: American Society of Anesthesiologists; MAP: mean arterial pressure; OR: 
operating room 
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Primary Outcome 
Intention-to-treat analysis revealed no significant difference in aural temperature 
change from baseline to the end of the procedure between groups: F (1, 47) = 1.2, p 
=0.28, partial eta squared = 0.03) (Table 2).  
Table 2: Temperature change (°C): baseline-end of procedure and hypothermic 
patients at each time point 
 Temperature change °C (baseline – end of 
procedure): mean (SD) number 
Preoperative 
warming 
Control  P value 
Intention-to- treat  0.5 (SD 0.32) (n=25) 0.7 (SD 0.57) 
(n=25) 
0.28 
Hypothermic patients (by group) at each time point 
 Intervention (n=25) Control (n=25) 
 Baseline 3 (12%) 1 (4%) 
 Pre Spinal  0 0 
 Post Spinal  0 0 
 OR 15 minutes 4 (16.7%) 6 (25%) 
 OR 30 minutes 6 (24%) 9 (36%) 
 OR End Procedure 11 (44%) 12 (48%) 
 PACU Arrival  12 (48%) 16 (64%) 
 Hypothermia: defined as a temperature of <36°C 
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Secondary outcomes 
Although the preoperative warming group experienced higher intraoperative mean 
temperatures, from the insertion of spinal anaesthesia until 30 minutes, this was not 
statistically significant and by 45 minutes temperatures in both groups were the 
same, when analysed using linear mixed model analysis, and controlling for baseline 
temperature (Figure 2). There were no statistically significant differences in 
hypothermia incidence between the groups (see Table 2).  
 
 
Figure 2:  Intraoperative temperature (°C) 
 
Maternal thermal comfort did not differ between groups at any time point (see Table 
3). There were no clinically significant differences in MAP between groups or 
differences in postoperative outcomes (see Table 3). No patients experienced wound 
infection or dehiscence, assessed at discharge, in either group.  On follow-up, one 
patient in the control group had a post-natal wound infection (10 days post-natally).  
Neonatal outcomes were also similar between groups (Table 3).   
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Table 3: Secondary Maternal and Neonatal Outcomes 
Variable  Preoperative 
warming (n=25) 
Control (n=25)  P 
value  
Mild shivering* 3 (12%)  8 (32%)  0.09 
Intense Shivering 0  3 (12%) n/a 
Any shivering* 3 (12%)  8 (32%)  0.09 
MAP (Pre-spinal)# 97 (70-113) 97 (84-116) 0.69 
MAP (Post-spinal)#  89 (68-112)  85 (56-118) 0.03 
Overall maternal thermal 
comfort 
5.4 (95%CI 5.1-5.7) 5.2 (95%CI 4.9-5.5) 0.58 
PACU: arrival to ready to 
discharge (mins)  
37 (30-76) 39 (27-81) n/a 
Warmed in PACU  17 (68%)  20 (80%)  0.52 
Neonatal outcomes 
Axillary temperature (°C)** 36.8 (36.0-37.3) 36.6 (36.2-37.3) 0.26 
Apgar at 1 min# 
   Apgar 7 
   Apgar 8 
   Apgar 9 
   Apgar 10 
 
1 (4%)  
4 (16%)  
20 (80%)  
0 
 
1 (4%)  
3 (12%)  
20 (80%)  
1 (4%) 
 
0.92 
Apgar at 5 mins## 
   Apgar 8 
   Apgar 9 
   Apgar 10 
 
1 (4%)  
24 (96%)  
0 
 
0 
24 (96%)  
1 (4%) 
 
0.74 
 SCN admission 
 ICN admission 
0 
0 
0 
1 
n/a 
1 
Respiratory distress 3 (12%) 5 (20%) 0.7 
Intention to breastfeed 21 (84%) 23 (92%) 0.3 
Breastfed at delivery 21 (84%) 22 (88%) 0.5 
Skin-to-skin >30 minutes 12 (48%) 7 (28%) 0.23 
Breastfed 10 days postnatally 13 (81%) 17 (85%) 1 
* median (range) # number (%) **Fisher’s Exact Test, ## median, range,  *** Estimated marginal means, linear 
mixed model analysis, SCN: Special Care Nursery, ICN: Intensive Care Nursery  
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Bland-Altman analysis indicated that, apart from one outlier, differences between 
aural canal (Genius™) and bladder (Mon-a-Therm™) temperature measurement 
devices appear to be consistent as temperature changes. The mean difference 
between devices was 0.04°C (SD 0.25).  The limits of agreement ranged from 0.93—
0.86°C, however only two paired measurements exceeded a difference of 0.5 °C, 
conventionally cited as a clinically acceptable measurement variation (see Figure 3). 
 
 
Figure 3:  Bland-Altman Plot – Agreement between aural (Genius™) and bladder 
(Mon-A-Therm™) temperature 
 
Discussion  
Twenty minutes of full body preoperative warming, prior to spinal anaesthesia with 
intrathecal morphine for caesarean delivery, does not result in a significant decrease 
in intraoperative maternal temperature decline.  Despite the increased core to 
periphery heat gradient that is proposed to result from preoperative warming (Horn, 
et al., 2002), by the end of the procedure both groups experienced temperature 
decline with similar end of procedure temperatures. 
The results of our study contrast with Horn et al.’s findings that 15 minutes of upper 
body preoperative warming 43°C, continued intraoperatively, resulted in over 1°C 
difference between control and intervention group at the end of surgery, in favour of 
warming (Horn, et al., 2002). However, ambient temperature was higher in Horn’s 
study, and surgical duration was slightly less than our study (Table 1).   In addition, 
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their population received epidural anaesthesia with no opioids, which may contribute 
to the marked differences between their warmed and unwarmed groups (Horn, et al., 
2002). Similarly, De Bernardis et al. also found temperature declined less when 
women received pre-operative warming that continued intraoperatively, (versus the 
control group receiving IV fluids warmed only to 37°C). All patients received spinal 
anaesthesia with 80mcg intrathecal morphine (de Bernardis, Siaulys, Vieira, & 
Mathias, 2015). 
 When considered in conjunction with the results from other comparable studies 
(Chung, et al., 2012; de Bernardis, et al., 2015; Horn, et al., 2002) several key 
variations appear important:  the use (and dose) of intrathecal morphine, surgical 
factors including ambient temperature and surgical duration, and the use of pre-
operative strategies that are both multi-modal and continued intraoperatively. 
Although it has been proposed that increased heat loss may occur with intrathecal 
morphine due to cephalic spread decreasing the temperature set-point, the reasons for 
this remain unconfirmed.   Given current evidence, it cannot be said with certainty 
that intrathecal morphine blunts the response to warming.  
Both groups in our study received IV fluid warming as per National Institute for 
Health and Care Excellence (NICE) guidelines that fluids of >500mls should be 
warmed to 37°C or more) (NCCNSC 2008), in the form of crystalloid co-loading at 
the time of spinal anaesthesia, as is usual care in our institution. This may help to 
maintain temperature during the period of intravascular volume shift that occurs 
during spinal anaesthesia (Cobb, et al., 2016 ). However, it is evident that IV fluid 
warming alone is not sufficient to prevent hypothermia in most patients, as indicated 
by the incidence of hypothermia in the control group in this study, again further 
suggesting that multi-modal interventions are likely to be of the most benefit (Cobb, 
et al., 2016 )   
Both researchers and clinicians have questioned whether forced air warming is 
tolerable or practical for obstetric patients (Chakladar & Harper, 2010; Petsas, et al., 
2009). While this study did not assess tolerability in any meaningful way beyond 
recording adverse events related to warming, or patient symptoms of sweating, 
nausea or discomfort, it appears that patients in this study largely found the duration 
and 43°C setting tolerable. Only one patient asked to cease the intervention two 
minutes early, which compares favourably with results from Fallis et al.’s study of 
 Chapter 6: Preoperative Warming for Maintenance of Normothermia in Women Receiving Intrathecal Morphine 
for Caesarean Section. 111 
upper-body intraoperative forced air warming, where 14 patients decreased the 
temperature of the forced air warmer from 43°C to a lower setting (Fallis, et al., 
2006). Research into obstetric patient’s preferences for warming interventions may 
be warranted.  
The intensity and incidence of shivering may indicate the severity of hypothermia. In 
our study, no pre-operatively warmed patients, as opposed to 3 patients in the control 
group, experienced severe shivering. Warmed IV fluids were found to be effective at 
reducing shivering in recent meta-analysis (Munday, Hines, Wallace, et al., 2013). 
Non-thermogenic factors, such as catecholamines resulting from pain or anxiety, 
may also contribute to shivering (Alfonsi, 2003; Chan, et al., 1989), and larger 
studies of the impact of combined warming strategies incorporating pre-operative 
warming upon shivering are warranted.  
This study was designed to test a pragmatic approach to warming by using a short 
preoperative full body warming regime, based on evidence of the optimal duration of 
effective preoperative warming (Horn, et al., 2012; Horn, et al., 2002). Warming was 
applied in the preoperative waiting area before women entered the OR. Our study 
protocol specified no greater than a 20 minute time delay between the end of the 
warming regime and entry to the OR but some participants experienced longer 
delays, which reduced power of the study to detect a difference between groups. The 
benefits of preoperative warming may be evident if warming is continued into the 
OR, through induction of neuraxial anaesthesia, through the commencement of the 
surgical skin preparation (Chung, et al., 2012; Horn, et al., 2002).  
The use of aural canal thermometry is not without controversy, and that disagreement 
exists as to the accuracy of this method.  However, this method is not invasive and 
therefore may be more acceptable to patients. Our study used measures to assess and 
increase the reliability of aural canal thermometry, including checking the visibility 
of the tympanic membrane via otoscopy, using one outcome assessor, and using an 
additional measurement of bladder temperature (cited as providing an acceptable 
near-core measurement). Temperature decline was assessed until the end of the 
procedure, while other studies also report temperature in PACU (Butwick, et al., 
2007). Temperatures measured after arrival in the PACU were not analysed because 
some patients received postoperative warming interventions; any measurements 
beyond the arrival temperature into PACU would therefore be confounded. 
 Chapter 6: Preoperative Warming for Maintenance of Normothermia in Women Receiving Intrathecal Morphine 
for Caesarean Section. 112 
In conclusion, based on the intention-to-treat results of this study, a short period of 
preoperative forced air warming, in conjunction with intraoperative IV fluid 
warming, is not effective at preventing temperature decline in women that receive 
intrathecal morphine for caesarean delivery.  These results do not correspond with 
the benefits reported for women undergoing caesarean delivery who have received 
pre-operative warming that continues intraoperatively or have not received 
intrathecal opioids.   However, as intrathecal opioid administration is common 
practice in many institutions, effective methods of preventing perioperative 
hypothermia in this population warrant further exploration; combined warming 
interventions are likely to be of the most benefit. 
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6.3 CHAPTER SUMMARY 
This study indicates that, while preoperative forced air warming appears to have 
some benefit, the results are less pronounced than the studies of pre-operative 
warming where intrathecal opioids have not been administered. The challenges of 
clinical research and applying rigorous study protocols in a busy clinical 
environment was also highlighted during the conduct of this study which, in part, 
contributed to the protocol deviations during the course of the study.  However, this 
also indicated the practicalities and likely clinical issues that would be experienced in 
implementing this intervention into practice, as well as the likely benefits seen in 
clinical practice.   Nevertheless, as the sample size was inflated to allow for protocol 
deviations and attrition, the per protocol population represented an adequate sample 
size as per the power calculation.     
When per protocol analysis was conducted (see Appendix T), the results of the pre-
operative warming intervention clearly indicated significantly less change from 
baseline temperature to end of procedure temperature in the intervention group. This 
degree of change has some clinical significance. The loss of 0.8°C in the control 
group (versus 0.4°C in the intervention group) is close to the 1.0 °C cited as being 
the common degree of heat loss experienced in the first hour of anaesthesia (Kurz, 
2008) if preventative measures are not taken.  This heat loss would have been further 
pronounced if it were not for the 0.2°C difference between the groups at baseline 
(where the control group had a higher temperature). 
In summary, this study indicates that temperature decline in women receiving 
intrathecal morphine remains a clinical issue that deserves further investigation. 
Warming strategies cited as beneficial in other populations may be less so in this 
population, and careful perioperative thermal care planning is required.  
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Chapter 7: Discussion 
7.1 INTRODUCTION 
Perioperative hypothermia is recognised as a significant issue for all patients 
undergoing surgery. Although awareness of this issue and investigation into effective 
methods of prevention and treatment has increased in recent years, guidance was still 
lacking for at least one distinct and vulnerable subgroup of surgical patients, that is, 
women undergoing caesarean section, leaving a significant gap in literature. The 
purpose of this multi-phased program of research was to systematically examine the 
existing evidence for preventing and treating perioperative hypothermia for women 
undergoing caesarean section, with the view to establishing evidence-based 
recommendations for practice.  The research program also aimed to examine whether 
special considerations needed to be taken in relation to hypothermia prevention 
interventions, notably active warming, for this vulnerable surgical population, and 
whether methods of warming utilised in other populations are suitable and effective 
for use in women undergoing caesarean section. This chapter will consider the 
findings from all phases of the research program and aims to situate findings from 
these studies in the context of current literature. 
 
7.2 THE STATE OF THE SCIENCE  
As far as we know, this program of research is the first of its kind to synthesise the 
current state of the science of hypothermia prevention and treatment specifically 
targeting women undergoing caesarean section. Internationally accepted guidelines 
and evidence-based recommendations (Association of Operating Room Nurses ARP 
Committee, 2007; Hooper, et al., 2010; NCCNSC 2008) have neglected to provide 
for the obstetric population, leaving health providers who care for women 
undergoing caesarean section with a lack of clear guidance around the treatment of 
this condition (Munday, Hines, Wallace, et al., 2013; Petsas, et al., 2009). The 
potential for the update of the most comprehensive of these guidelines (the NICE 
guidelines) to incorporate guidance for obstetric patients has been discussed and 
discounted, as recently as 2015 (National Institute for Health and Care Excellence 
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2015) despite the first three year review of the guideline in 2011 raising the proposal 
of widening the scope of the review to include obstetric patients (National Institute 
for Health and Clinical Excellence November 2011). The reasons behind this have 
been cited as due to the complex physiological concerns of obstetric patients, which 
differ to the general population (National Institute for Health and Care Excellence 
2015). An additional committee of obstetric experts was considered necessary to 
oversee this update, but unfortunately it was decided the matter was not a priority 
(National Institute for Health and Care Excellence 2015).   
Concerns regarding the practicality of warming strategies – particularly over body 
warming blankets – for the awake patient who desires to hold her newborn in the 
operating room may also have contributed to the decision not to extend 
recommendations to obstetric patients. It also appears likely that a contributing factor 
to the lack of guidance for the obstetric population is a lack of importance attached to 
providing adequate thermal care for this group. This is apparent in the Guideline 
Development Group’s aforementioned assertion that extending guidance to the 
obstetric population was not a priority (National Institute for Health and Care 
Excellence 2015), as well as the survey evidence that indicates the lack of attention 
paid to warming obstetric patients in practice (Woolnough, Hemingway, et al., 
2009). In 2010, Chakladar argued that existing recommendations from the 2008 
NICE guidelines (NCCNSC 2008) may at least be partly transferable to the 
caesarean section population, with ‘informed interpretation and implementation’p212 
(Chakladar & Harper, 2010). However, this is contrary to the reasons purported for 
not including obstetric patients in the guidelines - differing and complex 
physiological concerns of obstetric patients to the general population. Specific 
guidance for obstetric patients as a distinct group would be valuable, not least 
because interventions, and strategies deemed suitable and effective for use in the 
general adult population may not be as effective, and may present challenges in 
application in this population. Indeed, NICE conceded this by suggesting in 2015 
that a guideline to address perioperative hypothermia management for obstetric 
patients may be considered as part of an extension to a caesarean section guideline 
(National Institute for Health and Care Excellence 2015) rather than as part of the 
perioperative hypothermia guidelines for the general adult population (NCCNSC 
2008).  
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As opposed to the general adult population for which guidelines are provided, 
pregnancy-, surgical- and anaesthetic-related factors, such the vasodilation 
experienced by pregnant women, the degree of exposure required during caesarean 
section surgery and the propensity for neuraxial anaesthesia to be used, influence the 
potential benefits of warming interventions in the obstetric population. Spinal 
anaesthesia – the anaesthetic mode of choice for the majority of caesarean sections – 
results in vasodilation in all surgical populations.  For women undergoing caesarean 
section the detrimental thermoregulatory effects of anaesthesia-related 
thermoregulation may be heightened due to pregnancy related vasodilation, from 
which decreased vascular resistance also results (Sanghavi & Rutherford, 2014). 
Vasodilation results in heat being lost from the body’s core to the peripheries, and 
therefore obstetric patients are doubly predisposed to heat loss via vasodilation 
because of both pregnancy and anaesthetic factors. Women undergoing caesarean 
section are also inherently disposed to lose heat via body exposure in the operating 
suite, due to the degree of exposure required to access the surgical site. The centrality 
of the surgical site to the body also results in limited coverage from upper body 
coverings and blankets being a possibility, as compared to surgery requiring less 
exposure, whereby greater body coverage is usually possible.  Therefore, reducing 
convective and evaporative heat loss in caesarean section patients is problematic. 
Due to the adverse and undesirable side effects of perioperative hypothermia, 
together with the high reported rates of perioperative hypothermia in this population, 
(Chakladar, et al., 2011; Hess, et al., 2005) guidance on methods of prevention 
and/or treatment of this problem is needed. As well as contributing to the 
generalizability of the systematic review recommendations, the global significance of 
perioperative hypothermia is illustrated by the geographical spread of the included 
studies in the systematic review (the United Kingdom, Canada, Iran, the United 
States, Korea, India, Taiwan and Japan), indicating the scope of the problem 
internationally.  
 
7.2.1 Updates to the Evidence Base 
To consider relevant research that would have met the criteria for potential inclusion 
in the systematic review and to provide an up-to-date context for this research 
program, the initial Medline (via EBSCO) search strategy used during the conduct of 
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the review (in May 2012) was repeated, with the date range of May 2012 to May 
2016 (Munday, Hines, Wallace, et al., 2013; Munday, et al., 2014). This further 
search revealed that four randomised controlled trials specifically testing warming 
interventions to reduce hypothermia in women undergoing caesarean section have 
been published since searches were completed for the systematic review (Chakladar, 
Dixon, Crook, & Harper, 2014; Cobb, et al., 2016 ; de Bernardis, et al., 2015; Paris, 
Seitz, McElroy, & Regan, 2014). One of these studies (Chakladar, et al., 2014) is not 
specifically discussed further in this chapter, as the unpublished results were 
included in the systematic review, however results from the three remaining studies 
are discussed in the light of the systematic review recommendations.  In addition, 
following the publishing of our systematic review, a meta-analysis of 13 studies 
investigating the effect of forced air or fluid warming upon maximum maternal 
temperature change (with secondary outcomes of shivering, thermal comfort, 
hypothermia, neonatal temperature, umbilical pH and Apgar scores) was also 
published in 2015 (Sultan, Habib, Cho, & Carvalho, 2015 ).  Findings from this new 
meta-analysis (Sultan, et al., 2015 ) are also discussed in context with our systematic 
review recommendations (Munday, Hines, Wallace, et al., 2013). 
 
7.3 CONTRIBUTING FACTORS TO PERIOPERATIVE HYPOTHERMIA 
IN WOMEN UNDERGOING CAESAREAN SECTION  
While the propensity for obstetric patients to lose heat related to surgical and 
pregnancy factors has been well documented, this research program also identified 
and examined other factors related to surgery that influence the development of 
perioperative hypothermia for caesarean section patients, such as category of 
surgery, as well as examining the notable influence of anaesthesia and commonly 
administered medications during caesarean section surgery upon heat loss.  
While the predominant focus on the elective caesarean section population could be 
identified as a limitation of this research program, the retrospective case-control 
study revealed interesting findings related to the emergency caesarean section 
patient, establishing that heat loss is a lesser concern for the emergency population of 
women undergoing spinal anaesthesia, with a statistically significant difference in 
temperature decline and postoperative hypothermia between the elective and 
emergency population (see Chapter 5). The lesser incidence of hypothermia may be 
 Chapter 7:Discussion 125 
partly attributed to the higher incidence of pregnancy-induced hypertension (PIH) in 
the emergency population, as PIH in itself was found to result in significantly 
increased temperature, both preoperatively and postoperatively.  It seems probable 
that the vasoconstriction responsible for pregnancy-induced hypertension 
(Hladunewich, Karumanchi, & Lafayette, 2007) may explain this increase in 
temperature.  
Emergency caesarean section patients are less likely to be waiting for lengthy periods 
in cool waiting areas prior to surgery. The majority of women undergoing emergency 
caesarean are likely to have experienced labour, and it has been established that 
maternal temperature rises with each contraction (Marx & Loew, 1975). It is also 
widely recognised that some women receiving epidural analgesia during labour 
experienced fever.  The aetiology of epidural analgesia-related fever during labour 
remains poorly understood (Scott, 2010) but an inflammatory response to epidural 
anaesthesia remains the most popular theory (Scott, 2010).  
Although it seems reasonable to expect that the emergency population is likely to 
experience higher preoperative temperatures, this was not found to be the case in our 
study, with similar preoperative temperatures recorded between the emergency and 
elective groups. The lack of control over the timing of the preoperative 
measurements in this study should be acknowledged. The emergency group did, 
however, experience a normothermic mean postoperative temperature of 36.0°C.   
Nonetheless, a significant proportion of emergency patients (48%) still experienced 
postoperative hypothermia. Therefore, despite the findings from this study 
suggesting that preoperative temperature decline is less in this population, clinically 
significant numbers of emergency caesarean section patients are likely to still 
experience perioperative hypothermia and thermal care for this group should not be 
ignored. The challenges of implementing preventative measures in emergency 
caesarean section are likely to be more pronounced: preoperative warming strategies 
are less likely to be employed due to the urgency of surgery, therefore the utilisation 
of appropriate intraoperative warming is especially important. The importance of 
perioperative temperature monitoring is especially pronounced during emergency 
caesarean section. Care should be taken to detect not only perioperative hypothermia 
but also to detect maternal pyrexia, as well as to prevent the inappropriate application 
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of warming for women who are, in fact, pyrexial or at the upper limits of 
normothermia.  
The difficulties in conducting studies of warming interventions in the emergency 
population, due to the urgent nature of surgery providing less time for planning of 
warming interventions and potential recruitment issues, are indicated by the paucity 
of research examining this area. In total 12 randomised controlled trials were 
included in the systematic review, but in all but one study (Reidy, et al., 2008) which 
included ‘semi-urgent’ cases, participants were undergoing elective surgery.  
Most studies included in the systematic review used neuraxial anaesthesia (as spinal 
or epidural anaesthesia), rather than combined spinal-epidural or general anaesthesia. 
Phases two and three of the research program were also conducted in the neuraxial 
anaesthesia population, therefore the results of this research program may not be 
generalisable to caesarean section surgery under general anaesthesia. This is 
reflective of practice where neuraxial anaesthesia is generally preferred for caesarean 
section surgery, both by health care providers and women themselves.  
As with general anaesthesia, the potential for medications given during neuraxial 
anaesthesia to influence both temperature decline, and patient perceptions of 
temperature, is evident. It is therefore important that warming studies thoroughly 
report intraoperative medications administered. Some medications particular to 
caesarean section surgery, such as oxytocin, as discussed by Woolnough et al. 
(Woolnough, Allam, et al., 2009), have the potential to influence perceptions of 
warmth.  Phenylephrine infusion is commonly administered to patients undergoing 
caesarean section with neuraxial anaesthesia; it is titrated to blood pressure to 
prevent hypotension.  This approach was utilized during our RCT: however, there are 
conflicting reports of the effect of vasopressors on perioperative hypothermia. Recent 
evidence from an observational study suggests that larger doses of phenylephrine 
result in lower maternal temperatures (although the lowest temperature in this 
observational study was 36.3°C – well above the hypothermic range) (Hilton et al., 
2015). These findings conflict directly with results from an earlier study of patients 
undergoing elective orthopaedic surgery, where patients receiving phenylephrine 
(opposed to control) had significantly higher end of procedure temperatures (Ro et 
al., 2009). Future studies of hypothermia amongst women receiving neuraxial 
anaesthesia should therefore accurately measure the use and dose of vasopressors, 
 Chapter 7:Discussion 127 
and other medications such as oxytocics, which may influence maternal perception 
of heat due to flushing.   
While cephalad spread of local anaesthetics during neuraxial anaesthesia have not 
been intrinsically linked to thermoregulation (Buggy & Crossley, 2000), the 
influence of administration temperature of local anaesthetic solutions upon shivering 
(mainly in epidural anaesthesia) has been investigated (Ponte, Collett, & Walmsley, 
1986). These studies have considered the influence of cooling upon the extradural 
space upon the shivering (a heat-generating response), mainly focusing on the 
efficacy of warming local anaesthetic solutions in epidural anaesthesia (Ponte, et al., 
1986). A more recent study by Najafianaraki et al. considered a population of women 
undergoing elective caesarean section under spinal anaesthesia (Najafianaraki, 
Mirzaei, Akbari, & Macaire, 2012). In contrast to the epidural anaesthesia studies 
where warmed versus room temperature local anaesthetics were compared, 
Najafianaraki et al. compared the effects of cold (4°C) versus ‘warmed’ (23°C) 
hyperbaric bupivacaine and fentanyl upon shivering incidence and intensity. It could 
be argued that the ‘warmed’ temperature corresponds to what is considered ‘room 
temperature’ and that, in practice, cold local anaesthesia and fentanyl is unrealistic as 
neither drug is required to be refrigerated. The study concluded that the warmer 
(23°C) solution decreased the incidence and intensity of shivering (Najafianaraki, et 
al., 2012).  Due to the thermoregulatory function of most shivering, as emphasised by 
Crowley and Buggy (Crowley & Buggy, 2008), if shivering is treated then it is 
imperative that temperature is also monitored. It also appears reasonable to assert 
that local anaesthetic and opioid solutions – containing fentanyl and/or morphine - 
should at least be given at room temperature.  The administration of such opioids - 
integral to neuraxial anaesthesia for caesarean section - is a vital factor when 
considering perioperative hypothermia aetiology and prevention, and therefore was 
established as a major focus of this research program.  
 
7.4 INFLUENCE OF INTRATHECAL MORPHINE UPON 
PERIOPERATIVE HYPOTHERMIA  
The role of intrathecal opioids and their potential contribution to maternal heat loss 
in women receiving neuraxial anaesthesia for caesarean section was evident in the 
literature and further highlighted by our systematic review findings. The 
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phenomenon of profound heat loss together with paradoxical symptoms of sweating 
(as described in Chapter 2) has already been described by numerous authors in case 
reports (Giladi & Ioscovich, 2015; Hess, et al., 2005; Mach, Van Havel, Gadwood, & 
Biegner, 2016; Ryan, et al., 2012; Sayyid, et al., 2003; Wishaw, 1997), however the 
potential differences in effectiveness of warming between differing modes of 
anaesthesia and administrations of opioids, in ‘regular’ perioperative hypothermia 
has also been raised in the literature (Halloran, 2009).  In the context of considering 
the varying results between studies, Halloran raised the question of whether pre-
operative warming would be effective where intrathecal morphine had been given 
(Halloran, 2009). Our systematic review results also reiterated this clinical question 
(Munday, Hines, Wallace, et al., 2013): however, these results also raised the 
question of whether there are any differences in temperature decline where 
intrathecal opioids are given in comparison to non-administration of intrathecal 
morphine, and the scope of the clinical problem.   
Widespread non-administration of intrathecal morphine cannot be expected to be 
feasible due to the long-lasting, established effectiveness of intrathecal morphine to 
provide analgesia in this population. Notably, Cobb et al. recognised that a limitation 
of their recent warming study in this population was the non-utilisation of intrathecal 
morphine, as this may limit the generalizability of their findings (Cobb, et al., 2016 ). 
In addition, although de Bernardis et al.’s recent RCT considering the effectiveness 
of a pre-operative and intraoperative thermal gown (which was converted to upper 
body warming during surgery) versus no active warming, did utilise intrathecal 
morphine, the 80mcg used can be considered to be a low dose, which again may limit 
the generalizability of their findings (de Bernardis, et al., 2015). Therefore, as well as 
exploration of the influence of intrathecal morphine upon hypothermia, effective 
warming for the population of women receiving a clinically commonly given dose of 
intrathecal morphine needed to be investigated: these needs guided the development 
of phases two and three of this research program.     
The clinical area of the candidate’s workplace presented the ideal population to 
explore the incidence of perioperative hypothermia and temperature decline (phase 
two of the research program) amongst women who receive intrathecal morphine, in 
comparison to those who do not receive intrathecal morphine.  In this institution, 
standard anaesthetic practice is to administer intrathecal morphine for postoperative 
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analgesia during spinal anaesthesia, unless there are contraindications such as 
allergy, maternal preference or known herpes simplex varus labialis (as intrathecal 
morphine can reactivate this virus) (Crone et al., 1988).  While this study aimed to 
examine whether there were any differences in temperature decline or hypothermia 
in relation to administration versus non-administration of intrathecal morphine, a 
secondary aim was to establish the rate of profound intrathecal morphine related 
hypothermia (as per Chapters 2 and 5). However, this retrospective case-control 
study could not establish if there were any differences in effectiveness of warming 
between women who received intrathecal morphine, and those who did not.   
Our retrospective study differed from Hess et al.’s observational study (Hess, et al., 
2005) where the incidence of both ‘regular’ perioperative hypothermia, and 
profound, prolonged hypothermia, was investigated in 100 patients receiving a dose 
of 250mcg intrathecal morphine (reported alongside a case series of patients with 
profound hypothermia). Our study sought to compare perioperative hypothermia 
amongst both women receiving and not receiving intrathecal morphine in a larger 
case controlled study, establish temperature decline between these groups, and 
consider factors that may be associated with perioperative hypothermia.   
The low incidence of only 2% of the case-control study population (8/358 patients) 
experiencing postoperative hypothermia accompanied by sweating, nausea or 
vomiting, did not enable detailed further investigation of the condition of profound 
perioperative hypothermia to be conducted. In addition, it was noted that two of these 
eight patients had not received intrathecal morphine. Given the frequency that the 
phenomenon is observed to occur in practice, further exploration of this condition 
could be addressed by conducting a case series of patients experiencing the 
condition.    
Since our observational study was conducted, further case reports of profound 
hypothermia associated with intrathecal morphine amongst women undergoing 
caesarean section have been reported (Giladi & Ioscovich, 2015; Mach, et al., 2016), 
where doses of 150mcg (Giladi & Ioscovich, 2015) and 200mcg (Mach, et al., 2016) 
have been used. In both cases, the time to the onset of symptoms post spinal 
anaesthesia was similar and in one study the hypothermia was eventually resolved 
pharmacologically, via the administration of Naloxone (Mach, et al., 2016). Like 
earlier authors, both authors of these case reports support the assertion that 
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intrathecal morphine contributes to cases of hypothermia that are prolonged, 
characterized by a profound heat loss that is unable to be treated by conventional 
warming; and the mechanism for this appears to be via alteration of the 
thermoregulatory centre in the hypothalamus (Giladi & Ioscovich, 2015; Mach, et al., 
2016). 
It is possible that, despite the findings of our observational study suggesting that 
temperature decline is similar between women receiving intrathecal morphine and 
those who do not, that intrathecal morphine does intensify and prolong perioperative 
hypothermia generally, however in some women the alteration of the set point is 
markedly greater. In these women the alteration of the sweating, shivering and 
temperature set points appears to result in the profound and prolonged hypothermia 
observed in the many case reports described, and in clinical practice. For these 
women, conventional warming techniques may need to be set aside, as evidence 
from case reports suggests that pharmacological therapies are effective at resolving 
the hypothermia. As Mach et al. describe, (Mach, et al., 2016) Naloxone, a μ agonist, 
has been used to effectively treat the condition in some instances, with small doses 
being utilized so as to prevent the reversal of the analgesic effects of the morphine 
(Mach, et al., 2016; Sayyid, et al., 2003; Wishaw, 1997). Benzodiazepines have also 
been utilised. Midazolam has been reported to be of limited effect due to being short-
acting, with symptoms reverting after a period of time (Hess, et al., 2005), whereas 
Lorazepam is longer acting and there are several reports of this strategy being used to 
effectively reduce symptoms and assist in resolving the hypothermia, whilst being 
used with care so as not to result in sedation (Hess, et al., 2005; Ryan, et al., 2012). 
In the clinical area where the study was conducted, depending on anaesthetic 
preference, a conservative approach has often been observed with the use of comfort 
measures to alleviate some of the discomfort from sweating.  Once hypothermia is 
matched by expected symptoms of feeling cold, then warming can be initiated to 
commence rewarming; however, this can take several hours, during which women 
have endured significant discomfort and disruption to the post-delivery period, 
affecting breastfeeding and skin-to-skin.  
Although dosage is usually based upon clinician preference, or institutional practices, 
the optimal dosage of intrathecal morphine has not yet been established (Wong, 
Carvalho, & Riley, 2013). Lower doses tend to be associated with lesser incidence of 
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side effects. Girgin et al. found that a dosage of 100mcg, if combined with a low 
dose of bupivacaine, was comparable with a higher dose of 400mcg in terms of 
analgesia, but resulted in a lower incidence of itching (pruritus). They also stressed 
that delayed respiratory depression is less likely with a lower dose (Girgin, Gurbet, 
Turker, Aksu, & Gulhan, 2008). 
Our retrospective, uncontrolled study was able to consider if there were any dose-
dependent relationships between morphine and hypothermia, comparing dosages of 
up to 100mcg with 101-200mcg. No patients received dosages of greater than 
200mcg. There were no differences in PACU arrival temperature between these 
dosage groups, a finding echoed by Giladi et al. (2016) who assert that the severity of 
hypothermia may not be dose-related (Giladi & Ioscovich, 2015). Based upon 
literature and practice, Hess et al. used a relatively high dose of 250mcg morphine 
for all participants (Hess, et al., 2005). It is a possibility that the higher dose of 
intrathecal morphine used in Hess et al.’s study may have contributed to the 6% rates 
of profound hypothermia found, although the 32% rate of ‘regular’ perioperative 
hypothermia is at the lower end of the scale of published perioperative hypothermia 
rates in this population (Hess, et al., 2005). Our findings contrast with Hui et al.’s 
double-blinded RCT where 150mcg intrathecal morphine (compared to saline) 
resulted in a significantly greater drop in maternal temperature and a longer time to 
nadir temperature (Hui, et al., 2006), supporting the assertion that intrathecal 
morphine intensifies maternal temperature decline during spinal anaesthesia. Our 
study found that increased Body Mass Index, pregnancy-induced hypertension and 
undergoing emergency surgery were found to result in a decreased likelihood of 
developing hypothermia, however did not identify any further anaesthetic or surgical 
factors that may predispose women to develop perioperative hypothermia, or 
prolonged, profound intrathecal morphine related hypothermia. The findings did 
indicate that effective warming interventions are needed for all patients, irrespective 
of whether intrathecal morphine has been administered. The statistically and 
clinically significant temperature decline across the population found during the 
retrospective case-control study emphasised the need for further investigation into 
methods to prevent or minimise heat loss, raising the question as to whether warming 
strategies should be any less effective where women receive intrathecal morphine.   
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7.5 INTERVENTION TO PREVENT PERIOPERATIVE HYPOTHERMIA  
Strategies included in the systematic review predominantly included IV fluid 
warming, and/or forced air warming, which are commonly utilised methods of 
warming across all surgical specialties. Effectiveness is influenced by the timing, 
duration, temperature setting and method of application of warming and this research 
program aimed to produce recommendations that were specifically appropriate for 
caesarean section patients, taking into consideration the varied physiology and issues 
of practicality already described.   
As our review emphasises, warmed IV fluid administration is a feasible and easily 
applied strategy for reducing maternal temperature decline for women undergoing 
caesarean section (Munday, Hines, Wallace, et al., 2013; Munday, et al., 2014).  
Warmed IV fluids are standard care in our institution: therefore results from the 
retrospective case-control study are reflective of this, and IV fluid warming also 
comprised standard care during the RCT. It is common practice for caesarean section 
patients to be administered in excess of 500mls or more, due to the administration of 
fluid pre-load or co-load to mitigate the vasodilatation and hypotension experienced 
immediately following neuraxial anaesthesia, together with the operative fluid and 
blood loss.  
 In consideration of timing of IV fluid warming, the effectiveness of both 
preoperative and/or intraoperative IV fluid warming was established by our 
systematic review with fixed effect meta-analysis indicating IV fluid warming 
resulted in a higher temperature on arrival to PACU and at 30 minutes after PACU 
arrival, and a reduced incidence of shivering (see Chapters 3 and 4) (Munday, Hines, 
Wallace, et al., 2013; Munday, et al., 2014). Methods of warming IV fluids varied, as 
did the temperature of administration of the fluids, however fluids were analysed as 
either warmed or unwarmed, with the comparator in these studies commonly cited as 
‘room temperature’ between 20-25°C. Warmed fluids were administered at between 
37-42°C, which at the minimum temperature aligns with National Collaborating 
Centre for Nursing and Supportive Care (NCCNSC) guidance that fluids should be 
warmed to 37°C for volumes of 500mls or more (NCCNSC 2008).  
Differences in the effectiveness of IV fluid warming between studies, and in clinical 
areas, may be related to the volume of fluids infused, the temperature and timing of 
administration, but also the solution used. Yokoyama et al. concluded that warmed 
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(versus room temperature) colloid preload followed by warmed (versus room 
temperature) crystalloid co-load resulted in a higher maternal tympanic temperature 
(although it is noted that room temperature was kept to a relatively warm 25°C) 
(Yokoyama, et al., 2009). It was found that a higher volume of colloid was found to 
remain in the vascular space, as opposed to crystalloid (Yokoyama, et al., 2009), 
which could reduce thermal redistribution. Relatively high volumes of fluids (of 
around 2000mls) during are common during caesarean section surgery, which 
usually has a surgical duration of less than an hour. Based on the available evidence 
and the ease of use, it can be asserted that all patients undergoing caesarean section 
should receive warmed IV fluids as part of standard care. Future guidelines 
specifically aimed at obstetric patients should accommodate this recommendation, 
and further consideration can be given to preload with colloid rather than crystalloid 
solutions.  
IV fluid warming, however, may need to be considered as just one aspect of 
temperature decline prevention, as it may not be sufficient alone.  Since publication 
of our review, a randomised, controlled trial has been published which investigates 
the effectiveness of a combined warming intervention (IV fluid warming plus 
intraoperative lower body forced air warming) versus no warming in 46 women 
undergoing elective caesarean section (Cobb, et al., 2016 ). This study concluded that 
the combined warming intervention was effective at decreasing the incidence of 
hypothermia, however the majority of patients still became hypothermic (Cobb, et 
al., 2016 ). Participants receiving the warming intervention had significantly higher 
temperatures on arrival to PACU, however the mean temperature in both groups was 
below 36°C.  Shivering was not prevented by the warming intervention (Cobb, et al., 
2016 ). Another recently published three-group RCT compared the use of warmed IV 
fluids versus under body warming (via a warming pad) versus usual care (with room 
temperature fluids and no warming) in 226 elective caesarean section patients (Paris, 
et al., 2014), finding that temperatures of patients receiving warmed IV fluids were 
higher in the operating theatre, however patients with under body warming were the 
warmest group in PACU. 
As with IV fluid warming, timing and duration are also factors pertinent to 
effectiveness of forced air warming. Systems utilising forced air are commonly 
available for use with various sizes of blanket, which can be applied either or both 
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pre-, intra- and postoperatively. Our systematic review was able to recommend the 
use of preoperative upper body forced air warming, based upon results of narrative 
analysis, however intraoperative warming alone was not found to be effective, unless 
combined with preoperative warming. There were some limitations to this analysis: 
notably the differences in ambient operating room temperature, mode of anaesthesia 
and opioid administration between studies. In addition, no studies of lower-body 
warming were considered of sufficient quality for inclusion in the review.  Due to the 
practical difficulties that upper body warming may pose in the operating theatre 
(restricting the mother’s ability to hold her newborn after delivery), and the paucity 
of lower body warming studies, it was recommended that further intraoperative 
lower body warming studies were conducted.   
The use of under-body warming mattresses was recommended by the review based 
on a random effects meta-analysis of two studies of maternal temperature on arrival 
to PACU (Munday, Hines, Wallace, et al., 2013; Munday, et al., 2014). Due to the 
different modes of under-body warming, further study of the use of these mattresses 
(carbon polymer versus forced air warming) was also deemed to be necessary for 
further research. Paris et al.’s recent study of warmed IV fluids versus under-body 
warming (via a warming pad) versus usual care (with room temperature fluids and no 
warming) did find that the under-body warming group were the warmest group in 
PACU (Paris, et al., 2014), however, the incidence of hypothermia, although lower 
than the other groups, was still high in the under-body warming group. That is, in the 
operating theatre: 66% in the usual care group versus 38% in the IV fluids group 
versus 48% in the under-body warming group experienced hypothermia (Paris, et al., 
2014). There were some limitations to this study. The randomisation process was 
unclear, the outcome assessors were not blinded, details of anaesthetic mode or 
medications were not provided, and it was unclear how long prior to surgery 
warming interventions were administered nor when observations commenced.  
Nonetheless, when considered in the light of results from our systematic review, the 
use of under body mattresses has the potential to reduce practical difficulties that 
over body interventions may present, whilst applying effective warming to the entire 
body. This is associated with some benefits that intraoperative over body 
interventions are not able to achieve. It seems reasonable to assert that warmed body 
coverings or mattresses should aim for the maximum possible body coverage. It 
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should also be remembered that perception of warmth below the level of the 
anaesthetic block is impaired, whilst heat loss remains, therefore patient reporting of 
warmth below this level should not be relied upon as an indicator of thermal status 
(Kurz, 2008). 
Maximum body coverage should be achievable when utilising preoperative warming.   
Additionally, the value of preoperative active warming, utilising forced air, in 
reducing temperature decline is related to the potential to decrease the heat lost via 
redistribution through the core-periphery gradient by increasing peripheral heat 
content (Horn, et al., 2002). Recommendations from our review that forced air 
warming, particularly if applied preoperatively, appears to be effective at improving 
maternal temperature (although body coverage needs to be considered) are reinforced 
by the results of Sultan et al.’s recent meta-analysis. This meta-analysis also 
concluded that warming interventions reduced temperature change (decrease from 
baseline), resulting in higher end of surgery temperatures and decreased hypothermia 
(Sultan, et al., 2015 ). However, there were some differences between the approaches 
utilised for these systematic reviews, which should be considered. Our review 
considered different methods of warming separately, however Sultan et al. grouped 
all studies of different warming interventions together for meta-analysis for the 
primary outcome of maximum temperature change, and subsequently, significant 
heterogeneity was found (I2 = 92%). The authors also stated that publication bias was 
identified for this primary outcome, based upon the results of Egger’s test and funnel 
plot analysis (Sultan, et al., 2015 ). 
Despite the availability of studies testing preoperative warming for caesarean section, 
and the recommendations from the systematic review pertaining to preoperative 
warming, further questions remained as to the effectiveness of preoperative warming 
for the population of women that receive intrathecal morphine (noted to be related to 
perioperative hypothermia, as widely discussed). Besides recommending 
investigation into the influence of anaesthesia mode and intrathecal opioids, upon 
hypothermia and warming techniques, our systematic review also reiterated that 
future warming studies use standardized and clinically meaningful temperature 
measurement time points (Munday, Hines, Wallace, et al., 2013).  
At the time of development of the third phase of the research program, there were no 
published studies investigating the effectiveness of preoperative warming amongst 
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women that had received intrathecal morphine. Recently, as mentioned earlier, a 
non-blinded randomised controlled trial has been published that tests preoperative 
and intraoperative forced air warming amongst women given a small dose of 
intrathecal morphine (80mcg) (de Bernardis, et al., 2015). However, it is believed 
that the pragmatic study conducted during this research program is the first to test a 
short period of forced air pre-operative warming amongst women receiving a 
clinically common dose of intrathecal morphine. Both groups in our study received 
IV fluid warming, as per the recommendations from the systematic review (Munday, 
Hines, Wallace, et al., 2013), standard care in our institution, and existing guidelines 
for the non-obstetric, adult population (NCCNSC 2008). Therefore, our control 
group were not completely without any hypothermia prevention strategy, and 
therefore results between intervention and control groups may not be as marked as in 
studies where control groups have been completely un-warmed.  
Based upon linear mixed model analysis (which allowed for the repeated temperature 
measurements over time), predicted temperature decline appears to be slower in the 
preoperative warming group in our study, but not significantly so. This curvi-linear 
pattern was more pronounced when repeated in per protocol analysis (Appendix T).   
It appears that a short period of preoperative forced air warming resulted in delaying 
temperature decline. Patients that received the intervention appeared to experience a 
plateau in temperature that lasted longer than those who did not receive preoperative 
warming, before temperature declined to a similar nadir in both groups. De Bernardis 
et al. also reported the delayed onset of temperature decline in their study of 
preoperative and intraoperative warming (versus no warming) in women receiving a 
small dose of intrathecal morphine (de Bernardis, et al., 2015). Significant 
differences in aural temperature were found between groups, in favour of the 
intervention group, however the clinical setting for the 60 minute end point is 
unclear, that is how many patients were in PACU or in the operating theatre at this 
point, as is surgery duration and anaesthesia time. However, overall they found a 
statistically significant difference in temperature decline over time between groups.  
Poor lipid solubility contributes to the slow onset of neuraxial analgesia achieved 
with morphine (Goma, Flores-Carillo, & Whizar-Lugo, 2014), therefore the 
possibility of a slower onset of hypothermia, as seen in these studies, should also be 
considered.  
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In our RCT, the control group experienced a 0.8°C change from baseline 
temperature, both during ITT and per-protocol analysis, as opposed to a lower 
change in temperature in the intervention group (0.5°C in the ITT group versus 0.4°C 
in the per-protocol group) (Appendix T), which aligns with the theory that while both 
groups declined in temperature, the decline was more pronounced in the control 
group.  The overall change in de Bernardis et al.’s study cannot be used for 
comparison, as actual baseline temperature and overall change was not reported (de 
Bernardis, et al., 2015). The study sample size for our RCT was inflated from the 
required sample size, based upon power analysis, however utilising a larger sample 
may have meant that the difference in baseline temperature of 0.2 °C was less 
significant.  In addition, if both groups had commenced at the same baseline 
temperature, then temperature decline in the control group would have been more 
pronounced.  
Results from ITT analysis in this study may be indicative of results that could be 
expected to be seen in normal clinical practice, when strict study protocols are not 
being adhered to; however, in this respect normal clinical practice adjustments would 
also be possible that may result in greater benefit from warming. For example, the 
study protocol required 20 minutes of pre-operative warming, and aimed for less than 
20 minute delay between the intervention finishing and entry into the OR. This 
resulted in some protocol deviations, where surgery was delayed due to unforeseen 
and unpreventable circumstances and a greater than 20 minute delay between 
warming and entry to the OR ensued.  Therefore, in these instances the benefit from 
the warming intervention was lessened.  In normal clinical practice, warming could 
be extended if similar circumstances arose, therefore maintaining the potential 
benefit of warming until entry into the OR.  
It appears that pre-operative warming in the dose as tested by this study, is 
insufficient to avoid the development of perioperative hypothermia, but can only 
delay temperature decline in women receiving intrathecal morphine for caesarean 
section. A combination approach to warming women receiving intrathecal morphine 
may be worthy of consideration.  Based on the results of their IV fluid warming and 
intraoperative forced air warming study (versus no active warming) study, Cobb et 
al. concluded that the recommendations for the use of these modalities proposed by 
guidelines and regulatory bodies may not be transferable to caesarean section 
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patients receiving spinal anaesthesia, with only minor benefits expected to be seen 
(Cobb, et al., 2016 ). While de Bernardis et al. used a combination approach, 
intraoperative warming was provided in the form of upper body warming which 
presents difficulties for mothers when they want to hold their newborns after delivery 
(de Bernardis, et al., 2015). The use of preoperative forced air warming, IV fluid 
warming and under-body warming could be explored as a multi-modal approach to 
preventing the stubborn temperature decline observed in women receiving intrathecal 
morphine during caesarean section. Preoperative warming may delay temperature 
decline, while under-body warming could provide an intraoperative mode of 
warming that can continue during cleaning up time and avoid presenting difficulties 
for women wanting to hold their babies after delivery.      
During the RCT conducted here, it was also observed that the cleaning up time, at the 
end of the procedure before transfer to PACU, when patients are rolled onto their 
sides and cleaned, necessitates a large degree of exposure and can result in a 
temperature drop via radiation before patients reach PACU. It may be that a 
combination approach, continuing intraoperative warming or use of methods such as 
under body warming mattresses during the clean-up process, may be of benefit to 
address this problem.  In addition, ensuring the use of warmed fluid used for clean-
up may be a simple method to assist in reducing temperature decline lost via 
convection.   
In our RCT, the intervention group commenced at baseline with a 0.2 °C lower 
temperature than the control group and some patients in both groups could already be 
considered mildly hypothermic. Therefore, as was emphasized in phase 2 of this 
research program, results from this randomised controlled trial and other studies, 
confirm the importance of utilising pre-operative temperature monitoring to identify 
those patients already thermally compromised, and those at risk. Most caesarean 
section surgery lasts in excess of 30 minutes duration from incision to clean up.   
Guidelines for the adult population recommend intraoperative temperature 
monitoring for surgery expected to be of 30 minutes duration or greater (NCCNSC 
2008). Given the duration of caesarean section surgery and the incidence of 
hypothermia, it seems reasonable to expect that this recommendation can be applied 
to the obstetric population.  
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7.6 EFFECT OF WARMING UPON SECONDARY MATERNAL AND 
NEONATAL OUTCOMES  
Varying degrees of benefit have been found from maternal warming upon other 
maternal and neonatal outcomes, besides maternal temperature.  In addition, the issue 
of whether warming is tolerable to pregnant women is vital to consider: if warming is 
not acceptable to patients then it cannot be implemented.   Tolerability of warming 
amongst the population is not well reported by studies, however Fallis et al. did 
report a total of 14/32 patients decreased the temperature of forced air warming in 
their randomised controlled trial (Fallis, et al., 2006). Overall, warming was found to 
be well tolerated in our randomised controlled trial, with only one patient ceasing the 
intervention early (and an additional three patients experiencing a degree of 
sweating). Therefore, our results indicate that the warming intervention was found to 
be acceptable to women. During recruitment it appeared that the experience of 
feeling cold during caesarean section was one that was often remembered by women 
who had been hypothermic during and after previous caesarean section. Our study 
did not measure any subjective data regarding temperature and warming, other than 
maternal thermal comfort, however further qualitative data may be useful in terms of 
maternal experiences with perioperative hypothermia and the acceptability of 
warming interventions.   There is a paucity of evidence surrounding the experiences 
of patients in relation to perioperative hypothermia, and the acceptability of warming 
interventions.  
The influence of warming interventions alone upon maternal comfort remains 
unclear. Narrative analysis from our systematic review found the evidence 
inconclusive as to the benefit of forced air or IV fluid warming upon maternal 
comfort (Munday, Hines, Wallace, et al., 2013), while Sultan et al.’s review found 
warming did improve maternal comfort (however which mode of warming in 
particular is not clear) (Sultan, et al., 2015 ). Recently, de Bernardis et al. also found 
that there was no difference in thermal comfort between women receiving pre-
operative and intra-operative warming versus no active warming (de Bernardis, et al., 
2015). Our RCT also found no differences in maternal thermal comfort between 
groups, with no significant difference in ambient temperature between groups (see 
Chapter 6). As our systematic review discussed, thermal comfort should be 
considered in relation to ambient operating room and preoperative holding bay 
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temperature (Munday et al 2013). Studies included in our review indicated that 
comfort derived from any forced air warming intervention may be greater if ambient 
temperature is low (Munday, Hines, Wallace, et al., 2013). Our review recommended 
the maintenance of ambient temperature as an additional strategy to maintain thermal 
comfort (Munday, Hines, Wallace, et al., 2013).  In addition, as found by Fallis et al. 
(Fallis, et al.), the potential for forced air warmers to increase ambient temperature 
should also be considered. Future warming studies should also ensure the use of 
validated scales to measure thermal comfort. Notably, in Cobb et al.’s recent three-
group RCT, the authors acknowledged that they used a non-validated thermal 
comfort scale (Cobb, et al., 2016 ). As such, as they describe it, the tool appears to 
measure satisfaction with temperature, rather than thermal comfort itself. As 
described earlier, the potential for some medications, such as oxytocics, to alter 
perception of warmth (Woolnough, Allam, et al., 2009) should also be considered 
when considering thermal comfort scores.  
Besides maternal comfort itself, shivering (which commonly causes some 
discomfort) is commonly included as a secondary outcome or a primary outcome, in 
warming studies in this population.  Intravenous fluid warming and preoperative 
forced air warming were found to be effective at reducing, what can be considered as 
presumably thermoregulatory shivering in our systematic review (Munday, Hines, 
Wallace, et al., 2013), and similarly Sultan et al.’s review found that warming 
reduced shivering (Sultan, et al., 2015 ). Although the differences in incidence and 
intensity of shivering between preoperative warming and usual care groups in our 
RCT were not statistically significant, there may be limited clinical significance, with 
3 patients in the usual care group, versus no patients in preoperative warming group, 
experiencing shivering assessed as severe.      
It should be remembered that shivering is acknowledged as being multi-factorial 
(Chan, et al., 1989) with thermoregulation responses being only one (but the main) 
causative factor that contribute to this common, problematic and uncomfortable 
experience for patients and caregivers. Therefore, while pharmacological therapies 
were considered for inclusion in our systematic review protocol (Munday, et al., 
2012), and pharmacological studies that included maternal temperature as a 
secondary outcome (and shivering as a primary outcome) were identified, they were 
excluded from the review itself as the inclusion of these therapies was felt to have 
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been problematic due to the multi-factorial aspects of shivering. This deviation from 
the protocol was acknowledged in the published review (Munday, Hines, Wallace, et 
al., 2013), which also recommended that a further systematic review that focused on 
pharmacological interventions for shivering might be appropriate, as well as research 
into the multi-factorial aspects of shivering amongst women undergoing caesarean 
section.   The findings that warming can reduce shivering should therefore be 
considered in the context of shivering not only being caused by heat loss, as warming 
may only be able to contribute to at least some decrease in incidence of shivering. 
Shivering in normothermic patients is often observed in this population, and in these 
instances, may be considered non-thermoregulatory, but based upon the evidence, it 
appears that it is reasonable to expect at least some reduction in shivering incidence 
and severity will result from the application of warming interventions for obstetric 
patients.  
Besides maternal comfort and shivering, related secondary neonatal outcomes of 
temperature at birth, umbilical pH and Apgar scores have been commonly evaluated 
in warming studies and were considered during both our systematic review and RCT.  
Results remain inconclusive, as to the potential direct benefit these neonatal 
outcomes may receive from maternal warming.  No conclusive benefits were found 
from warming upon neonatal outcomes in our systematic review (Munday, Hines, 
Wallace, et al., 2013), and the preoperative warming intervention tested in the RCT 
did not result in any significant difference in median neonatal temperature or Apgar 
score between groups. The RCT found only a 0.2°C difference in median neonatal 
temperature in favour of babies born to mothers who had received preoperative 
warming, with the median temperature in both groups within the normothermic range 
for neonates. Sultan et al. found that umbilical pH was improved in babies born to 
mothers who had received warming but Apgar scores were not altered by warming 
(Sultan, et al., 2015 ). Similarly, Cobb et al. also found no significant differences in 
Apgar score or umbilical vein blood gases (Cobb, et al., 2016 ).  Despite the lack of 
direct benefit upon neonatal outcomes, it is likely that benefit is derived from 
preventing hypothermia in mothers, which can enable earlier breastfeeding and 
bonding to occur, as indicated from the greater proportion of participants in the 
preoperative warming group that achieved skin-to-skin contact of over 30 minutes 
during our RCT.    
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Therefore, it can be asserted that overall results conflict (based upon this RCT, the 
systematic review and recent published literature) as to whether maternal warming 
can improve neonatal outcomes (Munday, Hines, Wallace, et al., 2013), but also that 
further research of the potential effect of maternal warming and environmental 
operating theatre factors upon neonatal outcomes is warranted. A recent study 
evaluated the impact of ambient OR temperature upon neonatal temperature (and 
maternal temperature), suggesting that an increase to 23°C (versus a cool 20°C) 
decreased neonatal hypothermia (Duryea et al., 2016). The influence of external, 
environmental factors upon neonatal hypothermia such as ambient temperature and 
skin-to-skin contact at birth should be considered further to improve 
thermoregulatory care of the newborn after caesarean section.  
 
7.7 CHALLENGES TO IMPLEMENTING THERMAL CARE 
RECOMMENDATIONS FOR OBSTETRIC PATIENTS  
Our systematic review was used as the basis for a JBI Best Practice Information 
Sheet (Giles, et al., 2013), which therefore contributed in part to the fulfilment of the 
aim to formulate up-to-date and specific recommendations for temperature 
management in women undergoing caesarean section. The retrospective case-control 
study highlighted the lack of consistent documentation for temperature monitoring 
and treatment and the greater concern for elective caesarean section hypothermia 
prevention versus emergency surgery. It appears reasonable to assert that elective 
surgery pathways should therefore employ consistent temperature monitoring, pre-
emptive methods of preventing temperature decline and safeguards to ensure these 
strategies are recorded.  
The potential challenges of applying the above and other recommendations related to 
perioperative thermal care into anaesthetic practice should not be underestimated. As 
Levin et al. emphasise evidence-based changes to perioperative practices require 
partnership between the many professional groups that are involved in the 
perioperative suite if they are to achieve sustainability (Levin, Wright, Pecoraro, & 
Kopec, 2016). The challenges of involving such large groups of staff have been 
recognized by the candidate as a practice implementation barrier in an earlier 
evidence-based practice implementation project (Munday, Hines, & Chang, 2013).  
Gaining consensus is vital to the success of implementation change and the early 
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involvement of stakeholders is viewed as a facilitator to effective practice change 
(Levin, et al., 2016; Munday, Hines, & Chang, 2013). Potential barriers may also 
arise from the hierarchical structure that is evident within the perioperative 
environment and a practice change that is nurse-led but impacts directly upon 
anaesthetic practice may experience resistance. Therefore, the benefit to establishing 
a multidisciplinary team, specifically including anaesthetic staff and also surgical 
staff, to lead the evidence-based practice change cannot be underestimated. This 
approach can also be a facilitator to the successful conduct of primary research in the 
perioperative environment, and indeed the involvement of anaesthetic personnel in 
the research team for the RCT conducted during this research program was 
considered to be instrumental in easing the conduct of the RCT. Also found to be 
vital was the careful consultation of all involved parties in the planning and 
preparation stages of the RCT before recruitment and data collection commenced.    
Similar approaches as used during the conduct of the RCT, can therefore considered 
as worthy of consideration during the stage of practice change implementation.  
 
7.8 CHALLENGES TO PRAGMATIC CLINICAL RESEARCH IN 
VULNERABLE POPULATIONS 
Widespread consultation and communication is also pertinent in the context of 
ethical approvals for planned research.   Careful consideration was taken regarding 
the potential ethical issues of conducting experimental research upon pregnant 
women during the planning stages of the RCT. Pre-emptive communication and 
advice from the hospital human research ethics committee office, prior to submitting 
the application, also facilitated the process of ethical approval by ensuring that 
relevant issues were considered in depth during the application development. The 
application was also developed with reference to the National Statement on Ethical 
Conduct in Human Research 2007 (updated 2015), acknowledging section 4.1.1 that 
‘the wellbeing and care of the woman and of her fetus always takes precedence over 
research considerations’p47 (National Health and Medical Research Council , 
Australian Research Council , & Australian Vice-Chancellor's Committee 2007 
)(p47), as well as the implication that by participating in the research women also 
involved their unborn baby (as per the National Statement 4.1.4) (National Health 
and Medical Research Council , et al., 2007 ). Particular attention was given to the 
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potential risk of overheating by preoperative warming for both mother and baby. 
This was reflected in the exclusion criteria stipulating that any participant with a 
preoperative baseline temperature of >37.0°C was excluded.  Such considerations are 
considered pertinent to future warming studies conducted in the obstetric population. 
 
7.9 LIMITATIONS 
While the systematic review did not specifically exclude studies including women 
undergoing emergency caesarean section, as previously mentioned only one included 
study (Reidy, et al., 2008) included both elective and ‘semi-urgent’ cases.    
Therefore, there may be limited generalisability of the recommendations to 
emergency caesarean section surgery. In addition, the randomised controlled trial 
included only patients undergoing elective surgery. Although potentially problematic 
to undertake, further research may be needed because the urgent nature of emergency 
caesarean section may render preoperative warming interventions that require 
forward planning and adequate time to implement prior to surgery unachievable:  
however, as discussed earlier, findings from the retrospective case-control study did 
indicate that the population of women undergoing emergency caesarean section 
experienced significantly less heat loss.  
Furthermore, phases two and three of this research program focus upon the 
population of women receiving spinal, rather than epidural anaesthesia, which could 
be considered to limit the generalisability of the overall research findings. The 
systematic review did include studies where either mode of anaesthesia was utilised.  
Meta-analysis was inhibited in the systematic review due to the clinical heterogeneity 
of the included studies in the systematic review; therefore, only a few meta-analyses 
were undertaken. There were many variations in temperature outcomes related to 
time-points, particularly intraoperatively. Mode of temperature measurement was not 
specified in the inclusion criteria for the systematic review, however the use of a 
consistent method of measurement with studies was considered vital (Munday, 
Hines, Wallace, et al., 2013). Variation in reliability between temperature 
measurement methods is a well-recognised limitation in studies of temperature and 
warming.  The randomised controlled trial aimed to use temperature measurement 
time points that would be clinically useful, and also aid comparability with other 
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published research. Nonetheless, the potential limitations of aural canal 
thermometers are also recognised. Therefore, measures to partially address these 
issues were implemented. Firstly, one operator used one calibrated device for the 
entirety of the study.  Secondly, the exclusion criteria allowed for the exclusion of 
patients if, upon otoscopy, the tympanic membrane was not visible, including if this 
was due to earwax. Thirdly, intraoperative bladder temperatures, considered to 
represent near-core temperature, were utilised as a secondary measure of temperature 
measurement and Bland-Altman analysis was undertaken to measure agreement 
between these two routes.   
Data collection for the retrospective case-control study was subject to the problems 
inherent in utilising pre-collected data from patient charts. While data collection in 
this manner is problematic, due to missing data and because the data collected was 
not collected for the primary aim of research, there are further challenges in relation 
to collecting temperature data via this method.  Firstly, the importance attached to the 
monitoring and recording of temperature within the perioperative department both in 
the practice area (and internationally) appears to be low (Arkilic, et al., 2000).  
Secondly, the reliability of temperature monitoring devices used over the study 
period cannot be assured, nor can consistent practice between operators. It is well 
known that some methods of temperature measurement, including the aural canal 
measurements used in the practice area, are particularly vulnerable to operator 
inefficiency. Thirdly, there is a limited ability to control for confounding factors 
influencing temperature; ambient temperature is not recorded in patient health 
records and warming strategies may not be thoroughly documented. It should be 
noted that, according to Australian College of Operating Room Nurses (ACORN) 
Standards for Perioperative Nurses in Australia, ambient OR temperature is required 
to be maintained within a specific range of 20-22°C, (Australian College of 
Operating Room Nurses 2012. ), however waiting and postoperative areas may have 
more variance.  
Due to incomplete documentation in patient charts, the retrospective case-control 
study lacked data on intraoperative temperature and warming, and therefore 
postoperative hypothermia on arrival to PACU was used as an indicator for 
intraoperative temperature decline.  To address this, the randomised controlled study 
collected and used intraoperative data to the end of procedure as an indicator of 
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intraoperative temperature decline rather than postoperative data from PACU. This 
was due to the necessary variations in practice and the requirement to implement 
further warming on an individualised basis, prior to breastfeeding, in PACU, which 
would have resulted in confounding if this data had been included in further 
analyses.   
The existence of protocol deviations during the conduct of the RCT could be 
considered as a limitation of this study: however, the sample size was inflated to 
allow for protocol deviations in view of the anticipated challenges of conducting the 
study in the busy clinical setting. The conduct of research requiring adherence to 
strict study protocols in clinical environments presents challenges, which cannot be 
underestimated or, in some cases, planned for. Anticipated situations that would 
require deviation from the study protocol were considered during the development of 
the study, particularly related to the exclusion criteria and protocol (such as extended 
time between preoperative warming and entry to the operating theatre). The 
widespread education of staff in all areas affected by the study was undertaken to 
reduce protocol deviations due to staff not understanding, or not being aware of the 
study aims and protocol. To this end, gaining agreement and consensus between key 
personnel and managers during the planning stages of the study was also vital. Some 
situations that occur in a fast-paced, tertiary clinical environment, such as the 
perioperative department where the RCT was conducted, cannot be anticipated.   The 
protocol deviations related to suspected bladder injury requiring blue dye and bladder 
irrigation invalidated the bladder temperature measurements in those three cases: 
such instances are unexpected and generally rare.    
Despite the challenges of conducting research in the clinical setting, the benefits of 
using a pragmatic trial approach are evident. The RCT was aimed to test an 
intervention that could, if effective, be integrated into existing care pathways with 
minimal disruption.  Such a pragmatic approach also promotes the generalisability of 
the findings and provides an indication to how the intervention may work in real-life 
clinical practice (Patsopoulos, 2011), and such studies may be more valuable to those 
responsible for developing policy (Patsopoulos, 2011; Ware & Hamel, 2011). Our 
study indicates that this intervention can be feasibly integrated into similar existing 
care pathways: outside of a research setting, the benefits of the preoperative warming 
may actually be maximised as necessary alterations can be made and the strict study 
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limits (for example, in relation to maximum time between warming and entry to the 
operating theatre) can be adjusted for maximum benefit (as discussed in Chapter 6).  
 
7.10 SUMMARY 
The challenge of maintaining temperature and reducing heat loss in this population 
remains. Based upon this program of research, some recommendations formulated 
for the general adult population (NCCNSC 2008) can be applied to the obstetric 
population: namely, that pre-operative and intraoperative temperature monitoring 
should occur, and that IV fluid warming should be instigated.  However, whilst some 
clear benefit is derived from IV fluid warming, pre-operative warming and intra-
operative warming in terms of reducing maternal temperature decline and shivering, 
any of these interventions alone is insufficient to prevent the significant temperature 
decline that the majority of caesarean section patients are vulnerable to, due to 
neuraxial anaesthesia itself, and the use of intrathecal morphine which contributes to 
intensify temperature decline. Conventional warming methods are also not effective 
in the small subset of women that experience the less common, but particularly 
problematic and uncomfortable, severe and prolonged temperature decline attributed 
to the cephalic spread of morphine altering the temperature set point. For these 
women, pharmacological therapy appears to reverse the hypothermia, but needs to be 
used with care. Warming appears to be well tolerated in this population, and a 
combination approach to warming incorporating pre-operative and intra-operative 
strategies with careful temperature monitoring should be considered. 
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Chapter 8: Conclusion 
8.1 INTRODUCTION 
Inadvertent perioperative hypothermia is a significant adverse event for women 
undergoing caesarean section surgery, associated with numerous unwanted side 
effects for women as well as increased healthcare costs, prolonged stay and 
significant disruption to the surgical pathway. Yet, recommendations to guide health 
care providers to decrease the incidence of this condition have been absent. The 
studies presented here are believed to represent the first comprehensive three-phased 
research program that seek to provide guidance for perioperative hypothermia 
prevention specifically for obstetric patients. This chapter presents the implications 
for practice and future research arising from the findings of this research program. 
 
8.2 IMPLICATIONS FOR PRACTICE 
This research program has resulted in specific recommendations, previously lacking 
and clearly needed, for the thermal care of women undergoing caesarean section, as 
well as highlighting areas for future research. These recommendations reflect the 
need for proactive, evidence-based thermal management to prevent perioperative 
maternal temperature decline and to reduce the incidence of perioperative 
hypothermia, enhancing and improving the perioperative care provided to women 
undergoing caesarean section for delivery of their babies.  
Recommendations for practice that are supported by this research program are 
detailed below and presented in order of importance: 
1. Firstly, regular and timely assessment and documentation of 
preoperative, intraoperative, and postoperative maternal temperature should be 
integrated into routine practice. Regular and timely assessment of maternal 
temperature enables effective care planning aimed at not only preventing temperature 
decline and reducing risk of hypothermia but also early detection of hypothermia and 
timely intervention to reduce further temperature decline and restore normothermia.    
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To facilitate this, temperature monitoring devices need to be readily available, and 
perioperative documentation (such as preoperative checklists) should clearly allow 
for the recording of preoperative and intraoperative temperature.      
2. Combined, multi-modal, warming strategies should be considered in 
the place of single interventions for all women undergoing caesarean section, as 
appropriate and with consideration to maternal temperature readings, to ensure 
warming is instigated where appropriate. These strategies should include:  warmed 
IV fluid preload and intraoperative IV fluid warming, preoperative forced air 
warming and active intraoperative warming which may include over body forced air 
or under body warming mattresses.  
3. Health care providers should be cognisant of the exacerbation of 
temperature loss and decreased ability of warming to prevent hypothermia, in 
settings where intrathecal morphine administration is routine. In these settings, it is 
imperative that monitoring of temperature, in conjunction with preoperative and 
intraoperative warming interventions, form standard care and that this is reflected in 
hospital policies.   
4. Maintenance of ambient temperature within existing guidelines for 
OR ambient temperature, – such as the ACORN Standards in Australia (Australian 
College of Operating Room Nurses 2012. ) - should be used to maintain thermal 
comfort and a protective thermal environment for both mothers and neonates.   
6. Health care organisations should develop evidence-based thermal care 
guidelines that incorporate strategies with demonstrated effectiveness in reducing 
risk for perioperative hypothermia specifically for the perioperative care of obstetric 
patients. Guidelines should consider and specifically address such needs as unique 
changes in physiology, anaesthetic risk factors, maternal comfort, challenges in 
implementing hypothermia prevention strategies, and the influence of intrathecal 
opioids upon temperature decline and the effectiveness of warming.  In conjunction 
with the guidelines, evidence-based, useable clinician tools should be developed and 
promoted for use by medical, nursing and ancillary staff, to reduce the incidence of 
perioperative hypothermia in this vulnerable population. Specifically, clinical tools 
related to temperature monitoring are required that promote timely preoperative, 
intraoperative and postoperative monitoring. Clinical algorithms that direct the 
appropriate use of warming, as indicated by preoperative temperature status, and 
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planned intrathecal opioid use, should be available for use for clinicians caring for 
women undergoing caesarean section, such the tools developed by NICE for use in 
adult surgical populations (NCCNSC 2008).  
7. Education of perioperative and anaesthetic staff should reinforce the 
importance of avoiding perioperative hypothermia, emphasise the necessity to 
consistently monitor maternal perioperative temperature and equip staff with the 
knowledge of appropriate warming strategies. Staff should also be educated 
regarding the use of clinical algorithms, where developed, that aid decision-making 
regarding appropriate thermal care for women undergoing caesarean section.  
 
8.3 FUTURE RESEARCH 
This research program provides evidence that is predominantly relevant to elective, 
rather than emergency caesarean section surgery.  Therefore, further research into the 
effectiveness of warming interventions, which also considers the feasibility of these 
interventions for emergency caesarean section is warranted. In addition, given that 
most caesarean section surgery is undertaken on awake patients under neuraxial 
anaesthesia, the perspectives of women regarding warming interventions, particularly 
acceptability, would be worthy of exploration. Finally, further work is needed to 
identify factors that may contribute to prolonged intrathecal morphine related 
hypothermia, to optimise appropriate perioperative care planning and risk 
management. 
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perioperative temperature management for women 
undergoing caesarean section: a systematic review. 
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Executive summary 
Background  
Women undergoing caesarean sections are vulnerable to the adverse effects 
associated with inadvertent perioperative hypothermia. Effective methods for 
preventing or managing hypothermia in this group would be valuable. 
 
Objectives  
To synthesize the best available evidence in relation to preventing and/or treating 
hypothermia in mothers after caesarean sections.  
 
Inclusion criteria 
Types of participants  
Adult patients of any ethnic background, with or without co-morbidities, undergoing 
any mode of anaesthesia for any type of caesarean section were included.  
 
Types of interventions  
Active or passive warming methods, versus usual care or placebo, that aim to limit or 
manage core heat loss as applied to women undergoing caesarean sections  are 
included. 
     
Types of studies  
Randomised controlled trials that met the inclusion criteria were considered.  
 
Types of outcomes  
Primary outcome: maternal core temperature during preoperative, intraoperative and 
postoperative phases of care. 
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Secondary outcomes: newborn core temperature at birth, umbilical pH measured via 
blood gas analysis, Apgar scores, length of Post Anaesthetic Care Unit stay, maternal 
thermal comfort.  
 
Search strategy  
A comprehensive search was undertaken of the following databases from their 
inception until May 2012: ProQuest, Web of Science, Scopus, Dissertation and 
Theses PQDT (via ProQuest), Current Contents, CENTRAL, MedNar, OpenGrey 
and Clinical Trials. There were no language restrictions. 
 
Methodological quality  
Retrieved papers were assessed for methodological quality by two independent 
reviewers using the standardized critical appraisal instruments for randomised 
controlled trials from the Joanna Briggs Institute Meta-Analysis of Statistics 
Assessment and Review Instruments (JBI-MAStARI). 
  
Data collection  
Two independent reviewers extracted data from the included papers using a 
customized data extraction tool.   
 
Data synthesis  
Where meta-analysis was possible, results were combined in a fixed effects meta-
analysis using the Cochrane Collaboration Review Manager software. Due to 
heterogeneity for one comparison/outcome, random effects meta-analysis was also 
used.  
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Results  
Twelve studies with a combined total of 719 participants were included. Intravenous 
fluid warming was found to be effective at maintaining maternal temperature and 
also aided in  shivering prevention. Intravenous fluids did not improve thermal 
comfort or neonatal  temperature, and the effectiveness on Apgar scores and 
umbilical pH remains unclear. 
Warming devices, including forced air warming devices and under-body carbon 
polymer mattresses, were effective at preventing hypothermia; however effectiveness 
increased if  applied preoperatively. Preoperative body warming devices also 
reduced shivering. Preoperative forced air warming improves neonatal temperatures. 
Forced air warming did not improve Apgar scores. The effectiveness of body 
warming devices on umbilical pH and thermal comfort remains unclear.   
Leg wrapping was not effective for maintaining maternal temperature. 
 
Conclusions  
Intravenous fluid warming, by any method, improves maternal temperature for 
women undergoing caesarean section and reduces shivering. Preoperative body 
warming devices also improve maternal temperature, in addition to reducing 
shivering.  
 
Implications for practice  
Preoperative warming strategies should be utilized where possible for women 
undergoing caesarean section (Level 2) and preoperative and/or intraoperative 
warmed IV fluids should be standard practice (Level 1).  
Under-body warming mattresses should be used (Level 1) and upper body forced air 
warming should be utilized preoperatively (Level 2). 
Additional strategies, such as ambient temperature maintenance, should be used to 
maintain thermal comfort (Level 2). Warming strategies have less effect when 
intrathecal opioids are administered (Level 2). 
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Implications for research  
Research is needed to investigate the effectiveness of interventions in emergency 
caesarean section surgery. Larger scale studies of warming interventions using 
standardized and clinically meaningful temperature measurement time points are also 
required.  
 
Keywords  
perioperative, hypothermia, caesarean section, warming, systematic review   
 
Introduction 
Background 
Women undergoing caesarean section (CS) are vulnerable to the adverse effects 
associated with perioperative core temperature drop during surgery, in part due to the 
tendency for this surgery to be performed under neuraxial anaesthesia, and due to 
higher rates of blood and fluid loss. Vasodilation, which occurs in all pregnant 
patients, also predisposes obstetric patients (Dunn, et al., 1993) to inadvertent 
perioperative hypothermia (IPH).  
IPH is a common condition that affects patients undergoing surgery of all surgical 
specialties and is detrimental to all age groups, including neonates. Numerous serious 
adverse effects are associated with IPH for all patient groups. Increased blood loss 
and transfusion requirements (Rajagopalan, et al., 2008) stem from impaired platelet 
function in hypothermic patients. Even in this respect alone, the prevention of 
hypothermia would be particularly beneficial for caesarean section patients, for 
whom perioperative bleeding can present significant problems (Woolnough, Allam, 
et al., 2009). Delayed wound healing (Kurz, et al., 1996), decreased immune 
response (Beilin, et al., 1998) leading to increased wound infection rates (NCCNSC 
2008), prolonged stay in Post Anaesthetic Care Units (PACU), prolonged hospital 
stay and increased costs (Lenhardt, et al., 1997), altered drug metabolism and 
increased likelihood of cardiac arrhythmias (NCCNSC 2008) have also been 
associated with IPH, and this list may not be exhaustive. Shivering associated with 
hypothermia also places patients under increased cardiac strain.  
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In the early 1990s, maternal hypothermia was described as being rarely discussed in 
obstetric literature (Dunn, et al., 1993) but in recent years studies have scrutinized 
methods of preventing hypothermia specifically for this group of patients. Also, in 
recent years, multiple systematic reviews and guidelines have been published with 
the aim to provide evidence for the effective prevention and management of IPH. 
These largely focus on either adult or all ages’ populations, but have mainly 
overlooked, or excluded, pregnant or CS patients as a distinct and vulnerable group. 
A JBI systematic review on the management of perioperative hypothermia included 
three studies that focused on the warming of CS patients (and identified no other 
studies of CS warming in excluded articles), (Moola & Lockwood, 2011) with 
searches complete to 2008. A meta-analysis on cutaneous warming systems (Galvao, 
et al., 2010) included two studies that pertain to the warming of CS patients. While 
the National Institute for Health and Care Excellence (NICE) guidelines (2008) 
(NCCNSC 2008) on IPH excluded pregnant women, Chakladar & Harper suggest 
that guidelines and clear evidence are needed to establish what constitutes best 
practice in terms of preventing IPH in this group of patients (Chakladar & Harper, 
2010).  
In addition, not all recommendations made by systematic reviews targeting all adult 
patients are readily transferable to CS patients. Practical problems may exist with 
using forced air warming for obstetric patients.(Chakladar & Harper, 2010) (Petsas, 
et al., 2009) Forced air warming blankets (the warming mode of choice 
recommended by NICE (NCCNSC 2008)) have been described as difficult to apply 
in such a way that they do not interfere with the mother and baby.(Chakladar, et al., 
2011) Obstetric patients may also have different thermoregulatory responses in 
comparison to non-pregnant controls (Liu & Luxton, 1991) which may affect the 
effectiveness and appropriateness of warming devices. The vasodilation experienced 
by all pregnant patients is exacerbated by neuraxial anaesthesia, thus increasing heat 
loss. Oxytocics also produce vasodilation thus increasing heat loss. CS patients may 
also be particularly vulnerable to hypothermia due to the amount of exposure 
required during surgery and the large amount of fluid loss experienced, in particular 
during emergency surgery. Hypothermia is usually initially undetected during 
neuraxial anaesthesia (commonly used for CS). This occurs if the temperature is not 
monitored by the anaesthetist during neuraxial anaesthesia (Arkilic, et al., 2000; 
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Lenhardt, et al., 1997). In addition, behavioural thermoregulation is impaired. 
Patients may not perceive and therefore report that they are cold (Arkilic, et al., 
2000). 
Skin surface heat loss occurs via the four mechanisms of radiation, convection, 
evaporation and conduction (Dunn, et al., 1993) – all of these mechanisms combine 
during surgery to produce a problematic heat loss which can result in hypothermia. 
Environmental factors, such as the ambient temperature of the operating theatre and 
downward draft, result in convective and radiant heat loss, when large areas of the 
skin’s surface are exposed to the relatively cool surrounding environment. Wet linen, 
room temperature irrigating fluids and skin cleansing fluids contribute to conductive 
and evaporative heat loss (Dunn, et al., 1993). The duration of the surgery, and 
systemic and neuraxial medications also contribute to the overall likelihood or extent 
to which hypothermia will develop. 
It has been suggested that all CS patients should receive intraoperative warming, 
(Harper & Alexander, 2006) because if it is not managed, the rate of hypothermia in 
patients undergoing spinal anaesthesia for CS could be as high as 80% (Harper & 
Alexander, 2006). During spinal anaesthesia, as in general anaesthesia, heat 
redistributes down a core-periphery heat gradient. Heat is therefore redistributed 
from the core compartment to the peripheries due to the vasodilation caused by the 
sympathetic block. (Sayyid, et al., 2003) Secondly, below the level of the block there 
is a loss of thermoregulatory vasoconstriction (Sayyid, et al., 2003), and, thirdly, 
thermoregulation impairment results in reduced thresholds for shivering and 
vasoconstriction during spinal anaesthesia (Sayyid, et al., 2003). 
The effects of certain drugs used during spinal anaesthesia, notably intrathecal 
morphine, may also exacerbate IPH. Morphine is commonly used in spinal 
anaesthesia for CS to give a longer duration of postoperative pain relief, but is known 
to be associated with hypothermia, even in small amounts (Hui, et al., 2006).  It is 
thought that the drug spreads in the cerebrospinal fluid to the body’s 
thermoregulation control centre – the hypothalamus – and impairs thermoregulation 
(Hui, et al., 2006).  The paradoxical symptoms that sometimes occur with 
hypothermia associated with intrathecal morphine have been attributed to the 
decrease in the thermoregulatory set point that is believed to occur due to the 
cephalic spread of the opioid. In these patients, paradoxical symptoms of feeling hot 
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combined with diaphoresis alongside hypothermia have been observed (Hess, et al., 
2005). Active warming may not be tolerable for patients experiencing these 
paradoxical symptoms, although they are hypothermic. Maintenance of 
normothermia in patients given intrathecal morphine therefore presents a greater 
challenge and it may be that warming methods that are effective for other patients 
may have a reduced effect or appropriateness in this group of patients. Alternative, 
effective methods for preventing or managing hypothermia in this group would 
therefore be valuable.  
In all obstetric patients, the temperature status of the mother and the unborn baby are 
related. A temperature gradient exists between the warmer unborn baby and the 
cooler mother (Yentur et al., 2009). Babies born to hypothermic mothers may also be 
at risk of lower temperatures at birth and possibly lower umbilical pH and Apgar 
scores at birth (Horn, et al., 2002; Petsas, et al., 2009). 
Warming interventions are usually classified into two groups, according to the means 
of transferring heat. Passive warming measures warm the peripheries or skin surface 
and include reflective (space) blankets, cotton blankets and other types of coverings. 
Active warming measures aim to increase the core heat content, and employ 
convective means of heating. Forced air warming devices, circulating water 
garments, heated mattresses and intravenous fluid warmers are all examples of active 
warming measures. Active warming – forced air warming blankets in particular – is 
the recommended means of preventing and managing IPH according to evidence-
based guidelines published by NICE (NCCNSC 2008) and by the JBI systematic 
review on IPH (Moola & Lockwood, 2011). Circulating water garments have also 
shown potential to be at least as effective, if not more effective, as forced air 
warming blankets, according to a recent meta-analysis (Galvao, et al., 2010). 
Prewarming patients prior to surgery, usually via active warming methods, has been 
recommended (NCCNSC 2008) to decrease the redistribution of heat occurring 
during the first phase of anaesthesia by increasing the peripheral heat content. These 
interventions may have varying degrees of usefulness, effectiveness and applicability 
for CS patients. Any risks associated with using warming interventions may also be 
magnified for pregnant patients, for example, maternal overheating or high maternal 
body temperature may adversely affect fetal wellbeing (Lieberman et al., 2000). 
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Apart from the undesirable physiological adverse side effects associated with IPH, 
the condition can also have the potential to adversely affect maternal experiences in, 
and satisfaction with, the Recovery Unit phase. Discomfort and shivering, both side 
effects of IPH, can create problems during the postoperative period (Butwick, et al., 
2007) which may interfere with the mother’s ability to be with and bond with her 
newborn, at a time when breastfeeding is often instigated. 
As indicated above, no other systematic reviews have been published that deal 
exclusively with the effectiveness of warming methods for patients undergoing CS. 
Recommended methods of warming other patient groups may have differing levels 
of effectiveness, applicability and practicality for this population. This review aims 
to address the lack of existing guidance by providing recommendations specifically 
for women undergoing CS.  
 
Objectives 
This systematic review sought to synthesize the best available evidence in relation to 
preventing and/or treating hypothermia in mothers after CS surgery.  
More specifically, the objective was to synthesize the best available evidence on the 
effectiveness of interventions to prevent heat loss in this group of patients. This 
included active warming measures (such as forced air warming and intravenous [IV] 
fluid warming) or passive warming measures (such as leg wrapping and 
prewarming), on the core temperature of the mother and newborn after surgery.  
 
Review questions 
• What are the most effective interventions for preventing and 
managing perioperative hypothermia in women undergoing CS surgery?  
• Are there any differences in effectiveness for warming interventions 
between patients undergoing different modes of anaesthesia for CS (general 
/epidural/spinal)? 
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Definitions 
Hypothermia: a patient core temperature of below 36°C (NCCNSC 2008). 
Normothermia: a core temperature between 36°C and 38°C (Hooper, et al., 2010). 
Gravida: number of pregnancies (Johnson, 2010). 
Parity: the number of previous deliveries (Kenner & Lott, 2007). 
Neuraxial: spinal or epidural anaesthesia (Arkilic, et al., 2000). 
Active warming: methods that minimize convective heat loss (Torossian, 2008), for 
example, forced air warming, circulating water garments and fluid warming devices.  
Passive warming: methods that warm the patient by minimizing heat dispersion and 
insulating the patient from the environment (Putzu, Casati, Berti, Pagliarini, & 
Farelli, 2007), for example, cotton blankets and aluminium foil covers.  
 
Inclusion criteria 
Types of participants 
All studies of adult patients over the age of 18 years, of any ethnic background, with 
or without co-morbidities, undergoing any of the different modes of anaesthesia 
(general/epidural /spinal) for any type of CS (emergency or planned) at healthcare 
facilities who have received interventions that may limit or manage perioperative 
core heat loss were included. Studies focusing on patients undergoing any other type 
of surgery other than CS or pregnant patients not undergoing CS were excluded. 
Types of interventions 
The types of intervention considered were: active warming methods or passive 
warming methods versus usual care or placebo, that aim to limit or manage core heat 
loss as applied to women undergoing CS. Active warming methods include forced air 
warming devices, warmed fluids, warmed mattresses and warmed coverings. Passive 
interventions include unheated coverings, such as leg wrapping.  
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Types of studies 
This review considered any randomised controlled trials (RCTs) that met the 
inclusion criteria, with reduction of perioperative hypothermia a primary or 
secondary outcome. 
 
Types of outcomes 
The review focused on the following outcomes: 
Primary outcome: maternal core temperature measured via the following sites: 
pulmonary artery, oesophageal, tympanic, bladder or oral, during the preoperative, 
intraoperative and postoperative phases of care. 
Secondary outcomes: newborn core temperature at birth obtained immediately after 
birth, umbilical pH measured via blood gas analysis from a sample obtained 
immediately after birth, Apgar scores, length of Post Anaesthetic Care Unit (PACU) 
stay measured in minutes from the time the patient arrives into PACU until discharge 
to ward areas, and maternal thermal comfort (preferably measured by a validated 
scale).  
 
Search strategy 
The search strategy incorporated both published and unpublished literature, including 
grey literature, in any language. A three-step search strategy was utilized. An initial 
limited search of Medline, CINAHL and EMBASE was conducted, followed by an 
analysis of the text words contained in the title and abstract, and the index terms used 
to describe the article. A second search included all identified keywords and index 
terms across all databases listed. Thirdly, the reference lists of all identified studies 
and articles were hand searched. The date range for searches was from the inception 
of the databases until May 2012. 
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Additional databases searched: 
ProQuest 
Web of Science 
Scopus 
Dissertation and Theses PQDT (via ProQuest) 
Current Contents 
CENTRAL 
MedNar 
OpenGrey 
Clinical Trials 
All studies identified during the database search were assessed for relevance to the 
review based on information via the title, abstract and description by two 
independent reviewers. A third reviewer was consulted if consensus could be 
reached. The full article was retrieved for all those that appeared to meet the 
inclusion criteria. Any articles that appeared unclear in this respect were also 
retrieved for clarification. Details of search terms used are detailed in Appendix C. 
Search results are detailed in Appendix D.  
 
Initial keywords 
perioperative or peri-operative or intra-operative 
surgical 
temperature OR core temperature  
thermoregulation 
hypothermia  
shivering 
C*esarean section 
C*esarean delivery 
parturient 
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maternal 
warming  
active warming  
passive warming 
 
Verification of relevance 
All studies were assessed for relevance to the inclusion criteria using a form 
developed by the reviewers and based on the recommendations of the Cochrane 
Collaboration (Deeks, et al., 2011) (Appendix E). 
 
Method of the review 
Assessment of methodological quality 
Papers selected for retrieval were assessed for methodological quality by two 
independent reviewers (JM, SH) prior for inclusion in the review using the 
standardized critical appraisal instrument for RCTs (Appendix B) from JBI-
MAStARI. Disagreements regarding three papers were resolved via consultation 
with the third reviewer (KW).  
In addition, an assessment of quality of the included papers was made in relation to 
five key quality factors. Studies were stratified as low, medium or high quality 
according to how these factors were addressed in each included study. Description of 
the random assignment to treatment groups was examined, as were details of 
participant blinding to treatment allocation, the concealment of allocation to 
treatment groups to allocator, the description and inclusion in the analysis of those 
participants who withdrew, and the blinding of outcome assessors.   
 
Data collection 
Two independent reviewers (JM, SH), extracted data from the included papers using 
a customized data extraction tool, based on the JBI data extraction tool for 
quantitative studies. This tool was piloted by two of the reviewers (JM, SH) 
extracting data from the same study during protocol development, prior to use with 
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the included studies (Appendix F). The extracted data included details of the 
intervention, population, study design, outcomes and data relevant to the review 
question and objectives.  
 
Data analysis 
Where meta-analysis was possible, results were combined in a fixed effects meta-
analysis using the Cochrane Collaboration Review Manager software. JBI-MAStARI 
was not used, as per the published protocol, as it did not allow for multiple analyses 
to be conducted at the same time. Due to heterogeneity for one comparison/outcome, 
random effects meta-analysis was also used. Results of the meta-analysis are 
presented using odds ratio (OR) (for categorical data) and weighted mean difference 
(for continuous data), along with their 95% confidence intervals (CI). The presence 
of heterogeneity was determined using the standard Chi-square test. The degree of 
heterogeneity was assessed using I2. Standard deviation (SD) was calculated from 
the standard error of the mean (SEM) (Institute, 2008; Rosner, 2011) reported for one 
study (Smith, et al., 2000). 
The variations between studies, particularly in relation to the variety in treatment 
received by control and intervention groups, and time points of temperature 
measurements, meant that only limited meta-analyses were possible. The remaining 
data were synthesized into a narrative summary. A table was developed to provide an 
outline of the interventions and outcomes of the included studies (see Appendix G).  
 
Results 
Description of studies 
After removal of duplicates from the original searches, and title and abstract 
checking, 86 studies were identified. After verification of study eligibility, 24 studies 
were identified as potentially eligible for inclusion in the review. Following the 
addition of two studies identified from reference lists, 26 studies were critically 
appraised. Finally 12 studies remained (see Figure 1), giving a combined total of 719 
participants. Full details of the excluded studies are provided together with reasons 
for exclusion (see Appendix H). 
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The 12 included studies were all RCTs. Temperature was the primary outcome in the 
majority of studies, but some studies of shivering were also included in which 
temperature was recorded as a secondary outcome.  
The populations among studies were very similar - most participants underwent 
elective CS apart from in one study (n= 68) where ‘semi-urgent’ cases were also 
included.(Reidy, et al., 2008) Mode of anaesthesia also differed between studies but 
the majority included patients undergoing spinal or epidural anaesthesia rather than 
combined spinal-epidural (CSE) or general anaesthesia. The included studies were 
conducted in the United Kingdom (Chakladar, Dixon, & Harper, 2012), (Woolnough, 
Allam, et al., 2009), Canada (Chan, et al., 1989; Fallis, et al., 2006; Reidy, et al., 
2008), Iran (Oshvandi, et al., 2011), the United States (Horn, et al., 2002),(Smith, et 
al., 2000), Korea (Chung, et al., 2012), India (Goyal, et al., 2011), Taiwan (Sun, et 
al., 2004), and Japan (Yokoyama, et al., 2009). 
The method used to measure maternal core temperature varied widely between 
studies, with temporal artery, bladder, oral, aural infrared, tympanic thermocouple, 
skin and axillary measurements all utilized. Although it is acknowledged that there 
are issues of reliability between temperature measurement sites and core temperature, 
the choice of site was not used as a basis for inclusion or exclusion in this review. 
The findings of the review are organized according to the interventions utilized in the 
included studies, and within these groups, sub-headings according to outcome are 
used. 
Once studies had been critically appraised with the appropriate JBI critical appraisal 
tool for experimental studies (Appendix B) and found to be of sufficient quality to 
include in the review by satisfying the majority of the criteria on the tool, the 
included studies were then further rated as high (one study) (Woolnough, Allam, et 
al., 2009), moderate (five studies) (Chakladar, et al., 2012; Horn, et al., 2002; 
Oshvandi, et al., 2011; Sun, et al., 2004; Yokoyama, et al., 2009) or low quality (six 
studies) (Chan, et al., 1989; Chung, et al., 2012; Fallis, et al., 2006; Goyal, et al., 
2011; Reidy, et al., 2008; Smith, et al., 2000) based on the randomization methods, 
blinding to treatment allocation, concealment of allocation from the allocator, 
blinding of outcome assessors and the inclusion in the analysis of participants who 
withdrew from the study. 
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Six studies were considered to have unclear or less than rigorous randomization 
methods (Chung, et al., 2012; Oshvandi, et al., 2011) (Chan, et al., 1989; Reidy, et 
al., 2008; Smith, et al., 2000; Sun, et al., 2004). The main methods used for 
randomisation were computer-generated randomisation (Chakladar, et al., 2012; 
Goyal, et al., 2011; Horn, et al., 2002; Woolnough, Allam, et al., 2009; Yokoyama, et 
al., 2009) but block randomization (Fallis, et al., 2006) and card drawing (Chan, et 
al., 1989) were also used.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Flowchart of study retrieval and selection 
Participant blinding was unclear or not addressed by six studies (Chan, et al., 1989; 
Chung, et al., 2012; Goyal, et al., 2011; Reidy, et al., 2008; Smith, et al., 2000; 
Total number of papers 
identified from database 
searches: n=2467 
Total papers after removal of 
duplicates, title/abstract 
checking: n= 86 
Studies for critical appraisal: 
n= 26 
Studies for inclusion in the 
review: n= 12 
 
Papers excluded after removal 
of duplicates, title/abstract 
checking: n= 2381 
Papers excluded after 
verification of relevance to 
study criteria: n=62   
 
 
 
Papers excluded after critical 
appraisal: n= 14 
Addition of papers identified 
from reference lists: n= 2  
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Yokoyama, et al., 2009). The practical difficulties of blinding participants to the 
relevant interventions should be acknowledged here and depended on the nature of 
the intervention. Forced air warmers tend to generate noise and their use may be 
difficult to conceal. Lack of blinding was a common issue in the included forced air 
warming studies.   Fallis et al. (Fallis, et al., 2006) acknowledge that the lack of 
participant blinding in their forced air warming study may have precipitated bias. 
Horn et al. (Horn, et al., 2002) also acknowledged the lack of participant blinding in 
their forced air warming study. Chakladar’s unpublished study on the use of an 
under-body carbon polymer mattress was not blinded, which the authors attribute to 
the lack of feasibility of doing so (Chakladar, et al., 2012).    
Similarly, the blinding of investigators assessing outcomes was unclear in four 
studies (Chan, et al., 1989; Chung, et al., 2012; Reidy, et al., 2008). In two studies it 
appears that while some outcomes were measured by blinded observers, it remains 
unclear if all the outcomes were measured by blinded observers (Smith, et al., 2000; 
Sun, et al., 2004). Two studies of forced air warming did not attempt to blind 
outcome assessors (Chakladar, et al., 2012; Fallis, et al., 2006) and this might be 
related to the practicalities of doing so.    
Additional information was requested from five authors of included studies 
(Chakladar, et al., 2012; Chung, et al., 2012; Fallis, et al., 2006; Reidy, et al., 2008; 
Woolnough, Allam, et al., 2009) three of whom provided additional information 
(Chakladar, et al., 2012; Fallis, et al., 2006; Reidy, et al., 2008). This was particularly 
important in relation to the as yet unpublished studies (Chakladar, et al., 2012; Reidy, 
et al., 2008). Only limited data could be combined in meta-analysis due to the 
variations between studies, particularly between time points of temperature 
measurement. The timing of temperature measurement varied widely between 
studies, particularly in regard to intervals between measurements, end points (for 
example, some studies ceased temperature measurements at the end of surgery whilst 
others continued into the postoperative period) and the time point for which data was 
reported. Limited data reporting, and the use of figures and graphs to display results, 
reduced the amount of usable data that could be extracted for analysis. Where 
possible, specific p-values are presented but the included studies did not always 
report them.  
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Findings of the review 
Intravenous fluid warming 
Overview of studies 
Seven included studies (Chan, et al., 1989; Chung, et al., 2012; Goyal, et al., 2011; 
Oshvandi, et al., 2011; Smith, et al., 2000; Woolnough, Allam, et al., 2009; 
Yokoyama, et al., 2009) compared intravenous fluid (IV) warming with other 
interventions and most of these (Chan, et al., 1989; Goyal, et al., 2011; Oshvandi, et 
al., 2011; Smith, et al., 2000; Yokoyama, et al., 2009) used room temperature fluids 
as a comparator. Two studies (Chung, et al., 2012; Woolnough, Allam, et al., 2009) 
used a three group design: one compared two different methods of fluid warming 
versus room temperature fluids (Hotline™ fluid warmer – a method which warms 
fluids in the IV tubing via circulating water bath during delivery to the patient – 
versus warming cabinet) (Woolnough, Allam, et al., 2009) and another study 
compared warmed IV preload versus forced air warming plus room temperature fluid 
preload versus room temperature fluid preload alone (Chung, et al., 2012). The use of 
additional interventions such as reflective (‘space’) blankets (Yokoyama, et al., 
2009) or warmed skin preparations (Chan, et al., 1989) by two other studies to either 
one or both groups, limited meta-analysis. Meta-analysis was performed between 
comparable groups (see below) for the outcomes of mean temperature on arrival to 
PACU, temperature at 30 minutes in PACU and shivering.  
There was a wide variation in both fluid warming methods and temperatures for 
administration of warmed fluids. Data extracted were not separated according to 
method of warming but simply as warmed or unwarmed. Warming cupboards were 
used to store warmed fluids in four studies (Woolnough, Allam, et al., 2009) (Chan, 
et al., 1989; Chung, et al., 2012; Yokoyama, et al., 2009) and the temperature 
settings ranged between 38-45°C. Two of these studies (Chung, et al., 2012; 
Woolnough, Allam, et al., 2009) measured the actual administration temperature of 
the fluids at the distal end when passed through the apparatus or giving set and found 
this to be 37-38°C. Fluid warmers were used in three studies: Hotline™ warmers in 
studies by Woolnough et al. (Woolnough, Allam, et al., 2009) and Smith et al. 
(Smith, et al., 2000) and an Astotherm™ by Goyal et al (Goyal, et al., 2011). This 
method warms fluids via the tubing as they pass through the device, which is situated 
between the IV fluid reservoir (bag) and the patient. Fluids in these studies were 
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warmed to 42°C (Smith, et al., 2000; Woolnough, Allam, et al., 2009) and 39°C 
(Goyal, et al., 2011). Water baths were also utilized as a method of fluid warming in 
two studies (Oshvandi, et al., 2011; Yokoyama, et al., 2009) although in one of these 
studies this was a secondary method of warming the IV tubing to maintain the 
temperature of the fluids that had been already warmed in a warming cupboard 
(Yokoyama, et al., 2009).  
The commonly used comparator in these studies was ‘room temperature’ fluids and 
the temperature of these was unspecified in two studies (Woolnough, Allam, et al., 
2009) (Chung, et al., 2012) but typically ranged in the remaining studies from 20-
25°C (Chan, et al., 1989; Oshvandi, et al., 2011; Smith, et al., 2000) (Goyal, et al., 
2011) (Yokoyama, et al., 2009).  As stated above, the studies were not separated 
according to the equipment or method used to warm the fluids, but have been 
assessed in this systematic review according to the interventions and comparators.  
 
Intravenous fluid warming and maintenance of maternal temperature 
Maternal temperature was measured at different time points by the studies of warmed 
IV fluids, thus limiting comparability. The most abundant data extracted from the 
fluid warming studies relates to the recovery phase of care. Yokoyama et al.’s study 
of warmed IV fluids and reflective blanket versus unwarmed IV fluids and reflective 
blanket measured tympanic temperature (via thermocouple) and forearm-fingertip 
temperature gradient at multiple time points (Yokoyama, et al., 2009). Tympanic 
temperature at the time of delivery was higher in patients with warmed IV fluids 
compared to those with unwarmed IV fluids: 36.7°C (SD: +/- 0.3°C) versus 36.2°C 
(SD: +/- 0.3°C), p <0.05 and remained so at 15 minutes, 30 minutes and 45 minutes 
after delivery: 36.4° C (SD: +/- 0.2°C) versus 35.5°C (SD +/- 0.3°C) at 45 minutes 
after delivery (p<0.05, as examined by repeated measures of analysis of variance 
(ANOVA).   These findings also appear to be clinically significant, particularly at the 
45 minute time point. In this study, it remains unclear whether the 45 minutes after 
delivery time point included patients who were actually in the recovery phase or 
were still in the operating room. Another study found that the average core 
temperature at the end of anaesthesia was also higher in patients administered pre-
surgery warmed IV fluids versus room temperature fluids (36°C, SD: +/- 0.5°C 
versus 35.34°C, SD: +/- 0.06°C, p<0.05).  
 Appendix A 184 
Smith et al.’s study of warmed IV fluids via Hotline versus room temperature fluids 
also reported multiple temperature measurement time points (using a tympanic Mon-
a-Therm thermocouple) throughout the intraoperative and postoperative periods 
(Smith, et al., 2000). This study found a statistically significant greater number of 
hypothermic (<36°C) patients at the end of surgery for the unwarmed group (24/32 
patients or 75%) versus 16/32 patients (46%) in the warmed group, p <0.05 using 
Student’s t test). In addition, they also found a significantly lower core final 
temperature for the unwarmed (control) group (35.6 °C, SD: +/- 0.7°C versus 
36.1°C, SD: +/- 0.6°C in the warmed group, p <0.05).  Differences in the lowest 
temperature between groups (35.5°C, SD: +/- 0.6°C in the control group versus 
36.0°C, SD: +/- 0.6°C in the warmed group, p<0.05) were also statistically and 
clinically significant.  
Chan et al.’s study of warmed IV fluids plus warmed skin preparation fluids and 
extra clothing versus room temperature fluids found a statistically and clinically 
significant (p<0.05) lower drop in the mean aural temperature (via Mon-A-Therm™ 
thermocouple) and the mean bladder temperature between baseline to arrival in 
recovery room using student’s t test (Chan, et al., 1989). Mean bladder temperature 
drop between baseline and arrival in recovery room was 1.0°C (SD: +/- 0.02°C) in 
the control group versus 0.6°C (SD: +/- 0.01°C) in the intervention group (p<0.05) 
and for aural temperature was 0.9°C (SD: +/- 0.06°C) in the control group versus 
0.5°C (SD: +/- 0.04°C) in the intervention group (p<0.05). However the addition of 
these extra warming interventions in this study limits comparability with other study 
results.  
Three studies found that administration of warmed fluid preload versus room 
temperature fluids (administered in the operating theatre but prior to anaesthesia) 
appears to result in higher temperatures when measured 60 minutes after induction of 
anaesthesia or in the recovery phase (Chung, et al., 2012; Oshvandi, et al., 2011; 
Woolnough, Allam, et al., 2009). Oshvandi et al.’s study of women undergoing 
elective CS under general anaesthesia found a statistically significant higher mean 
infrared aural temperature (using a Tympanic FT55™ thermometer) for women who 
received a preload of warmed intravenous fluids compared to those who received 
room temperature fluids (Oshvandi, et al., 2011). The mean temperature of the 
intervention group was 35.9°C (SD: +/- 0.5°C) compared with 35.4°C (SD: +/- 
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0.6°C) (p=0.001, with ANOVA) which may be less clinically than statistically 
significant. Similarly, the greatest temperature decrease during the 60 minutes after 
combined spinal-epidural (CSE) insertion in Chung et al.’s three group study 
(warmed fluid preload versus room temperature preload versus forced air warming) 
was experienced by the room temperature group (0.4°C difference, 95% confidence 
interval 0.2-0.6°C, p=0.015) (Chung, et al., 2012). Woolnough et al.’s three group 
study of warmed IV fluids via Hotline versus cabinet warmed IV fluids versus room 
temperature fluids reports significantly greater mean infrared aural temperature 
decrease (measured via ThermoScan Exac Temp thermometers) in the room 
temperature group during the first 60 minutes following CSE, but only results for the 
decrease in room temperature fluids are reported: 0.4°C (95% CI 0.2-0.6°C, p=0.015) 
(Woolnough, Allam, et al., 2009).  
Two studies of intravenous fluid warming were combined using meta-analysis for 
mean temperature on arrival to PACU (Figure 2) (Goyal, et al., 2011; Smith, et al., 
2000). Goyal et al. compared intravenous fluids at room temperature (22°C) with 
intravenous fluids warmed via a fluid warmer (to 39°C) (Goyal, et al., 2011), whilst 
Smith et al. also studied room temperature fluids (20-22°C) with warmed intravenous 
fluids (via Hotline™, 42°C) (Smith, et al., 2000). The summary estimate of these 
studies found that administration of warmed IV fluids compared to room temperature 
fluids at 20-22°C resulted in a statistically significant higher mean temperature on 
arrival to PACU (mean difference 0.30, 95% CI 0.11-0.49).   
 
Figure 2: Intravenous fluid warming versus room temperature fluids and mean 
temperature on arrival to PACU 
The two studies in Figure 2 (Goyal, et al., 2011; Smith, et al., 2000) were also 
analysed for the outcome of mean temperature after 30 minutes in PACU (Figure 3), 
showing the effectiveness of IV fluid warming in increasing mean temperature 
persisted into the recovery phase (mean difference 0.51, 95% CI 0.35-0.68). 
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Figure 3: Intravenous fluid warming versus room temperature fluids and mean 
temperature at 30 minutes in PACU 
Smith et al.’s study also demonstrated a statistically significantly higher maternal 
temperature at discharge from recovery in the warmed fluid group using Student’s t 
test (36.5°C, SD: +/- 0.6°C versus 36.1°C, SD: +/- 0.6°C, p <0.05), but the lack of 
discharge temperature time points in other studies limits comparability (Smith, et al., 
2000). Both warmed IV fluids administered pre-surgery and during surgery appeared 
to have benefits for increasing maternal temperature, as measured in the latter 
intraoperative phase and into the recovery phase, until discharge.  
 
Intravenous fluid warming and prevention of shivering  
Six of the seven fluid warming studies (Chan, et al., 1989; Chung, et al., 2012; 
Goyal, et al., 2011; Oshvandi, et al., 2011; Smith, et al., 2000; Woolnough, Allam, et 
al., 2009) also measured participant shivering. In two studies dichotomous data is 
presented from the assessment of the presence or absence of shivering before and 
after CS (Goyal, et al., 2011) or in PACU (Smith, et al., 2000). In addition, details of 
interventions to treat the shivering once it occurred were recorded (number and type) 
(Goyal, et al., 2011; Smith, et al., 2000). Similar four-point scales recording the 
degree of shivering intensity were used by two studies, (Woolnough, Allam, et al., 
2009) (Chan, et al., 1989) while a five point scale was used by Oshvandi et al. 
(Oshvandi, et al., 2011) (attributed to Crossley and Mahajan) (Crossley & Mahajan, 
1994) and a four point scale was used by Chung et al (Chung, et al., 2012) (attributed 
to Wrench) (Wrench, et al., 1997). Three studies utilizing shivering scales also 
reported on presence and absence of shivering (Chung, et al., 2012; Oshvandi, et al., 
2011; Woolnough, Allam, et al., 2009). 
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The single study that compared an intervention of warmed fluids, warmed skin 
preparation and additional clothing with another intervention of room temperature 
fluids, room temperature skin preparation and single hospital gown (Chan, et al., 
1989) could not be included in the meta-analysis (because of the extra interventions) 
and did not find a significant difference in incidence of shivering between groups (11 
of 21 patients reported shivering in the intervention group versus 13/19 in control 
group, no p value reported). Five studies comparing IV fluid warming with room 
temperature fluids were combined in a meta-analysis of effectiveness warmed IV 
fluids on the incidence of shivering (Chung, et al., 2012; Goyal, et al., 2011; 
Oshvandi, et al., 2011; Smith, et al., 2000; Woolnough, Allam, et al., 2009) (Figure 
4).  
 
Figure 4: Intravenous fluid warming versus room temperature fluids and the 
incidence of shivering  
Two of the three groups in Oshvandi et al.’s study, the warmed IV fluid and room 
temperature groups (Oshvandi, et al., 2011), were included in this meta-analysis, as 
per advice for managing multiple-group studies in the Cochrane Handbook for 
Systematic Reviews of Interventions (Deeks, et al., 2011). In addition, for 
Woolnough et al.’s three group study the two warmed fluid groups were combined 
together, as the interventions were sufficiently similar, and compared to the room 
temperature group (Woolnough, Allam, et al., 2009). The combined result 
significantly favours intravenous fluid warming (OR 0.54, 95% CI 0.33-0.89) for 
reducing shivering in this population. 
  
  
 Appendix A 188 
Intravenous fluid warming and maternal thermal comfort 
Maternal thermal comfort was assessed by both of the three group studies (Chung, et 
al., 2012; Woolnough, Allam, et al., 2009). Woolnough et al.’s study of Hotline™ 
warmed fluids versus warming cabinet fluids versus room temperature fluids used a 
0-10 numerical rating scale with 0 indicating ‘worst imaginable cold’, 5 as ‘thermally 
neutral/comfortable’ and 10 indicating ‘insufferably hot’ (Woolnough, Allam, et al., 
2009). The authors considered a score of less than 4 to correspond to feeling cold, 
whilst a score of more than 6 corresponded to feeling hot. Similarly, Chung et al.’s 
three group study of warmed IV preload versus unwarmed IV preload (and versus 
upper body forced air prewarming) which used a 100mm Visual Analogue Scale 
(VAS) with 0mm indicating ‘insufferably hot’, 50mm ‘thermally neutral’ and 
100mm as ‘worst imaginable cold’, reported on thermal discomfort (reporting on 
data for cold VAS scores between 50mm-100mm) (Chung, et al., 2012).  
There was a statistically significant difference in the number of patients reporting 
thermal discomfort (a thermal comfort score of <4) between the three groups in 
Woolnough et al.’s three group study (p=0.32) although the statistical test is not 
specified (Woolnough, Allam, et al., 2009). In the room temperature fluids group: 
8/25 (32%) scored <4, whereas 3/25 (12%) scored <4 in the warming cabinet group 
and only 1/25 (4%) scored <4 in the Hotline group (Woolnough, Allam, et al., 2009). 
This also appears to be clinically significant: in this study patients appear to 
demonstrate greater thermal comfort if receiving warmed intravenous fluids. No 
statistically significant difference or clinically significant (p= 0.093) difference in 
maternal thermal comfort was found between preload of warmed IV fluid, upper 
body forced air warming with room temperature preload and room temperature 
preload (no warming) in Chung et al.’s study with cold VAS data reported (59.3mm, 
SD: 13.2mm versus 59.0mm, SD: 12.1mm versus 69.0mm, SD: 15.9mm 
respectively) (Chung, et al., 2012). There were differences between these studies in 
relation to the temperature settings of fluid warming devices: fluids in Chung et al.’s 
study were warmed to 40°C via a warming cabinet (Chung, et al., 2012), whereas in 
Woolnough et al.’s study which found a significant difference in thermal comfort 
from warmed fluids, warming cabinet fluids were stored at 45°C and Hotline™ 
fluids were set to 42°C (Woolnough, Allam, et al., 2009). Greater volumes of fluid 
were infused in Woolnough et al.’s study (2.0 litres, SD: 0.4 litres in the room 
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temperature group, 2.1 litres, SD: 0.4 litres in the warming cabinet group and 2.4 
litres, SD: 1.4 litres in the Hotline group) (Woolnough, Allam, et al., 2009) as 
opposed to Chung et al.’s study (1.1litres, SD: 0.1litres in the room temperature 
group, 1.2 litres, SD: 0.2litres in the warmed fluid preload group and 1.2litres, SD: 
0.1 litres in the forced air warming group) (Chung, et al., 2012). 
These differing results could also be examined in the context of what ‘room 
temperature’ refers to in each study. Chung et al.’s study did not report data on 
ambient temperature (Chung, et al., 2012), whereas Woolnough et al. report that 
ambient temperature was 24.2°C (SD: +/- 0.9°C) in the room temperature group, 
23.9°C (SD: +/-1.4°C) in the warming cabinet group and 24.2 °C (SD: +/-0.8°C) in 
the Hotline group (Woolnough, Allam, et al., 2009).  Woolnough et al. did not 
examine the differences in ambient temperature between groups in this study 
(Woolnough, Allam, et al., 2009). Thus it remains unclear whether differences in 
ambient temperature play a role in the conflicting results between these studies.   
 
Intravenous warmed fluids and time to discharge from PACU 
Time to discharge from PACU was assessed only in two IV fluid warming studies 
(Goyal, et al., 2011; Smith, et al., 2000) but for one (Smith, et al., 2000) it remains 
unclear whether time to discharge as reported actually refers to time to fitness for 
discharge, or actual time to discharge (which may be dependent on many external 
factors, such as availability of ward staff).  
Goyal et al.’s study of warmed IV fluids versus room temperature IV fluids found no 
statistically significant difference in PACU discharge times in minutes (min) 
between groups: 105.5min (SD: +/- 9.5min) in the room temperature group versus 
107.3min (SD: +/- 9.2min) in the intervention group (Goyal, et al., 2011). Similarly, 
Smith et al.’s study of warmed IV fluids versus room temperature IV fluids found no 
significant difference in time to PACU discharge in minutes between groups: 109min 
(SD: 6min) in the intervention group versus 103min (SD: +/- 7min) in the control 
group (no p value was reported) (Smith, et al., 2000). The administration of 
intraoperative warmed IV fluids does not appear to shorten PACU stays for patients.  
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Intravenous fluid warming and neonatal outcomes 
Apgar scores.   
Apgar scores were evaluated by a paediatrician at one minute after delivery in two 
IV warming studies, both also using reflective blankets (Chung, et al., 2012; 
Yokoyama, et al., 2009) but these two studies could not be combined in meta-
analysis due to clinical heterogeneity. While study groups were similar in both 
studies, there were differences between studies in the temperature of warmed fluids, 
methods of administering warmed fluids and methods of temperature measurement. 
The Apgar score was significantly higher for the warmed IV fluids group in 
Yokoyama et al.’s study in comparison to the room temperature fluids group 
(Yokoyama, et al., 2009). Whereas in Chung et al.’s three group study the Apgar 
score was lower, but not significantly, for the warmed IV fluid preload compared to 
the room temperature fluid preload and the upper body forced air warming groups 
(see Table 1) (Chung, et al., 2012).    
Table 1: Apgar scores at one minute – IV fluid warming  
Study Apgar score at one minute  
 Warmed IV 
fluid* 
Room 
temperature 
fluids* 
Upper body 
forced air 
warming 
p 
value 
Yokoyama et al. 
(2009) ^ 
9 (8-9) 8 (8-9) n/a 0.029 
(Mann-
Whitney 
U-test) 
Chung et al. (2012) # 
*preload  
8.07 ± 1.10 8.20 ± 0.86 8.13 ± 0.86 0.927* 
(statistical 
test not 
specified) 
^ median (range), # mean (SD)* across three groups 
 
No significant difference in Apgar score between groups at five minutes after 
delivery (p= 0.18) was found by Yokoyama et al. (Table 2), in contrast to the 
statistically significant result for Apgar scores at one minute (Yokoyama, et al., 
2009). 
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Table 2: Apgar scores at five minutes – IV fluid warming versus room temperature 
fluids (Yokoyama et al., 2009)  
Study - Yokoyama et 
al. (2009)  
Apgar Score at five minutes (number/total number)  
Apgar score Warmed IV fluids Room temperature 
fluids 
p value Mann-
Whitney U-test 
8 1/15 0/15 0.18 
9 12/15 15/15 
10 2/15 0/15 
 
Umbilical pH 
While umbilical pH was also evaluated in the same two IV fluid warming studies 
that compared Apgar scores, these could not be combined due to clinical 
heterogeneity because of the source of blood for pH measurement. Chung et al. 
measured umbilical vein pH immediately after birth (Chung, et al., 2012), whilst 
Yokoyama et al. measured umbilical artery pH (Yokoyama, et al., 2009). Yokoyama 
et al. reported a statistically significantly higher pH for the warmed IV fluid group in 
comparison to the room temperature fluid group but there is little clinical 
significance to these results (Yokoyama, et al., 2009), while Chung et al.’s study 
found no statistically or clinically significant difference between the three groups 
receiving warming (Chung, et al., 2012) (Table 3). Yokoyama et al. also reported 
that umbilical pH data were averaged according to the number of patients receiving 
ephedrine (five participants in both groups) (Yokoyama, et al., 2009), but it is 
unclear as to what this refers to.  
Table 3: Umbilical pH – IV fluid warming versus room temperature fluids 
Study  Umbilical pH: artery (Yokoyama et al. 2009)/ vein (Chung 
et al. 2012) 
p value 
 Warmed IV 
fluids*^ 
Room temperature 
fluids*^ 
Upper body forced 
air warming^ 
 
Yokoyama 
et al (2009)  
7.33 ± 0.045 7.29 ± 0.034 n/a 0.023 
(via analysis 
of 
covariance) 
Chung et al 
(2012) *preload  
7.33 ± 0.06 7.35 ± 0.04 7.32 ± 0.04 0.349 
(statistical 
test not  
specified) 
^ mean ± SD 
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Neonatal temperature 
Of the fluid warming studies, the only study that measured newborn temperature via 
the rectal route at five minutes after delivery (and after newborn head wrapping and 
placement under radiant heater) found no statistically or clinically significant 
difference (p=0.16 Student’s t test) between groups (37.2°C, SD: +/- 0.3°C in the 
warmed fluid group versus 37.0°C, SD: +/- 0.4°C in the unwarmed fluid group) 
(Yokoyama, et al., 2009). Again, neonatal temperature data in Yokoyama et al.’s 
study was averaged according to the number of patients receiving ephedrine 
(Yokoyama, et al., 2009).  
 
Summary 
Warmed IV fluids are effective at improving maternal temperature whether 
administered pre or intraoperatively, and are also effective at reducing shivering. It 
remains unclear whether warmed IV fluids have a positive effect on maternal thermal 
comfort, umbilical pH or Apgar scores. This intervention was also not found to 
improve newborn temperature at birth or reduce time to discharge from PACU.  
 
Warming devices: covers and mattresses 
Overview of studies 
Five studies compared warming devices with other interventions (Table 4). Chung et 
al. used a three group design with upper body forced air prewarming plus unwarmed 
IV fluid preload versus warmed IV fluid preload with no forced air warming versus 
unwarmed fluid preload with no forced air warming (Chung, et al., 2012). The 
remaining four studies used a two group design (Chakladar, et al., 2012; Fallis, et al., 
2006; Horn, et al., 2002; Reidy, et al., 2008). 
Three studies utilized upper body forced air warming (Horn, et al., 2002) (Chung, et 
al., 2012; Fallis, et al., 2006) via Bair Hugger™ devices. Clinical heterogeneity that 
limited comparability between these studies included: outcomes measured at 
different time points and also likely key differences between interventions and 
comparators. Fallis et al. utilized intraoperative forced air warming post insertion of 
spinal anaesthesia, once patients were supine (Fallis, et al., 2006), whereas Chung et 
al. utilized 15 minutes of preoperative forced air warming (Chung, et al., 2012) and 
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Horn et al. utilized both a 15-minute preoperative warming period and continued 
with intraoperative forced air warming (Horn, et al., 2002). Warmed cotton blankets 
were used as a comparator by Fallis et al. (Fallis, et al., 2006) whereas unwarmed 
cotton blankets were used by Horn (Horn, et al., 2002). As described earlier, Chung 
et al.’s study utilized a three group design with warmed or unwarmed IV fluids 
comparison groups, with both of these groups receiving identical forced air warming 
blankets with the unit switched off (Chung, et al., 2012). 
    
Table 4: Forced air warming studies – intervention and comparison groups 
Study  Intervention/s Control  Control 2  
Forced 
air 
warming 
Warmed 
IV 
fluids 
Covering/ 
blanket 
Warmed 
IV 
fluids 
Covering/ 
blanket 
Warmed 
IV 
fluids 
Fallis et al. 
2006 
Upper 
body 
forced air 
warming 
Yes Warmed 
cotton 
blanket 
Yes n/a n/a 
Horn et al 
2002  
Upper 
body 
forced air 
warming 
Yes Single 
cotton 
blanket 
Yes n/a n/a 
Chung et 
al. 2012 
Upper 
body 
forced air 
warming 
No Forced air 
warming 
blanket 
switched 
OFF 
Yes Forced air 
warming 
blanket 
switched 
OFF 
No 
Chakladar 
et al. 2012 
Under-
body 
carbon 
polymer 
warming 
switched 
ON 
Yes Carbon 
polymer 
warming 
blanket 
switched 
OFF 
Yes n/a n/a 
Reidy et al. 
2008 
Under-
body 
forced air 
warming 
Yes ‘standard 
care’ 
warmed 
cotton 
blankets  
Yes n/a n/a 
 
All of the above studies used a 43°C setting for the warming devices. In Fallis et al.’s 
study (Fallis, et al., 2006) however, one participant commenced at 38°C before 
progressing to the high setting and 14 of 32 participants also subsequently adjusted to 
a lower setting.  
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Two unpublished studies (Chakladar, et al., 2012; Reidy, et al., 2008) investigated 
the effectiveness of full under-body warming mattresses (Table 4), utilizing forced 
air warming (Reidy, et al., 2008) and carbon polymer (Chakladar, et al., 2012) 
mattresses. Data available in these as yet unpublished studies was minimal and 
therefore additional data was requested from both authors. Additional information 
obtained from the authors revealed that the mattress temperature settings in these 
studies also differed, with settings of 38°C (Reidy, et al., 2008) and 40°C (Chakladar, 
et al., 2012). As described, clinical heterogeneity contributed to the inappropriateness 
of meta-analysis for the warming device studies. Data is therefore largely presented 
by means of narrative analysis. 
 
Warming devices and maintenance of maternal temperature 
Data enabling the assessment of the effectiveness of forced air and carbon polymer 
mattress warming on maintaining maternal temperature were not abundant. As stated 
above, data were especially lacking from the as yet unpublished studies (Chakladar, 
et al., 2012; Reidy, et al., 2008) and additional data were obtained from the studies’ 
authors.  
Chakladar et al.’s study of a carbon polymer mattress turned on (40°C) versus carbon 
polymer warming mattress turned off (and warmed IV fluids to 41°C in both groups) 
presented useful data relating to the incidence of IPH (temperature <36°C) in both 
groups (Chakladar, et al., 2012). The authors found a significantly lower incidence of 
IPH in the intervention group (3/58 participants) versus the control group (11/58 
participants, p = 0.043, but the statistical test was not specified). 
Reidy et al.’s study of a forced air warming mattress versus ‘standard care’ (as 
described above) also found a significant difference between groups in relation to 
mean maternal temperature on entering PACU: 36.1°C (SD +/- 0.4°C) in the 
intervention group versus 35.7°C (SD +/- 0.5°C) in the control group (p=0.01). No 
other maternal temperature data was available from this study (Reidy, et al., 2008). 
Although it is unfortunate that only minimal maternal temperature data is available 
from this study, the summary estimate of the two studies when combined using 
random effects meta-analysis favour under-body warming, in comparison to warmed 
cotton blankets or warmed IV fluids alone, for initial admission temperature to 
PACU (Figure 5) (mean difference 0.29, 95% CI 0.09 to 0.48).  
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Figure 5: Under-body warming mattress versus control and temperature (°C) on 
arrival to PACU. 
The I2 value (Figure 5) above suggests moderate heterogeneity (Deeks, et al., 2011) 
In consideration of possible explanations, it should be noted that there are some 
differences in the interventions. While both studies utilized under-body warming, the 
devices differed (a carbon polymer mattress in Chakladar et al.’s study (Chakladar, et 
al., 2012), and a forced air mattress in Reidy et al.’s study (Reidy, et al., 2008). In 
addition, Chakladar et al. used a setting of 40°C (Chakladar, et al., 2012) while the 
other study used a setting of 38°C, as mentioned earlier (Reidy, et al., 2008). 
Treatment of the control groups also varied slightly: control participants in 
Chakladar’s study received the under-body mattress turned off and warmed IV fluids 
(Chakladar, et al., 2012), whereas in Reidy et al.’s study the control group received 
two warmed cotton blankets (initially, with the potential for more) plus warmed IV 
fluids (Reidy, et al., 2008). Mode of temperature measurement also differed, with 
temporal artery measurements used by Chakladar et al. (Chakladar, et al., 2012) and 
oral measurements used by Reidy et al (Reidy, et al., 2008). 
Although Chung et al.’s three group study does report significant differences 
between the group’s skin (arm) temperatures at 15 and 30 minutes after prewarming 
(Chung, et al., 2012), peripheral temperature is not an outcome considered by this 
review (although it may be closely related to thermal comfort). This study does, 
however, report on statistically significant differences between ‘core’ temperature 
decreases (as measured by aural infrared thermometry) at 45 minutes, reporting that 
there was less temperature decrease in the warmed IV fluid and forced air warming 
groups than the control group: a temperature decrease of -0.6°C (SD: +/- 0.4°C) in 
the forced air warming group versus a temperature decrease of -0.5°C (SD: +/- 
0.3°C) in the warmed IV fluid group versus -0.9°C (SD: +/- 0.4°C) in the control 
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(room temperature and no forced air warming) group (p=0.004, but the statistical test 
is not specified).  
Fallis et al.’s study of intraoperative upper body forced air warming also reported 
mean oral temperature decrease during the procedure but data after 60 minutes was 
omitted due to decreased sample size (Fallis, et al., 2006). Mean temperature 
decrease between the measured time periods was not statistically or clinically 
significant between the groups: -0.8°C (SD: +/- 0.5°C) for the control group versus -
0.7°C (SD: +/-0.4°C) for the intervention group (p=0.508, via repeated measures 
ANOVA). Similarly, difference in the mean final temperature on exit from the 
operating theatre was not statistically significant between the groups: 35.9°C (SD: 
+/- 0.4°C) in the control group versus 36.1°C (SD: +/- 0.4°C) in the intervention 
group (p=0.189).  
Horn et al.’s study of prewarming (Horn, et al., 2002) also presents data on final 
operating theatre temperature (as measured via Mon-a-Therm™ tympanic 
thermocouple) but found that patients in the forced air warming group had 
statistically significantly higher temperatures: 36.1°C (SD +/- 0.5°C) in the control 
group versus 37.1°C (SD: +/- 0.4°C) in the intervention group (p<0.001).   
These results suggest that forced air preoperative warming plus intraoperative 
warming is more effective at intraoperative forced air warming alone in relation to 
maintaining maternal intraoperative temperature but there are other differences 
between the studies which should be considered (Table 5), such as ambient operating 
theatre between the studies and mode of anaesthesia (in addition to opioid 
administration).  
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Table 5: Upper body forced air warming, final maternal OT temperature and 
variations between studies  
 
Study Ambient  
OT temp* (°C) 
Anaesthet
ic Mode 
Opioid Warming 
(timing) 
Final maternal temperature 
in OT * (°C) 
Interventi-
on  
Control Interve-
ntion 
Control P 
value 
Fallis 
et al., 
2006  
Entrance: 
21.6 ± 1.2. 
Exit: 23 ± 
1.2. 
Entrance: 
21.6 ± 0.9 
Exit: 22.2 
±0.6 
Spinal Intrathecal 
morphine  
Fentanyl 
citrate  
Intraopera
-tive 
36.1°C± 
0.4°C 
35.9°C ±  
0.4°C 
NS (via 
independe
nt t test)  
Horn 
et al., 
2002 
23.9± 0.5 24.1 ± 0.3 Epidural  Nil  Preoperati
-ve and 
intraopera
-tive 
37.1°C 
± SD 
0.4°C 
36.0°C ± 
0.5°C 
<0.05 
(via 
Student’s t 
test) 
* * mean ± SD  
Clear differences in the characteristics of the studies are evident. Ambient operating 
theatre temperature appears to be warmer in Horn et al.’s study (Horn, et al., 2002) 
(Table 4), but mode of anaesthesia and opioid administration also differs between the 
studies. Duration of surgery or intraoperative time was not entered into this table due 
to variations in the reporting of this between the two studies (Fallis et al. report time 
spent in the operating theatre, whereas Horn et al. report duration of surgery, 
although this is another contrasting factor between the studies) (Fallis, et al., 2006; 
Horn, et al., 2002). Participants in Horn et al.’s study received only passive 
insulation in the form of cotton blankets (Horn, et al., 2002), whereas the blankets 
applied in Fallis et al.’s study were warmed (Fallis, et al., 2006). Forced air warming 
was commenced preoperatively in Horn’s study (Horn, et al., 2002) but warming in 
the latter study was applied intraoperatively only. In addition, method of temperature 
measurement also differed. Tympanic thermocouples were used by Horn (Horn, et 
al., 2002) and oral electronic thermometers were used by Fallis et al (Fallis, et al., 
2006).  
Forced air warming largely appears to provide positive results in maintaining 
maternal temperature during CS, but the strongest results thus far appear to be 
achieved from applying warming in the preoperative phase of care. Under-body 
warming mattresses have also achieved higher maternal core temperatures when 
compared with warmed cotton blankets or warming mattress switched off, although 
there are few studies available examining under-body warming.   
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Warming devices and prevention of shivering 
Three of the five forced air warming studies included shivering as a secondary 
outcome (Horn, et al., 2002) (Chung, et al., 2012; Fallis, et al., 2006) Dichotomous 
data is presented in terms of presence or absence of shivering, but two studies (Horn, 
et al., 2002) (Fallis, et al., 2006) also present ordinal data in relation to intensity of 
shivering (slight, moderate/intensive shivering). These two studies (Horn, et al., 
2002) (Fallis, et al., 2006) use the same four-point shivering scale (0=no shivering, 
1=mild shivering, 2=moderate shivering, 3=severe shivering) as used by Chan et al.’s 
study of warmed IV fluids effect on temperature and shivering in women undergoing 
CS (Chan, et al., 1989). Details of these two studies are presented in Table 6. Chung 
et al.’s three-group study (Chung, et al., 2012) uses an alternative four-point scale 
with different descriptors (referenced to Wrench 1997) (Wrench, et al., 1997) and 
was not entered into the table due to its three-group design and the different scale 
used for assessing shivering. Again, clinical heterogeneity prevented meta-analysis 
of these studies in relation to shivering.  
Possible bias resulting from unblinded investigators assessing shivering in two of the 
studies (Horn, et al., 2002) (Fallis, et al., 2006) should be highlighted. Blinding of 
investigators is unclear in the remaining study (Chung, et al., 2012). Shivering 
assessment took place both during and after surgery (Chung, et al., 2012) and after 
every 15-minute temperature measurement (Horn, et al., 2002) (Fallis, et al., 2006).  
Fallis et al. (Fallis, et al., 2006) and Horn (Horn, et al., 2002)  again present differing 
results in relation to the effectiveness of upper body forced air warming but this time 
related to the presence of shivering: Fallis et al. report that there was no statistically 
significant difference between groups (Fallis, et al., 2006) whereas Horn et al. found 
that there was a significantly lower level of shivering presence in the preoperative 
forced air warming group (Horn, et al., 2002) (Table 6).  These results can also be 
considered in light of the other characteristics of these studies presented in Table 5 
and discussed above. 
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Table 6: Presence of shivering in preoperative upper body forced air warming 
studies  
Study Presence of shivering p value 
Upper body forced 
air warming 
Control 
Fallis et al. 
(2006)  
10/32 10/30 p=0.861(Mantel-
Haenszel test) 
Horn et al. (2002)  2/15 9/15 p<0.05(Fisher’s 
exact test) 
 
Results from Chung et al.’s three group study also support the effectiveness of 
preoperative forced air warming in reducing shivering to 20% (3/15) but not to the 
extent of warmed IV fluids in which 13% (2/15) experienced shivering versus 53.3% 
(8/15) in the room temperature fluid group (p=0.035) (Chung, et al., 2012).   
Results from these studies (Horn, et al., 2002) (Chung, et al., 2012; Fallis, et al., 
2006) suggest that forced air warming applied in the preoperative phase of care 
reduces shivering, but forced air warming applied intraoperatively may have less 
effect on reducing shivering.   
Warming devices and thermal comfort 
Maternal thermal comfort was measured by the four (Horn, et al., 2002; Reidy, et al., 
2008) (Chung, et al., 2012; Fallis, et al., 2006) forced air warming studies, with 
continuous data gained from the utilization of self-reported thermal comfort scales. 
Descriptors of thermal comfort status were common between three studies: ‘worst 
imaginable cold’, ‘thermally neutral’ and ‘insufferably hot’; but again narrative 
summary only is possible due to clinical heterogeneity in relation to slight variations 
in interventions and controls between the studies (Chung, et al., 2012; Fallis, et al., 
2006; Horn, et al., 2002).    
Chung et al. and Horn et al. (Horn, et al., 2002) both used a 100mm Visual Analogue 
Scale (VAS) but with hot/cold scores reversed between the studies (for example, 0 = 
cold on Horn’s scale but 0 = hot on Chung’s scale) (Chung, et al., 2012; Horn, et al., 
2002). Fallis et al. used a 0-10 scale with the above descriptors, with 0 referring to 
cold and 10 referring to hot (Fallis, et al., 2006). Thermal comfort scores were 
assessed at 15-minute intervals throughout surgery in both Horn and Fallis et al.’s 
studies (Fallis, et al., 2006; Horn, et al., 2002)but time points of thermal comfort 
assessment remain unclear in the remaining two studies (Chung, et al., 2012; Reidy, 
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et al., 2008). Additional information was obtained from Fallis et al. in relation to 
their thermal comfort data, as no data could be extracted from the figures presented 
in the original published article (Fallis, et al., 2006). 
Reidy et al.’s study of an under-body forced air warming mattress versus ‘standard 
care’ used a three point Likert scale (with responses of ‘too cold’, ‘comfortable’, ‘too 
hot’) and reports that maternal thermal comfort did not increase (Reidy, et al., 2008), 
although no data is provided for this outcome. Again, the risk of bias arising from the 
lack of blinding of investigators assessing thermal comfort needs to be recognized, 
but with consideration of the practical difficulties of blinding both patients and 
investigators to forced air warming. The other under-body warming mattress study in 
this review did not measure thermal comfort but it is interesting to note that further 
data obtained from the authors confirms that the intervention was discontinued for 
one patient in the warming group due to the patient feeling hot.  
VAS scores were not statistically or clinically significantly different between groups 
in Chung et al.’s three group study comparing preoperative upper body forced air 
warming, warmed IV fluid preload and room temperature fluids: 59.0mm (SD: 
12.1mm) in the forced air warming group versus 59.3mm (SD 13.2mm) in the 
warmed IV fluid preload versus 69.0mm (SD: 15.9mm) in the room temperature 
fluid group (p=0.927, but statistical test not specified) (Chung, et al., 2012), although 
the latter group’s thermal comfort appeared to be warmer.  
Horn et al. reports data for thermal comfort after 15 minutes of treatment: 52mm 
(SD: 9mm) in the control group versus 63mm (SD: 11mm) but reports that there 
were no statistically significant differences in thermal comfort between the groups at 
other time points (Horn, et al., 2002).     
Contrastingly, Fallis et al.’s study of intraoperative forced air warming found 
statistically and clinically significant differences in thermal comfort between the 
study groups in favour of intraoperative warming at 30, 45, 60 and 75 minutes 
(although at the 75 minute time interval, subject numbers were greatly reduced in 
both groups) (Fallis, et al., 2006). No data is provided for the 15 minute interval 
which would facilitate comparison with Horn et al.’s study (Horn, et al., 2002) and 
vice versa no data for further time intervals were provided by Horn et al (Horn, et al., 
2002). Thermal comfort scores were consistently lower in the control group in Fallis 
et al.’s study (Fallis, et al., 2006) (Table 7). 
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Table 7: Thermal comfort scores: intraoperative upper body forced air warming 
(Fallis et al 2006) 
Time 
(mins) 
Sample 
size 
Thermal comfort scores  (0=cold   to 10 =hot) P value 
(repeated 
measures 
ANOVA) 
Intervention: upper body 
forced air warming 
Control: warmed 
cotton blanket 
Mean ± SD Mean ± SD 
30  62 5.7 ± 0.3 4.8 ± 0.3 0.016 
45  52 6.3 ± 0.3 4.84 ± 0.3 <0.001 
60 37 5.8± 0.4 4.6 ± 0.3 0.014 
75 17 5.5 ± 0.3 4.5 ± 0.3  0.045 
 
Again, the characteristics of both Horn et al.’s and Fallis et al.’s studies (Table 4) are 
interesting in the context of these varying results, especially in relation to ambient 
temperature (Fallis, et al., 2006; Horn, et al., 2002). Ambient temperature on 
entrance to the operating theatre was lower in Fallis et al.’s study (Fallis, et al., 2006) 
– a cooler environment may mean that greater thermal comfort could be gained from 
the application of a warming device. It is also worth noting that 14 women in Fallis 
et al.’s study requested that the warming device be lowered to a reduced temperature 
setting during surgery (Fallis, et al., 2006) suggesting that thermal comfort, in terms 
of feeling too hot, was not optimal for these women throughout surgery.  
Results on the effectiveness of forced air warming on maternal comfort are, 
therefore, inconclusive with varying results between studies. The relationship 
between ambient temperature and the possibly linked receptiveness of patients to 
forced air warming should be considered, as should the possibility of high forced air 
warming settings being intolerable for some patients.  
 
Warming devices and time to discharge from PACU 
Time to discharge from PACU was not an outcome of interest in the included 
warming mattress and coverings studies.  
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Warming devices and neonatal outcomes 
Apgar scores 
Apgar scores measured at one minute were an outcome of interest in four studies 
(Horn, et al., 2002) (Reidy, et al., 2008) (Chung, et al., 2012; Fallis, et al., 2006). 
Two studies measured Apgar scores at five minutes (Horn, et al., 2002) (Chung, et 
al., 2012) and one continued to report at ten minutes (Horn, et al., 2002).  A 
paediatrician determined Apgar scores in both Chung et al.’s and Horn et al.’s studies 
(Chung, et al., 2012; Horn, et al., 2002) but it is unclear which healthcare 
professional measured Apgar scores in the remaining two studies (Reidy, et al., 
2008) (Fallis, et al., 2006). No significant difference in Apgar scores between groups 
in any of the above studies was found.  
Reidy’s study of maternal under-body forced air warming mattress (Reidy, et al., 
2008) found no statistically significant effect on Apgar scores at one or five minutes: 
the median Apgar score at one minute was 9 (range 6-10) in the intervention group 
versus 9 (range 4-10) for the control group (p=0.12, the statistical test was not 
specified), and median Apgar score at five minutes was 9 (range 8-10) in the 
intervention group, and 9 (range 9-10) in the control group (p=0.12, the statistical 
test was not specified). 
Upper body forced air prewarming versus warmed IV fluid preload versus room 
temperature preload and no forced air warming (Chung, et al., 2012) also found no 
statistical or clinically significant difference in mean Apgar scores at one minute 
between groups (8.1, SD: +/- 0.8 in the upper body warming group versus 8.1, SD: 
+/-1.1 in the warmed IV fluid group versus 8.2, SD: +/-0.9 in the room temperature 
group, p=0.927 via analysis of variance). Intraoperative forced air warming also 
demonstrated no statistically or clinically significant difference in Apgar scores at 
one and five minutes (Fallis, et al., 2006): median 8 (range 5-9) for the intervention 
group, median 8.5 (range 3-9) for the control group at one minute and median 9 
(range 8-9) for the intervention group, 9 (8-9) for the control group at five minutes 
(although no p value is provided and it is not clear what statistical test was used). 
Again, results were similar between groups, and no statistically or clinically 
significant difference was found in the upper body forced air prewarming study 
(Horn, et al., 2002) that measured Apgar at one, five and ten minutes: at one minute, 
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9/15 patients obtained an Apgar of 9 in the warmed group, and 9/15 obtained an 
Apgar of 9 in the control group (no p values reported).  It therefore appears that 
forced air warming does not appear to either increase or decrease Apgar scores at one 
or five minutes. 
 
Umbilical pH 
Umbilical pH was also assessed by the four studies above (in which Apgar score was 
also assessed).  Both Chung et al. and Horn et al. both measured umbilical vein pH 
directly after birth (Chung, et al., 2012; Horn, et al., 2002). Fallis et al. and Reidy et 
al. also measured umbilical vein pH (Fallis, et al., 2006; Reidy, et al., 2008) but the 
time at which this occurred was not reported.  Again, these studies could not be 
combined for meta-analysis due to key differences in interventions and controls, thus 
a narrative analysis is presented. Chung et al.’s three group study (with a sample size 
of 15 participants in each of the three groups) found no significant difference in 
umbilical vein pH measured directly after birth between the three groups (7.3, SD: 
+/- 0.04 in the forced air warming group versus 7.3, SD: +/- 0.06 in the warmed IV 
fluid group versus 7.4, SD: +/-0.04 in the room temperature fluid group, p= 0.35 via 
analysis of variance) (Chung, et al., 2012).  
The remaining three studies are presented in Table 8. As with Chung et al.’s study 
(Chung, et al., 2012) both studies by Fallis (Fallis, et al., 2006) and Reidy (Reidy, et 
al., 2008) found no benefit from maternal forced air warming in regards to umbilical 
pH. Horn et al.’s study of upper body prewarming presents contrasting results and 
found that umbilical vein pH was significantly improved in babies born to mothers in 
the warmed group (Horn, et al., 2002) (see Table 6), with babies in the control 
groups having a mean umbilical vein pH of 7.24 (SD ± 0.07) versus a mean 
umbilical vein pH of 7.32 (SD ±0.07) in the intervention group. Information 
regarding gestation in weeks is not provided by Horn et al. (Horn, et al., 2002) but 
participants were ‘healthy’ and booked for elective surgery, suggesting that gestation 
or maternal medical history may not be relevant in the respect of differences in 
neonatal outcomes in this study. Both Horn et al. (Horn, et al., 2002) and Chung et 
al. (Chung, et al., 2012) utilized preoperative warming but with differing results. It 
remains unclear whether forced air warming, in particular when applied during the 
preoperative phase of care, improves umbilical pH.  
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Table 8: Umbilical vein pH and forced air warming 
Study  Umbilical vein pH # P value 
Upper body forced 
air warming* 
Under-body forced 
air warming 
mattress 
Control 
Mean ± SD Mean ± SD Mean ± SD 
Fallis et al. 
(2006) 
7.30 ± 0.0^ 
(n= 31) 
n/a 7.30 ± 0.0^ 
(n= 28) 
Not 
provided 
Horn et al. 
(2002)*  
7.32 ± 0.07 
(n=15) 
n/a 7.24  ± 0.07 
(n=15) 
<0.05 
(one-way 
analysis of 
variance) 
Reidy et al. 
(2008)  
n/a 7.30 ± 0.1 
(n=36) 
7.30 ± 0.04 
(n=32) 
0.09 
(statistical 
test not 
specified) 
  # Mean ± SD; ^ SD 0.0 taken directly from article; *applied preoperatively  
 
 
Neonatal temperature  
Three of the forced air warming studies also measured neonatal temperature, either 
as rectal temperature at delivery (Horn, et al., 2002) (Fallis, et al., 2006) or axillary 
temperature one minute after delivery(Reidy, et al., 2008). In Reidy et al.’s study of 
the use of forced air warming mattress neonatal temperature was a primary outcome 
but the study found no statistically or clinically significant difference in neonatal 
temperature between the warmed and control groups (Reidy, et al., 2008). Mean 
neonatal axillary temperature at one minute was 36.8°C (SD: +/- 0.3°C) in the 
warmed group versus 36.9 °C (SD: +/- 0.3°C) in the control group (p= 0.40). The 
authors report that temperature was also checked at five and ten minutes after 
delivery but no data was available for inclusion in this review.     
Mean newborn rectal temperature was found to be 37.7°C (SD: +/- 0.4°C) in the 
warmed group (of 32 participants) in Fallis et al.s’ study of upper body forced air 
warming and 37.5°C (SD: 0.4°C) in the control group (of 29 participants) (Fallis, et 
al., 2006), which was stated to be a non-significant statistical difference although no 
p-value was reported. Horn’s study of upper body forced air prewarming (Horn, et 
al., 2002), in contrast, did find a statistically and clinically significant higher 
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newborn rectal temperature for the warmed air group (37.1°C, SD: +/-0.5°C) versus 
36.2°C, SD: +/-0.6°C for the control group, p<0.001).  
Forced air intraoperative warming (upper body or under body) did not therefore 
significantly improve newborn temperature at birth, but upper body forced air 
prewarming was found to have a positive effect.  
 
Summary 
Forced air warming is effective at improving maternal temperatures, particularly if 
applied preoperatively. Similarly, preoperative warming was found to have an 
increase in almost 1°C (0.9°C) in mean neonatal rectal temperature at birth whereas 
intraoperative warming did not. Under-body warming appears to have a positive 
effect on maternal temperature. Preoperative forced air warming was also found to 
reduce shivering. Results were inconclusive on the effects of forced air and 
underbody warming on maternal thermal comfort, Apgar scores and umbilical pH.  
 
Leg wrapping 
Overview of study 
One study (Sun, et al., 2004) compared leg wrapping with tight elastic bandages with 
leg wrapping with loose elastic bandages in women undergoing elective CS surgery 
under epidural anaesthesia, with 30 participants in each group. The primary outcome 
was the effect of the intervention on hypotension (a common occurrence during 
epidural anaesthesia) but reduction of hypothermia and shivering were secondary 
outcomes.   
Leg wrapping is reported as being applied before administration of the epidural but 
after the attachment of monitoring, preload of unwarmed fluids and the elevation of 
the patient’s legs to 45° (which seems unlikely given the practicalities of 
administering the epidural).  
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Leg wrapping and maintenance of maternal temperature 
Maternal sublingual temperature was recorded in the right or left posterior sublingual 
pocket every three minutes (Sun, et al., 2004) (using a Datex Cardiocap II CG series 
probe) but was only recorded at five ‘observation times’: baseline, immediately after 
epidural anaesthesia, at abdominal skin disinfection, at skin incision and at delivery. 
Temperature results were only provided for two observation times: at baseline and at 
delivery (36.5°C, SD: +/- 0.4°C at delivery in the tightly wrapped group versus 
36.4°C, SD: +/- 0.3°C in the loosely wrapped group) with the average reduction from 
baseline to delivery also given (0.4°C, SD: 0.2°C in the tightly wrapped group versus 
0.5°C, SD: 0.3°C in the loosely wrapped group). There was no significant difference 
in temperature between the two groups at these time points and for each group (no p-
values reported). Data for the other time points were not presented in an extractable 
form but we are told that no significant differences existed between the groups for 
temperature at these time points. Leg wrapping, therefore, presents no benefits in 
terms of maintenance of maternal temperature, based on evidence from this single 
study.  
 
Leg wrapping and prevention of shivering 
Shivering was measured by an observer, blinded to group assignment, and simply 
assessed as being either present or absent. There was no difference in the presence of 
shivering between the groups (21/30 participants shivered in both the tight leg 
wrapping and also the loose leg wrapping group, p= 0.61) (Sun, et al., 2004). Data 
for this outcome, as with hypothermia, was only collected until immediately 
following delivery. As with maternal temperature, leg wrapping is therefore not 
effective at preventing shivering in this population, based on evidence from this 
single study.  
 
Leg wrapping and other outcomes 
Thermal comfort, time to discharge from PACU, Apgar score, umbilical pH and 
neonatal temperature were not included as outcomes of interest in this leg wrapping 
study (Sun, et al., 2004). 
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Summary 
Leg wrapping was therefore not effective at improving maternal temperature or 
shivering; however, these observations are derived from a single study and therefore 
should be considered with caution. 
 
Discussion 
Perioperative hypothermia is a common occurrence during all types of surgery 
including CS surgery.  Guidance for clinicians in regard to prevention and 
management of IPH in adult patients is available (NCCNSC 2008) but pregnant 
patients are excluded from these guidelines. There has been a call for clear guidance 
to be formulated for CS patients (Chakladar & Harper, 2010), or at least an extension 
of the current NICE guidelines (NCCNSC 2008) to cover this patient group as 
perioperative hypothermia can be a disruptive and unpleasant experience for women 
undergoing CS. Furthermore IPH is associated with numerous undesirable adverse 
clinical side effects, such as increased blood loss (Rajagopalan, et al., 2008) and 
delayed wound healing (Kurz, et al., 1996) and is, in most cases, avoidable with 
careful prevention and management strategies. Utilization of strategies to reduce 
hypothermia incidence and related adverse effects will also enhance the experience 
of women having their babies by CS, reducing interference with the time when 
bonding and breastfeeding can commence. Discussion of these strategies will follow 
an explanation of the limitations experienced during the systematic review process.   
This review includes 12 RCT studies in three broad categories of interventions 
within the specific population of women undergoing CS.  Methodological study 
issues, such as variations in intervention design and key differences in outcome 
measurements limited synthesis by meta-analysis. In addition, the reporting of data in 
graphs and/or figures only meant that extractable data was, in some cases, limited, 
particularly when authors were largely not contactable. Wide variation in the 
methods of outcome measurement presented difficulties in the analysis of findings 
and restricted the meta-analysis undertaken. Temperature was measured at baseline 
in all studies, but thereafter intervals between measurements and end points of 
measurement differed. In addition, data was commonly reported for only a limited 
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number of measurement points, restricting the amount of data available across 
studies for common time points. There was limited comparability of control groups 
with very few studies being sufficiently homogenous for meta-analysis, which 
reduces the strength of determining the benefits of one intervention over another. The 
wide but subtle variations in treatments also impacted on the heterogeneity of 
studies.     
Wide variations in temperature measurement existed between studies with most 
methods used as a predictor of core temperature considered for inclusion. Skin 
temperature measurements were, however, excluded, as peripheral temperature was 
not an outcome of interest in this review. There are questions about the reliability and 
accuracy of the wide range of devices and routes used to measure or estimate ‘core’ 
temperature, but it is beyond the scope of this review. Consistency within studies of 
the route for measuring core temperature was considered as vital and an indicator of 
the quality of outcome measurements. 
Visual analogue scales (VAS) or numerical rating scales were used to measure 
thermal comfort but there was a variety of shivering scales used, albeit similar in 
nature of descriptors. The assessment of shivering relied largely on the subjective 
assessment of the (often unblinded) observers. The reliability of the scales used was 
not addressed – no scale used appears to have been cross-validated.   
There were also variations in hypothermia definition evident between studies, despite 
increasing guidance (NCCNSC 2008) (Association of Operating Room Nurses ARP 
Committee, 2007; Hooper, et al., 2010) that core temperatures below 36°C should be 
considered as hypothermic in perioperative patients and treated accordingly. In this 
review, variations in hypothermia cut-off temperature did not cause difficulties as 
studies tended to report on temperature decline rather than overall incidence of 
IPH/core temperatures <36°C. In fact, only one study reported on incidences of IPH 
(core temperature <36°C) (Chakladar, et al., 2012), and one other study (Smith, et 
al., 2000) _ENREF_48of IV fluid warming reported on both final intraoperative core 
temperatures at <35.5°C and <36°C. As the indicator of temperatures <36°C being 
considered hypothermic becomes more widely accepted and incorporated into 
practice guidelines on a wider scale, its usefulness in clinical studies will increase.  
Insufficient studies utilizing each mode of anaesthesia for each intervention group 
were included in this review to enable us to identify which interventions were most 
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effective for use with the different anaesthetic modes (as per the review question). 
Heat loss during neuraxial anaesthesia, although not subject to the same degree of 
redistribution as in general anaesthesia, is aggravated by the loss of behavioural 
thermal regulation below the level of the block and also the lack of a heat loss 
plateau during longer procedures (as is reached during general anaesthesia). The 
protective mechanism of shivering is also ablated below the level of block (Saito, et 
al., 1998). Spinal anaesthesia may have an increased thermoregulatory effect in 
comparison to epidural anaesthesia (Saito, et al., 1998). 
It is clear from the results that forced air warming was less effective where 
participants received spinal (intrathecal) morphine (Fallis, et al., 2006) (see Table 5), 
which is thought to be one of the factors contributing to intraoperative hypothermia 
by altering thermoregulatory thresholds after cephalic spread (Kosai, et al., 1992). 
Case reports (Hess, et al., 2005; Kosai, et al., 1992),(Ryan, et al., 2012) and one 
observational study (Hess, et al., 2005) describe a manifestation of hypothermia, 
presumed related to intrathecal morphine, which tends to be prolonged, accompanied 
by paradoxical side effects and unresponsive to conventional forced air warming 
methods (Hess, et al., 2005). Addition of intrathecal opioids, in particular morphine, 
may have influenced the degree and incidence of hypothermia and therefore the 
effectiveness of interventions included in this review, as demonstrated by the 
decreased effectiveness of forced air warming where intrathecal morphine was used. 
The use or non-use of opioids is not clear in all studies therefore limiting the analysis 
of this issue in relation to the effectiveness of warming interventions. In order to 
expand knowledge of the influence of intrathecal opioids on perioperative 
hypothermia and interventions to treat the condition, further studies specifically 
investigating this area are required.  
Although it is known that the temperature status of both mother and newborn are 
related, the clinical benefit of warming mothers in relation to newborn outcomes is 
not clear. Populations studied were similar in terms of gestation, age and excluded 
conditions. Horn et al.’s study of pre- and intraoperative warming (Horn, et al., 2002) 
versus unwarmed cotton blankets resulted in the most positive neonatal outcomes in 
regards to umbilical pH and rectal temperature, although reasons for this are unclear. 
Chung et al. suggest that the short prewarming period of 15 minutes in their study 
was insufficient to affect neonatal outcomes (Chung, et al., 2012). Some conflicting 
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results were found in relation to neonatal outcomes from IV fluid warming: while 
one study found IV fluid warming increased both Apgar at one minute and umbilical 
pH (Yokoyama, et al., 2009), another study did not (Chung, et al., 2012). Only one 
IV fluid warming study measured rectal temperature at birth (Yokoyama, et al., 
2009), and this study measured temperature after five minutes, during which time the 
newborn had been placed under a warmer. While the disparity in neonatal outcomes 
between existing studies can be considered in relation to study variations, further 
studies of key neonatal outcomes and maternal warming are required to make more 
substantive conclusions about clinical benefits to neonates.  
Shivering is commonly experienced during CS surgery performed under neuraxial 
anaesthesia. Findings from this review indicate that intravenous fluid warming and 
preoperative forced air warming have a role to play in shivering prevention. 
Pharmacological therapies, which may be used for shivering, were beyond the scope 
of this review. Shivering is a complex multifactorial (Chan, et al., 1989) 
phenomenon and not purely thermoregulatory in all instances. Possible explanations 
for shivering have been described: thermoregulatory shivering triggered by core 
hypothermia (Sessler, 2008), shivering as a response to fever development (Sessler, 
2008), shivering due to local anaesthetic injection stimulation of cold receptors 
(Chan, et al., 1989; Sessler, 2008) and finally, shivering due to tremulous muscular 
activity that is in fact non-thermoregulatory. Intrathecal drugs may also contribute to 
the development of shivering (Woolnough, Allam, et al., 2009).  
Findings that warmed IV fluids are effective in maintaining normothermia and 
reducing shivering are consistent with a previously conducted systematic review of a 
broad population (Moola & Lockwood, 2011) and support guidance provided by the 
NICE guidelines (NCCNSC 2008) that have so far applied to only non-pregnant 
patients. NICE guidelines support the warming of fluids to 37°C for volumes of 
500mls and above (NCCNSC 2008). All but one (Chan, et al., 1989) of the included 
fluid warming studies warmed fluids to 37°C or above. The one study that warmed 
fluids to a lower temperature of 36.5°C still found that heat loss was reduced in the 
warmed group; however this group also received extra interventions in the form of 
warmed preparation fluids and extra clothing (Chan, et al., 1989). 
A variety of methods of warming IV fluids were used in the included studies – this 
review does not make a recommendation of one method of warming the fluids over 
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another. Woolnough et al. compared Hotline™ warmed fluids with fluids prewarmed 
in a warming cabinet and recommended that both modes of fluid warming were as 
efficient (Woolnough, Allam, et al., 2009). Due to ongoing cost considerations, 
however, they did favour the use of warming cabinets. The use of warmed IV fluids 
should be standard practice for maintaining normothermia for patients undergoing 
CS, are easy to administer and do not appear to cause practical concerns for patients 
and caregivers.  
The effectiveness of preoperative warming strategies for women undergoing CS, in 
particular forced air warming, is confirmed by the results of this review. Again, this 
recommendation had previously only been provided for either general population 
groups (Moola & Lockwood, 2011) or non-pregnant patients (NCCNSC 2008). 
Concerns about whether forced air warming would be practical and tolerable for 
pregnant patients were not widespread within the included studies, although issues of 
ability to tolerate active warming were found by one upper body warming study. One 
participant in the Fallis et al.’s study commenced on a lower temperature setting 
before increasing it; however, 14 of 32 patients in the intervention group also later 
adjusted the temperature to a lower setting (Fallis, et al., 2006). Forced air warmers 
are generally designed to progress to a lower setting automatically after a certain 
period if the highest setting is chosen. Therefore, the reduction in the temperature 
setting in Fallis et al.’s study (Fallis, et al., 2006) does not appear to be extraordinary. 
Fallis et al. also found that thermal comfort was enhanced by active warming (Fallis, 
et al., 2006), perhaps suggesting that the reduction in the operating temperature of 
the device does not signify widespread warming related thermal discomfort.  
Issues regarding forced air warming for women undergoing CS have been raised by 
clinicians (Chakladar, et al., 2011). Forced air warming blankets tend to be bulky and 
the presence of an upper body warming blanket may present difficulties for both 
women and clinicians especially after delivery of the baby, when women often want 
to hold and be with their newborn (Chakladar, et al., 2011). Concerns regarding 
practicality have been raised in the literature (Chakladar, et al., 2011; Chakladar & 
Harper, 2010; Chan, et al., 1989) but were not raised in the forced air warming 
studies included in this review. These concerns may be addressed by the utilization 
of active under-body or lower body warming – unfortunately no study of lower body 
warming was found to be of sufficient quality for inclusion in the review. Under-
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body warming mattresses warm a greater surface area of the body than partial (upper 
or lower) body warming blankets. In regard to tolerability of under-body warming, 
the only issue reported by Chakladar et al. (Chakladar, et al., 2012) was the 
discontinuation of warming for one patient (out of 58 participants in the intervention 
group) who found the intervention too hot. Additional studies on the effectiveness of 
carbon polymer mattresses would be beneficial, particularly in comparison to forced 
air warming mattresses. For this review, the two studies were grouped together as 
under-body warming and no distinction made as to the particular device employed. 
Despite the moderate heterogeneity displayed in the meta-analysis, it does appear 
that under-body warming mattresses (both carbon polymer and forced air warming) 
are effective for maintaining perioperative temperature, thereby resulting in an 
increased postoperative temperature and reduced incidence of IPH.  
Practical difficulties surrounding the use of upper body forced air warming during 
surgery may also be partially addressed by the utilization of preoperative forced air 
warming. Preoperative warming also presents clinical value in reducing 
intraoperative heat loss and, even relatively short periods such as those utilized by 
the included studies, may be cost-effective, especially if utilizing resources already in 
place. Preoperative forced air warming increases peripheral heat content, therefore 
the core-periphery temperature gradient (which contributes to heat loss during 
anaesthesia) is decreased (Leslie & Sessler, 2003). Horn et al. emphasize that 
warming prior to epidural insertion precedes the vasodilation that follows epidural 
anaesthesia, and contributes to hypothermia (Horn, et al., 2002). The relatively short 
phase of prewarming used in the included studies, which clinically is probably most 
achievable, will result in this raising of peripheral temperature. Although 
prewarming shows real clinical benefits, its feasibility and implementation in 
practice does depend heavily on the model of care practised, and additional resources 
required by different institutions, which may present a barrier to implementation. 
Where possible, preoperative warming should be implemented to protect against 
intraoperative heat loss. 
The overall effectiveness of intraoperative, as opposed to preoperative, upper body 
forced air warming is less clear. Horn et al.  utilised both preoperative and 
intraoperative warming and found this combination to be effective (Horn, et al., 
2002). Fallis et al. utilized only intraoperative warming and found that neither the 
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control (warmed cotton blankets) nor the intervention group maintained 
normothermia (Fallis, et al., 2006). The role of intrathecal opioids administered in 
this study may have influenced these results as discussed earlier. Additional studies 
on intraoperative warming, both with and without intrathecal opioids, are warranted 
in this population.  
Thermal comfort should also be considered in the context of ambient temperature. 
Operating theatres are generally cool environments, in accordance with clinical 
guidelines to this effect – for example, in Australia, Australian College of Operating 
Room Nurses (ACORN) standards guide operating room temperatures to be between 
20-22°C, although provision is made that in certain circumstances, such as for 
obstetric patients, variations in ambient temperature may be necessary (Australian 
College of Operating Room Nurses 2012. ). The American Society of PeriAnesthesia 
Nurses (ASPAN) clinical practice guidelines for the promotion of normothermia 
state that ambient operating room temperatures should be between 20-25°C (Hooper, 
et al., 2010) while NICE guidelines state that ambient temperatures should be over 
21°C while patients are exposed, and can be reduced once the active warming 
commences (NCCNSC 2008). Ambient temperature was generally above 22°C for 
the majority of studies included in this review. The degree of comfort derived from 
an active warming intervention may be greater if the commencing ambient 
temperature is lower, as may be evident in the contrasting results seen between Fallis 
et al. and Horn et al.’s studies (Fallis, et al., 2006; Horn, et al., 2002). Participants in 
Fallis et al.’s study (Fallis, et al., 2006) were subject to an initially cooler ambient 
temperature in contrast to those in Horn et al.’s study (Horn, et al., 2002) where the 
ambient temperature was higher. Those in the cooler initial environment had a 
significant increase in thermal comfort scores (Fallis, et al., 2006), whereas those in 
the warmer environment did not significantly increase thermal comfort (Horn, et al., 
2002). Ambient operating room temperature also increased in the forced air warming 
group in Fallis et al.’s study (Fallis, et al., 2006), and the authors highlight this as a 
possible contributing factor to higher thermal comfort scores in this group. Ambient 
temperature was insufficiently reported in some studies but it is also particularly 
relevant to the administration of room temperature fluids. Unfortunately, one study 
that utilized room temperature fluids neglected to provide details of ambient 
temperature for any of the study groups (Chung, et al., 2012), therefore omitting any 
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indication of the administration temperature of the room temperature fluids. Details 
of oxytocin administration would also be useful when assessing thermal comfort 
score results: as Woolnough et al. discuss, this drug may alter perceptions of warmth 
due to its tendency to cause facial flushing (Woolnough, Allam, et al., 2009).  
Although their study included elective patients only, Horn et al. recommend active 
warming strategies for emergency CS surgery (Horn, et al., 2002). The majority of 
patients included in this review underwent elective surgery and therefore the findings 
are largely applicable to this group. However the application of some warming 
strategies supported by this review, for example forced air prewarming, may be less 
practical in true emergency CS situations, with IV fluid warming or even under-body 
warming being easier to initiate. Chakladar et al. suggest that under-body warming 
mattresses may make clinical differences for this group, and reduce preparation time 
as they can be already in place on the operating table ready for use (Chakladar, et al., 
2012). The clinical need for hypothermia prevention in emergency cases needs to be 
individually assessed. Emergency CS patients may be more likely to experience 
increased blood loss (Chakladar, et al., 2012), intraoperative and postoperative 
complications, but as with all patients, maternal pyrexia and/or existence of a 
labouring period prior to CS would need to be considered. Therefore, knowledge of 
appropriate and effective strategies to maintain thermal balance in this population 
would be valuable and therefore more research on this is required.  
 
Conclusion 
Preoperative warming interventions tend to lead to improved maternal 
thermoregulatory outcomes in CS surgery. The warming of IV fluids increases 
intraoperative and postoperative temperatures, whether given as a preload or 
intraoperatively. Upper body forced air warming applied in the preoperative phase 
achieves better maintenance of temperature than if applied only during the 
intraoperative phase. There is also evidence to suggest that under-body warming 
mattresses are effective at maintaining normothermia, having been shown to be 
effective at increasing postoperative temperatures on arrival to PACU. 
Whether interventions to maintain temperature status in women undergoing CS also 
improve thermal comfort is less clear, which may depend on a number of factors, 
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including ambient temperature and the setting of the warming device in question. 
Both warmed IV fluids and forced air warming interventions (applied preoperatively) 
have a positive effect on reducing shivering. IV fluid warming is ineffective at 
improving neonatal temperatures but its effect on Apgar and umbilical pH remains 
unclear. The use of forced air warming is not effective at improving Apgar scores, 
but if applied preoperatively appears to be effective at improving newborn rectal 
temperatures. The effectiveness of forced air warming in improving umbilical pH 
remains unclear. Findings from this systematic review, in relation to IV fluid 
warming and preoperative forced air warming, confirm that recommendations made 
for general adult groups may be applied to the population of women undergoing CS 
surgery under neuraxial anaesthesia.  
 
Limitations 
The included studies in this review predominantly included patients undergoing 
elective CS surgery, which may limit applicability of the results to those undergoing 
emergency CS surgery. Studies were mainly small scale and of medium to low 
quality. Meta-analysis was limited due to the clinical heterogeneity of the included 
studies. Analysis of intraoperative temperature status was limited due to the many 
variations in temperature reporting points utilized by the studies. Exploration of the 
influence of anaesthesia mode on the effectiveness of intervention was also limited 
due to the lack of studies within each intervention relating to each mode of 
anaesthesia.  
 
Differences between the review and the published protocol 
The review also deviated from the published protocol in relation to exclusion of 
pharmacological studies. Pharmacological studies that aimed to reduce shivering and 
that included temperature only as a secondary outcome were identified but their 
inclusion in the review would have been problematic, as shivering is a complex 
phenomenon with multiple causes. A review focusing on pharmacological shivering 
interventions for this population would be an appropriate method to assess this 
further, as would an exploration of the ‘multifactorial’ (Chan, et al., 1989) aspects of 
shivering in this population.  
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Implications for practice 
• Preoperative warming strategies should be utilized where possible 
(Level 2). 
• Preoperative and/or intraoperative warmed IV fluids should be 
standard practice for women undergoing CS surgery (Level 1). 
• Upper body forced air warming should be utilized pre operatively 
(Level 2). 
• Under-body warming mattresses should be used during CS surgery 
(Level 1). 
• Additional strategies, such as the maintenance of ambient temperature, 
should be used to maintain thermal comfort (Level 2). 
• Warming strategies have less effect when intrathecal opioids are 
administered (Level 2). 
 
Recommendations for practice are based on the JBI Levels of Evidence (JBI ) as 
detailed in Appendix VIII. 
 
Implications for research 
• Research is needed to investigate the effectiveness of interventions in 
emergency CS surgery. Effective and appropriate interventions for protecting 
thermal balance in these patients may be especially important.  
• Investigation into the influence of anaesthetic mode and influence of 
intrathecal opioids on the incidence of hypothermia and effectiveness of warming 
interventions would be beneficial. The effectiveness of warming interventions may 
be altered where intrathecal opioids have been administered, or where hypothermia is 
related to intrathecal opioids.   
• Further investigation into maternal warming and neonatal outcomes 
would be beneficial as potential benefits for neonates remain unclear.  
• Studies on the effectiveness and efficacy of lower body in comparison 
to upper body forced air warming devices are required: lower body warming may 
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have reduced practical difficulties for this population, whilst retaining effective heat 
maintenance but research is needed to confirm this. 
• Further study of the use of under-body warming mattresses (carbon 
polymer versus forced air warming) is required.   
• Larger scale studies of warming interventions using standardized and 
clinically meaningful temperature measurement time points are required, thus 
facilitating analysis and comparisons of effectiveness of these interventions. 
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CINAHL (via EBSCO) 02/05/12  
Limits:  Human 
1. ‘C#esarean’ 
2. MM ‘Cesarean Section’ 
3. MH ‘Delivery+’ 
4. ‘parturient’ 
5. ‘parturition’ 
6. ‘maternity’ 
7. ‘maternal' 
8. MH ‘Obstetrics’  
9. MH ‘ Obstetric Patients’ 
10. MH ‘Surgery, Obstetrical+’ 
11. MH ‘Pregnancy Outcomes’ 
12.  MH ‘ Anesthesia, Obstetrical’ 
13. MH ‘Obstetric Care’ 
14. MH ‘Obstetric Nursing’ 
15. 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 
OR 14 
16. ‘temperature’ 
17. MH ‘Body Temperature Regulation+’ 
18. MH ‘Body Temperature Changes+’ 
19. MH ‘Body Temperature+’ 
20. MH ‘Core Body Temperature+’ 
21. ‘thermoregulation’ 
22. ‘hypothermi*’ 
23. MH ‘Hypothermia’ 
24. ‘shivering’ 
25. MH ‘Shivering’ 
26. MM ‘Thermogenesis’ 
27. ‘heat loss’ 
28. MH ‘Heat Loss’ 
29. 16 OR 17 OR 18 OR 19 OR 20 OR 21 OR 22 OR 23 OR 24 OR 25 OR 26 
OR 27 OR 28 
30. ‘warm’ 
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31. MH ‘Warming Techniques’ 
32. ‘active warm*’ 
33. ‘passive warm*’ 
34. ‘prewarm*’ 
35. ‘rewarm*’ 
36. ‘forced air warm*’ 
37. ‘heat*’ 
38. MH ‘Heat’ 
39. MH ‘Heating’ 
40. MH ‘Fluid Therapy+/UT’ 
41. 30 OR 31 OR 32 OR 33 OR 34 OR 35 OR 36 OR 37 OR 38 OR 39 OR 40 
42. 15 AND 29 AND 41 
Embase (via OVID) (30/4/12) 
Limits: Human 
1. c?esarean.mp 
2. MH caesarean section/ 
3. delivery.mp 
4. MH instrumental delivery/ 
5. c$esarean delivery.mp 
6. parturient.mp 
7. parturition.mp 
8. MH birth/ 
9. obstetric$.mp 
10. MH obstetrics/ 
11. MH obstetric operation/ 
12. MH obstetrical nursing/ 
13. MH pregnancy outcome/ 
14. MH obstetric anesthesia/ 
15. matern$.mp 
16. MH maternal care/ 
17. 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 
OR  13 OR 14 OR 15 OR 16 
18. temperature.mp 
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19. MH temperature/ 
20. MH body temperature/ 
21. MH body temperature disorder/ 
22. MH body temperature sensation/ 
23. MH core temperature/ 
24. MH skin temperature/ 
25. MH low temperature/ 
26. MH hypothermia/ 
27. MH hypothermi$.mp 
28. MH thermoregulation/ 
29. thermoregulation.mp 
30. MH thermogenesis and thermoregulation/ 
31. thermogenesis.mp 
32. MH thermogenesis/ 
33. MH shivering.mp 
34. MH shivering/ 
35. heat loss.mp 
36. MH heat loss/ 
37. MH cold/ 
38. MH cold sensation/ 
39. MH exp accidental hypothermia/su (Surgery) 
40. 18 OR 19 OR 20 OR 21 OR 22 OR 23 OR 24 OR 25 OR 26 OR 27 OR 
28 OR 29 OR 30 OR 31 OR 32 OR 33 OR 34 OR 35 OR 36 OR 37 OR 
38 OR 39 
41. MH warm$.mp 
42. MH warming/ 
43. MH heat/ 
44. MH heat treatment/ 
45. heat$.mp 
46. prewarm$.mp 
47. active warm$.mp 
48. passive warm$.mp 
49. forced air warm$.mp 
50. MH fluid therapy/ 
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51. 41 OR 42 OR 43 OR 44 OR 45 OR 46 OR 47 OR 48 OR 49 
52. 17 AND 40 AND 51 
 
Medline (via OVID) (02/05/12) 
Limits: Human 
1. C?esarean.mp 
2. MH Cesarean Section/ 
3. C?esarean delivery.mp 
4. Delivery, Obstetric.mp 
5. parturient.mp 
6. parturition.mp 
7. MH Parturition/ 
8. MH Obstetrics/ 
9. obstetric$.mp 
10. MH Obstetrical Surgical Procedures/ 
11. MH Obstetrical Nursing/ 
12. MH Pregnancy Outcome/ 
13. MH Anesthesia, Obstetrical/ 
14. matern$ 
15. 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 
OR 14 
16. MH Body Temperature Regulation/ 
17. MH Body Temperature/ 
18. temperature.mp 
19. MH Temperature/ 
20. MH Cold Temperature/ 
21. hypotherm$.mp 
22. MH Hypothermia/ 
23. thermogenesis.mp 
24. MH Thermogenesis/ 
25. shivering.mp 
26. MH Shivering/ 
27. heat loss.mp 
28. thermoregulation.mp 
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29. 16 OR 17 OR 18 OR 19 OR 20 OR 21 OR 22 OR 23 OR 24 OR 25 OR 26 
OR 27 OR 28  
30. warm$.mp 
31. MH Hot Temperature/tu, th (Therapeutic Use, Therapy) 
32. rewarm$.mp 
33. MH Rewarming/ 
34. prewarm$.mp 
35. active warm$.mp 
36. passive warm$.mp 
37. forced air warm$.mp 
38. MH ‘Bedding and Linens’/ut (Utilization) 
39. heat$.mp 
40. MH exp Hypothermia/pc (Prevention and Control) 
41. MH Fluid Therapy/ut (Utilization) 
42. 30 OR 31 OR 32 OR 33 OR 34 OR 35 OR 36 OR 37 OR 38 OR 39 OR 40 
OR 41 
15 AND 29 AND 42 
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Appendix D 
 
 
Systematic Review Search Results 
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Search Results 
 
Database Date Strategy  Results  
CINAHL 02/05/12 See Appendix C 31 
Current Contents 14/05/12 (Cesarean OR Caesarean) AND 
(hypotherm*OR warm*) excl. vet and 
zoology 
109 
Embase 30/4/12 See Appendix C 268 
Medline (via OVID) 02/05/12 See Appendix C 299 
Mednar  02/05/12 (cesarean OR caesarean) AND 
(hypothermia OR warming) Full text 
932 
ProQuest (incl. 
PQDT) 
14/05/12 C*esarean AND hypotherm* (exclude: 
animal science, veterinary science, 
political science, American history, 
journalism, mass communication, adult 
education, rhetoric, animals, artificial 
intelligence, audiology, Canada, 
Canadian literature, education history, 
American literature) 
348 
(incl.30 
from 
PQDT) 
Web of Science 
11/05/12 
11/05/12 (hypotherm* OR warm*) (TOPIC) AND 
(cesarean OR caesarean) (TOPIC) excl. 
zoology and veterinary science   
165 
CENTRAL 14/05/12 C*esarean AND (hypotherm* OR 
warm*) (Title, Abs, Keywords) 
29 
OpenGrey 14/05/12 (caesarean OR caesarean) AND 
(hypothermia OR warming) 
0 
Scopus 14/05/12 C*esarean AND (hypotherm* OR 
warm*) in (TITLE-ABS-KEY-AUTHOR) 
ANDEXCLUDE(SUBJAREA“AGRI”)O
REXCLUDE(SUBJAREA“ENGI”) 
279 
Clinical Trials 14/05/12 (cesarean OR caesarean) AND 
(hypothermia OR warming) 
7 
Total  2467 
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Systematic Review 
 
Verification of Study Eligibility Form 
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Systematic Review Verification of Eligibility Form 
 INCLUSION CRITERIA 
AUTHOR AND YEAR 
 
JOURNAL 
      
TITLE 
      
REVIEWER      
Population:  The study population is women undergoing caesarean section. 
                                                                                                                                                
Yes 
 
 
Intervention: The study participants received active or passive warming measures to 
prevent or manage heat loss    
                                                                                                                                                 
Yes 
 
Outcome:  The primary or secondary outcomes include prevention or reduction of 
maternal or neonatal heat loss       
                                                                                                                                                  
Yes 
                                                     
IF YOU HAVE NOT ANSWERED YES TO ALL OF THE ABOVE 
QUESTIONS, YOU SHOULD EXCLUDE THE STUDY. IF YOU ANSWERED 
YES TO ALL, PLEASE CONTINUE. 
 
 
 Appendix F 231 
Appendix F 
Systematic Review  
Data Extraction Instrument  
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PREVENTION OF PERIOPERATIVE HYPOTHERMIA FOR WOMEN 
UNDERGOING CAESAREAN SECTION   DATA EXTRACTION TOOL 
Record Number                                            
 
Author  
 
Journal  
 
Year                                    Reviewer                                            
 
Study Method                                                                                                                                                      
 
Setting                                                                                                                                                                 
Participants 
 Group 1 Group 2 Group 3 
Number in group    
Mean age and range    
Category: 
elective/emergency surgery 
   
Gestation in weeks     
BMI 1    
ASA status 2    
Anaesthetic type    
Drugs administered    
Gravida3/Parity4    
Singleton/multiple birth    
Excluded participants    
Patients who left the study 
and why 
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Notes 
1 BMI – Body Mass Index 
2 ASA status – American Society of Anesthesiologists status 
3 Gravida – refers to the number of pregnancies (Johnson, 2010) 
4 Parity – refers to the number of deliveries (Kenner & Lott, 2007) 
 
Intervention 
Method of warming    
Setting (if applicable)    
Duration of warming    
Fluids (if applicable)    
Volume of fluids 
administered (if applicable) 
   
Method of warming fluids    
Temperature setting of fluid 
warmer 
   
Duration fluids in warmer    
Method of fluid delivery    
Ambient operating theatre 
temperature 
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Outcome 
Mode of temperature 
measurement 
   
Baseline/start point of 
temperature measurement 
   
Timings of temperature 
measurement 
   
Timing of end temperature 
measurement 
   
Hypothermia definition/cut 
off 
   
Maternal thermal comfort 
(validated scale?) 
   
Epidural or spinal block 
height 
   
Maternal satisfaction 
(validated scale?) 
   
PACU length of stay    
Umbilical pH    
Apgar score    
Newborn core temperature    
Newborn core temperature 
measured at what interval? 
   
Method of newborn core 
temperature measurement 
   
Other outcomes    
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Results 
Dichotomous data 
Outcome Treatment group 
number/total number 
Control group number/total 
number 
   
   
   
   
 
 
Continuous data 
Outcome Treatment group mean and 
SD (number)  
Control group mean and SD 
(number)  
   
   
   
   
 
Author’s conclusions 
                                                                                                                                                                                                                                                                                                                                                                                                                
 
 
 
Appen 
Reviewer’s conclusions 
                                                                                                                                                                                                                                                                                                                                                                                                                
 
 
 
 
 
 
 Appendix G 237 
Appendix G 
Systematic Review  
Included Studies  
 Appendix G 238 
 
 
  
Author 
Year 
Design Population Intervention 
Comparator 
Outcomes Results/conclusions 
Cat Anaesth No Temperature Other  
Mode 
Chakladar 
2011 
RCT Elective Spinal/CSE/ 
Epidural/GA 
(opioids) 
116 Full body carbon 
polymer warming 
mattress switched ON 
and warmed IV fluids 
(40°C) vs full body 
warming mattress 
switched OFF and 
warmed IV fluids (40°C) 
Incidence of 
inadvertent 
perioperative 
hypothermia(< 
36°C)  
Mean Hb drop Incidence of IPH was reduced in the 
warming mattress group.  
Temporal artery  
Chan 1989 RCT Elective  Epidural 40 Warmed IV fluids 
(36.5°C), warmed prep 
and extra clothing vs 
room temp fluids, prep 
and single hospital gown 
Mean drop in 
temperature 
 
Shivering Warmed IV fluids, with additional 
clothing, reduced heat loss but did not 
reduce the incidence of shivering.  
Bladder, oral 
Chung 
2012 
RCT Elective Spinal (no 
opioids) 
45 Warmed IV fluid preload  
(37-38°C administration 
temperature) vs upper 
body forced air 
prewarming (43°C) with 
unwarmed IV fluid 
preload vs unwarmed 
fluid preload 
Core temperature at 
45 mins 
Skin temperature at 
15 mins, 30 mins 
Maternal 
thermal 
comfort, pain, 
shivering, 
nausea, 
umbilical vein 
pH, Apgar at 1 
min, nausea, 
vomiting. 
Both preoperative upper body forced air 
warming and warmed IV fluids reduced 
hypothermia and shivering in patients, 
compared to the control group.  
Neonatal outcomes were not improved 
in any group.   
Aural infrared and 
skin temperature of 
upper arm and thigh 
 Appendix G 239 
 
  Author 
Year 
Design Population  Intervention 
Comparator 
Outcomes Results/conclusions 
Cat Anaesth No Temperature Other 
Mode 
Fallis 
2006 
RCT Elective Spinal 
(intrathecal 
morphine) 
62 Upper body forced air 
warming (43°C) vs 
warmed cotton blanket 
Mean baseline oral 
temperature 
decrease throughout 
procedure 
Final temperature 
Maternal 
thermal 
comfort, 
umbilical pH, 
Apgar at 1 & 5 
minutes, 
newborn rectal 
temp at 
delivery, pain 
scores, 
shivering, 
interventions 
for 
hypoglycemia 
for newborn 
<3hrs of 
delivery 
Warmed cotton blankets were 
comparable to upper body forced air 
warming in relation to body 
temperature of mothers and newborns. 
Forced air warming resulted in higher 
thermal comfort scores at 30 minutes. 
Authors suggest further research on 
lower body warming. Warmed cotton 
blankets suggested as standard care for 
this population.  
 
Oral  
Goyal 
2011 
RCT Elective Spinal (no 
opioids) 
64 IV fluids at room 
temperature (22°C) vs IV 
fluids from fluid warmer 
(39°C) 
Core temp <36°C 
on arrival to PACU. 
Mean baseline core 
temperature, on 
arrival to PACU, 30 
mins after arrival, 
mean discharge 
temp from PACU. 
Time to 
discharge 
from PACU, 
shivering 
IV fluid warming resulted in less core 
temperature drop than room 
temperature fluids but was not effective 
in preventing shivering and reducing 
time to discharge in PACU.  
Aural infrared 
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Author 
Year 
Design Population Intervention 
Comparator 
Outcomes Results/conclusions 
Cat Anaesthetic No Temperature Other 
Mode 
Horn  
2002 
RCT Elective Epidural 30 Preoperative and 
intraoperative upper 
body forced air warming 
(43°C) preoperatively vs 
single cotton blanket 
Final intraoperative 
core temperature 
Maternal 
thermal 
comfort, pain 
umbilical vein 
pH, newborn 
rectal temp, 
shivering 
Preoperative upper body forced air 
warming reduced core temperature heat 
loss and maternal shivering, and 
improved umbilical vein pH Period of 
15 minutes prewarming recommended 
for this population.  
Tympanic 
thermocouple 
Oshvandi 
2011 
RCT Elective General 62 Warmed IV fluids (37°C) 
vs room temperature 
(25°C) fluids (pre 
surgery) 
Average temp at the 
end of anaesthesia  
Shivering, 
pethidine 
intake 
Preoperative administration of warmed 
fluids improved postoperative core 
temperature and reduced shivering in 
the intervention group.  
Aural infrared 
Reidy 
2008 
RCT Elective 
or ‘semi-
urgent’ 
Spinal or 
spinal-
epidural 
(intrathecal 
opioids) 
68 Under body forced air 
warming blanket vs 
'standard care' 
Baseline 
temperature and 
temperature on 
entering PACU  
 
Maternal 
thermal 
comfort, 
umbilical pH, 
Apgar at 1 and 
5 mins, 
newborn 
axillary temp 
1 minute 
delivery, 
surgeon's 
thermal 
comfort scores 
 
Full under body forced air warming 
resulted in warmer maternal 
temperatures but did not improve 
maternal thermal comfort.  
Oral 
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Author 
Year 
Design Population Intervention 
Comparator 
Outcomes Results/conclusions 
Cat Anaesth No Temperature  Other 
Mode 
Smith 
2000 
RCT Elective Spinal or 
epidural 
67 Warmed IV fluids via 
Hotline (42°C set point) 
vs room temp fluids (20-
22°C) 
Final core <36 °C, 
final core <35.5°C, 
core temp decrease 
after induction of 
regional 
anaesthesia, core 
baseline  
temperature, core 
lowest temperature, 
core final temp, 
core change (lowest 
– baseline)   
Change range (core 
lowest-baseline), 
core change (final-
baseline), change 
range (core final –
baseline), PACU 
core temp on 
arrival, PACU core 
temp after 30 mins, 
PACU core temp 
after 60mins 
PACU at discharge  
 
Shivering, 
number of 
interventions 
to treat 
hypothermia 
Patients in the warmed IV fluids group 
experienced a lesser core temperature 
decrease to those in the control group 
but did not experience decreased 
incidence of shivering or time to 
discharge in PACU. A combined 
approach to warming, utilizing fluid 
warming in conjunction with 
convective warming is recommended.  
Tympanic 
thermocouple  
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Author 
Year 
Design Population Intervention 
Comparator 
Outcomes Results/conclusions 
Cat Anaesth No Temperature Other 
Mode 
Sun 2004 RCT Elective Epidural 60 Leg wrapping with tight 
elastic bandages vs leg 
wrapping with loose 
elastic bandages 
Baseline temp, 
temp at delivery, 
average reduction 
(°C) baseline to 
delivery 
Shivering, 
hypotension, 
Apgar scores 
Leg wrapping with elastic bandages 
does not prevent hypothermia or 
shivering in this population.  
Sublingual 
Woolnough 
2009 
RCT Elective CSE with 
intrathecal 
diamorphine 
75 Room temp IV fluid 
preload vs warmed IV 
fluid preload (warming 
cabinet) (40-41°C) vs IV 
fluid preload via Hotline 
fluid warmer (42°C) 
Temp decrease 
during first 60 mins 
following CSE  
Pain, shivering A preload of warmed IV fluids reduced 
maternal temperature decline and 
improved thermal comfort, but did not 
reduce shivering. It is suggested that IV 
fluids should be routinely warmed for 
all CS patients in line with NICE 
guidelines for adult (non-pregnant) 
patients.6  
Aural infrared  
Yokoyama 
2009 
RCT Elective Spinal (no 
opioids) 
30 Warmed IV fluids (38°C) 
and reflective blanket vs 
unwarmed IV fluids and 
reflective blanket (25°C) 
Temp at baseline, at 
delivery, 15, 30 and 
45 minutes after 
delivery.  Forearm-
fingertip temp 
gradient after spinal 
administration and 
at time of incision.  
Newborn 
rectal temp at 
5 mins, Apgar 
scores at 1 and 
5 mins, 
umbilical 
artery pH, Hb 
concentration, 
lowest BP, 
blood loss 
Prewarmed IV fluid administration 
resulted in higher maternal core 
temperatures, higher umbilical arterial 
pH and higher Apgar scores at 1 
minute.  
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JBI Levels of Evidence (JBI ) 
Levels 
of 
evidence 
Feasibility 
F (1-4) 
Appropriateness 
A (1-4) 
Meaningfulness 
M (1-4) 
Effectiveness E 
(1-4) 
Economic 
evidence 
1 
Meta-
synthesis of 
research 
with 
unequivocal 
synthesized 
findings 
Meta-synthesis 
of research with 
unequivocal 
synthesized 
findings 
Meta-synthesis 
of research with 
unequivocal 
synthesized 
findings 
Meta-analysis 
(with 
homogeneity) of 
experimental 
studies (eg RCT 
with concealed 
randomisation) 
OR One or more 
large 
experimental 
studies with 
narrow 
confidence 
intervals 
Meta-synthesis 
(with homogeneity) 
of evaluations of 
important 
alternative 
interventions 
comparing all 
clinically relevant 
outcomes against 
appropriate cost 
measurement, and 
including a 
clinically sensible 
sensitivity analysis 
2 
Meta-
synthesis of 
research 
with 
credible 
synthesized 
findings 
Meta-synthesis 
of research with 
credible 
synthesized 
findings 
Meta-synthesis 
of research with 
credible 
synthesized 
findings 
One or more 
smaller RCTs 
with wider 
confidence 
intervals OR 
Quasi-
experimental 
studies(without 
randomisation) 
Evaluations of 
important 
alternative 
interventions 
comparing all 
clinically relevant 
outcomes against 
appropriate cost 
measurement, and 
including a 
clinically sensible 
sensitivity analysis 
3 
a. Meta-
synthesis of 
text/opinion 
with 
credible 
synthesized 
findings  
b. One or 
more single 
research 
studies of 
high quality 
a. Meta-synthesis 
of text/opinion 
with credible 
synthesized 
findings  
b. One or more 
single research 
studies of high 
quality 
a. Meta-
synthesis of 
text/opinion 
with credible 
synthesized 
findings  
b. One or more 
single research 
studies of high 
quality 
a. Cohort studies 
(with control 
group)  
b. Case-controlled  
c. Observational 
studies(without 
control group) 
Evaluations of 
important 
alternative 
interventions 
comparing a 
limited number of 
appropriate cost 
measurement, 
without a clinically 
sensible sensitivity 
analysis 
4 
Expert 
opinion 
Expert opinion Expert opinion Expert opinion, or 
physiology bench 
research, or 
consensus 
Expert opinion, or 
based on economic 
theory 
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Governance and Queensland University of Technology 
Ethics Approvals 
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QUT Administrative Ethics Approval  
 
Dear Mrs Judy Munday 
Project Title:  Intrathecal morphine related perioperative hypothermia in 
women undergoing Caesarean Section: An observational study 
Ethics category:   Human - Administrative Review 
QUT approval number:  1300000365 (Mater Health Services HREC approval 
number: 2013-32) 
QUT clearance until:  27/05/2016 (as per Mater Health Services HREC 
approval) We are pleased to advise that your administrative review application has 
been reviewed by the Chair, University Human Research Ethics Committee 
(UHREC), and confirmed as meeting the requirements of the National 
Statement on Ethical Conduct in Human Research (2007). 
I can therefore confirm that your application has received QUT 
administrative review approval based on the approval gained from Mater 
Health Services Human Research Ethics Committee (HREC), approval number 
2013-32. We note this HREC has awarded the project ethical clearance until 
27/05/2016. 
CONDITIONS OF APPROVAL 
Please ensure you and all other team members read through and understand 
all UHREC conditions of approval prior to commencing any data collection: 
   - Standard: Please see attached or 
www.research.qut.edu.au/ethics/humans/stdconditions.jsp 
   - Specific:   None apply 
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Projects approved through an external organisation may be subject to that 
organisation's review arrangements. Researchers must immediately notify the 
Research Ethics Unit if their project is selected for investigation / 
review by an external organisation. 
VARIATIONS 
Mater Health Services HREC should be considered the lead HREC in terms of 
the ethical review of this project. As such, all variations must first be 
approved by Mater Health Services HREC before submission to QUT for 
ratification.  Please submit to QUT using our online variation form: 
www.research.qut.edu.au/ethics/humans/var/ 
MONITORING 
Please ensure you also provide QUT with a copy of each adverse event report 
and progress report submitted to Mater Health Services HREC. 
 Administrative review decisions are subject to ratification at the next 
available UHREC meeting. You will only be contacted again in relation to 
this matter if UHREC raises additional questions or concerns. 
Please don't hesitate to contact us if you have any queries. 
 
We wish you all the best with your research 
 
Kind regards 
Janette Lamb on behalf of the Chair UHREC 
Research Ethics Unit  |  Office of Research  |  Level 4 88 Musk Avenue 
Kelvin Grove  | Queensland University of Technology 
p: +61 7 3138 5123  |  e: ethicscontact@qut.edu.au  |  w: 
www.research.qut.edu.au/ethics/ 
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Appendix L 
Retrospective case-control study 
Data Collection Tool  
 
 
 
 
 
  
 Appendix L 272 
DATA COLLECTION FORM Intrathecal morphine and hypothermia observational study   Date 
           
    
Maternal / Demographic details       Identifier No 
Age  Indication for CS  
BMI  Current medication  
ASA score  
Ethnicity  
Parity  
Gravida  Known Adverse Drug 
Reactions 
 
Gestation  Maternity history  
Category Select 
appropriate: 
Emergency Past Medical History   
 
Elective 
Multiple birth 
Select appropriate: 
Yes 
No 
Drugs in 
labour (if 
applicable) 
 
 
Perioperative Details 
Adm Temp (°C)  In OR suite 
time 
 Active warming  Yes 
No 
Holding Bay 
Temp(°C) 
 Knife to 
skin time 
 Type  
Start time  
Pre op 
warming  
Yes Out OR 
time  
 Operating temp of 
warmer 
 
No 
Type  
Intra op temp    
(°C)    
Time Temp IV fluids 
Select 
appropriate                          
Volume Solution/additive Warmed 
(yes/no) 
1   1   Yes No 
2   2   Yes No 
3   3   Yes No 
Temp route  4   Yes No 
 
Anaesthetic / Intra operative Medication Route Time Dose 
Intrathecal Morphine  Yes    
No 
Other anaesthetic/ intra operative medication Route Time Dose 
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Needle type  Level of 
insertion 
 
Failure to insert spinal Yes If yes, details:  
No 
Inadequate block Yes If yes details:  
No 
Reinsertion Yes If yes, details:   
No 
High block  Yes If yes details:  
No 
Other spinal insertion 
complications 
 
Intraoperative nausea and 
vomiting 
Yes If yes, details:  
No 
Intraoperative hypotension Yes If yes, details:  
No 
Other complications/ events  
 
 
Postoperative Details 
PACU Admission time  Patient met all discharge criteria? Yes 
No  
PACU Ready to discharge time  PACU Discharge Temp  
 
PACU temp 
(°C) 
Time Notes / actions  
   
   
   
   
   
   
   
Warming 
interventions 
Yes/No Notes/Actions 
Forced air  Yes  
No 
Space blanket Yes  
No 
Warmed 
blanket 
Yes  
No 
Overhead 
heater 
Yes  
No 
Other   
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Postoperative Medication In PACU Route Time Dose 
    
    
    
    
    
    
    
 
Conditions in 
PACU 
Yes No Additional information 
Shivering    
Nausea    
Vomiting    
Sweating    
Hypotension    
Pruritus    
Haemorrhage    
High spinal block    
Bromage on 
discharge 
   
 
Notes 
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Intrathecal morphine and hypothermia data collection: background 
information  
 
Field  Where/what  
Surgery date On Operation report (purple edge)  
Age On admission report/ work out from patient 
sticker 
BMI Pre-pregnancy BMI – in orange handheld 
notes.  Also on antenatal summary.  
Height/ weight  Pre-pregnancy – in orange handheld notes.  
ASA score  On front of anaesthetic chart (purple/white 
striped edge)  
Ethnicity  Antenatal summary 
Parity / gravidity/ gestation  Operation report / matrix (birth summary). 
Parity should include this pregnancy.  
Category  Operation report  
Multiple birth Operation report / matrix 
Indication for CS Operation report / matrix 
Current medication  Anaesthetic chart / medication chart  
Allergies  Anaesthetic chart / medication chart 
Maternity history  Matrix / operation report / antenatal 
summary/ anaesthetic chart 
Past medical history  Anaesthetic chart / antenatal summary 
Drugs in Labour  Matrix  / medication chart / labour record 
  
PreOpCheck time Pre Op checklist (middle column)  
In OR suite time / Knife to Skin / End Proc  Operation details (purple edge)  - note that 
Out Proc time is time that procedure ends 
(not the Out OR time at the top of the page)  
Pre Op temp / adm temp Front of anaesthetic chart  / last temp on 
labour record (if labouring) / MET form  
Pre Op warming  Pre Op checklist / anaesthetic chart  
OT warming  / fluid warming Inside anaesthetic chart  
OT temps  Inside anaesthetic chart 
IV fluids  Inside anaesthetic chart  
Intrathecal morphine?  Inside anaesthetic chart – with details of 
spinal technique  
Other medication incl oxytocics Inside anaesthetic chart  
Spinal needle /level of insertion /  failure to 
insert/ reinsertion/ high block / intraoperative 
nausea and vomiting 
Inside anaesthetic chart 
Intraoperative hypotension  Inside anaesthetic chart – see observations. If 
systolic bp <100mmHg or if <20% from 
baseline 
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PACU admission time  On PACU form (see admission to PACU 
time at top) 
Ready to discharge time On PACU form – see discharge box bottom 
right side 
Discharge criteria met?  On PACU form – see discharge box bottom 
right side 
PACU admission temp  On PACU form – see box on left hand side  
PACU discharge temp  On PACU form – see box on left hand side 
PACU temps  PACU form  
Warming interventions  PACU form – note that Warm Touch often 
ticked when forced air warming used.  Also 
read notes at bottom of page to see if 
warming noted there.  
PACU medication  PACU form / medication chart 
Other conditions in PACU (shivering, 
hypothermia etc)  
This info, if present, will be found in the 
notes section of the form, which also 
continues overleaf. May also need to cross-
reference with medications given.  
Bromage In notes / observations on PACU form  
OT blood loss Operation report / matrix 
PACU blood loss PACU form / shared handover form  
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Table 2: Demographic and intraoperative variables  
  Variable Morphine (n=179):  
Mean (SD) / number (%) 
No Morphine (n=179): 
Mean (SD) / number (%) 
Age (yrs) 30.6 (SD 5.6) (n=178) 30.5 (SD 6.2) (n-178) 
Pre-pregnancy BMI  25.4 (SD 6.13) (n =174)  25.7 (SD 5.3) (n=168) 
Pre-pregnancy weight (kg) 68.7 (SD 17.8) (n=145) 68.6 (SD 15.5) (n=144) 
Height (cm) 162 (SD 7.2) (n=140)  163.3 (SD 7.3) (n=141)  
Gestation (days)  264.1 (SD 20.1) (n=177)  265.1 (SD 17.7) (n=179)  
Gravidity:  
 
3 (range 1-11) (n = 178)  3 (1-10) (n = 179)  
Parity:  
 
2 (range: 1-8) (n = 177)  2 (1-8) (n = 178)  
Intraoperative blood loss (mls)  450 (range: 150-2200) (n = 
178)  
500 (range: 100 – 1300) (n = 174)  
Surgical duration (mins): median 41 (n=171) 44  (n=170) 
Pre-operative temperature (°C) 36.6 (SD 0.48) (n=155) 36.5 (SD 0.43) (n=137) 
Pre-operative waiting time (mins)  36.3 (SD 21.9) (n=170) 37.2 (SD 22.8) (n=163) 
Local anaesthetic volume (mls)  2.3 (SD 0.19) (n=172)  2.3 (SD 0.16) (n=165)  
Intrathecal fentanyl dose (mcg)  
10mcg 
15mcg 
20mcg 
25mcg 
Missing 
 
6 (3.4%) 
139 (78.5%) 
32 (18.1%) 
0 
2 (1.1%)  
 
9 (5.3%) 
84 (49.7%) 
65 (38.5%) 
11 (6.5%) 
10 (5.6%)  
Category: number (%): 
             Emergency  
             Elective   
 
82 (46.3%) 
95 (53.7%)  
 
85 (47.5%)  
94 (52.5%) 
Multiple Birth: number (%): 
             Yes 
             No 
 
8 (4.5%) 
168 (95.5%)  
 
7 (3.9%) 
172 (96.1%)  
ASA: number (%): 
             Missing 
             1 
             2 
             3 
             4 
             5 
 
43 (24.2%) 
70 (39.3%) 
55 (30.9%) 
7 (3.9%) 
2 (1.1%) 
1 (0.6%) 
 
44 (24.9%) 
55 (31.1%) 
64 (36.2%) 
14 (7.9%) 
0 (0%) 
0 (0%) 
OT Warming: number (%) 
             Missing 
             Fluid 
             Forced air 
             Fluid and forced air 
   
154 (86%) 
16 (8.9% 
7 (3.9%) 
2 (1.1%)        
 
135 (75.8%) 
37 (20.8%) 
4 (2.2%) 
2 (1.1%)  
Level of insertion: number (%) 
        Missing 
            L2/L3 
           L3/L4 
           L4/L5 
           L5/S1 
 
45 (25.1%) 
9 (5.0%) 
107 (59.8%) 
18 (10.1%) 
0 (0%) 
 
45 (25.3%) 
8 (4.5%) 
96 (53.9%) 
28 (15.7%) 
1 (0.6%)  
Spinal position (insertion): 
              Missing 
              Supine 
              Lateral 
              Sitting  
 
 
64 (36%)  
3 (2 %) 
11 (6%)  
101 (56%)  
 
57 (32%) 
2 (1%)  
16 (9%)  
104 (58%)  
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Table 3: Postoperative variables 
Variable  Morphine group (n = 
179)  
No Morphine group (n = 179)  
Mean PACU arrival temperature (°C) 35.91 (SD 0.6) 35.88 (SD 0.6)  
Mean PACU discharge temperature 
(°C) 
36.25 (SD 0.5) (n = 169)  36.21 (SD 0.48) (n = 162)  
Shivering: Yes 
                   No 
                   Missing 
2 (1%) 
176 (98%)  
1 (0.5%) 
 
4 (2%)  
165 (92%)  
10 (6%)  
Hypotension (PACU): Yes 
                                        No 
                                        Missing 
 
40 (22%) 
136 (76%)  
3 (2%)  
23 (13%) 
154 (86%)  
2 (1%)  
Nausea: Yes 
                No 
                Missing 
 
14 (8%) 
164 (91.5%)  
1 (0.5%)  
9 9 (5%) 
166 (93%)  
4 (2%)  
Vomiting:  Yes 
                   No 
                   Missing 
 
6 (3%)  
168 (94%)  
5 (3%)  
3 (2%)  
172 (96%)  
4 (2%)  
Pruritus: Yes 
                  No 
                 Missing 
 
10 (5.5%)  
168 (94%)  
1 (0.5%)  
6 (3%)  
169 (94%)  
4 (2%)  
Haemorrhage: Yes 
                            No 
                            Missing 
 
7 (4%)  
166 (93%)  
6 (3%)   
6 (3%)  
168 (94%)  
5 (3%)  
Sweating: Yes 
                    No 
                    Missing 
 
3 (2%)  
175 (97.5%) 
1 (0.5%)  
1 (0.5%)  
172 (96%)  
6 (3%)  
PACU duration (mins): median  38.5 (n = 158)  38.5 (n = 162)  
Bromage: 0 
                   1 
                   2 
                   3 
                   Missing 
0 (0%)  
2 (1%)  
8 (4.5%)  
17 (9.5%)  
152 (85%)  
8 (4.5%)  
7 (4%)  
15 (8%)  
41 (23%)  
108 (60.5%)  
High Block: Yes 
                     No 
                     Missing 
 
3 (2%)  
168 (94%)  
8 (4.5%)  
0 (0%)  
166 (94%)  
11 (6%)  
Postoperative hypothermia (on arrival 
to PACU):  Yes 
               No 
               Missing 
 
 
98 (55%)  
81 (45%)  
0 (0%)  
 
103 (58%)  
76 (42%)  
0 (0%)  
Profound hypothermia: Yes 
               No 
               Missing 
 
6 (3%)  
173 (97%)  
0 (0%)  
2 (1%)  
177 (99%) 
0 (0%)  
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Table 5:  Temperature, anaesthetic and surgical variables by year.  
Year  Mean 
preoperative 
temperature 
(°C)  
Mean 
postoperative 
PACU 
temperature 
(°C) 
Mean 
intrathecal 
morphine 
dose (mcg)  
Mean 
temperatu
re decline 
(°C) 
Mean 
intrathecal 
fentanyl 
dose (mcg)  
Median 
duration of 
procedure 
(mins)  
2007 36.6 (SD 0.5) 36.0 (SD 0.6) 125 (SD 
25.4) 
-0.68 (SD 
0.69) 
16.8 (SD 
3.2) 
38.5 (n = 
66) 
2008 36.5 (SD 0.5) 35.7 (SD 0.6) 141.7 (SD 
19.2) 
 - 0.71 (SD 
0.8) 
16.1 (SD 
4.4) 
37.5 (n = 
32)  
2009 36.5 (SD 0.4)  35.6 (SD 0.6) 136.1 (SD 
23.0) 
-0.80 (SD 
0.6) 
14.9 (SD 
2.6) 
41 (n = 33)  
2010 36.5 (SD 0.4) 35.9 (SD 0.6) 112.5 (SD 
22.1) 
- 0.59 (0.6) 16.0 (SD 
2.5) 
44 (n = 45)  
2011 36.6 (SD 0.5)  36.0 (SD 0.6) 119.0 (SD 
24.2) 
-0.60 (SD 
0.6) 
17.0 (SD 
2.9) 
44 (n = 63)  
2012 36.4 (SD 0.4) 36.0 (SD 0.5) 117.7 (SD 
27.2) 
- 0.46 (SD 
0.5) 
17.1 (SD 
2.5) 
45.5 (n = 
66)  
2013 36.3 (SD 0.4) 35.8 (SD 0.6) 109.0 (SD 
23.2)  
- 0.59 (SD 
0.5) 
16.2 (SD 
2.5) 
43 (n = 30)  
2014 36.2 (SD 0.6)  36.0 (SD 0.6) (Insufficient 
numbers)  
0.15 (SD 
1.1) 
17.0 (SD 
2.7)  
52 (n = 5)  
P 
value 
0.06 0.01* < 0.001** 0.172 0.014* 0.006** 
* significance  < 0.05 
** significance < 0.01  
 
 
Table 6: Temperature outcomes: emergency and elective patients  
Temperature outcome Category  Significance 
Emergency  Elective  
Mean preoperative 
temperature (°C) 
36.4 (SD 
0.5)  
36.5 (0.5)  0.4 
Mean PACU arrival 
temperature (°C)  
36.0 (SD 
0.6)  
35.8 (SD 0.5)  0.001** 
Postoperative hypothermia  80 (48%)  121 (64%)  0.03* 
Temperature decline: 
preoperative temperature to 
PACU arrival (°C) 
-0.53 (SD 
0.6) 
-0.69 (SD 0.6)  0.03* 
Pregnancy-induced 
hypertension (PIH) 
26 (15.6%)  6 (3.2%)  0.001** 
* significance  < 0.05 
** significance < 0.01  
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Participant Information Brochure 
Title:  A preoperative warming regime versus no preoperative 
warming for maintenance of normothermia in women 
receiving intrathecal morphine for caesarean section.  
Principal Investigator:  Judy Munday (Affiliations: Mater Health 
Services, Queensland      University of Technology)  
Associate Investigators:  Dr David Sturgess (Affiliation: Mater Health Services), 
Dr Simon Maffey (Affiliation: Mater Health Services), 
Dr Sonya Osborne (Affiliation: Queensland University 
of Technology, Professor Patsy Yates: Queensland 
University of Technology).   
 
Location:   Mater Mother’s Hospital Operating Theatres 
 
Part One What does my participation involve?  
1. Introduction 
We would like to invite you to participate in this research study.  You are eligible to 
participate in this study because you are being admitted for an elective caesarean 
section at the Mater Mother’s Hospital.  This study aims to test a regime to keep 
women warm whilst they are undergoing caesarean section and reduce the amount of 
temperature decline that they experience. 
This Participant Information Brochure tells you about the research project. This 
information aims to help you decide whether or not you would like to take part in the 
research.   
Please read the information provided carefully. Please also ask questions about 
anything that you don’t understand or want to know more about.   You can also 
discuss this with someone else before deciding whether to take part. 
Participation in the study is entirely voluntary – you do not have to take part if you 
do not want to.  You will still receive the best possible care whether you take part or 
not.  It is also important to consider that your participation also involves your unborn 
baby. 
If you do decide to take part in the research project, you will be asked to sign the 
Consent Form.  If you sign this, you are confirming that you understand what you 
have read, provide consent to take part in the project, consent to have treatments that 
are described and consent to the use of your personal and health information as 
described.   A copy of this Participant Information Brochure, along with the Consent 
Form, will be given to you.  
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2. What is the purpose of this research? 
The overall aims of the research study are to improve methods of temperature 
management that we provide to women undergoing caesarean section and reduce the 
incidence of heat loss during and after surgery.   
It is recognized that many women undergoing caesarean section experience a 
reduction in their temperature and some will experience mild perioperative 
hypothermia (that is, heat loss or a low body temperature directly related to 
undergoing a surgical procedure).  It is also known that this can cause other 
complications, along with discomfort.  Research suggests that some women who 
receive a dose of morphine into their spine for pain relief during caesarean section, 
experience lower body temperatures.  Providing warming to patients before surgery 
has been shown to be effective in other patient groups, but it is unknown if this is 
effective when women are receiving spinal morphine for caesarean section.  
To develop more effective methods of keeping women warm whilst they undergo 
caesarean section we plan to test the effectiveness of a warming regime to maintain 
body temperature.    It is hoped that this research will improve the care we provide 
for women in terms of their temperature management in theatre, and improve their 
experience of caesarean section.  
Medications, drugs and devices have to be approved for use by the Australian 
Federal Government. The Cocoon™ warming device used in this study is approved 
in Australia for patient warming.  
The results of this research will be used by the primary investigator (Judy Munday) 
to obtain a Doctor of Philosophy (PhD) degree. 
 
3. What does participation in this research involve?  
You will need to have time to read the participant information brochure and ask any 
questions that you have, before signing the consent form.  The research assistant or 
primary investigator will then conduct further screening of your medical history to 
ensure that you are eligible to participate, as some pre-existing conditions may have 
an effect on the appropriateness of the intervention, for example thyroid disorders (as 
they may affect the way that the body controls temperature), vascular disease or a 
known allergy to morphine.    
You will be participating in a randomised controlled research project. Sometimes we 
do not know which treatment is best for treating a condition.  To find out we need to 
compare different treatments.  We put people into groups and give each group a 
different treatment.   The results are compared to see if one is better.  To try to make 
sure the groups are the same, each participant is put into a group by chance (random).  
Depending on the theatre schedule, you may or may not be approached to take part in 
the study on the day of surgery Also on the day of surgery the principal investigator 
will assess whether you are still eligible to take part – for example, if you have 
developed a high body temperature on the day of surgery or had developed high 
blood pressure then you would not be able to take part in the study.  As temperature 
measurements will be taken via the ear canal (as is usual practice), to ensure 
accuracy of this reading for this study, all participants in the study will also receive 
otoscopy – that is, inspection of the ear canal – on the day of surgery.  Participants in 
this research project will be assigned to one of two groups.  One group will receive 
the warming regime, whilst the other group will receive usual care.   Participants will 
be randomly assigned to one of the two groups. There is a one in two chance of 
receiving the intervention under investigation. 
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Once randomization has been carried out, the research assistant or principal 
investigator will collect some basic information about you, such as your age, height, 
weight and the number of babies and pregnancies you have had.  
If assigned to the control group you will not receive the preoperative warming 
intervention.  You will be asked to wear hospital gown, dressing gown and slip-on 
footwear, as is normal procedure.   You will be transferred to the Preoperative 
Waiting Area approximately 30 minutes before your expected procedure time. If you 
become cold, warmed blankets will be provided.  After the anaesthetic is given, a 
warmed blanket will be wrapped around you.   
If in the intervention group you will also be asked to wear hospital gown, dressing 
gown and slip-on footwear, as is normal procedure.  You will be transferred to the 
Preoperative Waiting Area approximately 30 minutes before your expected 
procedure time.  Whilst awaiting surgery a warming blanket will be applied that uses 
warm air – the duration of this procedure will be 20 minutes. After the anaesthetic is 
given, a warmed blanket will be wrapped around you. If changes to theatre 
scheduling arise that involve a longer waiting period between the application of the 
warming and the commencement of surgery, then this may mean that your data will 
not be included in the study and for the remainder of the procedure you will then 
receive standard care.  
Both groups will receive temperature measurements when they arrive in the 
Preoperative Waiting Area and at further regular intervals throughout the waiting 
period, through surgery and in the Post Anaesthetic Care Unit.  In the Preoperative 
Waiting Area and in the Post Anaesthetic Care Unit these measurements will be 
taken using a thermometer which is inserted into your ear canal, which is usual 
practice.  Whilst in the operating theatre, your temperature will also be measured via 
the urinary catheter which you receive as part of normal care  The principal 
investigator will be responsible for recording the temperature measurements and also 
other information including the duration of the operation and blood loss. The 
temperature at birth, and Apgar scores, of your baby are routinely collected for 
normal clinical care: these will also form part of the data collection for the study. The 
primary investigator will be present throughout the operation and the recovery period 
in the Post Anaesthetic Care Unit, until you are transferred to the ward for further 
recovery.  Information about feeding, skin-to-skin contact and wound infection both 
in hospital and postnatally is routinely collected as part of your normal care:  this 
data will also form part of the data collection for this study.  
This research project has been designed to make sure the researchers interpret the 
results in a fair and appropriate way and avoids study investigators or participants 
jumping to conclusions.  
There are no additional costs associated with participating in this research project, 
nor will you be paid.  All medication, tests and medical care required as part of the 
research project will be provided to you free of charge.  
 
 
4. Other relevant information about the research project 
In total 50 people will be taking part in the project overall.  This is a single-site study 
and is only being run at the Mater Mother’s Hospital.    
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5. Do I have to take part in this research project? 
Participation in any research project is voluntary.  If you do not wish to take part, 
you do not have to.  If you decide to take part and later change your mind, you are 
free to withdraw from the project at any stage.  
If you do decide to take part, you will be given this Participant Information and 
Consent Form to sign and you will be given a copy to keep.  
Your decision whether to take part or not to take part, or to take part and then 
withdraw, will not affect your routine treatment, your relationship with those treating 
you or your relationship with Mater Mother’s Hospital.  
 
6. What are the alternatives to participation? 
You do not have to take part in this research project to receive treatment at this 
hospital.   Other options are available; these include receiving usual care.  Usual care 
provided does not include the use of a warming regime using a warm air blanket 
whilst waiting for surgery, however warmed cotton blankets are available at any 
stage if you feel cold.  
 
7. What are the possible benefits of taking part? 
We cannot guarantee or promise that you will receive any benefits from this 
research; this research will benefit patients in the future by helping us to develop 
warming regimes that are suitable for women undergoing caesarean section and 
reduce rates of heat loss in women 
 
8. What are the possible risks and disadvantages of taking part? 
Treatments often cause side effects.  You may have none, some or all of the effects 
listed below.  If you have any of these side effects please talk with the investigators.  
The investigators and research assistants will also be looking out for side effects.  
The warming device used is already in use in Mater Mother’s Hospital, however it is 
usually used during and after surgery rather than before. Possible side effects from 
the forced air warming blanket may include, in some people, feeling too hot, or 
sweating – if this occurs the research assistant will cease the warming.  Where 
procedures regarding the use of the forced air warming blanket have been incorrectly 
followed, and the hose has not been connected to the blanket correctly, there have 
been reported cases of thermal burns, however this is extremely rare and unlikely.   
This study follows a strict procedure to ensure safe usage of this device, which is 
already in use in the study hospital for patient warming.     
If any of the above symptoms commence during warming then the warming blanket 
will be removed and appropriate care provided to you to make you more 
comfortable. 
 
9. What if new information arises during this research project? 
Sometimes during the course of a research project, new information becomes 
available out the treatment that is being studied.  If this happens, the investigator will 
tell you about it and discuss with you whether you want to continue in the research 
project.  If you decide to withdraw from either group, the investigator will make 
arrangements for your regular health care to continue, without any further data 
collected. Also, on receiving new information, the investigator might consider it to 
be in your best interest to withdraw you from the research project.  If this happens 
she will explain the reasons and arrange for your regular health care to continue.  
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10. Can I have other treatments during this research project? 
You can receive all other care, medications and treatments as normal during this 
research project.  No treatments or medications need to be stopped for the time you 
are involved in the research project.  
 
11. What if I withdraw from this research project? 
If you decide to withdraw from the project, please notify a member of the research 
team before you withdraw.   If you do withdraw your consent during the research 
project, the investigator and relevant study staff will not collect additional personal 
information from you, although personal information already collected will be 
retained to ensure that the results of the research project can be measured properly 
and to comply with law.   You should be aware that data collected up to the time you 
withdraw will form part of the research project results.  If you do not want them to 
do this, you must tell them before you join the research project. 
 
12. Could this research project be stopped unexpectedly? 
The research project may be stopped unexpectedly for a variety of reasons.  These 
may include reasons such as: 
 Unacceptable side effects 
 The treatment was not shown to be effective 
 The treatment was shown to work and did not need further testing 
 
13. What happens when the research project ends? 
It is anticipated that the outcomes of this research will be finalised by June 2015.  It 
is also intended that the outcomes of the research will be published by the 
investigators.  If you would like to receive feedback or information regarding the 
success of the project, please indicate by ticking the box on the consent form. 
 
Part Two How is the research project being conducted? 
1. What will happen to information about me? 
By signing the consent form you consent to the relevant research staff collecting and 
using personal information about you for the research project. Any information 
obtained in connection with this research project that can identify you will remain 
confidential.  No names will be used.  The data will only be accessible by the 
researchers and will be kept in a locked cabinet and in a password projected 
computer file at Mater Health Services and then destroyed in accordance with legal 
requirements.  Your information will only be used for the purpose of this research 
project and it will only be disclosed with your permission, except as required by law.  
Any information obtained during the research project and your health records are 
subject to inspection (for the purpose of verifying the procedures and the data) by the 
relevant authorities, Mater Health Services, the institution relevant to this Participant 
Information Brochure, or as required by law.   By signing the Consent Form, you 
authorize release of, or access to, this confidential information to the relevant study 
personnel and regulatory authorities as noted above.  
It is anticipated that the results of this research project will be published and/or 
presented in a variety of forums.  In any publication and/or presentation, information 
will be provided in such a way that you cannot be identified and results will be 
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collated. Information about your participation in this research project may be 
recorded in your health records.  
In accordance with relevant and /or Queensland privacy and other relevant laws, you 
have the right to request access to your information collected and stored by the 
research team.   Please contact the study team member named at the end of this 
document if you would like to access your information.  
Any information obtained for the purpose of this research project that can identify 
you will be treated as confidential and securely stored.   It will only be disclosed with 
your permission, or as required by law.  
 
2. Complaints 
If you suffer any injuries or complications as a result of this research project, you 
should contact the research team as soon as possible and you will be assisted with 
arranging appropriate medical treatment.  If you are eligible for Medicare, you can 
receive any medical treatment required to treat the injury or complication, free of 
charge, as a public patient in any Australian public hospital. If you have concerns 
regarding the research you may contact the Principal Investigator, Judy Munday, on 
mobile 0406721314 or 07 3163 5368 (Mater Nursing Research Centre).   If you have 
any concerns regarding your care at Mater Mother’s Hospital please contact the 
Mater Mother’s Patient Liaison Officer (details below).    
 
3. Who has reviewed the research project?   
All research in Australia involving humans is reviewed by an independent group of 
people called a Human Research Ethics Committee (HREC).  The ethical aspects of 
this research project have been approved by the HREC of Mater Health Services and 
Queensland University of Technology. 
The research will be carried out according to the National Statement on Ethical 
Conduct in Human Research (2007).   This statement has been developed to protect 
the interests of people who agree to participate in human research studies.    
 
4. Further information and who to contact 
The person you may need to contact will depend on the nature of your query. 
If you want any further information concerning this project or if you have any 
medical problems which may be related to your involvement in the project (for 
example, any side effects), you can contact the principal study investigator Judy 
Munday on 0406721314.  Alternatively you may contact the Clinical Contact Person 
listed below:  
 
Clinical Contact Person 
Name Dr Simon Maffey. 
Position  Deputy Director – Obstetric Anaesthesia 
Telephone 3163 8646 
Email  Simon.maffey@mater.org.au 
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Primary Supervisor 
This study is being conducted as part of a PhD program.  The contact details for the 
Primary Supervisor for the Principal Investigator (Judy Munday) are as follows: 
 
Name Dr Sonya Osborne 
Position  Senior Lecturer 
Telephone 3138 3785 
Email  s.osborne@qut.edu.au 
 
 
 
For matters relating to research at the site at which you are participating, the details 
of the local site complaints person are: 
Complaints Contact Person 
Name Roxanne Regan  
Position  Patient representative 
Telephone 3163 8303 
Email  Roxanne.Regan@mater.org.au 
 
If you have any complaints about any aspect of the project, the way it is being 
conducted or any questions about being a research participant in general, then you 
may contact: 
Reviewing HREC approving this research and HREC Executive Officer details 
Reviewing HREC name Mater Health Services 
HREC Executive Officer  HREC Coordinator 
Telephone 3163 2392 
Email   research.ethics@mmri.mater.org.au 
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Consent Form 
 
Title:  A preoperative warming regime versus no preoperative 
warming for maintenance of normothermia in women 
receiving intrathecal morphine for caesarean section.  
Principal Investigator: Judy Munday (Affiliations: Mater Health Services, 
Queensland University of Technology 
Associate Investigators:  Dr David Sturgess (Affiliation: Mater Health Services), Dr 
Sonya Osborne (QUT), Professor Patsy Yates (QUT)   
Location:   Mater Mother’s Hospital Operating Theatres 
 
Declaration by participant 
I have read the Participant Information Sheet or someone has read it to me in a language that 
I understand. 
I understand the purposes, procedures and risks of the research described in the project. 
I give permission for the use of my personal information for the purposes of this project.  I 
understand that such information will remain confidential. 
I have had an opportunity to ask questions and I am satisfied with the answers I have 
received.   
I freely agree to participate in this research project as described and understand that I am free 
to withdraw at any time during the study without affecting my future health care. 
I understand that I will be given a signed copy of this document to keep. 
I would like to receive feedback on the outcomes of the study: Yes               No   If yes, 
please provide preferred contact details below to enable us to provide you with feedback: 
 
 
 
Name of participant (please print):                                   
 
Signature:                                           Date:                               
Under certain circumstances (see Note for Guidance on Good Clinical Practice 
CPMP/ICH/135/95 at 4.8.9) a witness* to informed consent is required. 
 
 
 
 
 
  
Contact details for feedback:  
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Declaration by Senior Researcher 
I have given a verbal explanation of the research project, its procedures and risks and I 
believe that the participant has understood that explanation. 
Name of Senior Researcher# (please print): 
 
 
Signature:                                       Date:           
# A senior member of the research team must provide the explanation of, and information 
concerning, the research project. 
Note: All parties signing the consent form must date their own signature
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Appendix R 
Randomised controlled trial 
Intraoperative and Anaesthetic Protocol 
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Intraoperative Protocol 
Exclusions prior to randomisation for the following:  
Planned avoidance of intrathecal morphine use: for example, morphine allergy, 
planned epidural top-up, planned general anaesthetic  
Non-elective CS 
Planned ICU admission post-op 
Known altered thermoregulation: previous or current thyroid disorder requiring 
surgery or medical therapy 
Vascular disease or poor cutaneous perfusion 
Aural canal not visible on otoscopy  
Inability to apply preoperative warming strategy or admission temperature > 37°C 
ASA score >II  
History of preeclampsia or eclampsia 
Clinician declined patient involvement. 
  
Exclusions after randomisation for the following:   
CSE with opioids via epidural catheter 
CSE with > 10mls of local anaesthetic via epidural catheter 
 Delay between completion of warming intervention and the transfer to theatre >20 
minutes.  
Any other deviation from stated intraoperative protocol (see below)  
 
 
Spinal anaesthetic protocol  
Spinal anaesthetic technique:    spinal (or CSE with no opioids via epidural 
catheter) 
Kit/equipment:     any 
Spinal local anaesthetic:   heavy 0.5% bupivacaine 1.8-2.5mls 
Spinal morphine:    100mcg 
Spinal fentanyl:     15-20mcg 
CSE epidural local anaesthetic (if used):  1% ropivicaine < 10mls 
 
Additional medication 
Vasopressor 
Antibiotic 
Anti-emetic 
Analgesia:     Paracetamol 1g PR, Diclofenac 100mg PR  
Oxytocic:     Carbetocin 100mg 
Additional (as required) 
 
Fluids (< 2 litres) via Biegler Fluid Warmer at 38.5°C 
Solution  Additive Time Commenced  Volume Rate  
    
 
Intraoperative Warming 
Blankets (warmed):  < 2 
IV Fluid warming (as above): 38.5°C via Biegler fluid warmer  
 
Temperature Monitoring 
Mon-a-Therm™ foley catheter bladder temperature measurements 
Aural canal (tympanic) Genius™ thermometers 
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Appendix S 
Randomised controlled trial 
Data Collection Tool 
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A preoperative warming regime versus no preoperative warming for maintenance of 
normothermia in women receiving intrathecal morphine for caesarean section.  
 
Participant Demographic Data Collection Form 
 
Study ID No:                            Date:  
 
5. Age  
 
6. Parity 
 
7. Gravidity  
 
8. Pre-pregnancy BMI:  
 
 
 
 
  
  
 Appendix S 307 
A preoperative warming regime versus no preoperative warming for maintenance of 
normothermia in women receiving intrathecal morphine for caesarean section.  
 
Preoperative Intervention / Control Data Collection (to be detached 
from Outcome Measurement Form) 
Study ID No:  
 
Patient attire (tick all that apply) 
  
Surgical gown                    Dressing gown  Footwear 
Maternal thermal comfort *recorded on separate outcomes measurement form  
 
Preoperative Maternal temperature *recorded on separate outcomes 
measurement form 
 
Preoperative Warming Protocol (FOR INTERVENTION GROUP ONLY) 
Blanket size:  
Time Preoperative Warming Commenced:  
Setting:  
Time Preoperative Warming Ceased:   
Further information (please tick all that apply and provide further 
information): 
   Warming ceased early  
    If yes, reason  
 
   Nausea  Further info  
   Vomiting  Further info 
   Sweating  Further info  
   Other    Further info  
Temperature (°C) at 10 mins:  
 
Ambient Temp (°C):   
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A preoperative warming regime versus no preoperative warming for maintenance of 
normothermia in women receiving intrathecal morphine for caesarean section.  
 
Anaesthetic and Intraoperative Data Collection     Study ID No     
Preoperative medication 
ASA score 
Spinal Anaesthetic Information  
Position 
Procedure 
Level 
Needle 
Local anaesthetic and volume 
Opioids 
Block level  
Reinsertion  
Additional medication 
Vasopressor 
Antibiotic 
Anti-emetic 
Analgesia 
Oxytocic 
Additional  
Fluids 
Solution  Additive Time Commenced  Volume Rate  
     
     
     
 
Warming 
Blankets 
IV Fluid warming 
IV Fluid warming method 
Temperature Monitoring  
Details  
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A preoperative warming regime versus no preoperative warming for maintenance of 
normothermia in women receiving intrathecal morphine for caesarean section.  
 
Outcomes Measurement 
Study ID No       
Maternal Temperature  
Timepoint Actual 
Time 
Temperature (°C) Measurement 
device 
Comments 
Baseline*     
Pre-spinal     
Post-spinal     
OT: 15 mins         Aural     
                             IDC     
OT: 30 mins         Aural     
                             IDC     
OT: 45 mins        Aural      
                             IDC     
OT: 60mins          Aural       
                             IDC     
OT: 90mins          Aural     
                              IDC     
OT: end of procedure Aural     
                              IDC     
PACU arrival     
PACU: 15 mins     
PACU: 30 mins     
PACU: 45 mins     
PACU: 60 mins     
PACU: ready for discharge     
 
Mean Arterial Pressure (MAP) (mmHg) 
Baseline  
Pre-spinal   
Post-spinal  
OT:end of procedure  
 
Maternal Thermal Comfort (via 100mm Visual Analogue Scale)  
Baseline  
Pre-spinal   
OT:end of procedure  
PACU: 30 mins  
 
Maternal Shivering  
0= no shivering, 1= mild, intermittent shivering, 2= intense, continuous shivering1  
Baseline  
Pre-spinal  
OT:end of procedure  
PACU: arrival  
PACU: 15 mins  
PACU: 30 mins  
Therapies administered for shivering 
Time  Therapy Outcome 
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A preoperative warming regime versus no preoperative warming for maintenance of 
normothermia in women receiving intrathecal morphine for caesarean section.  
 
Study ID No   
 
Intraoperative Data 
Outcome Comments 
Intraoperative blood loss (mls)   
Intravenous fluid infusion volume 
(mls)  
  
Procedure duration (mins): knife to 
skin to end procedure  
  
Ambient Temp (°C):   
 
 Neonatal Data 
Outcome Comments 
Apgar 1 minute   
Apgar 5 minutes   
 (°C) Route  
Temperature at birth (°C)    
 
Neonatal Data – adverse events  
Outcome Comments 
Admission to 
ICN? (circle)  
Yes No  
Admission to 
SCN? (circle) 
Yes No  
 (mmols) Time Comments 
Blood sugar (if 
applicable)  
   
 Comments / intervention  
Respiratory 
distress 
  
 
Adverse Events (if applicable)  
Event  Time  Comments  Outcome (eg 
withdrawal) 
    
    
    
    
 
Deviations from protocol (if applicable)  
Event  Time  Comments  
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A preoperative warming regime versus no preoperative warming for maintenance of 
normothermia in women receiving intrathecal morphine for caesarean section.  
 
 
Study ID No   
 
Breastfeeding and Skin-to-skin  
Skin-to-skin at 
birth  
Not at all            Up to 15 mins             15-30 mins                    34-45mins 
45-60 mins         >60mins                     N/A 
 
Infant feeding 
intention at birth 
Breastfeeding         Breastfeeding & EBM*          EBM 
Breastfeeding & Formula           Formula        N/A        Not known  
 
Feeding at birth  Breastfeeding          EBM            Breast milk & Formula      
No feed given               N/A               Other  
 
Timing of feed 
(how soon after 
birth)  
15 min       30 min        45 min         60 min            1-2hrs      
2 hrs               > 2hrs          Not known             N/A    
 
Universal 
Postnatal Contact : 
Feeding  
Breastfeeding                  Suppressing Lactation  
 
 
Wound Infection  
Event  Comments  
Wound infection 
on discharge  
Yes  No   
Management: 
antibiotics (if 
applicable)?   
Yes No   
Wound dehiscence 
on discharge  
Yes No  Management (if applicable):   Antibiotics             Return to OT 
Wound dressing                   Other/comment:  
Universal 
Postnatal contact: 
Caesarean wound 
concerns?   
Yes No Comments:  
 
Postoperative warming (if applicable)  
Method Time  Comments  
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Appendix T 
Randomised controlled trial  
Per protocol analysis 
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Pre-operative warming versus no preoperative warming for maintenance of 
normothermia in women receiving intrathecal morphine for caesarean delivery: 
a single-blinded, randomised controlled trial.  
 
Per-protocol analysis  
The per-protocol population excluded participants who had not received the entire 20 
minute warming intervention, or had been exposed to other deviations from the 
stated protocol, such as an extended duration between the intervention and 
commencement of surgery.  
 
Results  
Per-protocol analysis indicated a statistically significant difference in temperature 
change from baseline to end of procedure in favour of active preoperative warming: 
F (1,34) = 5.42, p = 0.03, partial eta squared = 0.14 (see Table 1). 
The lowest individual intraoperative temperature of 34.7°C was experienced at 15 
minutes after spinal anaesthesia by a single patient in the control group, while the 
lowest individual intraoperative temperature experienced by a patient in the pre-
operative warming group was 35.1°C at 45 minutes post spinal anaesthesia, in the 
ITT population. When considered using per-protocol analysis, the nadir temperature 
for the control group remained the same, however the lowest individual 
intraoperative temperature in the pre-operative warming group was 35.4°C at 30 
minutes post spinal anaesthesia.  
Table 1: Temperature change (°C): baseline-end of procedure and hypothermic 
patients at each time point 
 Temperature change °C (baseline – end of 
procedure): mean (SD) number 
Intervention Control  P value 
Intention-to- treat  0.5 (SD 0.32) (n=25) 0.7 (SD 0.57) 
(n=25) 
0.28 
Per-protocol 0.4 (SD 0.27) (n=18) 0.8 (SD 0.43) 
(n=19) 
0.03 
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Randomised controlled trial 
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